data_2n4o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n4o _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.2 mt -101.75 112.37 65.16 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.52 125.01 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.417 2.078 . . . . 0.0 111.227 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.81 82.29 6.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.28 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.71 -64.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.553 2.168 . . . . 0.0 111.665 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.49 53.02 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.991 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.76 -49.14 8.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.569 0.223 . . . . 0.0 111.183 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.87 -146.23 10.39 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.752 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.1 169.47 19.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.502 2.801 . . . . 0.0 113.085 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.719 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -102.94 167.47 9.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.001 -179.293 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.526 HG12 HD22 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -63.22 -25.3 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.513 -175.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.508 ' N ' HG11 ' A' ' 12' ' ' VAL . 62.2 m -50.18 -33.9 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.602 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -45.71 64.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.66 -50.81 32.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.706 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -59.39 -29.86 68.03 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.09 68.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.444 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 15.5 2.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.032 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 174.24 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.96 143.87 37.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.528 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 -16.24 62.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 0.0 111.369 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.09 4.09 53.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.595 0.712 . . . . 0.0 110.104 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.23 153.57 20.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.618 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -97.01 141.41 15.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.0 t -93.37 128.94 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 110.997 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.17 138.28 23.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.64 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' H ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -100.98 124.37 46.59 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.661 -0.649 . . . . 0.0 109.681 175.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -156.17 126.04 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.451 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.615 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . 8.9 t-20 -95.13 93.04 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.33 147.8 22.6 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.435 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -69.89 -34.12 73.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.076 0.465 . . . . 0.0 109.792 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.435 ' OE2' ' HG2' ' A' ' 31' ' ' LYS . 2.0 pm0 -70.73 -40.23 72.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.419 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.783 179.637 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.761 HG23 ' HB2' ' A' ' 90' ' ' CYS . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.667 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.6 123.09 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.599 HD12 HD11 ' A' ' 88' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.206 0.526 . . . . 0.0 110.697 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 5.2 m . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 141.46 18.56 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.403 0.44 . . . . 0.0 110.172 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.55 130.56 35.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -100.62 132.05 22.85 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.731 ' HB3' HD22 ' A' ' 57' ' ' ASN . 75.9 Cg_exo -49.26 119.81 4.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.109 2.539 . . . . 0.0 112.881 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.516 ' HA ' HD13 ' A' ' 59' ' ' LEU . 4.5 tp -79.89 -11.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.731 HD22 ' HB3' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -57.27 -50.22 73.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.411 -177.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -78.5 -27.72 14.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.148 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.526 HD22 HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -58.35 -27.23 63.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -55.51 6.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 111.888 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.452 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -94.96 -28.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.193 0.52 . . . . 0.0 111.398 -175.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' HB3' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -101.84 34.78 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -68.87 -13.06 62.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.689 . . . . 0.0 109.824 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.487 ' HA ' HD13 ' A' ' 64' ' ' LEU . 1.9 mm? -70.07 -11.5 60.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.181 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 62' ' ' ASN . 26.1 mt -64.44 120.6 66.68 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.253 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.719 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 21.6 Cg_exo -66.82 164.48 29.35 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.939 2.426 . . . . 0.0 112.139 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.23 -9.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.467 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -21.77 56.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.666 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -108.15 31.19 5.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 109.891 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -149.41 172.28 15.2 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.69 117.46 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.161 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 96.78 1.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.615 ' OD1' ' HB2' ' A' ' 29' ' ' ASN . 12.0 t0 -156.92 165.19 36.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.505 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.32 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.614 0.571 . . . . 0.0 109.482 170.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.531 ' H ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -69.49 137.18 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.339 -174.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 m -123.97 137.67 54.58 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.601 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.62 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -122.1 120.32 33.93 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.854 0.835 . . . . 0.0 109.093 175.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 4.8 m -112.97 163.05 15.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.849 -172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.27 128.87 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -41.03 107.84 0.1 OUTLIER Glycine 0 C--N 1.337 0.603 0 O-C-N 123.761 0.663 . . . . 0.0 113.27 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -77.94 91.6 4.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.323 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.0 159.11 15.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -53.41 111.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.1 -18.29 6.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.165 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -87.26 72.76 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.086 178.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.38 31.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.906 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -141.52 126.22 17.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.213 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.599 HD11 HD12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -148.61 177.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.5 139.84 37.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.137 0.494 . . . . 0.0 110.858 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.761 ' HB2' HG23 ' A' ' 42' ' ' ILE . 57.4 m -109.77 143.22 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.544 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 141.78 33.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.48 131.45 36.03 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.62 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.9 OUTLIER -77.31 -58.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.486 0.66 . . . . 0.0 110.093 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tp -114.9 101.63 9.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.639 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.014 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 mt -100.56 110.56 60.75 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.345 . . . . 0.0 111.019 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD2' HD22 ' A' ' 69' ' ' ASN . 7.2 Cg_endo -89.68 126.3 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.261 2.641 . . . . 0.0 111.803 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.21 70.15 55.42 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.99 -61.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.682 2.255 . . . . 0.0 112.846 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.76 18.78 41.22 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.887 -172.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 50.39 56.8 7.39 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.679 0.392 . . . . 0.0 112.025 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 161.27 35.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.458 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.56 149.79 88.22 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.833 2.355 . . . . 0.0 111.574 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 153.3 38.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.034 0.445 . . . . 0.0 111.943 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -71.37 -25.37 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.612 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -59.7 -26.22 65.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.924 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.95 88.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.107 0.48 . . . . 0.0 109.91 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HA ' HD13 ' A' ' 94' ' ' LEU . . . -70.81 -41.36 71.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 176.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -61.99 -31.79 72.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.606 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -32.4 67.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.281 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -85.89 -5.91 59.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.841 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.528 ' HB2' HG22 ' A' ' 93' ' ' ILE . 19.9 t -115.75 175.99 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -170.9 34.95 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.807 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.85 -39.77 16.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.34 37.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.312 0.577 . . . . 0.0 110.382 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG3' ' HA ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -131.61 153.05 50.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.127 -177.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.65 HG21 HD22 ' A' ' 53' ' ' ASN . 12.2 p -100.86 144.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.201 0.524 . . . . 0.0 111.146 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.62 127.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.822 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 157.96 45.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 22.9 p -115.28 100.62 8.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.602 . . . . 0.0 109.854 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.8 m -143.07 111.36 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.911 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.33 0.585 . . . . 0.0 110.225 177.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 147.59 37.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.879 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.551 ' HD2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.53 -28.98 70.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.755 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 31' ' ' LYS . 7.1 mp0 -68.18 -38.71 82.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.646 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.537 178.756 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.712 HD13 ' H ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.621 0.248 . . . . 0.0 111.507 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -98.78 116.21 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.579 2.852 . . . . 0.0 112.871 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' A' ' 53' ' ' ASN . 20.5 mt . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.054 0.454 . . . . 0.0 110.294 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 15.7 t . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -161.2 147.21 14.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.167 0.508 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.668 ' HB2' HG22 ' A' ' 44' ' ' ILE . 10.1 t-20 -97.57 89.95 4.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.799 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.526 HG22 HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -64.13 127.07 91.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.226 -176.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HB3' HD22 ' A' ' 57' ' ' ASN . 50.6 Cg_exo -52.53 121.21 8.69 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.011 2.474 . . . . 0.0 112.824 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -19.23 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.831 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.579 HD22 ' HB3' ' A' ' 55' ' ' PRO . 7.0 p30 -61.84 -31.53 71.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.157 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pp -80.0 -37.6 17.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.577 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -14.43 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -170.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -40.48 64.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.736 0.303 . . . . 0.0 111.641 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.485 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -116.86 -24.14 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.338 0.59 . . . . 0.0 111.216 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.559 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.4 OUTLIER -92.57 34.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.733 -178.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -19.0 65.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.292 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -3.01 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.846 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -70.27 131.83 88.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.333 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 8.7 Cg_exo -73.43 154.41 50.62 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.763 2.309 . . . . 0.0 111.925 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 70' ' ' PHE . 2.1 tp -61.7 -8.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.318 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -12.53 20.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.767 0.317 . . . . 0.0 111.504 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.467 HD22 ' HD2' ' A' ' 4' ' ' PRO . 48.5 m-80 -97.14 3.45 51.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.49 0.662 . . . . 0.0 109.986 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.455 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -116.33 174.21 6.18 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.07 138.89 39.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.82 97.52 5.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.493 0.664 . . . . 0.0 110.563 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.421 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.56 159.72 39.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.08 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 4.2 m -50.47 102.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 110.725 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -61.49 120.04 6.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.425 -174.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -127.45 125.61 40.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.624 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.741 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -106.72 141.89 37.25 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 17.9 t -134.12 163.47 29.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.107 -167.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.555 ' HB2' HG21 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -57.43 133.67 55.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.31 115.86 6.74 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.982 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.77 92.88 0.91 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.986 0.422 . . . . 0.0 110.391 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -124.63 168.89 12.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.61 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.19 113.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.85 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.31 -30.79 3.58 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 102.73 13.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.807 0.337 . . . . 0.0 110.4 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -16.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.438 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -150.35 143.87 25.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.879 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 79' ' ' SER . 11.3 pt -130.23 153.78 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.512 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.0 113.37 23.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.958 0.409 . . . . 0.0 110.331 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.712 ' H ' HD13 ' A' ' 42' ' ' ILE . 1.4 m -109.02 142.4 39.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.944 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 154.86 30.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.458 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.87 129.72 31.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.535 2.157 . . . . 0.0 112.005 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.741 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -91.86 -34.17 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.754 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 15' ' ' ALA . 3.3 mp -105.43 131.31 53.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.25 1.113 0 O-C-N 124.378 1.049 . . . . 0.0 110.313 -177.563 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.593 HG21 ' HA ' ' A' ' 65' ' ' ILE . 4.0 mt -91.07 114.14 60.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.657 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 3.0 Cg_exo -81.69 126.18 5.18 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.188 2.592 . . . . 0.0 111.907 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.49 78.09 38.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.739 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.94 -72.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.692 2.261 . . . . 0.0 110.904 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.92 123.05 6.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.74 68.58 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.608 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 178.71 47.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.281 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.95 147.81 91.83 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.581 2.187 . . . . 0.0 111.729 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.28 154.83 40.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.92 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.558 HG13 ' CE1' ' A' ' 70' ' ' PHE . 35.6 m -65.29 -24.67 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.341 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.622 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -60.58 -29.34 69.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.885 177.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.1 tpt -69.48 -35.76 75.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.506 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.67 -30.95 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.77 -30.17 68.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.901 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -58.37 -32.34 68.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.243 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -73.81 -10.83 60.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.789 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 177.56 7.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.85 0.357 . . . . 0.0 110.644 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 163.47 29.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.58 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 10.13 37.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.612 . . . . 0.0 109.607 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -118.61 170.87 8.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.353 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.522 HG23 HD22 ' A' ' 53' ' ' ASN . 7.1 p -116.22 131.23 69.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.097 0.475 . . . . 0.0 110.943 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.4 133.12 30.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.918 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.37 161.22 43.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 4.4 p -110.16 99.68 8.71 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.181 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -130.02 113.45 14.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.149 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -92.7 124.85 37.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.914 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -119.47 151.7 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -71.29 -48.42 50.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.61 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -19.09 52.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.914 ' HB2' ' HB3' ' A' ' 30' ' ' SER . 4.8 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.107 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.25 148.5 13.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.79 2.326 . . . . 0.0 111.863 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.824 HG21 ' HB2' ' A' ' 53' ' ' ASN . 3.4 mm . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.799 0.333 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 73.6 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 119.42 8.02 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.431 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.824 ' HB2' HG21 ' A' ' 44' ' ' ILE . 19.8 t-20 -77.72 110.22 12.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -88.9 120.95 70.09 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.545 ' HB2' HD21 ' A' ' 57' ' ' ASN . 11.5 Cg_endo -54.65 121.28 9.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.024 2.483 . . . . 0.0 112.561 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.46 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -74.09 -8.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.624 -175.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.545 HD21 ' HB2' ' A' ' 55' ' ' PRO . 1.1 m-80 -59.83 -43.37 94.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.11 -17.38 13.22 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.657 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.46 HD11 ' HA ' ' A' ' 56' ' ' ILE . 5.6 mp -74.61 -21.08 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.718 0.294 . . . . 0.0 111.041 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 -42.81 15.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.661 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.627 HG13 ' H ' ' A' ' 62' ' ' ASN . 8.7 pt -107.57 -48.66 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.239 0.543 . . . . 0.0 111.343 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.627 ' H ' HG13 ' A' ' 61' ' ' ILE . 42.4 m-20 -84.8 34.42 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.788 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.622 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 22.1 pt20 -64.52 -12.14 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.549 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 3' ' ' ILE . 3.9 mt -80.27 -0.43 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.354 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.593 ' HA ' HG21 ' A' ' 3' ' ' ILE . 15.5 mt -75.84 127.28 85.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.991 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.88 157.03 61.23 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 70' ' ' PHE . 1.7 tp -62.72 -7.85 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -27.89 16.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 175.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.452 HD22 ' HG2' ' A' ' 4' ' ' PRO . 22.3 m-20 -86.02 8.67 19.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.208 0.528 . . . . 0.0 111.086 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.606 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -111.43 172.9 6.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.93 136.9 44.75 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.28 97.71 9.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.315 0.578 . . . . 0.0 111.092 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -156.31 162.78 40.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 m -44.42 104.24 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.812 0.695 . . . . 0.0 110.837 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.793 HG21 HD23 ' A' ' 94' ' ' LEU . 1.5 t -56.04 122.45 5.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.968 -173.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.58 157.46 33.63 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.628 ' HB2' HG12 ' A' ' 93' ' ' ILE . 51.2 t -139.29 130.18 26.26 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 4.1 m -117.14 163.47 16.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.905 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.455 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.87 135.75 47.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 174.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -42.97 106.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.389 0 O-C-N 123.884 0.74 . . . . 0.0 113.39 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 122.82 16.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.412 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.76 149.32 32.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -65.92 112.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.99 176.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.84 -18.49 8.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 119.49 25.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -81.77 87.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.036 -178.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.5 t30 72.46 163.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.132 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -138.17 170.18 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.445 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -116.15 126.82 54.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 178.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 73.3 m -108.81 130.03 55.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.384 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -133.54 146.92 62.57 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.266 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.5 131.54 30.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 111.672 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.628 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -108.91 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.65 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.793 HD23 HG21 ' A' ' 75' ' ' VAL . 7.5 tp -81.59 74.14 8.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.451 0.643 . . . . 0.0 111.008 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.246 0.903 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.639 174.575 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.412 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.558 HG21 ' HA ' ' A' ' 65' ' ' ILE . 2.2 mp -83.16 111.23 29.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 9.6 Cg_endo -89.42 126.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.56 2.84 . . . . 0.0 112.023 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.63 81.05 70.56 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 120.902 0.382 . . . . 0.0 111.7 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.99 -41.02 47.43 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.906 2.404 . . . . 0.0 110.756 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.64 149.08 20.82 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.983 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.06 88.14 4.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.229 0.514 . . . . 0.0 110.887 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.85 165.46 19.95 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 140.93 96.5 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.476 2.117 . . . . 0.0 111.779 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.92 154.15 28.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 0.0 111.115 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.05 -24.88 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.915 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.514 ' HG ' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -55.11 -32.31 61.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.801 175.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -48.01 79.67 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.086 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.73 73.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.82 -29.49 70.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.744 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -31.23 64.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -16.19 61.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.932 -176.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 175.46 6.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 111.558 -176.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.16 154.58 25.5 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.633 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -16.36 62.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.777 0.322 . . . . 0.0 111.21 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.0 22.14 9.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.359 0.6 . . . . 0.0 110.379 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 171.31 8.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 78' ' ' CYS . 14.9 p -114.68 132.31 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -175.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.535 HG21 ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -92.92 136.38 25.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.602 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.403 ' HA ' HD13 ' A' ' 54' ' ' ILE . 53.2 m -155.27 162.17 40.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.743 0.306 . . . . 0.0 110.344 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 13.2 m -99.99 101.53 12.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.3 100.36 6.8 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.177 -175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -102.84 93.74 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.147 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.07 150.74 24.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.094 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -40.65 96.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -34.98 70.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.343 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.258 -176.177 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.27 166.76 2.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.019 2.479 . . . . 0.0 111.951 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.607 HD13 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 23.7 m . . . . . 0 C--O 1.224 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -142.47 119.06 11.01 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.69 135.82 36.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -112.74 139.4 22.76 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.98 122.07 11.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.808 2.338 . . . . 0.0 112.754 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 24' ' ' VAL . 9.9 tp -71.24 -19.77 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.573 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -39.69 76.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.759 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -80.6 -25.14 11.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.738 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.535 ' HG ' HG21 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -62.97 -15.27 55.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -35.64 21.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 0.0 111.787 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 62' ' ' ASN . 2.3 pt -109.35 -22.32 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.4 0.619 . . . . 0.0 111.61 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.656 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -108.39 26.15 10.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -174.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' HB2' ' HG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.411 0.624 . . . . 0.0 109.851 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -81.86 -2.52 51.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.378 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -70.04 141.4 89.22 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.051 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.508 ' HB2' HD21 ' A' ' 68' ' ' ASN . 3.3 Cg_exo -76.97 150.77 30.27 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.593 2.195 . . . . 0.0 110.723 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 tp -58.04 -9.54 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.508 HD21 ' HB2' ' A' ' 66' ' ' PRO . 0.4 OUTLIER -63.96 -19.45 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 176.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.67 24.33 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 109.618 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.24 173.65 11.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.8 124.87 49.71 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.344 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.0 m -76.93 94.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.851 0.834 . . . . 0.0 109.368 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.94 160.89 39.52 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -42.34 104.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.558 0.694 . . . . 0.0 111.326 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.17 124.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.687 -173.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 47.1 m -129.36 147.05 51.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.083 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.4 t -120.23 119.55 33.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 24' ' ' VAL . 3.9 m -109.53 163.45 13.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.313 -173.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.05 128.39 30.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.45 103.71 0.16 Allowed Glycine 0 C--N 1.331 0.272 0 O-C-N 123.552 0.532 . . . . 0.0 112.919 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -72.92 135.61 45.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.047 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.484 ' H ' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -151.8 149.25 28.81 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.492 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -45.41 111.98 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.975 0.797 . . . . 0.0 110.988 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.86 -13.8 5.79 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.941 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.484 HD11 ' H ' ' A' ' 82' ' ' GLN . 2.1 mt -99.21 149.71 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -49.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 149.7 50.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.502 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -149.74 178.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.723 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -117.1 132.89 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.528 ' H ' HD13 ' A' ' 42' ' ' ILE . 8.1 m -107.52 128.94 54.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.418 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 91' ' ' THR . 1.3 t -134.6 142.81 44.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.099 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 35.3 Cg_endo -65.01 137.54 53.09 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.534 2.156 . . . . 0.0 112.508 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.695 HD13 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -82.4 -25.66 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.222 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.69 115.99 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.255 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.568 0.223 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 mt -81.19 112.83 36.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.704 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HG2' HD22 ' A' ' 69' ' ' ASN . 1.3 Cg_endo -85.18 126.03 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.066 2.511 . . . . 0.0 111.329 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 68.88 67.12 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.78 -27.01 5.13 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 111.059 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.32 100.47 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.779 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -70.04 89.2 0.61 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.477 . . . . 0.0 111.031 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.14 -140.37 11.28 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.09 136.09 43.05 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.489 2.126 . . . . 0.0 110.991 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -102.07 164.45 11.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.555 0.217 . . . . 0.0 110.918 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 1.4 p -64.74 -25.5 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -69.55 -27.12 64.87 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 ttt -62.01 -48.78 78.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.207 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.71 -30.1 66.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -67.61 -30.53 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.021 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.4 -31.69 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.52 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -10.31 44.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.645 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -113.62 176.54 4.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.88 169.55 38.77 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.958 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.14 -7.43 59.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 111.024 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.28 13.43 33.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 0.0 109.81 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.08 146.96 43.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.85 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 123.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.634 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.661 ' HB ' HD23 ' A' ' 59' ' ' LEU . 42.5 t -85.65 104.33 13.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.674 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -109.91 165.39 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.063 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.1 p -107.46 99.91 9.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 42.4 t -133.62 121.04 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.52 ' HB2' ' H ' ' A' ' 74' ' ' THR . 1.9 t30 -121.52 100.08 6.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.944 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.8 162.17 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.838 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -71.53 -40.4 70.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.304 0.573 . . . . 0.0 110.258 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.2 pm0 -64.05 -31.81 73.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.687 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.478 HD21 ' HA ' ' A' ' 33' ' ' LEU . 3.0 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.868 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 tp . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.404 0.621 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.64 135.54 18.05 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.842 2.361 . . . . 0.0 111.619 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.429 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 93.9 m . . . . . 0 CA--C 1.518 -0.25 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 124.62 18.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.152 0.501 . . . . 0.0 110.977 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 56.1 t30 -86.57 131.83 34.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.645 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -111.5 128.24 25.69 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.066 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 72.0 Cg_exo -49.67 123.2 10.13 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.643 2.895 . . . . 0.0 113.129 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 18.4 tt -68.85 -12.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.049 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -46.02 91.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.035 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 pt -77.97 -17.62 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.661 HD23 ' HB ' ' A' ' 25' ' ' VAL . 5.2 mp -72.74 -24.57 60.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.394 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -86.02 -56.68 3.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.561 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.8 pt -93.66 -39.43 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.561 ' N ' HG13 ' A' ' 61' ' ' ILE . 34.4 m-20 -94.02 31.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 0.0 110.061 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 pt20 -66.79 -8.1 26.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.08 -6.49 57.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.182 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.455 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 71.6 mt -71.57 123.02 88.76 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.739 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 2.7 Cg_exo -77.0 167.62 24.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.906 2.404 . . . . 0.0 112.268 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.89 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.24 -9.92 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.247 0.619 . . . . 0.0 112.179 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.12 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.696 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.452 HD22 ' HG2' ' A' ' 4' ' ' PRO . 1.7 m-80 -111.59 15.48 21.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 110.51 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.89 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 58.7 m-85 -129.55 173.69 10.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.879 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.37 142.97 33.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.061 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 95.93 10.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.638 0.732 . . . . 0.0 110.533 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.68 160.83 40.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.52 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 20.6 m -42.43 120.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 111.712 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.4 124.31 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.869 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -145.35 112.05 5.88 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -171.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.437 ' SG ' HG12 ' A' ' 93' ' ' ILE . 31.1 p -98.7 136.27 38.99 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 15.2 t -119.5 163.49 17.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.843 -174.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.521 ' HB2' HG23 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -53.9 124.93 16.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -39.25 112.08 0.22 Allowed Glycine 0 C--N 1.336 0.552 0 O-C-N 124.206 0.941 . . . . 0.0 112.772 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.24 102.44 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.167 0.508 . . . . 0.0 110.993 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.37 146.47 48.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.185 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -65.86 126.89 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.0 -13.44 11.35 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 113.51 16.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.75 -14.59 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.245 0.545 . . . . 0.0 110.54 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.54 89.27 3.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.311 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 79' ' ' SER . 3.0 pt -104.06 145.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.1 117.12 30.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.748 0.785 . . . . 0.0 110.199 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.9 m -108.98 139.76 43.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.999 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.47 145.54 32.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.882 0.373 . . . . 0.0 111.353 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.47 ' HD3' HD23 ' A' ' 33' ' ' LEU . 39.2 Cg_endo -69.12 126.84 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.459 2.106 . . . . 0.0 111.7 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.437 HG12 ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -87.8 -42.42 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 111.027 -177.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.51 129.66 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.347 178.237 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.56 0.219 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.33 112.21 54.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.601 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.33 125.25 3.9 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.695 2.264 . . . . 0.0 111.393 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.31 68.2 46.97 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.55 32.03 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.243 2.628 . . . . 0.0 110.829 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.69 77.85 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 96.98 6.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.936 0.398 . . . . 0.0 111.078 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.62 -143.57 15.08 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.48 130.04 33.85 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.368 2.045 . . . . 0.0 111.486 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -74.82 154.82 38.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 67' ' ' ILE . 34.2 m -67.6 -26.0 34.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 0.0 111.467 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -26.32 64.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -41.35 98.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.83 70.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.342 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.04 -30.96 69.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.472 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -56.0 -31.31 62.94 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.924 0.489 . . . . 0.0 111.19 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 0.88 24.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.528 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 t -141.77 175.91 9.33 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.242 -0.286 . . . . 0.0 110.323 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.14 133.51 48.83 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.64 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.84 -18.64 64.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.899 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 31.91 4.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 110.439 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 167.8 12.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 1.055 HG22 ' HB3' ' A' ' 78' ' ' CYS . 0.1 OUTLIER -86.76 126.05 40.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.941 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 m -94.7 131.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.585 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.9 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -148.89 167.76 24.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.335 -178.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.49 113.46 19.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.472 ' CA ' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m -130.29 123.12 29.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.211 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 1.4 p30 -88.4 97.05 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.737 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.788 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.7 m -126.81 146.93 50.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.372 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.81 -42.62 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.212 0.53 . . . . 0.0 110.659 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -71.77 -27.72 63.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 1.2 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.916 0.389 . . . . 0.0 111.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 96.0 Cg_endo -94.71 170.47 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.044 2.496 . . . . 0.0 112.895 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.441 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.466 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.472 ' HB2' ' CA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 124.3 28.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.053 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.9 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 17.9 t-20 -85.57 120.29 26.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.778 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -90.76 139.78 26.28 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.431 -172.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.778 ' HD2' HG22 ' A' ' 54' ' ' ILE . 9.1 Cg_endo -49.98 123.07 10.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.847 3.031 . . . . 0.0 113.27 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.811 ' HA ' HD21 ' A' ' 59' ' ' LEU . 6.1 tp -72.26 -22.85 21.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.224 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -31.18 68.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -26.74 12.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -176.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 56' ' ' ILE . 1.4 mm? -60.47 -27.77 67.81 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -168.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -43.83 66.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 112.047 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.0 pt -105.64 -37.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.351 0.596 . . . . 0.0 111.45 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.437 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.35 29.92 0.93 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.397 -175.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -63.65 -20.02 65.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.501 0.667 . . . . 0.0 109.708 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.12 0.56 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.764 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.436 HG12 HD21 ' A' ' 69' ' ' ASN . 1.9 tt -81.37 130.5 61.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.328 0.585 . . . . 0.0 109.86 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -75.19 158.18 41.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.414 2.076 . . . . 0.0 111.674 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 12' ' ' VAL . 3.1 tp -59.66 -9.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.413 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -21.01 66.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.634 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.436 HD21 HG12 ' A' ' 65' ' ' ILE . 50.7 m-80 -100.18 27.73 5.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.652 0.739 . . . . 0.0 109.661 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.26 174.45 10.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.95 118.96 37.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.609 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.58 97.86 1.39 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.479 -172.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.46 100.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 109.871 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -58.69 130.44 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.224 -172.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -120.94 119.8 33.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.279 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.0 t -110.86 121.17 44.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 1.055 ' HB3' HG22 ' A' ' 24' ' ' VAL . 6.2 t -120.67 162.65 19.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.501 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.631 ' HB2' HG23 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -60.49 124.8 21.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -46.47 113.44 1.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 O-C-N 123.692 0.62 . . . . 0.0 113.013 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 90.12 1.37 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.36 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -138.31 174.59 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.561 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.1 121.87 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.016 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.37 -21.71 9.16 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.703 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 95.51 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 111.331 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.496 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -91.21 -22.5 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.405 176.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.01 107.65 18.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 79' ' ' SER . 9.5 pt -121.43 159.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.394 . . . . 0.0 110.916 -172.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.85 113.32 17.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.767 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.37 134.27 50.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.767 179.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 157.27 77.07 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.839 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.7 Cg_exo -61.6 126.89 20.17 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.829 2.352 . . . . 0.0 112.341 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 75' ' ' VAL . 1.3 mt -76.92 -36.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.031 0.443 . . . . 0.0 111.814 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.32 116.19 17.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.034 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.531 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.608 HG21 HG13 ' A' ' 65' ' ' ILE . 12.9 mt -87.0 109.1 21.95 Favored Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.165 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -89.0 136.81 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.67 ' HB1' ' HG2' ' A' ' 66' ' ' PRO . . . -156.79 89.47 2.63 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.28 -53.29 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.627 2.218 . . . . 0.0 111.9 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.83 49.46 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.326 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -84.04 -47.17 11.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.99 -101.01 0.6 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.021 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.93 148.08 30.78 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.322 2.681 . . . . 0.0 113.297 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.49 167.15 10.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -66.36 -27.34 40.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 110.732 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -69.23 -26.61 64.89 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.979 -176.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -48.19 80.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.164 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.22 -41.75 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.221 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -61.4 -31.24 71.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -56.51 -31.2 63.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.06 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -80.93 -4.34 54.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.028 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -127.7 175.39 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.158 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.59 153.44 40.66 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.363 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.09 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.12 27.64 8.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 0.0 111.045 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.9 153.07 29.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG21 HD22 ' A' ' 53' ' ' ASN . 7.6 p -95.36 122.84 47.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.195 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -92.04 103.8 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.453 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.93 148.96 35.94 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.369 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.717 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 29.8 p -102.96 101.55 11.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.672 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -157.34 109.97 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.508 -176.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.72 147.97 22.77 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.44 155.06 45.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.803 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.48 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.84 -48.0 82.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.233 0.54 . . . . 0.0 110.566 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' A' ' 31' ' ' LYS . 2.3 pm0 -70.37 -23.79 62.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.5 tp . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.871 0.367 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.25 156.29 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.986 2.457 . . . . 0.0 111.579 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.405 HG13 ' SG ' ' A' ' 90' ' ' CYS . 2.7 mp . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.973 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 12.8 p . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.11 154.46 12.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.55 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.484 HD22 HG21 ' A' ' 24' ' ' VAL . 17.0 t-20 -77.5 114.88 16.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.321 172.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.699 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -83.63 141.21 41.52 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.532 -176.107 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' O ' HD13 ' A' ' 59' ' ' LEU . 23.4 Cg_endo -62.14 119.95 7.3 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.768 2.312 . . . . 0.0 113.173 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.562 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -78.75 -12.55 13.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.362 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -56.45 -45.88 80.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.193 -178.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -33.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.97 -23.24 31.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -54.38 15.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.77 0.319 . . . . 0.0 111.455 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.521 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -92.33 -35.94 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 0.0 110.736 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -91.12 35.99 0.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.779 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -66.88 -13.42 61.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.202 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.84 18.25 6.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.359 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.608 HG13 HG21 ' A' ' 3' ' ' ILE . 10.7 tt -91.94 135.85 26.84 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 7.3 Cg_exo -75.85 163.72 33.0 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.879 2.386 . . . . 0.0 112.309 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.782 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 4.4 tp -65.19 -8.71 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.564 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -56.88 -24.23 50.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.502 HD22 ' HG2' ' A' ' 4' ' ' PRO . 2.6 m-80 -94.8 12.3 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.782 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 86.9 m-85 -127.04 174.16 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.004 -174.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.38 138.8 40.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.225 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.47 99.42 7.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.205 0.526 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 0.7 OUTLIER -153.98 158.88 41.29 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 m -50.85 113.5 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.969 0.414 . . . . 0.0 110.419 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -61.95 125.58 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.354 -176.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -127.4 112.96 15.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.577 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.55 ' HB2' HG12 ' A' ' 93' ' ' ILE . 35.9 t -98.11 119.45 36.77 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.932 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 2.4 m -115.07 163.83 15.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.321 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.33 119.16 3.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -34.1 107.05 0.03 OUTLIER Glycine 0 C--N 1.337 0.635 0 O-C-N 124.442 1.089 . . . . 0.0 113.91 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 109.02 2.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.307 0.575 . . . . 0.0 110.598 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' H ' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -121.6 156.05 33.76 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.586 -179.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 pt -58.33 112.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 123.476 0.485 . . . . 0.0 110.605 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.01 -12.43 11.52 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.034 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD11 ' H ' ' A' ' 82' ' ' GLN . 10.9 mt -90.72 103.26 15.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.069 0.462 . . . . 0.0 110.488 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.14 -50.51 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.329 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.43 129.86 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 pt -146.56 170.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.11 131.65 55.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.023 0.44 . . . . 0.0 110.648 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.405 ' SG ' HG13 ' A' ' 44' ' ' ILE . 12.0 m -110.01 127.25 54.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.05 135.21 21.0 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.623 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.96 127.78 23.4 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.899 2.399 . . . . 0.0 112.038 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.28 -61.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.893 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 100.34 13.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.052 0.453 . . . . 0.0 110.651 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.033 176.232 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mt -100.76 109.58 58.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 8.9 Cg_endo -90.42 126.09 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.861 3.041 . . . . 0.0 111.818 175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.462 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -140.34 61.64 17.39 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.453 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 17.0 Cg_exo -68.04 -53.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.428 2.085 . . . . 0.0 110.325 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.47 78.75 0.28 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.33 2.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.532 . . . . 0.0 110.9 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.04 -155.08 7.89 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.081 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.08 124.6 16.67 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.47 2.113 . . . . 0.0 111.854 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -83.35 156.11 23.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.208 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.5 p -61.31 -27.81 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.109 0.481 . . . . 0.0 110.788 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 63' ' ' GLN . 36.6 m -56.04 -38.92 71.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.9 tpp -64.45 -47.24 79.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.911 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.25 74.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.884 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -31.97 64.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.173 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -77.22 -4.8 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.492 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 175.05 8.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.03 134.94 43.3 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.38 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -23.74 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.945 0.402 . . . . 0.0 111.054 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 37.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.703 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -125.4 158.66 33.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.296 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.06 125.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 110.25 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.2 114.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.573 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 144.15 50.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.79 101.99 12.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.514 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.805 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 1.8 t -142.4 112.89 7.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.181 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.865 ' HB2' ' H ' ' A' ' 74' ' ' THR . 26.9 t30 -106.07 94.2 5.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.48 150.93 23.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.904 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -36.62 79.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.276 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.419 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -61.83 -31.45 71.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.798 178.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.552 -178.347 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.53 152.76 20.3 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 123.346 2.697 . . . . 0.0 112.195 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.982 -178.781 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.805 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.38 147.18 25.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 112.155 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -83.55 110.2 18.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.625 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.675 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -87.67 143.18 33.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.279 -176.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 32.1 Cg_exo -59.19 120.75 8.79 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.86 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.428 ' O ' HG21 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -78.95 -23.56 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -34.95 70.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.22 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.39 -31.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.202 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -33.34 68.55 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -170.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -26.28 68.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.557 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.6 pt -121.15 -40.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.452 0.644 . . . . 0.0 110.749 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.557 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -89.48 35.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.507 -176.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -70.73 -8.47 52.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 179.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -5.05 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.144 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.504 HG23 ' CE2' ' A' ' 70' ' ' PHE . 5.4 mt -70.68 128.65 90.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.385 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.1 Cg_exo -81.08 164.72 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.288 2.659 . . . . 0.0 111.602 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.779 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -60.01 -13.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -13.65 59.17 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 111.4 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.56 12.64 36.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.384 0.611 . . . . 0.0 109.885 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.779 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 66.3 m-85 -130.99 177.55 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.35 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.11 145.02 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.074 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.23 96.72 7.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.0 110.125 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.2 159.47 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.26 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.865 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 65.2 m -51.9 107.96 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.13 0.49 . . . . 0.0 110.27 175.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.49 124.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.205 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.8 m -127.31 133.89 50.07 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.936 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.649 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -110.2 123.3 49.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -120.45 162.05 20.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.273 -173.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.51 126.68 20.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.502 0.192 . . . . 0.0 110.56 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.79 106.04 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.508 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.59 138.46 43.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.553 -0.324 . . . . 0.0 111.096 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.62 171.5 18.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.406 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 pt -62.94 123.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.72 -27.7 7.78 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.693 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.23 147.13 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.142 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -117.14 -66.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.344 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.77 127.12 56.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -113.68 152.26 15.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.74 118.72 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.03 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 9.5 t -116.43 138.64 51.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.583 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -143.1 141.23 19.04 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.312 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 25.9 Cg_exo -62.74 130.79 30.73 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -84.49 -43.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.678 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.06 120.41 37.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.726 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.858 -1.068 . . . . 0.0 109.264 176.796 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -80.8 111.22 21.56 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.742 0.306 . . . . 0.0 110.728 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.7 ' HG2' HD22 ' A' ' 69' ' ' ASN . 1.1 Cg_endo -87.95 128.74 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.219 2.612 . . . . 0.0 112.05 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.65 ' HB1' ' HG2' ' A' ' 66' ' ' PRO . . . -149.34 91.12 4.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.197 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.77 -53.63 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.25 47.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.311 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -83.12 -59.02 2.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.12 -89.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.242 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.92 137.1 77.9 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.23 2.62 . . . . 0.0 113.331 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.787 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -93.73 157.63 16.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.514 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.35 -27.27 23.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -37.14 85.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.021 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -42.73 86.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -49.67 38.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.21 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.404 ' HG3' ' CG2' ' A' ' 25' ' ' VAL . 3.3 tt0 -63.43 -28.83 70.25 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.745 -176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -30.25 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.942 0.401 . . . . 0.0 111.232 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -7.44 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.88 174.76 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.33 166.71 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.804 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.14 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.452 . . . . 0.0 110.967 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.92 37.46 1.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.42 0.629 . . . . 0.0 109.906 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.68 155.95 31.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.991 177.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.57 132.4 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.751 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 54' ' ' ILE . 89.1 t -86.17 137.49 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -148.32 150.76 34.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.917 0.389 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 108.86 16.99 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.9 t -151.38 103.57 3.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -85.28 93.22 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 110.025 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 147.46 25.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -70.57 -38.87 74.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.295 0.569 . . . . 0.0 109.841 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.04 -37.98 87.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.533 HD21 ' HG3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.886 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.605 ' HA ' HG13 ' A' ' 88' ' ' ILE . 86.5 Cg_endo -84.82 156.72 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.059 2.506 . . . . 0.0 112.585 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mm . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.416 . . . . 0.0 110.895 -178.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.94 139.35 14.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.69 175.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.18 114.69 22.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -80.15 134.09 56.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.796 -170.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.457 ' HB3' HD22 ' A' ' 57' ' ' ASN . 41.8 Cg_exo -58.07 122.56 11.91 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.394 2.729 . . . . 0.0 113.587 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 56' ' ' ILE . 4.7 mm -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.559 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.457 HD22 ' HB3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -53.35 -34.74 58.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.39 -174.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pt -79.81 -40.3 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.417 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -22.81 57.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -58.26 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.552 HG13 ' N ' ' A' ' 62' ' ' ASN . 12.7 pt -91.09 -35.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.575 ' HB3' HD12 ' A' ' 65' ' ' ILE . 7.4 m-20 -92.22 37.24 0.99 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.509 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -8.12 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.488 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 3' ' ' ILE . 1.4 mt -79.02 -9.49 59.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 62' ' ' ASN . 54.3 mt -69.49 124.96 91.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.63 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.787 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -77.91 174.77 12.05 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.25 -8.64 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.453 ' ND2' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -60.39 -21.91 62.72 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.7 HD22 ' HG2' ' A' ' 4' ' ' PRO . 5.9 m-80 -102.12 24.54 9.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.427 0.632 . . . . 0.0 110.003 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -142.94 172.76 12.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.62 139.11 40.72 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.076 0.465 . . . . 0.0 111.368 -171.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.91 98.39 6.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.653 0.74 . . . . 0.0 109.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.19 162.16 41.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.208 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -52.72 98.86 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -54.4 129.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.54 -171.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.0 140.29 51.19 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.387 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.631 ' HB2' HG12 ' A' ' 93' ' ' ILE . 48.2 t -135.55 122.98 21.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -122.86 164.34 18.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.612 -172.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.91 128.48 18.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.389 0.431 . . . . 0.0 110.548 174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.67 118.15 1.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.827 0.705 . . . . 0.0 113.641 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 93.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.458 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.38 160.39 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.61 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.12 113.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.69 -37.52 2.05 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.847 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.76 98.56 10.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.886 0.374 . . . . 0.0 110.182 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.52 -38.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.227 0.536 . . . . 0.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -118.61 114.59 23.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.508 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.605 HG13 ' HA ' ' A' ' 43' ' ' PRO . 21.0 pt -107.21 150.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.175 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -99.8 118.7 36.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 t -108.0 130.74 55.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.229 0.538 . . . . 0.0 110.346 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 m -131.51 136.23 28.24 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.26 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HG3' HD21 ' A' ' 33' ' ' LEU . 68.7 Cg_exo -53.39 127.53 25.62 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.686 2.257 . . . . 0.0 112.376 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.631 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -79.57 -23.08 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.352 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.92 139.92 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.02 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.125 0 O-C-N 123.988 0.805 . . . . 0.0 110.842 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.623 0.249 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mp -90.64 111.09 45.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.9 Cg_endo -89.18 128.79 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.317 2.678 . . . . 0.0 111.984 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -129.09 66.83 77.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.59 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 9.1 Cg_exo -73.27 -41.56 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.289 1.993 . . . . 0.0 110.547 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.92 110.97 2.3 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.328 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.33 113.61 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.74 0.305 . . . . 0.0 110.794 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.37 -166.35 13.78 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.29 153.05 17.95 Favored 'Trans proline' 0 N--CA 1.471 0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.236 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.66 155.67 17.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.748 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 3.6 p -62.04 -26.27 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.59 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -69.32 -26.72 64.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.962 -177.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ttt -65.32 -43.35 91.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.051 0.453 . . . . 0.0 110.123 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.73 69.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.032 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -56.36 -31.04 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.603 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.27 3.3 36.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -135.48 174.51 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.62 0.248 . . . . 0.0 110.536 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.92 151.62 33.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.284 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.62 59.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -90.5 0.83 57.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.934 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -105.76 160.24 15.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.561 ' HA ' HD11 ' A' ' 56' ' ' ILE . 14.4 p -101.73 146.69 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.745 0.307 . . . . 0.0 110.75 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' N ' HG21 ' A' ' 24' ' ' VAL . 44.4 t -101.23 129.06 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.866 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.562 ' OG ' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -138.29 150.99 47.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.5 115.85 26.55 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 2.9 m -132.8 146.79 52.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.168 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -111.41 93.48 4.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.983 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.02 145.92 27.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.578 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.87 61.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -61.48 -20.96 63.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.738 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.563 178.152 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.458 -0.053 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.95 120.02 6.39 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.567 2.178 . . . . 0.0 112.385 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.317 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 1.9 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.07 137.46 31.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.168 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.562 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 4.8 t-20 -79.33 97.43 6.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.367 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.459 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -60.73 125.07 82.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' HB3' HD22 ' A' ' 57' ' ' ASN . 51.9 Cg_exo -54.71 120.74 8.6 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.452 2.101 . . . . 0.0 112.047 -176.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.702 HG13 HD13 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -76.08 -14.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 -174.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.442 HD22 ' HB3' ' A' ' 55' ' ' PRO . 1.1 p30 -68.85 -31.48 70.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.293 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -78.83 -45.5 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.224 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.702 HD13 HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.97 -13.83 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -166.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -32.09 71.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.035 0.445 . . . . 0.0 110.929 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.3 pt -118.99 -39.03 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.959 175.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -82.36 34.06 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.674 -177.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.2 pt20 -70.34 -8.27 49.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.628 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.48 -5.94 59.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.721 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 62' ' ' ASN . 60.3 mt -73.4 122.7 88.26 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.85 157.49 58.78 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.849 2.366 . . . . 0.0 112.193 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.759 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 3.3 tp -61.0 -9.4 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.138 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -55.84 -24.9 39.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.141 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -100.22 9.36 42.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.254 0.55 . . . . 0.0 110.674 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.759 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 64.5 m-85 -127.21 175.0 8.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.439 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 122.69 44.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 96.42 9.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.651 0.739 . . . . 0.0 109.806 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -156.11 164.17 38.74 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.11 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.181 0.925 . . . . 0.0 112.013 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -64.76 136.85 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.726 -177.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.8 m -141.12 113.17 7.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.855 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.568 ' HB3' HD13 ' A' ' 93' ' ' ILE . 1.8 p -100.83 142.98 31.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.209 0.528 . . . . 0.0 110.051 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 6.8 m -126.57 164.08 22.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.24 132.18 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -46.92 110.1 0.49 Allowed Glycine 0 C--N 1.333 0.391 0 O-C-N 123.597 0.561 . . . . 0.0 113.098 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.34 100.47 4.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -113.86 154.4 27.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.576 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -55.92 113.06 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.37 0.605 . . . . 0.0 110.742 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.91 -18.89 3.76 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.675 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -101.39 149.35 24.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.99 -42.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.2 0.524 . . . . 0.0 110.432 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -120.62 134.73 55.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.73 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.9 pt -133.49 148.99 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.42 37.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.071 0.462 . . . . 0.0 110.322 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 77.3 m -110.61 144.57 39.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.31 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 142.36 30.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.496 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.15 129.2 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.674 2.249 . . . . 0.0 111.546 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.568 HD13 ' HB3' ' A' ' 77' ' ' CYS . 3.0 mt -76.31 -62.0 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.837 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.508 ' HG ' ' HG ' ' A' ' 95' ' ' SER . 7.1 tp -106.54 138.33 42.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.279 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.508 ' HG ' ' HG ' ' A' ' 94' ' ' LEU . 1.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.349 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.647 HG23 HG12 ' A' ' 65' ' ' ILE . 9.9 mt -88.92 111.46 44.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 1.8 Cg_endo -82.51 147.36 14.01 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.113 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.86 76.92 77.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.599 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -96.87 10.94 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 113.758 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.28 -32.51 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.623 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.5 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.186 0.993 . . . . 0.0 112.995 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.12 -141.72 4.09 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 67' ' ' ILE . 28.3 Cg_exo -62.21 160.86 28.88 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.198 1.932 . . . . 0.0 110.985 171.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -115.97 155.14 28.57 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -25.19 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 0.0 111.244 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.36 -28.32 69.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.797 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -67.74 -45.06 76.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.327 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.66 73.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.673 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.026 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.21 -31.64 71.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.087 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HG2' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -104.18 14.73 29.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.504 -175.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.41 174.32 7.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.82 154.0 33.5 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.79 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.55 65.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.54 36.46 2.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.472 0.654 . . . . 0.0 110.347 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 145.99 50.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.844 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 53' ' ' ASN . 5.9 p -99.53 129.11 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.941 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.8 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.744 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.46 ' HA ' HG12 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -139.07 162.04 35.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.501 -178.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 110.87 15.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 2.8 m -140.18 135.19 32.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -120.59 93.09 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.862 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.39 148.71 29.73 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.521 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -65.21 -35.39 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.2 pm0 -68.81 -31.47 70.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.453 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.417 179.373 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.27 171.24 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.68 2.253 . . . . 0.0 112.138 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.618 HG23 ' SG ' ' A' ' 51' ' ' CYS . 1.6 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.185 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.618 ' SG ' HG23 ' A' ' 44' ' ' ILE . 36.1 t . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.6 0.238 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 123.99 15.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.003 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.675 HD22 HG11 ' A' ' 24' ' ' VAL . 6.6 t-20 -75.92 131.58 39.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 173.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.46 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.96 130.31 23.07 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.432 ' HB3' HD22 ' A' ' 57' ' ' ASN . 51.0 Cg_exo -51.33 121.7 8.85 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.357 2.705 . . . . 0.0 113.181 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.569 ' HA ' HD13 ' A' ' 59' ' ' LEU . 3.2 tp -79.66 -12.19 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.936 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -60.57 -51.55 68.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -31.28 53.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.761 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.569 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -60.79 -14.8 23.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 m -70.09 -31.98 69.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.5 pt -131.06 -32.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.201 0.524 . . . . 0.0 111.392 -178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -87.62 29.63 0.88 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.469 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -69.82 -14.74 62.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.097 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mt -78.05 -5.4 51.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.683 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.647 HG12 HG23 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -69.8 126.53 92.56 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.635 ' HB2' HD21 ' A' ' 68' ' ' ASN . 6.3 Cg_exo -73.6 157.91 48.06 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.822 2.348 . . . . 0.0 111.871 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.728 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 1.5 tp -62.1 -9.6 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.81 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.635 HD21 ' HB2' ' A' ' 66' ' ' PRO . 2.8 p30 -59.37 -23.63 62.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.803 175.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.87 8.72 21.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.728 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 62.4 m-85 -139.53 174.21 10.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.527 -172.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.25 121.87 44.75 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.367 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.57 98.54 0.69 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.42 0.628 . . . . 0.0 109.764 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.77 162.44 41.11 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 106.61 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 O-C-N 123.673 0.608 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.636 HG21 ' H ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -60.35 135.95 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.038 -172.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 1.4 m -138.3 161.81 35.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' A' ' 93' ' ' ILE . 12.3 p -158.96 122.47 3.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.396 0.617 . . . . 0.0 110.124 173.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -97.95 163.5 12.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.76 -175.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.758 ' HB2' HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -51.37 136.72 24.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 175.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.59 104.57 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 123.714 0.634 . . . . 0.0 113.768 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.12 105.8 2.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -105.21 170.98 7.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.178 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.55 113.13 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.564 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.99 -12.25 57.49 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.258 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 85' ' ' LEU . 2.8 tp -82.04 75.56 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 109.957 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.63 -19.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.241 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.04 109.72 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.596 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 79' ' ' SER . 0.3 OUTLIER -142.96 157.49 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.546 177.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -95.5 134.62 38.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.816 0.341 . . . . 0.0 110.413 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 2.9 t -108.21 128.75 54.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.302 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p -123.84 145.26 47.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.672 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 24.6 Cg_exo -63.64 151.65 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.281 1.987 . . . . 0.0 111.45 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 75' ' ' VAL . 3.4 mt -83.15 -83.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.844 0.354 . . . . 0.0 110.41 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.636 ' H ' HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -96.51 105.09 17.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.404 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 65' ' ' ILE . 4.0 mt -82.86 111.19 27.82 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.4 Cg_endo -88.48 126.51 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.88 72.48 47.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.938 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.32 -56.25 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.855 2.37 . . . . 0.0 112.278 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.57 -18.28 60.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.046 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 60.97 2.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 111.175 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.27 -175.42 31.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.9 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.24 137.15 63.64 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.073 2.516 . . . . 0.0 112.668 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.836 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -86.88 166.69 14.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.143 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG22 HD22 ' A' ' 59' ' ' LEU . 4.9 p -61.89 -26.78 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.719 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -53.33 -32.85 51.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.174 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpt -65.48 -49.23 69.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 0.0 110.078 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.45 60.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.8 -29.58 70.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.895 -173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.17 -30.94 69.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 111.198 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.693 ' HB3' HG23 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -77.09 7.44 4.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.606 -176.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 174.65 10.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.02 168.01 36.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.329 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.17 -4.83 46.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.451 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -95.42 5.29 52.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 110.194 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 3.6 mptt -113.95 166.55 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.9 p -121.84 141.78 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.409 ' C ' ' HG ' ' A' ' 26' ' ' SER . 0.9 OUTLIER -93.39 137.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.365 177.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.495 ' HA ' HG12 ' A' ' 54' ' ' ILE . 40.0 m -155.3 159.74 40.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.434 ' H ' HD13 ' A' ' 54' ' ' ILE . 1.2 m -101.73 120.66 40.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.9 t -144.87 101.05 3.59 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.901 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -84.52 92.77 8.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.523 0.678 . . . . 0.0 109.52 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p -124.36 148.81 47.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.982 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -31.54 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 173.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -60.29 -47.47 85.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.648 -1.614 . . . . 0.0 111.018 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.473 HD22 ' HG3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.991 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 121.053 0.454 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 3.5 Cg_endo -85.93 135.56 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.179 2.586 . . . . 0.0 112.203 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.7 m . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.366 0.603 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.7 139.69 32.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.757 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -97.68 133.91 41.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -109.52 125.01 32.27 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.493 -174.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.408 ' HB3' ' ND2' ' A' ' 57' ' ' ASN . 52.4 Cg_exo -56.88 122.73 12.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.464 2.776 . . . . 0.0 113.702 -173.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.513 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -75.15 -16.91 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.745 -177.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -53.82 -43.15 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.23 -173.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -78.32 -36.24 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.57 HD22 HG22 ' A' ' 12' ' ' VAL . 2.7 mp -54.56 -33.32 59.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.868 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -32.5 34.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -121.84 -20.51 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.235 0.54 . . . . 0.0 110.971 177.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -99.09 28.1 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.286 -177.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -68.27 -13.83 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.371 0.605 . . . . 0.0 110.67 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.96 -8.04 55.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.6 ' O ' HG21 ' A' ' 65' ' ' ILE . 1.5 tt -67.99 133.58 91.92 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 110.652 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.836 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 3.7 Cg_exo -79.57 163.42 24.19 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.937 2.425 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 67' ' ' ILE . 3.2 tp -63.02 -9.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -25.38 67.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.26 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.436 HD22 ' HG2' ' A' ' 4' ' ' PRO . 1.5 m-80 -98.31 28.04 4.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.541 0.686 . . . . 0.0 109.623 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.436 ' HE1' HG13 ' A' ' 54' ' ' ILE . 14.9 m-85 -144.3 173.01 12.14 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.01 127.85 51.58 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.576 -172.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.3 98.78 1.81 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.426 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -154.55 161.4 41.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.218 -170.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.59 103.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.15 0.5 . . . . 0.0 109.94 172.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -54.6 115.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.695 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -113.97 135.92 53.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.326 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 5.3 t -122.99 120.68 34.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 3.2 t -118.03 163.21 16.94 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.23 138.39 50.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.6 104.91 0.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.458 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.89 134.33 54.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.367 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.16 154.58 37.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.937 -176.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.75 112.03 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 110.413 -178.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.86 -19.34 5.54 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.45 -37.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.797 0.332 . . . . 0.0 111.516 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 140.51 50.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.656 HD12 ' HG2' ' A' ' 81' ' ' GLU . 2.0 pt -137.99 157.29 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.79 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.501 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -98.81 121.38 40.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.676 178.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 m -114.4 132.54 56.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.318 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.99 151.05 77.26 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.584 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HG3' HD22 ' A' ' 33' ' ' LEU . 38.3 Cg_exo -61.3 127.03 20.79 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.653 2.235 . . . . 0.0 111.595 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.693 HG23 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -84.22 -41.73 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.553 ' HB2' HG21 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -105.94 104.04 13.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.692 -178.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.369 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.13 115.95 41.81 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.84 126.7 4.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.085 2.523 . . . . 0.0 112.037 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 73.87 23.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.56 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 37.8 Cg_endo -69.41 -25.64 30.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.164 1.91 . . . . 0.0 110.99 171.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.17 77.18 0.38 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.576 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -72.48 127.51 32.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.246 0.546 . . . . 0.0 111.83 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 10' ' ' PRO . . . -153.57 -126.78 1.14 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.434 ' HG2' HG23 ' A' ' 67' ' ' ILE . 19.2 Cg_endo -62.44 133.84 45.05 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.662 2.241 . . . . 0.0 112.21 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -81.22 154.79 26.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.235 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.547 HG13 HD12 ' A' ' 67' ' ' ILE . 35.8 m -67.72 -24.87 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.912 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -30.27 71.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.943 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -40.3 90.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.204 0.526 . . . . 0.0 110.13 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.15 73.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.427 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -61.01 -29.24 69.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -31.68 71.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.031 0.443 . . . . 0.0 110.997 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 9.61 21.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.59 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' SG ' ' HD2' ' A' ' 23' ' ' LYS . 5.4 t -133.84 174.39 10.51 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.16 156.02 39.09 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.193 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.42 87.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.54 38.65 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.393 0.616 . . . . 0.0 110.114 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 7.1 mttt -125.47 144.45 50.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.79 129.04 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.993 0.425 . . . . 0.0 110.362 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.499 HG11 ' HE2' ' A' ' 70' ' ' PHE . 16.1 t -85.57 106.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -120.21 171.49 8.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' SG ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -130.78 108.85 10.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.073 0.463 . . . . 0.0 110.482 170.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 44' ' ' ILE . 48.6 m -137.53 144.26 42.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.45 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -105.68 99.92 9.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.804 0.335 . . . . 0.0 111.527 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.79 141.62 28.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -23.28 57.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.841 0.829 . . . . 0.0 109.613 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -84.07 -18.42 37.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.027 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 179.323 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.56 0.219 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.24 -177.02 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.038 2.492 . . . . 0.0 112.606 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.417 HG23 ' SG ' ' A' ' 28' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.356 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 42.2 t . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.597 0.237 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.74 116.12 5.78 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.629 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.9 t30 -84.6 94.37 8.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.523 HD12 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -68.11 136.29 91.67 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.267 -172.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.43 ' O ' HD11 ' A' ' 59' ' ' LEU . 28.1 Cg_exo -61.84 123.45 12.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.171 2.581 . . . . 0.0 112.744 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.519 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -72.74 -12.68 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.433 -175.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -40.12 88.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.5 -175.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -79.84 -32.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.892 0.377 . . . . 0.0 110.576 175.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -65.58 -17.94 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 -173.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -60.83 2.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.448 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -96.22 -37.19 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.044 0.449 . . . . 0.0 111.576 -177.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.97 36.03 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.436 0.636 . . . . 0.0 109.907 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.67 -8.0 53.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.977 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.462 ' HA ' HD13 ' A' ' 64' ' ' LEU . 3.7 mm? -76.47 -7.98 56.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.953 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -62.84 137.16 96.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.969 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.2 Cg_exo -79.07 159.48 26.95 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.047 2.498 . . . . 0.0 111.679 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.547 HD12 HG13 ' A' ' 12' ' ' VAL . 2.6 tp -61.2 -9.25 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.56 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -58.74 -28.99 66.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.07 27.55 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.459 0.647 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.499 ' HE2' HG11 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -142.41 174.93 10.18 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -172.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.17 127.68 49.0 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.666 -173.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.93 94.68 3.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -156.44 161.69 40.06 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.7 98.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.411 0.444 . . . . 0.0 109.87 171.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG21 ' H ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -57.53 128.08 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -173.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.26 105.95 4.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.226 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 27.4 p -104.96 129.56 53.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.553 0.692 . . . . 0.0 110.851 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 11.8 m -105.27 164.09 12.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.076 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.534 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -54.99 139.3 41.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 173.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -50.41 114.59 2.68 Favored Glycine 0 C--N 1.331 0.252 0 O-C-N 123.309 0.381 . . . . 0.0 112.683 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 143.19 33.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.041 0.448 . . . . 0.0 110.675 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.59 174.87 14.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.33 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.68 119.28 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.799 0.333 . . . . 0.0 110.179 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.01 4.06 31.44 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.168 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 88' ' ' ILE . 2.4 mt -112.0 112.83 24.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.8 -27.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.61 135.7 16.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.338 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -131.76 174.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.93 -177.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.518 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -101.91 128.05 48.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 98.6 m -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.491 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.6 t -150.07 143.57 16.75 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.339 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.0 Cg_endo -57.41 136.64 77.27 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.64 2.227 . . . . 0.0 111.677 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.416 HD13 ' HB ' ' A' ' 75' ' ' VAL . 1.2 mt -88.39 -73.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.674 ' H ' HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -99.61 72.25 1.76 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.016 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.056 178.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.2 mt -80.25 109.92 14.46 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 4.2 Cg_endo -89.82 124.93 1.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.344 2.696 . . . . 0.0 112.261 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 8' ' ' GLU . . . -141.47 67.66 25.09 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.757 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.78 -28.72 7.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.776 1.651 . . . . 0.0 111.842 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.83 -44.21 2.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.618 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 57.38 50.53 11.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.385 177.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.78 -128.64 6.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.807 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.42 143.49 69.88 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -90.11 154.16 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 0.0 111.087 -178.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.576 HG21 HD23 ' A' ' 59' ' ' LEU . 8.5 p -69.06 -27.76 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.448 0.642 . . . . 0.0 110.028 176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -67.06 -26.32 66.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.941 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 ttm -64.11 -47.27 80.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.97 -36.99 72.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 20.9 tt0 -64.0 -29.58 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.139 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -31.29 64.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 111.404 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HB3' HG23 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -76.8 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 -177.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 175.03 7.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.85 -165.05 22.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.497 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.51 -7.07 48.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 0.0 110.942 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.83 9.64 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.274 0.559 . . . . 0.0 110.116 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -126.98 153.68 45.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 56' ' ' ILE . 6.6 p -108.53 131.17 59.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.058 0.456 . . . . 0.0 110.586 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG23 HD21 ' A' ' 59' ' ' LEU . 5.4 t -83.89 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.605 ' HA ' HG12 ' A' ' 54' ' ' ILE . 8.0 t -154.74 170.31 21.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.691 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.52 99.97 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 172.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.67 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 16.1 m -131.56 109.82 10.52 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 3.0 p30 -88.68 134.58 33.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 0.0 110.957 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 38.4 m -158.52 155.43 28.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.763 176.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -70.56 -38.23 74.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 109.888 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -20.44 64.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.465 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.04 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.58 HG13 ' HD2' ' A' ' 43' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--O 1.239 0.507 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' HD2' HG13 ' A' ' 42' ' ' ILE . 92.1 Cg_endo -88.72 -175.89 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.71 2.273 . . . . 0.0 112.366 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 88' ' ' ILE . 4.3 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.67 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.13 140.61 5.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.04 145.83 55.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.627 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.605 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.81 126.46 30.21 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.1 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 75.1 Cg_exo -51.01 122.47 10.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.393 2.729 . . . . 0.0 113.544 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -76.01 -12.82 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.491 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -64.21 -34.52 78.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.355 -175.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.33 -38.5 20.01 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.224 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.576 HD23 HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -62.07 -15.6 46.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -28.61 48.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.82 0.343 . . . . 0.0 111.856 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.529 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.4 pt -129.26 -41.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.206 0.527 . . . . 0.0 111.19 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.529 ' N ' HG13 ' A' ' 61' ' ' ILE . 5.6 m-80 -83.23 36.62 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.722 0.809 . . . . 0.0 110.194 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.617 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 24.5 pt20 -72.46 -7.4 49.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.253 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -1.45 45.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.656 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 59.3 mt -80.23 120.26 79.01 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.349 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 23.5 Cg_exo -64.85 164.38 24.68 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 112.284 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.5 tp -62.49 -8.89 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.515 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -65.24 -7.46 13.16 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 68' ' ' ASN . 74.1 m-80 -116.4 29.91 7.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.491 0.662 . . . . 0.0 110.107 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -143.82 173.14 11.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 121.49 43.92 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.933 0.397 . . . . 0.0 111.64 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -72.25 98.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.619 0.724 . . . . 0.0 109.158 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.487 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.49 161.94 40.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.17 104.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 0.0 110.273 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.62 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -59.65 127.05 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.614 -172.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.61 152.89 43.0 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.092 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.565 ' HB2' HG12 ' A' ' 93' ' ' ILE . 19.2 t -144.58 119.04 9.65 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -113.52 164.1 14.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.695 -172.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.19 127.25 18.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 175.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -36.42 108.86 0.06 OUTLIER Glycine 0 C--N 1.34 0.781 0 O-C-N 124.081 0.863 . . . . 0.0 112.763 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.624 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -82.84 129.23 34.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.17 -0.515 . . . . 0.0 110.883 -173.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 140.93 34.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.737 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -56.2 119.98 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 123.655 0.597 . . . . 0.0 111.053 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.84 -26.75 4.22 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.464 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.37 136.3 33.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.876 0.369 . . . . 0.0 110.305 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 t -74.81 -47.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -143.87 151.58 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.882 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -142.25 145.66 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.475 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.7 131.53 43.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.984 0.421 . . . . 0.0 110.69 -175.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 t -109.72 145.16 37.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.873 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.61 152.29 52.51 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 31.6 Cg_endo -64.09 140.44 71.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.645 2.23 . . . . 0.0 112.748 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.62 HD11 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -95.71 -62.68 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.913 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 100.94 13.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.521 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.138 178.352 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -77.91 111.94 21.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.725 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.1 Cg_endo -89.2 128.68 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.524 2.816 . . . . 0.0 112.381 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.588 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . -143.65 68.08 16.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.77 -39.83 8.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.224 1.949 . . . . 0.0 112.116 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.01 -21.23 59.51 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.868 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 49.49 69.42 0.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.29 0.567 . . . . 0.0 111.51 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.76 -173.4 14.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.205 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.46 142.73 37.67 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.345 2.696 . . . . 0.0 112.335 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -87.6 157.28 19.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.832 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.71 -25.82 38.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.006 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.2 m -60.45 -28.84 68.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.174 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -48.12 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.9 73.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.771 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -62.86 -31.48 72.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -32.75 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 0.0 111.277 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.89 16.49 6.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.141 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.19 175.02 10.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.898 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.67 167.43 22.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.09 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.19 -16.11 61.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.381 0.61 . . . . 0.0 110.157 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -89.76 19.37 4.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.459 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 79' ' ' SER . 1.8 mptt -132.6 156.0 47.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.597 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -105.1 123.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.197 0.522 . . . . 0.0 110.398 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -85.85 103.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.911 178.33 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -116.5 172.69 7.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 -177.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 p -126.74 128.4 46.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.921 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 34.0 t -157.32 141.38 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.379 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -98.65 94.02 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.93 0.871 . . . . 0.0 110.455 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.552 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -116.47 146.8 42.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.049 178.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -72.17 -26.03 61.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 0.0 110.269 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.42 -44.01 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.355 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 30' ' ' SER . 4.4 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.685 HG12 ' HB3' ' A' ' 90' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.285 0.564 . . . . 0.0 111.641 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -91.21 -168.56 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.683 2.922 . . . . 0.0 111.415 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 53' ' ' ASN . 5.3 tp . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.329 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 19.4 m . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -152.55 128.51 10.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.571 ' HB3' HG21 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -75.73 123.21 25.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.175 170.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.515 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -88.52 133.21 36.78 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.327 -175.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HB3' HD22 ' A' ' 57' ' ' ASN . 51.3 Cg_exo -53.86 127.56 26.09 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.506 2.804 . . . . 0.0 112.951 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.41 -12.53 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.921 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.609 HD22 ' HB3' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -59.24 -40.68 86.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.832 -176.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.13 -25.21 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.612 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.17 -18.91 64.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -30.48 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -133.11 -38.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -176.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.635 ' HB3' HD11 ' A' ' 65' ' ' ILE . 31.3 m-20 -83.25 28.19 0.54 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.36 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.01 -8.63 55.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.422 0.63 . . . . 0.0 109.717 175.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.406 ' HB2' HD13 ' A' ' 3' ' ' ILE . 2.8 mt -78.88 -7.52 58.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.213 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 3' ' ' ILE . 42.9 mt -75.99 126.94 86.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.247 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 14.9 Cg_exo -69.59 167.59 23.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.566 2.177 . . . . 0.0 111.93 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.598 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.25 -9.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.6 -177.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -24.92 64.86 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.409 HD22 ' HG2' ' A' ' 4' ' ' PRO . 15.3 m-80 -100.32 16.14 25.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.504 0.669 . . . . 0.0 109.766 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 98.9 m-85 -126.75 176.0 7.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.99 127.46 48.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.48 98.59 3.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.46 160.64 40.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.217 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.0 112.53 0.53 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.295 0.569 . . . . 0.0 110.441 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.861 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -61.61 130.77 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.53 -174.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 m -129.36 115.58 17.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.848 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.523 ' HB2' HD11 ' A' ' 93' ' ' ILE . 20.3 t -104.96 118.25 36.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.045 0.45 . . . . 0.0 110.096 -176.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -114.9 163.35 15.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 -175.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.51 133.75 24.65 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 174.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -43.92 109.68 0.27 Allowed Glycine 0 C--N 1.335 0.495 0 O-C-N 123.792 0.683 . . . . 0.0 112.737 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.01 29.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.587 . . . . 0.0 110.508 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.54 173.4 7.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.18 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.44 117.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 123.364 0.415 . . . . 0.0 110.693 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.37 -43.02 1.61 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 84.16 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.971 0.415 . . . . 0.0 110.153 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.486 ' H ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -71.02 -41.06 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 -178.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 131.33 55.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.9 pt -132.86 163.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -107.58 120.02 41.04 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 2.9 t -108.6 135.7 49.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.319 0.581 . . . . 0.0 111.043 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.672 HG23 ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -129.72 141.67 42.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.31 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.672 ' HD2' HG23 ' A' ' 91' ' ' THR . 22.7 Cg_exo -63.39 126.6 18.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.358 2.039 . . . . 0.0 111.63 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.861 HD12 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -82.52 -52.1 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.163 0.506 . . . . 0.0 110.151 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.84 144.71 45.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.014 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.672 178.336 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.543 0.211 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.46 114.02 54.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.972 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.84 124.96 10.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.735 2.29 . . . . 0.0 111.874 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.61 88.02 9.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.98 -45.19 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.008 2.472 . . . . 0.0 112.351 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.53 27.01 5.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.463 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 48.76 65.55 1.33 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.795 0.438 . . . . 0.0 111.554 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.47 160.98 27.14 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.161 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.54 144.86 96.7 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.092 2.528 . . . . 0.0 112.267 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 154.76 29.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 0.0 110.978 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.61 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.985 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -67.2 -26.68 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.214 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -45.1 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.002 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.87 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -59.21 -29.91 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.443 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -56.72 -30.85 63.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.124 0.488 . . . . 0.0 111.362 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.45 -4.15 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.697 ' HB2' HG21 ' A' ' 93' ' ' ILE . 18.6 t -127.84 174.74 8.89 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.93 146.65 41.85 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.739 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.77 -9.52 59.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 111.08 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.97 21.98 10.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.655 0.74 . . . . 0.0 109.85 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HE2' ' SG ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -121.02 147.19 45.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.547 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.788 HG13 ' HA2' ' A' ' 80' ' ' GLY . 6.7 m -88.83 140.6 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 0.0 110.772 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.18 121.12 43.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.2 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.653 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -135.67 159.12 42.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.8 m -101.3 121.31 41.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.47 118.39 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -106.48 95.45 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.28 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.43 151.07 20.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -64.71 -37.99 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.663 -178.485 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 2.3 pm0 -73.46 -30.26 63.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.41 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.529 179.032 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.664 HG13 ' HA ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.537 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.18 124.13 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.025 2.484 . . . . 0.0 112.183 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mm . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.462 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 129.24 15.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 22.8 t-20 -85.03 124.16 31.4 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -95.51 130.54 31.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.302 -174.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -47.95 121.88 6.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.462 2.774 . . . . 0.0 113.291 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.703 HD12 HG12 ' A' ' 24' ' ' VAL . 7.5 tp -75.17 -11.46 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.602 -173.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.24 -40.6 86.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.256 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.55 -25.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.72 -23.8 67.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -60.29 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.596 HG13 ' N ' ' A' ' 62' ' ' ASN . 5.7 pt -81.47 -44.3 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 111.141 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.596 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -92.04 38.54 1.0 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.88 -176.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.1 -14.17 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.921 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.21 1.29 51.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.89 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.703 HG22 HD22 ' A' ' 69' ' ' ASN . 1.5 tt -66.01 135.93 95.38 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.34 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 3.0 Cg_exo -77.82 161.09 30.59 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.009 2.473 . . . . 0.0 111.742 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tp -67.11 -8.68 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.887 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.433 HD21 ' HB2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -57.9 -32.3 67.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.903 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.703 HD22 HG22 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -103.48 60.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 109.316 176.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.89 173.15 16.91 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.2 133.48 49.04 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.313 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -80.54 94.18 6.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.063 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 17.9 m-20 -155.9 160.33 40.06 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -51.33 105.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.267 0.556 . . . . 0.0 110.812 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.24 135.33 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.778 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 m -144.13 148.66 35.37 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -172.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.1 p -129.18 119.62 24.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.694 0.759 . . . . 0.0 110.906 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 21.4 m -99.54 155.22 17.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.572 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.406 ' OG ' ' HG2' ' A' ' 89' ' ' GLN . 0.3 OUTLIER -52.35 128.41 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.788 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -32.6 104.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.786 0 O-C-N 124.271 0.982 . . . . 0.0 114.19 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.51 93.1 1.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.429 0.633 . . . . 0.0 110.165 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 173.1 10.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.109 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.95 129.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.352 0.596 . . . . 0.0 110.891 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.0 -26.71 11.08 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.753 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 122.84 34.81 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.0 -52.31 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.032 0.444 . . . . 0.0 110.876 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -99.12 117.48 33.7 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.7 pt -126.83 159.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.664 ' HA ' HG13 ' A' ' 42' ' ' ILE . 3.9 pt20 -109.65 128.46 55.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 42' ' ' ILE . 94.3 m -107.93 127.3 53.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.113 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 92' ' ' PRO . 18.3 m -138.3 135.61 18.5 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.581 -174.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.405 ' HD2' HG21 ' A' ' 91' ' ' THR . 11.8 Cg_endo -54.75 141.01 77.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.131 2.554 . . . . 0.0 112.794 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.697 HG21 ' HB2' ' A' ' 19' ' ' CYS . 2.1 mt -91.71 -77.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.581 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tp -74.51 121.48 21.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.787 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.969 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.529 0.204 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.482 HG21 HG12 ' A' ' 65' ' ' ILE . 26.9 mt -94.93 111.45 54.57 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.835 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.885 ' HD2' HG23 ' A' ' 65' ' ' ILE . 6.1 Cg_exo -78.74 126.02 7.09 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.007 2.471 . . . . 0.0 112.38 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.11 71.09 18.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.213 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.35 -23.83 32.22 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.743 2.295 . . . . 0.0 111.821 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.82 -21.9 4.1 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.09 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.83 51.75 15.31 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.08 0.552 . . . . 0.0 111.146 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.19 32.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.441 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.82 134.41 58.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.89 2.393 . . . . 0.0 112.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 m -89.73 155.66 19.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.536 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 67' ' ' ILE . 48.4 t -65.9 -25.2 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.223 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.92 -35.43 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.034 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpp -62.65 -42.27 99.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.369 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -66.7 -45.67 78.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -60.92 -32.75 72.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.367 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -30.3 62.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.836 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -80.07 -3.12 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.894 -175.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 174.79 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.8 151.06 38.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.254 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.02 -9.01 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 110.998 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.58 12.04 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.406 0.622 . . . . 0.0 109.748 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -119.89 166.78 12.86 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.332 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 81' ' ' GLU . 9.9 m -106.24 160.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.216 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 70' ' ' PHE . 96.6 t -115.02 116.2 51.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.668 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -131.42 149.02 52.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.504 -178.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 107.32 17.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 3.3 m -126.14 121.45 32.87 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.862 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 11.2 t-20 -86.42 113.94 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.742 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.2 144.19 32.07 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -74.79 -42.99 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.356 0.598 . . . . 0.0 110.329 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -68.77 -27.46 65.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.541 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.145 0.498 . . . . 0.0 110.757 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.787 HG21 ' HB2' ' A' ' 90' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 17.1 Cg_endo -91.63 99.0 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.24 2.627 . . . . 0.0 112.696 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.558 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 130.67 47.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.6 t-20 -79.59 101.1 8.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.735 HG23 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -64.88 131.59 95.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.101 -174.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.735 ' HD2' HG23 ' A' ' 54' ' ' ILE . 6.3 Cg_endo -47.84 123.62 8.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.994 3.129 . . . . 0.0 113.73 -171.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.76 -23.56 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.992 -174.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -59.45 -43.47 93.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.366 -176.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -80.12 -17.8 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 110.721 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.401 HD21 ' O ' ' A' ' 55' ' ' PRO . 1.9 mm? -71.02 -33.44 70.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.784 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -51.4 9.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.987 0.422 . . . . 0.0 112.132 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 62' ' ' ASN . 3.2 pt -99.46 -44.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.947 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.547 ' O ' HG13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -93.63 30.7 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.883 0.373 . . . . 0.0 110.987 -174.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.18 -8.43 54.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.668 . . . . 0.0 109.564 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.18 -13.26 60.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.848 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.885 HG23 ' HD2' ' A' ' 4' ' ' PRO . 21.4 mt -66.97 129.7 93.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' HG22 ' A' ' 65' ' ' ILE . 48.7 Cg_exo -56.46 152.14 41.66 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.545 2.163 . . . . 0.0 111.567 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.528 HD13 HG23 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -59.11 -8.54 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -175.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -26.09 54.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.723 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.75 13.59 19.76 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.843 0.83 . . . . 0.0 110.264 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HE2' HG13 ' A' ' 25' ' ' VAL . 1.1 m-85 -130.6 173.4 10.92 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 123.99 48.72 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.995 -170.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 96.73 2.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 3.4 t0 -156.79 163.58 39.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.213 -173.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.23 97.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 0.0 109.845 168.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.529 ' HB ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.97 135.53 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.312 -172.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 140.63 51.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.287 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.471 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 122.25 38.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.617 0.722 . . . . 0.0 109.346 174.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 14.4 m -111.87 162.97 14.72 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.686 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.403 ' HB2' HG21 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -53.38 135.36 39.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.016 0.371 . . . . 0.0 110.087 174.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -47.18 107.22 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 123.644 0.59 . . . . 0.0 112.729 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.1 tt0 -55.4 119.15 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.36 26.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.349 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.48 113.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 110.518 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.15 -17.76 5.92 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.804 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 108.54 10.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.872 0.368 . . . . 0.0 110.105 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.489 ' H ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -98.2 -28.79 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.013 0.435 . . . . 0.0 110.778 -177.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -101.09 108.77 20.55 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.403 HG21 ' HB2' ' A' ' 79' ' ' SER . 7.4 pt -110.35 162.58 7.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.822 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 23.7 mt-30 -99.47 121.09 40.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.712 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.787 ' HB2' HG21 ' A' ' 42' ' ' ILE . 89.2 m -108.3 127.61 54.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 t -132.47 139.99 36.48 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.284 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 9.5 Cg_endo -54.44 126.6 22.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.648 2.232 . . . . 0.0 111.658 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.529 HG13 ' HB ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -69.35 -38.98 78.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.0 110.437 -178.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -128.88 117.22 20.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.857 177.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.95 110.83 59.08 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.032 0.444 . . . . 0.0 110.046 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 131.23 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.498 2.799 . . . . 0.0 112.003 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . . . -135.77 66.44 62.8 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.91 -70.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.205 1.937 . . . . 0.0 110.27 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 74.99 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -69.24 129.6 40.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 0.0 111.251 -175.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.42 -141.07 3.23 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.423 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 133.43 58.07 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -91.64 155.09 18.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.72 -25.29 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.003 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -65.0 -29.29 70.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.582 -175.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -36.19 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 109.982 177.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.86 -35.17 78.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.116 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -70.3 -31.28 68.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -32.74 74.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.924 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 3.92 48.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.202 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HD2' ' A' ' 23' ' ' LYS . 32.7 t -127.2 175.75 7.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.68 159.47 30.57 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.167 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.83 -35.67 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 111.098 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.19 36.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.494 0.664 . . . . 0.0 110.011 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.629 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 11.2 mttt -135.97 166.01 24.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG12 ' HA2' ' A' ' 80' ' ' GLY . 2.8 m -118.8 130.1 74.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.187 0.518 . . . . 0.0 111.398 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.44 131.59 33.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.669 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.37 164.82 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.167 0.508 . . . . 0.0 110.861 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.803 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -123.76 110.14 14.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.725 ' HA ' ' CB ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -151.89 113.21 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.315 0.384 . . . . 0.0 110.15 178.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.793 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 9.8 p30 -85.29 152.84 22.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.71 0.766 . . . . 0.0 112.521 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.546 ' HB2' HD12 ' A' ' 33' ' ' LEU . 38.1 m -157.94 147.37 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.078 169.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -68.4 -31.57 71.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.154 0.502 . . . . 0.0 110.584 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -17.38 60.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.766 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 30' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.498 HG21 ' SG ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 37.3 Cg_exo -61.25 140.59 89.52 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.187 2.591 . . . . 0.0 112.774 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 53' ' ' ASN . 5.9 tt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.832 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.803 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 25.7 p . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -156.87 152.8 27.25 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.077 0.236 . . . . 0.0 110.781 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.592 ' HB2' HG12 ' A' ' 44' ' ' ILE . 64.6 t30 -91.56 133.04 35.87 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -97.25 136.77 21.28 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.489 -169.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.494 ' O ' HD12 ' A' ' 59' ' ' LEU . 31.7 Cg_exo -59.48 132.99 49.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.649 2.899 . . . . 0.0 113.454 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.488 HG12 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -77.97 -27.65 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.603 -175.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.59 -35.33 65.69 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -79.04 -39.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.084 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -55.39 -26.31 40.8 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -28.54 69.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -131.49 -37.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.041 0.448 . . . . 0.0 110.648 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.7 m-80 -80.27 24.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.986 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -69.92 -7.59 41.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.381 177.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.83 -10.8 59.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.667 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 78.7 mt -73.37 126.05 90.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 10.6 Cg_exo -71.62 164.18 36.53 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.689 2.259 . . . . 0.0 111.541 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.595 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 2.2 tp -57.88 -8.9 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -26.25 62.17 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -106.44 33.76 3.72 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.699 0.762 . . . . 0.0 109.383 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.595 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 80.1 m-85 -149.04 175.94 10.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.53 115.85 31.41 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.717 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 97.83 0.91 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.793 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 18.4 t0 -155.21 162.87 40.82 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.373 -173.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.51 99.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.98 0.8 . . . . 0.0 110.017 170.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -60.69 130.18 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.345 -169.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.3 m -124.08 153.84 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.117 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.46 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -144.29 121.9 11.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.716 0.77 . . . . 0.0 109.407 171.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 5.8 t -110.46 163.41 13.71 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.9 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.629 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -54.35 134.55 45.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 172.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.569 ' N ' ' HA ' ' A' ' 23' ' ' LYS . . . -48.09 108.24 0.33 Allowed Glycine 0 CA--C 1.507 -0.444 0 O-C-N 123.558 0.536 . . . . 0.0 112.172 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.02 130.56 44.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.323 0.582 . . . . 0.0 110.406 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.89 150.65 51.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.596 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.471 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -55.14 112.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 177.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.17 -32.06 6.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 89.26 7.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -41.35 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.704 -176.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.0 105.75 17.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.19 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 79' ' ' SER . 1.5 pt -114.42 164.49 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.665 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -106.46 112.34 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.295 . . . . 0.0 110.274 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.5 m -107.56 133.99 51.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.427 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 149.48 64.68 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.267 -175.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.23 121.85 8.66 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.871 2.381 . . . . 0.0 112.157 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.585 HD11 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -72.87 -30.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.86 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tp -133.84 103.47 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.938 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.13 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.967 0.413 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.643 HD13 HD13 ' A' ' 64' ' ' LEU . 4.5 mt -103.61 112.18 65.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.222 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.468 ' HG2' HD22 ' A' ' 69' ' ' ASN . 2.9 Cg_exo -76.55 125.11 8.07 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.68 2.254 . . . . 0.0 111.996 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.18 82.96 67.19 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.43 -71.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.964 2.443 . . . . 0.0 112.005 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.12 -0.82 61.47 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.753 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 53.31 54.2 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.099 0.56 . . . . 0.0 111.375 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.57 -171.22 38.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.363 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.01 145.29 98.12 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.913 2.408 . . . . 0.0 112.435 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.75 157.09 16.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.233 -177.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.558 HG11 ' HG ' ' A' ' 59' ' ' LEU . 5.3 p -63.32 -26.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.957 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.7 p -64.04 -31.13 72.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.303 -175.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -44.71 82.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.56 74.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.614 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.45 -29.3 70.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.451 HE21 ' HB3' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -57.79 -33.92 69.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.477 ' HB3' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -92.69 13.88 18.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.732 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.58 174.86 8.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.66 20.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.165 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.34 -22.45 54.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 109.842 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.53 25.45 7.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.67 0.748 . . . . 0.0 109.29 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.513 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -128.24 171.61 11.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.148 178.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' HD12 ' A' ' 56' ' ' ILE . 11.6 p -122.75 141.48 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.994 0.426 . . . . 0.0 111.443 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.429 ' N ' HG21 ' A' ' 24' ' ' VAL . 94.3 t -100.41 116.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.646 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.88 155.34 43.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 3.2 p -101.35 105.41 16.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 11.2 t -134.27 108.54 8.29 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.571 -175.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' H ' ' A' ' 74' ' ' THR . 22.6 t-20 -115.41 92.46 3.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.477 171.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.62 153.58 18.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -44.71 75.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.955 0.407 . . . . 0.0 110.658 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.23 -41.49 94.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.069 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -99.37 162.97 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.5 2.8 . . . . 0.0 113.154 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 3.2 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -132.87 131.7 41.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.203 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.64 111.03 21.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.947 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.654 HG22 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -87.5 150.08 47.98 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.432 ' O ' HD11 ' A' ' 59' ' ' LEU . 35.6 Cg_exo -57.25 118.71 5.62 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.261 1.974 . . . . 0.0 112.858 -173.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.534 HD13 HD23 ' A' ' 59' ' ' LEU . 4.7 tp -80.04 -26.79 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -33.8 73.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.118 -173.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB2' ' A' ' 55' ' ' PRO . 1.5 pt -80.22 -26.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.084 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.558 ' HG ' HG11 ' A' ' 12' ' ' VAL . 4.7 mp -56.2 -34.36 66.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -20.76 63.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.575 HG13 ' N ' ' A' ' 62' ' ' ASN . 4.0 pt -120.28 -32.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.298 0.57 . . . . 0.0 110.945 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.575 ' N ' HG13 ' A' ' 61' ' ' ILE . 6.8 m-20 -98.64 33.26 2.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.862 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 5.5 pt20 -68.51 -10.86 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.697 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -86.74 -5.04 59.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.46 178.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 4.5 mt -71.07 126.5 92.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 6.0 Cg_exo -80.17 167.21 19.97 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.015 2.477 . . . . 0.0 112.137 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.635 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -60.42 -12.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.961 -174.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -66.89 -18.72 65.52 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.01 -0.431 . . . . 0.0 111.169 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.468 HD22 ' HG2' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.35 7.87 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.564 0.697 . . . . 0.0 109.821 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.654 ' HD1' HG22 ' A' ' 54' ' ' ILE . 44.8 m-85 -125.41 176.34 6.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.84 -175.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 134.88 45.11 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.82 96.8 9.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.482 0.658 . . . . 0.0 110.562 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 2.3 m-20 -154.18 158.34 40.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.587 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 29.9 m -43.67 108.7 0.12 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.092 0.472 . . . . 0.0 112.19 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.82 116.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.0 m -122.92 132.15 54.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 t -107.16 118.16 35.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.405 ' O ' HG11 ' A' ' 24' ' ' VAL . 3.1 m -117.96 164.54 14.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.39 -174.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.632 ' HB2' HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -53.68 134.95 41.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 176.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.513 ' N ' ' HA ' ' A' ' 23' ' ' LYS . . . -33.83 113.71 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 O-C-N 123.821 0.701 . . . . 0.0 114.345 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.71 104.28 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.24 174.95 10.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.183 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 tp -67.39 137.9 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.23 46.39 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.608 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.0 130.52 36.18 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.768 -0.254 . . . . 0.0 110.752 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.1 t -79.66 -67.07 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -136.06 159.99 40.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.678 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.632 HG23 ' HB2' ' A' ' 79' ' ' SER . 1.9 pt -134.05 177.95 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.791 0.329 . . . . 0.0 110.834 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 123.87 46.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.831 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.477 ' H ' HD11 ' A' ' 42' ' ' ILE . 9.2 m -109.54 140.55 43.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.431 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 t -150.8 135.36 9.71 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.044 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.85 129.3 33.45 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.99 2.46 . . . . 0.0 112.059 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.59 HD11 ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -74.87 -65.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.335 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.22 117.04 32.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.013 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.809 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.621 0.248 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.64 HG22 HG13 ' A' ' 65' ' ' ILE . 4.1 mt -101.57 110.86 62.91 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.13 139.56 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.432 2.755 . . . . 0.0 112.243 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.6 71.38 71.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.743 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.98 -73.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 110.567 172.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.65 77.57 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.34 110.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 111.326 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.66 -149.2 5.42 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 139.92 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.441 2.094 . . . . 0.0 112.175 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -84.55 165.42 18.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.146 -177.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.483 HG11 ' N ' ' A' ' 13' ' ' SER . 2.7 p -65.62 -26.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.429 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.8 p -64.74 -27.47 68.92 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.821 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.3 ttm -63.13 -46.26 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.493 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.98 74.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.07 -30.27 71.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.161 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -57.29 -31.28 65.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.549 . . . . 0.0 110.897 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -84.66 12.06 7.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.455 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 174.86 10.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 110.326 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.42 161.85 45.18 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 -26.65 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.921 0.391 . . . . 0.0 110.669 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.19 27.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.545 0.688 . . . . 0.0 110.23 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -125.06 160.86 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.728 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.752 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 13.4 p -114.34 134.74 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.412 0.625 . . . . 0.0 110.284 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 t -99.99 104.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.059 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -111.58 163.31 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.69 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 14.0 p -101.27 104.17 15.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 101.73 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.078 0.466 . . . . 0.0 111.003 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.477 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 10.7 t-20 -100.23 119.9 39.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.21 147.91 39.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.277 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -71.44 -29.58 65.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 109.988 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.1 pm0 -71.1 -29.97 65.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.209 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 33' ' ' LEU . 2.3 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.364 0.602 . . . . 0.0 110.068 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.96 154.25 14.86 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.511 2.14 . . . . 0.0 112.004 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.557 179.298 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.73 141.44 7.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.066 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 53.6 t30 -96.01 109.79 22.13 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -79.72 149.32 70.87 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.704 -176.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.43 ' O ' HD23 ' A' ' 59' ' ' LEU . 37.0 Cg_endo -64.6 121.54 9.14 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.77 2.314 . . . . 0.0 112.797 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.511 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -80.08 -5.41 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -37.57 83.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.698 0.285 . . . . 0.0 111.232 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -16.78 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.889 175.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.2 -14.48 62.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.227 -170.126 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -51.16 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.988 0.423 . . . . 0.0 112.098 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.9 pt -106.89 -23.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.869 0.366 . . . . 0.0 111.805 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -105.69 21.34 17.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.278 -176.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -64.91 -14.19 59.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.355 0.598 . . . . 0.0 110.041 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -5.25 35.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.496 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.64 HG13 HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -70.35 134.1 87.05 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -74.44 159.28 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.203 . . . . 0.0 111.159 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 67' ' ' ILE . 3.2 tp -61.95 -10.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.588 HD21 ' HB2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -64.07 -22.66 67.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 175.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.444 ' HB2' HG23 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -99.53 34.07 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 109.887 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -150.65 177.01 10.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -172.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.62 116.65 32.22 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -76.99 97.29 4.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.7 0.762 . . . . 0.0 109.659 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.69 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 10.1 m-20 -153.85 159.71 41.92 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 29' ' ' ASN . 21.0 m -43.51 115.28 0.76 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.183 0.516 . . . . 0.0 111.26 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.627 ' HB ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -70.37 123.86 25.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.994 -174.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.7 p -123.83 127.24 47.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.389 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.67 118.4 36.45 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.271 0.558 . . . . 0.0 109.965 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 88' ' ' ILE . 14.5 t -118.33 165.44 13.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.543 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.56 122.42 8.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.752 ' HA2' ' HB ' ' A' ' 24' ' ' VAL . . . -54.7 104.77 0.28 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.294 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.54 119.31 6.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.569 -0.816 . . . . 0.0 112.106 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -142.82 151.85 41.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.85 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.58 112.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.497 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.49 -21.45 4.28 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.545 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD21 HG22 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -92.28 96.17 10.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 0.0 110.011 177.105 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.524 ' H ' HG21 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -69.38 -37.7 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.937 -178.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -130.12 148.37 51.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.641 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.671 ' HB ' ' SG ' ' A' ' 78' ' ' CYS . 1.5 pt -131.77 151.27 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.882 0.372 . . . . 0.0 111.275 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -106.85 109.14 20.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.513 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.6 m -112.59 136.02 52.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.2 143.61 39.85 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.357 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.57 147.82 90.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.735 2.29 . . . . 0.0 112.356 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.627 HD13 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -115.96 -73.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 78.08 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.571 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.598 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.64 143.0 41.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 111.389 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.2 mt -101.75 112.37 65.16 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.52 125.01 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.417 2.078 . . . . 0.0 111.227 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.81 82.29 6.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.28 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.71 -64.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.553 2.168 . . . . 0.0 111.665 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.49 53.02 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.991 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.76 -49.14 8.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.569 0.223 . . . . 0.0 111.183 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.87 -146.23 10.39 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.752 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.1 169.47 19.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.502 2.801 . . . . 0.0 113.085 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.719 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -102.94 167.47 9.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.001 -179.293 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.526 HG12 HD22 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -63.22 -25.3 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.513 -175.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.508 ' N ' HG11 ' A' ' 12' ' ' VAL . 62.2 m -50.18 -33.9 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.602 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -45.71 64.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.66 -50.81 32.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.706 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -59.39 -29.86 68.03 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.09 68.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.444 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 15.5 2.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.032 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 174.24 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.96 143.87 37.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.528 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 -16.24 62.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 0.0 111.369 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.09 4.09 53.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.595 0.712 . . . . 0.0 110.104 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.23 153.57 20.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.618 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -97.01 141.41 15.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.0 t -93.37 128.94 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 110.997 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.17 138.28 23.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.64 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' H ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -100.98 124.37 46.59 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.661 -0.649 . . . . 0.0 109.681 175.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -156.17 126.04 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.451 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.615 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . 8.9 t-20 -95.13 93.04 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.33 147.8 22.6 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.435 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -69.89 -34.12 73.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.076 0.465 . . . . 0.0 109.792 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' OE2' ' HG2' ' A' ' 31' ' ' LYS . 2.0 pm0 -70.73 -40.23 72.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.419 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.26 -39.67 71.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -23.98 66.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.368 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -107.38 10.57 29.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.32 45.96 27.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.066 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.29 41.82 3.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.047 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.96 108.49 4.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.781 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.2 -45.27 4.16 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 -12.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -82.03 50.63 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.294 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.761 HG23 ' HB2' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -129.14 123.94 21.99 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.847 0.356 . . . . 0.0 110.667 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.6 123.09 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.599 HD12 HD11 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -68.33 -51.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.206 0.526 . . . . 0.0 110.697 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.34 115.8 31.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.1 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.6 t -129.68 -98.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.824 0.345 . . . . 0.0 110.889 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 tp -121.44 150.39 41.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.861 0.363 . . . . 0.0 111.359 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 98.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.447 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.01 -8.68 9.12 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.276 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.2 mt-10 -115.19 -61.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 5.2 m -140.95 137.77 33.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.309 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 141.46 18.56 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.403 0.44 . . . . 0.0 110.172 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.55 130.56 35.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -100.62 132.05 22.85 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.731 ' HB3' HD22 ' A' ' 57' ' ' ASN . 75.9 Cg_exo -49.26 119.81 4.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.109 2.539 . . . . 0.0 112.881 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.516 ' HA ' HD13 ' A' ' 59' ' ' LEU . 4.5 tp -79.89 -11.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.731 HD22 ' HB3' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -57.27 -50.22 73.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.411 -177.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -78.5 -27.72 14.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.148 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.526 HD22 HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -58.35 -27.23 63.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -55.51 6.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 111.888 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.452 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -94.96 -28.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.193 0.52 . . . . 0.0 111.398 -175.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' HB3' HD11 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -101.84 34.78 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -68.87 -13.06 62.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.689 . . . . 0.0 109.824 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.487 ' HA ' HD13 ' A' ' 64' ' ' LEU . 1.9 mm? -70.07 -11.5 60.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.181 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 62' ' ' ASN . 26.1 mt -64.44 120.6 66.68 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.253 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.719 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 21.6 Cg_exo -66.82 164.48 29.35 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.939 2.426 . . . . 0.0 112.139 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.23 -9.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.467 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -21.77 56.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.666 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -108.15 31.19 5.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 109.891 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -149.41 172.28 15.2 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.69 117.46 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.161 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 96.78 1.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.615 ' OD1' ' HB2' ' A' ' 29' ' ' ASN . 12.0 t0 -156.92 165.19 36.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.505 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.32 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.614 0.571 . . . . 0.0 109.482 170.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.531 ' H ' HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -69.49 137.18 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.339 -174.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 m -123.97 137.67 54.58 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.601 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.62 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -122.1 120.32 33.93 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.854 0.835 . . . . 0.0 109.093 175.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 4.8 m -112.97 163.05 15.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.849 -172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.27 128.87 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -41.03 107.84 0.1 OUTLIER Glycine 0 C--N 1.337 0.603 0 O-C-N 123.761 0.663 . . . . 0.0 113.27 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -77.94 91.6 4.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.323 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.0 159.11 15.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -53.41 111.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.1 -18.29 6.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.165 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -87.26 72.76 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.086 178.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.38 31.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.906 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -141.52 126.22 17.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.213 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.599 HD11 HD12 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -148.61 177.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.5 139.84 37.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.137 0.494 . . . . 0.0 110.858 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.761 ' HB2' HG23 ' A' ' 42' ' ' ILE . 57.4 m -109.77 143.22 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.544 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 141.78 33.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.48 131.45 36.03 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.62 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.9 OUTLIER -77.31 -58.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.486 0.66 . . . . 0.0 110.093 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tp -114.9 101.63 9.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.639 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.014 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.44 ' HG ' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.859 0.361 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.6 154.15 28.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.052 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 mt -100.56 110.56 60.75 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.345 . . . . 0.0 111.019 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD2' HD22 ' A' ' 69' ' ' ASN . 7.2 Cg_endo -89.68 126.3 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.261 2.641 . . . . 0.0 111.803 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.21 70.15 55.42 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.99 -61.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.682 2.255 . . . . 0.0 112.846 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.76 18.78 41.22 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.887 -172.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 50.39 56.8 7.39 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.679 0.392 . . . . 0.0 112.025 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 161.27 35.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.458 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.56 149.79 88.22 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.833 2.355 . . . . 0.0 111.574 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 153.3 38.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.034 0.445 . . . . 0.0 111.943 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -71.37 -25.37 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.612 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -59.7 -26.22 65.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.924 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.95 88.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.107 0.48 . . . . 0.0 109.91 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HA ' HD13 ' A' ' 94' ' ' LEU . . . -70.81 -41.36 71.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 176.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -61.99 -31.79 72.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.606 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -32.4 67.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.281 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -85.89 -5.91 59.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.841 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.528 ' HB2' HG22 ' A' ' 93' ' ' ILE . 19.9 t -115.75 175.99 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -170.9 34.95 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.807 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.85 -39.77 16.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.34 37.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.312 0.577 . . . . 0.0 110.382 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG3' ' HA ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -131.61 153.05 50.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.127 -177.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG21 HD22 ' A' ' 53' ' ' ASN . 12.2 p -100.86 144.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.201 0.524 . . . . 0.0 111.146 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.62 127.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.822 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 157.96 45.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 22.9 p -115.28 100.62 8.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.602 . . . . 0.0 109.854 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.8 m -143.07 111.36 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.911 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.33 0.585 . . . . 0.0 110.225 177.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 147.59 37.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.879 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.551 ' HD2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.53 -28.98 70.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.755 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 31' ' ' LYS . 7.1 mp0 -68.18 -38.71 82.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.646 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.78 -31.58 69.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.537 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.5 -12.51 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.986 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.45 2.67 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.314 -177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 53.77 43.49 30.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.712 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 137.64 14.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 110.809 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.08 91.46 4.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.92 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.2 -21.03 78.67 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.721 177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.71 -171.91 2.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -81.58 158.26 24.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.712 HD13 ' H ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -100.83 101.57 16.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.621 0.248 . . . . 0.0 111.507 -174.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 58.5 Cg_endo -98.78 116.21 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.579 2.852 . . . . 0.0 112.871 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' A' ' 53' ' ' ASN . 20.5 mt -77.78 103.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.054 0.454 . . . . 0.0 110.294 176.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -165.03 -141.44 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 t -113.03 101.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.844 0.354 . . . . 0.0 110.169 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.451 ' H ' ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -96.9 -161.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.414 ' H ' ' HB2' ' A' ' 47' ' ' LEU . 63.7 m -75.2 81.79 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 111.113 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.39 -105.22 0.33 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.38 149.77 41.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 15.7 t -178.34 143.71 0.29 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -161.2 147.21 14.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.167 0.508 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.668 ' HB2' HG22 ' A' ' 44' ' ' ILE . 10.1 t-20 -97.57 89.95 4.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.799 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.526 HG22 HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -64.13 127.07 91.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.226 -176.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HB3' HD22 ' A' ' 57' ' ' ASN . 50.6 Cg_exo -52.53 121.21 8.69 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.011 2.474 . . . . 0.0 112.824 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -19.23 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.831 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.579 HD22 ' HB3' ' A' ' 55' ' ' PRO . 7.0 p30 -61.84 -31.53 71.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.157 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pp -80.0 -37.6 17.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.577 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -14.43 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -170.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -40.48 64.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.736 0.303 . . . . 0.0 111.641 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.485 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -116.86 -24.14 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.338 0.59 . . . . 0.0 111.216 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.559 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.4 OUTLIER -92.57 34.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.733 -178.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -19.0 65.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.292 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -3.01 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.846 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -70.27 131.83 88.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.333 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 8.7 Cg_exo -73.43 154.41 50.62 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.763 2.309 . . . . 0.0 111.925 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 70' ' ' PHE . 2.1 tp -61.7 -8.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.318 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -12.53 20.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.767 0.317 . . . . 0.0 111.504 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.467 HD22 ' HD2' ' A' ' 4' ' ' PRO . 48.5 m-80 -97.14 3.45 51.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.49 0.662 . . . . 0.0 109.986 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.455 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -116.33 174.21 6.18 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.07 138.89 39.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.82 97.52 5.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.493 0.664 . . . . 0.0 110.563 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.56 159.72 39.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.08 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 4.2 m -50.47 102.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 110.725 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -61.49 120.04 6.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.425 -174.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -127.45 125.61 40.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.624 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.741 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -106.72 141.89 37.25 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 17.9 t -134.12 163.47 29.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.107 -167.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.555 ' HB2' HG21 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -57.43 133.67 55.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.31 115.86 6.74 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.982 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.77 92.88 0.91 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.986 0.422 . . . . 0.0 110.391 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -124.63 168.89 12.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.61 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.19 113.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.85 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.31 -30.79 3.58 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 102.73 13.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.807 0.337 . . . . 0.0 110.4 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -16.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.438 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -150.35 143.87 25.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.879 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 79' ' ' SER . 11.3 pt -130.23 153.78 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.512 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.0 113.37 23.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.958 0.409 . . . . 0.0 110.331 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.712 ' H ' HD13 ' A' ' 42' ' ' ILE . 1.4 m -109.02 142.4 39.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.944 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 154.86 30.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.458 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.87 129.72 31.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.535 2.157 . . . . 0.0 112.005 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.741 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -91.86 -34.17 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.754 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 15' ' ' ALA . 3.3 mp -105.43 131.31 53.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.25 1.113 0 O-C-N 124.378 1.049 . . . . 0.0 110.313 -177.563 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.04 110.63 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.993 0.425 . . . . 0.0 110.584 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.593 HG21 ' HA ' ' A' ' 65' ' ' ILE . 4.0 mt -91.07 114.14 60.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.657 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 3.0 Cg_exo -81.69 126.18 5.18 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.188 2.592 . . . . 0.0 111.907 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.49 78.09 38.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.739 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.94 -72.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.692 2.261 . . . . 0.0 110.904 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.92 123.05 6.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.74 68.58 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.608 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 178.71 47.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.281 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.95 147.81 91.83 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.581 2.187 . . . . 0.0 111.729 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.28 154.83 40.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.92 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.558 HG13 ' CE1' ' A' ' 70' ' ' PHE . 35.6 m -65.29 -24.67 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.341 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.622 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -60.58 -29.34 69.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.885 177.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.1 tpt -69.48 -35.76 75.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.506 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.67 -30.95 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.77 -30.17 68.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.901 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -58.37 -32.34 68.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.243 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -73.81 -10.83 60.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.789 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 177.56 7.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.85 0.357 . . . . 0.0 110.644 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 163.47 29.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.58 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 10.13 37.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.612 . . . . 0.0 109.607 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -118.61 170.87 8.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.353 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.522 HG23 HD22 ' A' ' 53' ' ' ASN . 7.1 p -116.22 131.23 69.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.097 0.475 . . . . 0.0 110.943 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.4 133.12 30.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.918 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.37 161.22 43.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 4.4 p -110.16 99.68 8.71 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.181 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -130.02 113.45 14.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.149 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -92.7 124.85 37.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.914 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -119.47 151.7 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -71.29 -48.42 50.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.61 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -19.09 52.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.914 ' HB2' ' HB3' ' A' ' 30' ' ' SER . 4.8 tp -62.59 -28.02 69.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.107 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -81.98 -34.56 29.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.976 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -92.57 -23.32 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.001 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.64 -171.5 3.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.711 0.291 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -112.31 73.4 0.81 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.031 0.444 . . . . 0.0 110.487 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.419 ' HB2' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -100.4 -128.59 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.731 -178.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 38' ' ' SER . . . 79.17 19.95 71.0 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.048 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.48 -46.58 87.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.976 0.417 . . . . 0.0 111.277 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 87' ' ' ASN . 2.9 tt0 -137.42 114.76 10.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.812 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -155.24 124.08 3.03 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.683 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.25 148.5 13.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.79 2.326 . . . . 0.0 111.863 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.824 HG21 ' HB2' ' A' ' 53' ' ' ASN . 3.4 mm -102.73 137.2 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.799 0.333 . . . . 0.0 110.589 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.73 -170.5 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.92 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.79 108.48 25.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.84 118.67 5.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.562 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.17 91.77 1.3 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.716 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.24 6.61 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.902 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.411 ' HB3' ' H ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -131.56 -78.89 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 73.6 m -142.89 138.25 30.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.361 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 119.42 8.02 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.431 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.824 ' HB2' HG21 ' A' ' 44' ' ' ILE . 19.8 t-20 -77.72 110.22 12.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -88.9 120.95 70.09 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.545 ' HB2' HD21 ' A' ' 57' ' ' ASN . 11.5 Cg_endo -54.65 121.28 9.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.024 2.483 . . . . 0.0 112.561 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.46 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -74.09 -8.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.624 -175.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.545 HD21 ' HB2' ' A' ' 55' ' ' PRO . 1.1 m-80 -59.83 -43.37 94.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.11 -17.38 13.22 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.657 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.46 HD11 ' HA ' ' A' ' 56' ' ' ILE . 5.6 mp -74.61 -21.08 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.718 0.294 . . . . 0.0 111.041 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 -42.81 15.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.661 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.627 HG13 ' H ' ' A' ' 62' ' ' ASN . 8.7 pt -107.57 -48.66 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.239 0.543 . . . . 0.0 111.343 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.627 ' H ' HG13 ' A' ' 61' ' ' ILE . 42.4 m-20 -84.8 34.42 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.788 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.622 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 22.1 pt20 -64.52 -12.14 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.549 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 3' ' ' ILE . 3.9 mt -80.27 -0.43 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.354 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.593 ' HA ' HG21 ' A' ' 3' ' ' ILE . 15.5 mt -75.84 127.28 85.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.991 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.88 157.03 61.23 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 70' ' ' PHE . 1.7 tp -62.72 -7.85 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -27.89 16.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 175.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.452 HD22 ' HG2' ' A' ' 4' ' ' PRO . 22.3 m-20 -86.02 8.67 19.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.208 0.528 . . . . 0.0 111.086 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.606 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -111.43 172.9 6.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.93 136.9 44.75 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.28 97.71 9.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.315 0.578 . . . . 0.0 111.092 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -156.31 162.78 40.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 m -44.42 104.24 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.812 0.695 . . . . 0.0 110.837 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.793 HG21 HD23 ' A' ' 94' ' ' LEU . 1.5 t -56.04 122.45 5.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.968 -173.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.58 157.46 33.63 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.628 ' HB2' HG12 ' A' ' 93' ' ' ILE . 51.2 t -139.29 130.18 26.26 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 4.1 m -117.14 163.47 16.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.905 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.455 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.87 135.75 47.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 174.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -42.97 106.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.389 0 O-C-N 123.884 0.74 . . . . 0.0 113.39 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 122.82 16.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.412 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.76 149.32 32.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -65.92 112.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.99 176.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.84 -18.49 8.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 119.49 25.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -81.77 87.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.036 -178.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.46 HD21 ' HG2' ' A' ' 41' ' ' GLU . 11.5 t30 72.46 163.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.132 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -138.17 170.18 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.445 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -116.15 126.82 54.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 178.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 73.3 m -108.81 130.03 55.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.384 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -133.54 146.92 62.57 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.266 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.5 131.54 30.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 111.672 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.628 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -108.91 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.65 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.793 HD23 HG21 ' A' ' 75' ' ' VAL . 7.5 tp -81.59 74.14 8.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.451 0.643 . . . . 0.0 111.008 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.246 0.903 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.639 174.575 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -83.7 139.11 32.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.558 HG21 ' HA ' ' A' ' 65' ' ' ILE . 2.2 mp -83.16 111.23 29.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 9.6 Cg_endo -89.42 126.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.56 2.84 . . . . 0.0 112.023 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.63 81.05 70.56 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 120.902 0.382 . . . . 0.0 111.7 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.99 -41.02 47.43 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.906 2.404 . . . . 0.0 110.756 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.64 149.08 20.82 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.983 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.06 88.14 4.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.229 0.514 . . . . 0.0 110.887 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.85 165.46 19.95 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 140.93 96.5 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.476 2.117 . . . . 0.0 111.779 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.92 154.15 28.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 0.0 111.115 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.05 -24.88 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.915 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.514 ' HG ' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -55.11 -32.31 61.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.801 175.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -48.01 79.67 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.086 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.73 73.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.82 -29.49 70.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.744 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -31.23 64.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -16.19 61.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.932 -176.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 175.46 6.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 111.558 -176.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.16 154.58 25.5 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.633 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -16.36 62.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.777 0.322 . . . . 0.0 111.21 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.0 22.14 9.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.359 0.6 . . . . 0.0 110.379 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.98 171.31 8.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 78' ' ' CYS . 14.9 p -114.68 132.31 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -175.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.535 HG21 ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -92.92 136.38 25.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.602 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.403 ' HA ' HD13 ' A' ' 54' ' ' ILE . 53.2 m -155.27 162.17 40.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.743 0.306 . . . . 0.0 110.344 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 13.2 m -99.99 101.53 12.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.3 100.36 6.8 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.177 -175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -102.84 93.74 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.147 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.07 150.74 24.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.094 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -40.65 96.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -34.98 70.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.343 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 1.7 tp -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.258 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.65 -22.0 66.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.242 0.544 . . . . 0.0 110.756 -179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -96.03 26.38 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.713 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.81 47.18 24.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.77 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -153.49 136.91 15.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.947 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.79 76.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.393 0.616 . . . . 0.0 109.983 174.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 179.0 38.41 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.079 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.76 -23.6 10.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.391 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -107.1 85.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.55 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -119.38 96.14 49.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 -178.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.27 166.76 2.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.019 2.479 . . . . 0.0 111.951 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.607 HD13 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -131.75 -98.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.442 ' H ' ' HB ' ' A' ' 44' ' ' ILE . 3.7 t70 55.99 -140.88 0.86 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.588 0.555 . . . . 0.0 111.314 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.43 70.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -84.52 115.88 22.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.96 91.39 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.074 0.464 . . . . 0.0 111.62 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.46 19.63 9.72 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.534 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 47' ' ' LEU . 4.1 mt-10 -144.45 -76.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.033 0.416 . . . . 0.0 110.536 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 23.7 m -121.62 137.47 54.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.817 0.341 . . . . 0.0 110.083 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -142.47 119.06 11.01 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.69 135.82 36.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -112.74 139.4 22.76 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.98 122.07 11.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.808 2.338 . . . . 0.0 112.754 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 24' ' ' VAL . 9.9 tp -71.24 -19.77 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.573 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -39.69 76.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.759 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -80.6 -25.14 11.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.738 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.535 ' HG ' HG21 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -62.97 -15.27 55.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -35.64 21.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 0.0 111.787 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 62' ' ' ASN . 2.3 pt -109.35 -22.32 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.4 0.619 . . . . 0.0 111.61 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.656 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -108.39 26.15 10.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -174.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' HB2' ' HG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.411 0.624 . . . . 0.0 109.851 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -81.86 -2.52 51.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.378 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -70.04 141.4 89.22 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.051 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.508 ' HB2' HD21 ' A' ' 68' ' ' ASN . 3.3 Cg_exo -76.97 150.77 30.27 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.593 2.195 . . . . 0.0 110.723 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 tp -58.04 -9.54 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.508 HD21 ' HB2' ' A' ' 66' ' ' PRO . 0.4 OUTLIER -63.96 -19.45 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 176.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.67 24.33 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 109.618 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.24 173.65 11.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.8 124.87 49.71 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.344 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.0 m -76.93 94.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.851 0.834 . . . . 0.0 109.368 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.94 160.89 39.52 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -42.34 104.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.558 0.694 . . . . 0.0 111.326 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.17 124.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.687 -173.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 47.1 m -129.36 147.05 51.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.083 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.4 t -120.23 119.55 33.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 24' ' ' VAL . 3.9 m -109.53 163.45 13.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.313 -173.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.05 128.39 30.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.45 103.71 0.16 Allowed Glycine 0 C--N 1.331 0.272 0 O-C-N 123.552 0.532 . . . . 0.0 112.919 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -72.92 135.61 45.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.047 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.484 ' H ' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -151.8 149.25 28.81 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.492 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -45.41 111.98 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.975 0.797 . . . . 0.0 110.988 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.86 -13.8 5.79 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.941 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.484 HD11 ' H ' ' A' ' 82' ' ' GLN . 2.1 mt -99.21 149.71 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -49.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 149.7 50.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.502 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -149.74 178.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.723 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -117.1 132.89 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.528 ' H ' HD13 ' A' ' 42' ' ' ILE . 8.1 m -107.52 128.94 54.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.418 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 91' ' ' THR . 1.3 t -134.6 142.81 44.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.099 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 35.3 Cg_endo -65.01 137.54 53.09 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.534 2.156 . . . . 0.0 112.508 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.695 HD13 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -82.4 -25.66 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.222 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.69 115.99 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.255 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.632 0.253 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.54 163.02 17.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.67 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 mt -81.19 112.83 36.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.704 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HG2' HD22 ' A' ' 69' ' ' ASN . 1.3 Cg_endo -85.18 126.03 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.066 2.511 . . . . 0.0 111.329 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 68.88 67.12 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.78 -27.01 5.13 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 111.059 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.32 100.47 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.779 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -70.04 89.2 0.61 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.477 . . . . 0.0 111.031 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.14 -140.37 11.28 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.09 136.09 43.05 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.489 2.126 . . . . 0.0 110.991 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -102.07 164.45 11.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.555 0.217 . . . . 0.0 110.918 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 1.4 p -64.74 -25.5 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -69.55 -27.12 64.87 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 ttt -62.01 -48.78 78.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.207 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.71 -30.1 66.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -67.61 -30.53 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.021 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.4 -31.69 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.52 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -10.31 44.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.645 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -113.62 176.54 4.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.88 169.55 38.77 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.958 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.14 -7.43 59.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 111.024 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.28 13.43 33.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 0.0 109.81 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.08 146.96 43.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.85 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 123.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.634 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.661 ' HB ' HD23 ' A' ' 59' ' ' LEU . 42.5 t -85.65 104.33 13.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.674 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -109.91 165.39 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.063 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.1 p -107.46 99.91 9.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 42.4 t -133.62 121.04 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.52 ' HB2' ' H ' ' A' ' 74' ' ' THR . 1.9 t30 -121.52 100.08 6.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.944 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.8 162.17 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.838 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -71.53 -40.4 70.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.304 0.573 . . . . 0.0 110.258 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.2 pm0 -64.05 -31.81 73.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.687 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.478 HD21 ' HA ' ' A' ' 33' ' ' LEU . 3.0 mt -61.74 -28.19 69.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.868 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -8.41 55.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -121.51 13.87 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.005 0.431 . . . . 0.0 110.869 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 m -78.96 97.09 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.309 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -96.6 -48.38 5.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.076 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -22.56 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.383 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.34 153.85 8.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.096 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.98 177.6 9.71 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -104.35 117.9 35.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.177 0.298 . . . . 0.0 110.413 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 tp -151.59 86.61 4.62 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.404 0.621 . . . . 0.0 110.51 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.64 135.54 18.05 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.842 2.361 . . . . 0.0 111.619 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.1 131.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.429 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -120.82 -153.26 0.54 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.93 98.6 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.786 0.327 . . . . 0.0 110.353 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.73 100.03 4.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.998 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.65 99.18 0.43 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.952 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 5.21 10.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.216 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.65 -66.09 0.39 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.679 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 93.9 m -145.77 137.21 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.308 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 124.62 18.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.152 0.501 . . . . 0.0 110.977 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 56.1 t30 -86.57 131.83 34.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.645 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -111.5 128.24 25.69 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.066 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 72.0 Cg_exo -49.67 123.2 10.13 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.643 2.895 . . . . 0.0 113.129 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 18.4 tt -68.85 -12.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.049 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -46.02 91.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.035 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 pt -77.97 -17.62 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.661 HD23 ' HB ' ' A' ' 25' ' ' VAL . 5.2 mp -72.74 -24.57 60.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.394 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -86.02 -56.68 3.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.561 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.8 pt -93.66 -39.43 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.561 ' N ' HG13 ' A' ' 61' ' ' ILE . 34.4 m-20 -94.02 31.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 0.0 110.061 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 pt20 -66.79 -8.1 26.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.08 -6.49 57.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.182 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.455 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 71.6 mt -71.57 123.02 88.76 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.739 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 2.7 Cg_exo -77.0 167.62 24.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.906 2.404 . . . . 0.0 112.268 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.89 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.24 -9.92 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.247 0.619 . . . . 0.0 112.179 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.12 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.696 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.452 HD22 ' HG2' ' A' ' 4' ' ' PRO . 1.7 m-80 -111.59 15.48 21.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 110.51 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.89 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 58.7 m-85 -129.55 173.69 10.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.879 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.37 142.97 33.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.061 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 95.93 10.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.638 0.732 . . . . 0.0 110.533 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.68 160.83 40.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.52 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 20.6 m -42.43 120.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 111.712 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.4 124.31 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.869 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -145.35 112.05 5.88 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -171.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.437 ' SG ' HG12 ' A' ' 93' ' ' ILE . 31.1 p -98.7 136.27 38.99 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 15.2 t -119.5 163.49 17.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.843 -174.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.521 ' HB2' HG23 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -53.9 124.93 16.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -39.25 112.08 0.22 Allowed Glycine 0 C--N 1.336 0.552 0 O-C-N 124.206 0.941 . . . . 0.0 112.772 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.24 102.44 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.167 0.508 . . . . 0.0 110.993 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.37 146.47 48.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.185 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -65.86 126.89 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.0 -13.44 11.35 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 113.51 16.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.75 -14.59 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.245 0.545 . . . . 0.0 110.54 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.54 89.27 3.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.311 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 79' ' ' SER . 3.0 pt -104.06 145.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.1 117.12 30.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.748 0.785 . . . . 0.0 110.199 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.9 m -108.98 139.76 43.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.999 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.47 145.54 32.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.882 0.373 . . . . 0.0 111.353 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.47 ' HD3' HD23 ' A' ' 33' ' ' LEU . 39.2 Cg_endo -69.12 126.84 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.459 2.106 . . . . 0.0 111.7 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.437 HG12 ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -87.8 -42.42 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 111.027 -177.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.51 129.66 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.347 178.237 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.044 0.45 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.46 163.03 13.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.554 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.33 112.21 54.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.601 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.33 125.25 3.9 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.695 2.264 . . . . 0.0 111.393 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.31 68.2 46.97 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.55 32.03 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.243 2.628 . . . . 0.0 110.829 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.69 77.85 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 96.98 6.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.936 0.398 . . . . 0.0 111.078 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.62 -143.57 15.08 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.48 130.04 33.85 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.368 2.045 . . . . 0.0 111.486 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -74.82 154.82 38.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 67' ' ' ILE . 34.2 m -67.6 -26.0 34.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 0.0 111.467 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -26.32 64.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -41.35 98.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.83 70.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.342 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.04 -30.96 69.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.472 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -56.0 -31.31 62.94 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.924 0.489 . . . . 0.0 111.19 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 0.88 24.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.528 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 t -141.77 175.91 9.33 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.242 -0.286 . . . . 0.0 110.323 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.14 133.51 48.83 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.64 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.84 -18.64 64.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.899 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 31.91 4.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 110.439 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 167.8 12.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 1.055 HG22 ' HB3' ' A' ' 78' ' ' CYS . 0.1 OUTLIER -86.76 126.05 40.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.941 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 m -94.7 131.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.585 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.9 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -148.89 167.76 24.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.335 -178.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.49 113.46 19.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.472 ' CA ' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m -130.29 123.12 29.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.211 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 1.4 p30 -88.4 97.05 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.737 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.788 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.7 m -126.81 146.93 50.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.372 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.81 -42.62 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.212 0.53 . . . . 0.0 110.659 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -71.77 -27.72 63.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 1.2 tp -65.82 -36.98 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.916 0.389 . . . . 0.0 111.042 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -11.92 61.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.494 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -118.84 12.07 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.31 0.576 . . . . 0.0 110.425 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.433 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 61.3 m -81.57 74.73 8.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.213 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HG3' ' HG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -97.56 -4.4 37.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.471 ' HG ' ' HG3' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -118.31 -102.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.405 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 38' ' ' SER . . . -151.44 151.03 23.04 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.698 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.68 144.38 8.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -93.58 81.54 4.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.292 0.568 . . . . 0.0 110.488 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -117.24 127.59 26.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 176.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 96.0 Cg_endo -94.71 170.47 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.044 2.496 . . . . 0.0 112.895 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.441 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -104.79 74.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.466 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 11.2 p30 -95.66 16.77 16.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.989 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 53.8 t 74.43 -52.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.631 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.12 25.24 1.0 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.931 -0.481 . . . . 0.0 111.595 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.42 58.21 1.66 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.651 0.739 . . . . 0.0 109.598 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . 97.69 -47.21 1.56 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.777 -175.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 3.1 tt0 152.67 61.43 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.503 1.121 . . . . 0.0 109.423 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.472 ' HB2' ' CA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -116.81 154.18 31.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 124.3 28.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.053 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.9 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 17.9 t-20 -85.57 120.29 26.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.778 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -90.76 139.78 26.28 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.431 -172.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.778 ' HD2' HG22 ' A' ' 54' ' ' ILE . 9.1 Cg_endo -49.98 123.07 10.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.847 3.031 . . . . 0.0 113.27 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.811 ' HA ' HD21 ' A' ' 59' ' ' LEU . 6.1 tp -72.26 -22.85 21.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.224 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -31.18 68.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -26.74 12.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -176.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.811 HD21 ' HA ' ' A' ' 56' ' ' ILE . 1.4 mm? -60.47 -27.77 67.81 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -168.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -43.83 66.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 112.047 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.0 pt -105.64 -37.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.351 0.596 . . . . 0.0 111.45 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.437 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.35 29.92 0.93 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.397 -175.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -63.65 -20.02 65.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.501 0.667 . . . . 0.0 109.708 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.12 0.56 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.764 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.436 HG12 HD21 ' A' ' 69' ' ' ASN . 1.9 tt -81.37 130.5 61.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.328 0.585 . . . . 0.0 109.86 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -75.19 158.18 41.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.414 2.076 . . . . 0.0 111.674 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 12' ' ' VAL . 3.1 tp -59.66 -9.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.413 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -21.01 66.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.634 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.436 HD21 HG12 ' A' ' 65' ' ' ILE . 50.7 m-80 -100.18 27.73 5.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.652 0.739 . . . . 0.0 109.661 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.26 174.45 10.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.95 118.96 37.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.609 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.58 97.86 1.39 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.479 -172.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.46 100.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 109.871 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -58.69 130.44 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.224 -172.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -120.94 119.8 33.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.279 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.0 t -110.86 121.17 44.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 1.055 ' HB3' HG22 ' A' ' 24' ' ' VAL . 6.2 t -120.67 162.65 19.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.501 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.631 ' HB2' HG23 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -60.49 124.8 21.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -46.47 113.44 1.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 O-C-N 123.692 0.62 . . . . 0.0 113.013 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 90.12 1.37 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.36 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -138.31 174.59 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.561 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.1 121.87 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.016 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.37 -21.71 9.16 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.703 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 95.51 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 111.331 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.496 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -91.21 -22.5 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.405 176.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.01 107.65 18.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 79' ' ' SER . 9.5 pt -121.43 159.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.394 . . . . 0.0 110.916 -172.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.85 113.32 17.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.767 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.37 134.27 50.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.767 179.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 157.27 77.07 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.839 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.7 Cg_exo -61.6 126.89 20.17 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.829 2.352 . . . . 0.0 112.341 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 75' ' ' VAL . 1.3 mt -76.92 -36.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.031 0.443 . . . . 0.0 111.814 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.32 116.19 17.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.034 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.678 0.275 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.531 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -132.6 163.46 28.85 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.608 HG21 HG13 ' A' ' 65' ' ' ILE . 12.9 mt -87.0 109.1 21.95 Favored Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.165 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -89.0 136.81 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.67 ' HB1' ' HG2' ' A' ' 66' ' ' PRO . . . -156.79 89.47 2.63 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.28 -53.29 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.627 2.218 . . . . 0.0 111.9 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.83 49.46 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.326 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -84.04 -47.17 11.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.99 -101.01 0.6 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.021 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.93 148.08 30.78 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.322 2.681 . . . . 0.0 113.297 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.49 167.15 10.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -66.36 -27.34 40.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 110.732 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -69.23 -26.61 64.89 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.979 -176.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -48.19 80.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.164 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.22 -41.75 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.221 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -61.4 -31.24 71.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -56.51 -31.2 63.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.06 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -80.93 -4.34 54.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.028 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -127.7 175.39 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.158 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.59 153.44 40.66 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.363 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.09 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.12 27.64 8.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 0.0 111.045 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.9 153.07 29.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG21 HD22 ' A' ' 53' ' ' ASN . 7.6 p -95.36 122.84 47.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.195 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -92.04 103.8 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.453 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.93 148.96 35.94 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.369 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.717 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 29.8 p -102.96 101.55 11.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.672 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -157.34 109.97 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.508 -176.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.72 147.97 22.77 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.44 155.06 45.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.803 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.84 -48.0 82.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.233 0.54 . . . . 0.0 110.566 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' A' ' 31' ' ' LYS . 2.3 pm0 -70.37 -23.79 62.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.447 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -66.16 -32.86 74.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -70.31 -8.0 46.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.32 0.581 . . . . 0.0 110.74 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.43 12.83 9.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.571 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 33' ' ' LEU . 50.6 m -84.22 82.08 8.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.56 -14.26 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 109.624 173.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -124.19 172.69 8.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.693 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.65 107.55 3.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.949 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.15 139.7 33.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.74 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -80.38 70.8 7.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.244 0.545 . . . . 0.0 111.312 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.5 tp -106.91 110.85 63.83 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.414 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.25 156.29 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.986 2.457 . . . . 0.0 111.579 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.405 HG13 ' SG ' ' A' ' 90' ' ' CYS . 2.7 mp -72.67 110.63 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.973 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -72.25 144.42 48.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.961 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.26 81.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -174.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.501 HD13 ' HG3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER 62.11 25.52 15.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.955 172.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -80.23 56.08 2.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 109.477 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.06 -95.23 0.11 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.78 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.56 22.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.622 . . . . 0.0 109.949 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 12.8 p -139.1 169.69 17.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.511 -170.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' HG3' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -165.11 154.46 12.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.55 -177.299 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.484 HD22 HG21 ' A' ' 24' ' ' VAL . 17.0 t-20 -77.5 114.88 16.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.321 172.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.699 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -83.63 141.21 41.52 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.532 -176.107 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' O ' HD13 ' A' ' 59' ' ' LEU . 23.4 Cg_endo -62.14 119.95 7.3 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.768 2.312 . . . . 0.0 113.173 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.562 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -78.75 -12.55 13.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.362 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -56.45 -45.88 80.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.193 -178.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -33.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.97 -23.24 31.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -54.38 15.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.77 0.319 . . . . 0.0 111.455 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.521 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -92.33 -35.94 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 0.0 110.736 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -91.12 35.99 0.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.779 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -66.88 -13.42 61.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.202 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.84 18.25 6.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.359 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.608 HG13 HG21 ' A' ' 3' ' ' ILE . 10.7 tt -91.94 135.85 26.84 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 7.3 Cg_exo -75.85 163.72 33.0 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.879 2.386 . . . . 0.0 112.309 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.782 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 4.4 tp -65.19 -8.71 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.564 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -56.88 -24.23 50.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.502 HD22 ' HG2' ' A' ' 4' ' ' PRO . 2.6 m-80 -94.8 12.3 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.782 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 86.9 m-85 -127.04 174.16 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.004 -174.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.38 138.8 40.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.225 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.47 99.42 7.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.205 0.526 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 0.7 OUTLIER -153.98 158.88 41.29 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 m -50.85 113.5 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.969 0.414 . . . . 0.0 110.419 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -61.95 125.58 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.354 -176.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -127.4 112.96 15.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.577 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.55 ' HB2' HG12 ' A' ' 93' ' ' ILE . 35.9 t -98.11 119.45 36.77 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.932 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 2.4 m -115.07 163.83 15.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.321 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.33 119.16 3.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -34.1 107.05 0.03 OUTLIER Glycine 0 C--N 1.337 0.635 0 O-C-N 124.442 1.089 . . . . 0.0 113.91 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 109.02 2.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.307 0.575 . . . . 0.0 110.598 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' H ' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -121.6 156.05 33.76 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.586 -179.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 pt -58.33 112.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 123.476 0.485 . . . . 0.0 110.605 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.01 -12.43 11.52 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.034 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD11 ' H ' ' A' ' 82' ' ' GLN . 10.9 mt -90.72 103.26 15.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.069 0.462 . . . . 0.0 110.488 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.14 -50.51 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.329 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.43 129.86 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 pt -146.56 170.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.11 131.65 55.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.023 0.44 . . . . 0.0 110.648 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.405 ' SG ' HG13 ' A' ' 44' ' ' ILE . 12.0 m -110.01 127.25 54.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.05 135.21 21.0 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.623 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.96 127.78 23.4 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.899 2.399 . . . . 0.0 112.038 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.28 -61.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.893 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 100.34 13.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.052 0.453 . . . . 0.0 110.651 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.033 176.232 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -106.07 146.87 29.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mt -100.76 109.58 58.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 8.9 Cg_endo -90.42 126.09 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.861 3.041 . . . . 0.0 111.818 175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -140.34 61.64 17.39 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.453 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 17.0 Cg_exo -68.04 -53.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.428 2.085 . . . . 0.0 110.325 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.47 78.75 0.28 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.33 2.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.532 . . . . 0.0 110.9 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.04 -155.08 7.89 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.081 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.08 124.6 16.67 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.47 2.113 . . . . 0.0 111.854 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -83.35 156.11 23.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.208 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.5 p -61.31 -27.81 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.109 0.481 . . . . 0.0 110.788 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 63' ' ' GLN . 36.6 m -56.04 -38.92 71.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.9 tpp -64.45 -47.24 79.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.911 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.25 74.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.884 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -31.97 64.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.173 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -77.22 -4.8 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.492 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 175.05 8.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.03 134.94 43.3 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.38 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -23.74 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.945 0.402 . . . . 0.0 111.054 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 37.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.703 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -125.4 158.66 33.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.296 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.06 125.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 110.25 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.2 114.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.573 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 144.15 50.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.79 101.99 12.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.514 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.805 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 1.8 t -142.4 112.89 7.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.181 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.865 ' HB2' ' H ' ' A' ' 74' ' ' THR . 26.9 t30 -106.07 94.2 5.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.48 150.93 23.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.904 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -36.62 79.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.276 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.88 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -31.45 71.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.798 178.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.34 -42.67 25.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.552 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.92 -22.68 22.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.697 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.51 71.15 0.47 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.906 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 132.23 55.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.17 124.94 24.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.963 0.411 . . . . 0.0 110.26 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.91 -13.01 38.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.049 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.88 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . . . -75.72 168.58 19.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.576 0.227 . . . . 0.0 110.626 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.86 135.56 33.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 111.394 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.77 98.22 36.85 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.451 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.53 152.76 20.3 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 123.346 2.697 . . . . 0.0 112.195 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -138.64 -51.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.982 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -88.32 -13.3 41.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.099 -173.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.0 147.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.486 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HG ' ' N ' ' A' ' 48' ' ' SER . 7.7 tp -158.54 151.15 22.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.129 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.476 ' N ' ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -70.27 78.0 0.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.497 0.665 . . . . 0.0 110.722 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.12 -114.57 0.45 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.33 33.62 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.085 0.469 . . . . 0.0 109.856 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.805 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -90.35 140.45 29.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.629 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.38 147.18 25.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 112.155 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -83.55 110.2 18.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.625 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.675 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -87.67 143.18 33.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.279 -176.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 32.1 Cg_exo -59.19 120.75 8.79 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.86 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.428 ' O ' HG21 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -78.95 -23.56 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -34.95 70.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.22 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.39 -31.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.202 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -33.34 68.55 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -170.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -26.28 68.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.557 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.6 pt -121.15 -40.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.452 0.644 . . . . 0.0 110.749 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.557 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -89.48 35.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.507 -176.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -70.73 -8.47 52.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 179.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -5.05 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.144 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.504 HG23 ' CE2' ' A' ' 70' ' ' PHE . 5.4 mt -70.68 128.65 90.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.385 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.1 Cg_exo -81.08 164.72 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.288 2.659 . . . . 0.0 111.602 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.779 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -60.01 -13.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -13.65 59.17 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 111.4 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.56 12.64 36.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.384 0.611 . . . . 0.0 109.885 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.779 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 66.3 m-85 -130.99 177.55 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.35 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.11 145.02 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.074 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.23 96.72 7.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.0 110.125 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.2 159.47 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.26 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.865 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 65.2 m -51.9 107.96 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.13 0.49 . . . . 0.0 110.27 175.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.49 124.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.205 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.8 m -127.31 133.89 50.07 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.936 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.649 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -110.2 123.3 49.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -120.45 162.05 20.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.273 -173.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.51 126.68 20.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.502 0.192 . . . . 0.0 110.56 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.79 106.04 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.508 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.59 138.46 43.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.553 -0.324 . . . . 0.0 111.096 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.62 171.5 18.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.406 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 pt -62.94 123.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.72 -27.7 7.78 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.693 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.23 147.13 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.142 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -117.14 -66.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.344 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.77 127.12 56.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -113.68 152.26 15.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.74 118.72 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.03 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 9.5 t -116.43 138.64 51.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.583 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -143.1 141.23 19.04 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.312 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 25.9 Cg_exo -62.74 130.79 30.73 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.649 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -84.49 -43.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.678 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.06 120.41 37.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.726 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.858 -1.068 . . . . 0.0 109.264 176.796 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 121.042 0.449 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -97.71 164.1 12.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.948 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -80.8 111.22 21.56 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.742 0.306 . . . . 0.0 110.728 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.7 ' HG2' HD22 ' A' ' 69' ' ' ASN . 1.1 Cg_endo -87.95 128.74 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.219 2.612 . . . . 0.0 112.05 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.65 ' HB1' ' HG2' ' A' ' 66' ' ' PRO . . . -149.34 91.12 4.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.197 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.77 -53.63 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.25 47.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.311 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -83.12 -59.02 2.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.12 -89.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.242 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.92 137.1 77.9 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.23 2.62 . . . . 0.0 113.331 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.787 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -93.73 157.63 16.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.514 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.35 -27.27 23.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -37.14 85.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.021 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -42.73 86.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -49.67 38.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.21 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.404 ' HG3' ' CG2' ' A' ' 25' ' ' VAL . 3.3 tt0 -63.43 -28.83 70.25 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.745 -176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -30.25 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.942 0.401 . . . . 0.0 111.232 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -7.44 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.88 174.76 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.33 166.71 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.804 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.14 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.452 . . . . 0.0 110.967 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.92 37.46 1.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.42 0.629 . . . . 0.0 109.906 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.68 155.95 31.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.991 177.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.57 132.4 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.751 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 54' ' ' ILE . 89.1 t -86.17 137.49 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -148.32 150.76 34.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.917 0.389 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 108.86 16.99 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.9 t -151.38 103.57 3.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -85.28 93.22 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 110.025 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 147.46 25.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -70.57 -38.87 74.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.295 0.569 . . . . 0.0 109.841 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.04 -37.98 87.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.533 HD21 ' HG3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -69.51 -31.28 69.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.886 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -29.42 34.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -95.0 -30.28 14.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.867 0.365 . . . . 0.0 111.488 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.88 85.09 2.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 132.01 51.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.664 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m 65.33 59.03 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.599 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.22 137.84 23.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.45 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 -62.23 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HG2' ' ND2' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -102.23 94.39 5.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.131 -174.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 102.96 8.96 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.007 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.605 ' HA ' HG13 ' A' ' 88' ' ' ILE . 86.5 Cg_endo -84.82 156.72 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.059 2.506 . . . . 0.0 112.585 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.32 121.27 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.416 . . . . 0.0 110.895 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -127.21 156.21 42.21 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.72 91.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.28 174.72 6.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.61 -177.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.27 66.1 4.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.479 0.657 . . . . 0.0 110.343 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.63 -128.18 1.79 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.861 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 13.11 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.206 0.527 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.29 138.29 31.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.722 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.94 139.35 14.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.69 175.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.18 114.69 22.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -80.15 134.09 56.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.796 -170.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.457 ' HB3' HD22 ' A' ' 57' ' ' ASN . 41.8 Cg_exo -58.07 122.56 11.91 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.394 2.729 . . . . 0.0 113.587 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 56' ' ' ILE . 4.7 mm -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.559 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.457 HD22 ' HB3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -53.35 -34.74 58.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.39 -174.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pt -79.81 -40.3 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.417 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -22.81 57.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -58.26 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.552 HG13 ' N ' ' A' ' 62' ' ' ASN . 12.7 pt -91.09 -35.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.575 ' HB3' HD12 ' A' ' 65' ' ' ILE . 7.4 m-20 -92.22 37.24 0.99 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.509 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -8.12 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.488 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 3' ' ' ILE . 1.4 mt -79.02 -9.49 59.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 62' ' ' ASN . 54.3 mt -69.49 124.96 91.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.63 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.787 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -77.91 174.77 12.05 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.25 -8.64 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.453 ' ND2' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -60.39 -21.91 62.72 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.7 HD22 ' HG2' ' A' ' 4' ' ' PRO . 5.9 m-80 -102.12 24.54 9.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.427 0.632 . . . . 0.0 110.003 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -142.94 172.76 12.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.62 139.11 40.72 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.076 0.465 . . . . 0.0 111.368 -171.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.91 98.39 6.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.653 0.74 . . . . 0.0 109.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.19 162.16 41.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.208 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -52.72 98.86 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -54.4 129.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.54 -171.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.0 140.29 51.19 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.387 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.631 ' HB2' HG12 ' A' ' 93' ' ' ILE . 48.2 t -135.55 122.98 21.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -122.86 164.34 18.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.612 -172.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.91 128.48 18.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.389 0.431 . . . . 0.0 110.548 174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.67 118.15 1.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.827 0.705 . . . . 0.0 113.641 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 93.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.458 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.38 160.39 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.61 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.12 113.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.69 -37.52 2.05 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.847 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.76 98.56 10.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.886 0.374 . . . . 0.0 110.182 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.52 -38.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.227 0.536 . . . . 0.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.417 ' ND2' ' HG2' ' A' ' 41' ' ' GLU . 9.3 t-20 -118.61 114.59 23.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.508 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.605 HG13 ' HA ' ' A' ' 43' ' ' PRO . 21.0 pt -107.21 150.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.175 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -99.8 118.7 36.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 t -108.0 130.74 55.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.229 0.538 . . . . 0.0 110.346 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 m -131.51 136.23 28.24 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.26 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HG3' HD21 ' A' ' 33' ' ' LEU . 68.7 Cg_exo -53.39 127.53 25.62 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.686 2.257 . . . . 0.0 112.376 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.631 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -79.57 -23.08 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.352 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.92 139.92 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.02 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.125 0 O-C-N 123.988 0.805 . . . . 0.0 110.842 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.916 0.389 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.9 132.22 36.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mp -90.64 111.09 45.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.9 Cg_endo -89.18 128.79 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.317 2.678 . . . . 0.0 111.984 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -129.09 66.83 77.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.59 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.481 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 9.1 Cg_exo -73.27 -41.56 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.289 1.993 . . . . 0.0 110.547 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.92 110.97 2.3 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.328 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.33 113.61 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.74 0.305 . . . . 0.0 110.794 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.37 -166.35 13.78 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.29 153.05 17.95 Favored 'Trans proline' 0 N--CA 1.471 0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.236 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.66 155.67 17.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.748 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 3.6 p -62.04 -26.27 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.59 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -69.32 -26.72 64.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.962 -177.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ttt -65.32 -43.35 91.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.051 0.453 . . . . 0.0 110.123 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.73 69.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.032 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -56.36 -31.04 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.603 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.27 3.3 36.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -135.48 174.51 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.62 0.248 . . . . 0.0 110.536 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.92 151.62 33.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.284 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.62 59.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -90.5 0.83 57.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.934 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -105.76 160.24 15.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.561 ' HA ' HD11 ' A' ' 56' ' ' ILE . 14.4 p -101.73 146.69 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.745 0.307 . . . . 0.0 110.75 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' N ' HG21 ' A' ' 24' ' ' VAL . 44.4 t -101.23 129.06 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.866 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.562 ' OG ' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -138.29 150.99 47.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.5 115.85 26.55 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 2.9 m -132.8 146.79 52.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.168 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 15.3 t-20 -111.41 93.48 4.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.983 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.02 145.92 27.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.578 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.87 61.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -61.48 -20.96 63.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.738 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.96 -25.69 63.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.563 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 -8.76 23.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -113.04 22.74 14.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 51.62 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 111.388 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -87.46 37.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.427 . . . . 0.0 110.739 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.06 -55.76 0.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.202 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.56 46.24 3.79 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.579 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.61 -71.31 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.79 0.328 . . . . 0.0 111.206 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -137.17 135.01 36.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.61 119.88 20.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.828 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HB2' HG21 ' A' ' 46' ' ' VAL . 60.3 Cg_endo -72.95 120.02 6.39 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.567 2.178 . . . . 0.0 112.385 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -94.69 -100.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.317 177.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' H ' ' HB ' ' A' ' 44' ' ' ILE . 4.0 t70 -71.65 88.27 0.96 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.729 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG21 ' HB2' ' A' ' 43' ' ' PRO . 3.7 m -139.45 173.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.44 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.5 tp -80.59 -23.45 39.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.892 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 102.61 0.57 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 84.03 -11.75 56.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.695 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 58.84 65.5 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 110.997 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 1.9 t -90.04 146.19 24.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.07 137.46 31.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.168 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.562 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 4.8 t-20 -79.33 97.43 6.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.367 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.459 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -60.73 125.07 82.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' HB3' HD22 ' A' ' 57' ' ' ASN . 51.9 Cg_exo -54.71 120.74 8.6 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.452 2.101 . . . . 0.0 112.047 -176.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.702 HG13 HD13 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -76.08 -14.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 -174.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.442 HD22 ' HB3' ' A' ' 55' ' ' PRO . 1.1 p30 -68.85 -31.48 70.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.293 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -78.83 -45.5 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.224 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.702 HD13 HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.97 -13.83 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -166.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -32.09 71.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.035 0.445 . . . . 0.0 110.929 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.3 pt -118.99 -39.03 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.959 175.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -82.36 34.06 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.674 -177.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.2 pt20 -70.34 -8.27 49.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.628 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.48 -5.94 59.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.721 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 62' ' ' ASN . 60.3 mt -73.4 122.7 88.26 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.85 157.49 58.78 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.849 2.366 . . . . 0.0 112.193 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.759 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 3.3 tp -61.0 -9.4 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.138 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -55.84 -24.9 39.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.141 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -100.22 9.36 42.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.254 0.55 . . . . 0.0 110.674 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.759 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 64.5 m-85 -127.21 175.0 8.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.439 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 122.69 44.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 96.42 9.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.651 0.739 . . . . 0.0 109.806 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -156.11 164.17 38.74 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.11 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.181 0.925 . . . . 0.0 112.013 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -64.76 136.85 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.726 -177.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.8 m -141.12 113.17 7.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.855 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.568 ' HB3' HD13 ' A' ' 93' ' ' ILE . 1.8 p -100.83 142.98 31.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.209 0.528 . . . . 0.0 110.051 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 6.8 m -126.57 164.08 22.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.24 132.18 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -46.92 110.1 0.49 Allowed Glycine 0 C--N 1.333 0.391 0 O-C-N 123.597 0.561 . . . . 0.0 113.098 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.34 100.47 4.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -113.86 154.4 27.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.576 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -55.92 113.06 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.37 0.605 . . . . 0.0 110.742 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.91 -18.89 3.76 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.675 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -101.39 149.35 24.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.99 -42.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.2 0.524 . . . . 0.0 110.432 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -120.62 134.73 55.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.73 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.9 pt -133.49 148.99 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.42 37.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.071 0.462 . . . . 0.0 110.322 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 77.3 m -110.61 144.57 39.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.31 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 142.36 30.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.496 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.15 129.2 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.674 2.249 . . . . 0.0 111.546 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.568 HD13 ' HB3' ' A' ' 77' ' ' CYS . 3.0 mt -76.31 -62.0 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.837 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.508 ' HG ' ' HG ' ' A' ' 95' ' ' SER . 7.1 tp -106.54 138.33 42.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.279 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.508 ' HG ' ' HG ' ' A' ' 94' ' ' LEU . 1.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.349 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 121.013 0.435 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.81 148.18 23.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.96 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.647 HG23 HG12 ' A' ' 65' ' ' ILE . 9.9 mt -88.92 111.46 44.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 1.8 Cg_endo -82.51 147.36 14.01 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.113 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.86 76.92 77.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.599 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -96.87 10.94 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 113.758 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.28 -32.51 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.623 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.5 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.186 0.993 . . . . 0.0 112.995 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.12 -141.72 4.09 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 67' ' ' ILE . 28.3 Cg_exo -62.21 160.86 28.88 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.198 1.932 . . . . 0.0 110.985 171.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -115.97 155.14 28.57 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -25.19 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 0.0 111.244 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.36 -28.32 69.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.797 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -67.74 -45.06 76.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.327 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.66 73.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.673 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.026 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.21 -31.64 71.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.087 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HG2' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -104.18 14.73 29.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.504 -175.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.41 174.32 7.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.82 154.0 33.5 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.79 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.55 65.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.54 36.46 2.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.472 0.654 . . . . 0.0 110.347 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 145.99 50.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.844 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 53' ' ' ASN . 5.9 p -99.53 129.11 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.941 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.8 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.744 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.46 ' HA ' HG12 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -139.07 162.04 35.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.501 -178.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 110.87 15.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 2.8 m -140.18 135.19 32.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -120.59 93.09 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.862 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.39 148.71 29.73 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.521 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 7.6 mttp -65.21 -35.39 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.2 pm0 -68.81 -31.47 70.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.453 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.53 -45.48 21.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.417 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -8.67 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.832 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -118.23 4.23 11.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.052 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m 50.13 43.57 25.93 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.718 0.636 . . . . 0.0 111.479 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -89.73 -49.0 6.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.219 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 m -134.8 163.73 29.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.666 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.02 58.53 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.483 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.15 -77.4 0.17 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 110.721 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.73 74.81 9.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.23 0.538 . . . . 0.0 110.492 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.39 122.76 19.14 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.27 171.24 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.68 2.253 . . . . 0.0 112.138 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.618 HG23 ' SG ' ' A' ' 51' ' ' CYS . 1.6 mt -89.25 -55.1 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.185 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 46' ' ' VAL . 10.6 t70 61.86 -147.68 0.4 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.478 ' H ' ' CG ' ' A' ' 45' ' ' ASP . 4.8 p -152.02 -18.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.67 -32.33 1.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.481 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -68.95 86.86 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 111.153 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.9 29.4 7.29 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.942 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER 41.84 64.94 0.95 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.453 0.701 . . . . 0.0 111.672 176.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.618 ' SG ' HG23 ' A' ' 44' ' ' ILE . 36.1 t -131.82 139.39 48.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.516 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 123.99 15.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.003 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.675 HD22 HG11 ' A' ' 24' ' ' VAL . 6.6 t-20 -75.92 131.58 39.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 173.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.46 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.96 130.31 23.07 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.432 ' HB3' HD22 ' A' ' 57' ' ' ASN . 51.0 Cg_exo -51.33 121.7 8.85 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.357 2.705 . . . . 0.0 113.181 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.569 ' HA ' HD13 ' A' ' 59' ' ' LEU . 3.2 tp -79.66 -12.19 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.936 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -60.57 -51.55 68.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -31.28 53.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.761 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.569 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -60.79 -14.8 23.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 m -70.09 -31.98 69.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.5 pt -131.06 -32.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.201 0.524 . . . . 0.0 111.392 -178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -87.62 29.63 0.88 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.469 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -69.82 -14.74 62.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.097 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mt -78.05 -5.4 51.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.683 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.647 HG12 HG23 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -69.8 126.53 92.56 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.635 ' HB2' HD21 ' A' ' 68' ' ' ASN . 6.3 Cg_exo -73.6 157.91 48.06 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.822 2.348 . . . . 0.0 111.871 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.728 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 1.5 tp -62.1 -9.6 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.81 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.635 HD21 ' HB2' ' A' ' 66' ' ' PRO . 2.8 p30 -59.37 -23.63 62.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.803 175.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.87 8.72 21.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.728 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 62.4 m-85 -139.53 174.21 10.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.527 -172.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.25 121.87 44.75 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.367 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.57 98.54 0.69 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.42 0.628 . . . . 0.0 109.764 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.77 162.44 41.11 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 106.61 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 O-C-N 123.673 0.608 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.636 HG21 ' H ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -60.35 135.95 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.038 -172.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 1.4 m -138.3 161.81 35.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' A' ' 93' ' ' ILE . 12.3 p -158.96 122.47 3.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.396 0.617 . . . . 0.0 110.124 173.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -97.95 163.5 12.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.76 -175.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.758 ' HB2' HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -51.37 136.72 24.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 175.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.59 104.57 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 123.714 0.634 . . . . 0.0 113.768 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.12 105.8 2.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -105.21 170.98 7.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.178 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.55 113.13 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.564 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.99 -12.25 57.49 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.258 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 85' ' ' LEU . 2.8 tp -82.04 75.56 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 109.957 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.63 -19.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.241 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.04 109.72 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.596 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 79' ' ' SER . 0.3 OUTLIER -142.96 157.49 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.546 177.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -95.5 134.62 38.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.816 0.341 . . . . 0.0 110.413 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 2.9 t -108.21 128.75 54.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.302 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p -123.84 145.26 47.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.672 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 24.6 Cg_exo -63.64 151.65 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.281 1.987 . . . . 0.0 111.45 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 75' ' ' VAL . 3.4 mt -83.15 -83.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.844 0.354 . . . . 0.0 110.41 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.636 ' H ' HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -96.51 105.09 17.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.404 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.84 32.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.581 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 65' ' ' ILE . 4.0 mt -82.86 111.19 27.82 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.4 Cg_endo -88.48 126.51 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.88 72.48 47.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.938 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.32 -56.25 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.855 2.37 . . . . 0.0 112.278 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.57 -18.28 60.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.046 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 60.97 2.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 111.175 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.27 -175.42 31.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.9 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.24 137.15 63.64 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.073 2.516 . . . . 0.0 112.668 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.836 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -86.88 166.69 14.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.143 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG22 HD22 ' A' ' 59' ' ' LEU . 4.9 p -61.89 -26.78 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.719 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -53.33 -32.85 51.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.174 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpt -65.48 -49.23 69.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 0.0 110.078 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.45 60.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.8 -29.58 70.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.895 -173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.17 -30.94 69.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 111.198 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.693 ' HB3' HG23 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -77.09 7.44 4.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.606 -176.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 174.65 10.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.02 168.01 36.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.329 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.17 -4.83 46.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.451 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -95.42 5.29 52.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 110.194 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 3.6 mptt -113.95 166.55 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.9 p -121.84 141.78 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.409 ' C ' ' HG ' ' A' ' 26' ' ' SER . 0.9 OUTLIER -93.39 137.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.365 177.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.495 ' HA ' HG12 ' A' ' 54' ' ' ILE . 40.0 m -155.3 159.74 40.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.434 ' H ' HD13 ' A' ' 54' ' ' ILE . 1.2 m -101.73 120.66 40.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.9 t -144.87 101.05 3.59 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.901 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -84.52 92.77 8.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.523 0.678 . . . . 0.0 109.52 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p -124.36 148.81 47.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.982 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -31.54 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 173.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -60.29 -47.47 85.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.648 -1.614 . . . . 0.0 111.018 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.473 HD22 ' HG3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -65.01 -52.42 56.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.991 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -74.91 -8.62 57.0 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.52 26.12 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.929 0.395 . . . . 0.0 110.302 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -75.59 144.59 41.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.861 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -92.74 43.58 1.13 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.998 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.15 57.13 4.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.09 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.77 -128.06 2.1 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.365 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 65.69 -157.68 0.27 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 122.834 0.454 . . . . 0.0 110.867 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.21 142.74 50.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.771 0.319 . . . . 0.0 110.407 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -158.89 114.86 1.64 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.527 177.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 3.5 Cg_endo -85.93 135.56 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.179 2.586 . . . . 0.0 112.203 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -108.38 167.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.636 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.842 ' HB2' ' HB3' ' A' ' 53' ' ' ASN . 3.6 t0 62.69 14.6 7.36 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.375 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 43' ' ' PRO . 2.4 m -108.23 9.35 9.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.338 0.59 . . . . 0.0 109.492 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 51.25 9.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.547 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.17 61.77 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.834 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' C ' ' HG2' ' A' ' 50' ' ' GLU . . . 99.8 -67.28 0.57 Allowed Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.566 -176.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HG2' ' C ' ' A' ' 49' ' ' GLY . 1.9 mm-40 -147.19 6.33 0.87 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.514 0.197 . . . . 0.0 110.923 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.7 m -88.54 137.73 32.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.366 0.603 . . . . 0.0 112.397 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.7 139.69 32.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.757 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.842 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.7 t-20 -97.68 133.91 41.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -109.52 125.01 32.27 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.493 -174.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.408 ' HB3' ' ND2' ' A' ' 57' ' ' ASN . 52.4 Cg_exo -56.88 122.73 12.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.464 2.776 . . . . 0.0 113.702 -173.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.513 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -75.15 -16.91 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.745 -177.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -53.82 -43.15 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.23 -173.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -78.32 -36.24 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.57 HD22 HG22 ' A' ' 12' ' ' VAL . 2.7 mp -54.56 -33.32 59.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.868 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -32.5 34.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -121.84 -20.51 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.235 0.54 . . . . 0.0 110.971 177.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -99.09 28.1 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.286 -177.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -68.27 -13.83 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.371 0.605 . . . . 0.0 110.67 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.96 -8.04 55.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.6 ' O ' HG21 ' A' ' 65' ' ' ILE . 1.5 tt -67.99 133.58 91.92 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 110.652 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.836 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 3.7 Cg_exo -79.57 163.42 24.19 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.937 2.425 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 67' ' ' ILE . 3.2 tp -63.02 -9.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -25.38 67.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.26 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.436 HD22 ' HG2' ' A' ' 4' ' ' PRO . 1.5 m-80 -98.31 28.04 4.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.541 0.686 . . . . 0.0 109.623 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.436 ' HE1' HG13 ' A' ' 54' ' ' ILE . 14.9 m-85 -144.3 173.01 12.14 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.01 127.85 51.58 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.576 -172.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.3 98.78 1.81 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -154.55 161.4 41.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.218 -170.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.59 103.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.15 0.5 . . . . 0.0 109.94 172.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -54.6 115.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.695 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -113.97 135.92 53.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.326 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 5.3 t -122.99 120.68 34.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 3.2 t -118.03 163.21 16.94 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.23 138.39 50.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.6 104.91 0.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.458 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.89 134.33 54.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.367 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.16 154.58 37.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.937 -176.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.75 112.03 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 110.413 -178.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.86 -19.34 5.54 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.45 -37.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.797 0.332 . . . . 0.0 111.516 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 140.51 50.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.656 HD12 ' HG2' ' A' ' 81' ' ' GLU . 2.0 pt -137.99 157.29 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.79 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.501 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -98.81 121.38 40.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.676 178.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 m -114.4 132.54 56.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.318 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.99 151.05 77.26 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.584 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HG3' HD22 ' A' ' 33' ' ' LEU . 38.3 Cg_exo -61.3 127.03 20.79 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.653 2.235 . . . . 0.0 111.595 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.693 HG23 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -84.22 -41.73 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.553 ' HB2' HG21 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -105.94 104.04 13.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.692 -178.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.369 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.995 0.426 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.69 150.07 23.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.505 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.13 115.95 41.81 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.84 126.7 4.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.085 2.523 . . . . 0.0 112.037 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 73.87 23.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.56 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 37.8 Cg_endo -69.41 -25.64 30.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.164 1.91 . . . . 0.0 110.99 171.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.17 77.18 0.38 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.576 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -72.48 127.51 32.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.246 0.546 . . . . 0.0 111.83 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 10' ' ' PRO . . . -153.57 -126.78 1.14 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.434 ' HG2' HG23 ' A' ' 67' ' ' ILE . 19.2 Cg_endo -62.44 133.84 45.05 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.662 2.241 . . . . 0.0 112.21 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -81.22 154.79 26.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.235 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.547 HG13 HD12 ' A' ' 67' ' ' ILE . 35.8 m -67.72 -24.87 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.912 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -30.27 71.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.943 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -40.3 90.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.204 0.526 . . . . 0.0 110.13 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.15 73.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.427 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -61.01 -29.24 69.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -31.68 71.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.031 0.443 . . . . 0.0 110.997 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 9.61 21.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.59 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' SG ' ' HD2' ' A' ' 23' ' ' LYS . 5.4 t -133.84 174.39 10.51 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.16 156.02 39.09 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.193 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.42 87.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.54 38.65 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.393 0.616 . . . . 0.0 110.114 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 7.1 mttt -125.47 144.45 50.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.79 129.04 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.993 0.425 . . . . 0.0 110.362 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.499 HG11 ' HE2' ' A' ' 70' ' ' PHE . 16.1 t -85.57 106.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -120.21 171.49 8.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' SG ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -130.78 108.85 10.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.073 0.463 . . . . 0.0 110.482 170.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 44' ' ' ILE . 48.6 m -137.53 144.26 42.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.45 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.479 HD21 ' HB3' ' A' ' 50' ' ' GLU . 71.9 m-20 -105.68 99.92 9.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.804 0.335 . . . . 0.0 111.527 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.79 141.62 28.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -23.28 57.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.841 0.829 . . . . 0.0 109.613 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -84.07 -18.42 37.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.027 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.37 -32.23 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -32.9 72.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.996 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.83 -4.31 59.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.832 -177.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.76 33.68 20.13 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 38.41 2.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.225 0.536 . . . . 0.0 110.462 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.64 110.29 22.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.432 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.56 28.5 2.98 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.62 -102.75 0.41 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.69 132.99 43.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.37 71.97 26.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.645 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.24 -177.02 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.038 2.492 . . . . 0.0 112.606 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.417 HG23 ' SG ' ' A' ' 28' ' ' CYS . 0.3 OUTLIER -142.29 169.26 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.356 -179.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.572 ' OD1' ' HG ' ' A' ' 47' ' ' LEU . 2.8 p30 -147.45 -172.25 3.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.492 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.45 35.84 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.727 0.299 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HG ' ' OD1' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -95.88 179.67 5.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.091 0.472 . . . . 0.0 111.083 -177.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.56 71.39 4.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.897 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 -126.79 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.487 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HB3' HD21 ' A' ' 29' ' ' ASN . 24.2 mt-10 -113.99 44.54 1.63 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.458 0.171 . . . . 0.0 111.26 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 42.2 t -163.65 139.29 6.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.597 0.237 . . . . 0.0 110.386 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.74 116.12 5.78 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.629 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.9 t30 -84.6 94.37 8.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.523 HD12 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -68.11 136.29 91.67 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.267 -172.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' O ' HD11 ' A' ' 59' ' ' LEU . 28.1 Cg_exo -61.84 123.45 12.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.171 2.581 . . . . 0.0 112.744 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.519 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -72.74 -12.68 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.433 -175.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -40.12 88.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.5 -175.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -79.84 -32.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.892 0.377 . . . . 0.0 110.576 175.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -65.58 -17.94 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 -173.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -60.83 2.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.448 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -96.22 -37.19 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.044 0.449 . . . . 0.0 111.576 -177.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.97 36.03 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.436 0.636 . . . . 0.0 109.907 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.67 -8.0 53.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.977 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.462 ' HA ' HD13 ' A' ' 64' ' ' LEU . 3.7 mm? -76.47 -7.98 56.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.953 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -62.84 137.16 96.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.969 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.2 Cg_exo -79.07 159.48 26.95 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.047 2.498 . . . . 0.0 111.679 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.547 HD12 HG13 ' A' ' 12' ' ' VAL . 2.6 tp -61.2 -9.25 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.56 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -58.74 -28.99 66.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.07 27.55 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.459 0.647 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.499 ' HE2' HG11 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -142.41 174.93 10.18 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -172.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.17 127.68 49.0 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.666 -173.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.93 94.68 3.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -156.44 161.69 40.06 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.7 98.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.411 0.444 . . . . 0.0 109.87 171.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG21 ' H ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -57.53 128.08 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -173.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.26 105.95 4.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.226 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 27.4 p -104.96 129.56 53.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.553 0.692 . . . . 0.0 110.851 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 11.8 m -105.27 164.09 12.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.076 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.534 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -54.99 139.3 41.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 173.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -50.41 114.59 2.68 Favored Glycine 0 C--N 1.331 0.252 0 O-C-N 123.309 0.381 . . . . 0.0 112.683 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 143.19 33.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.041 0.448 . . . . 0.0 110.675 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.59 174.87 14.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.33 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.68 119.28 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.799 0.333 . . . . 0.0 110.179 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.01 4.06 31.44 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.168 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 88' ' ' ILE . 2.4 mt -112.0 112.83 24.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.8 -27.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.61 135.7 16.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.338 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD21 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -131.76 174.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.93 -177.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.518 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -101.91 128.05 48.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 98.6 m -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.491 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.6 t -150.07 143.57 16.75 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.339 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.0 Cg_endo -57.41 136.64 77.27 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.64 2.227 . . . . 0.0 111.677 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.416 HD13 ' HB ' ' A' ' 75' ' ' VAL . 1.2 mt -88.39 -73.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.674 ' H ' HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -99.61 72.25 1.76 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.016 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.056 178.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.53 158.15 17.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.2 mt -80.25 109.92 14.46 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 4.2 Cg_endo -89.82 124.93 1.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.344 2.696 . . . . 0.0 112.261 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' A' ' 8' ' ' GLU . . . -141.47 67.66 25.09 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.757 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.78 -28.72 7.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.776 1.651 . . . . 0.0 111.842 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.83 -44.21 2.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.618 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HG3' ' HB1' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 57.38 50.53 11.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.385 177.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.78 -128.64 6.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.807 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.42 143.49 69.88 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -90.11 154.16 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 0.0 111.087 -178.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.576 HG21 HD23 ' A' ' 59' ' ' LEU . 8.5 p -69.06 -27.76 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.448 0.642 . . . . 0.0 110.028 176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -67.06 -26.32 66.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.941 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 ttm -64.11 -47.27 80.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.97 -36.99 72.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 20.9 tt0 -64.0 -29.58 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.139 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -31.29 64.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 111.404 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HB3' HG23 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -76.8 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 -177.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 175.03 7.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.85 -165.05 22.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.497 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.51 -7.07 48.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 0.0 110.942 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.83 9.64 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.274 0.559 . . . . 0.0 110.116 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -126.98 153.68 45.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 56' ' ' ILE . 6.6 p -108.53 131.17 59.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.058 0.456 . . . . 0.0 110.586 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG23 HD21 ' A' ' 59' ' ' LEU . 5.4 t -83.89 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.605 ' HA ' HG12 ' A' ' 54' ' ' ILE . 8.0 t -154.74 170.31 21.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.691 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.52 99.97 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 172.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.67 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 16.1 m -131.56 109.82 10.52 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 3.0 p30 -88.68 134.58 33.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 0.0 110.957 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 38.4 m -158.52 155.43 28.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.763 176.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -70.56 -38.23 74.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 109.888 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -20.44 64.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.465 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -74.12 -29.77 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.04 177.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -90.56 -34.87 15.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -100.79 29.15 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.266 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.1 67.72 0.3 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -80.73 107.27 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 39.3 m 76.47 -51.72 0.59 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.136 0.897 . . . . 0.0 109.535 -168.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.52 164.86 34.62 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.277 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.81 155.89 49.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.87 110.32 7.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 0.0 111.094 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.58 HG13 ' HD2' ' A' ' 43' ' ' PRO . 0.4 OUTLIER -111.35 133.94 21.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.158 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' HD2' HG13 ' A' ' 42' ' ' ILE . 92.1 Cg_endo -88.72 -175.89 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.71 2.273 . . . . 0.0 112.366 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 88' ' ' ILE . 4.3 mp -119.97 120.88 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -164.33 157.91 18.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.085 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.6 45.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.418 0.628 . . . . 0.0 111.21 -176.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.23 -49.86 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.821 177.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.7 86.99 2.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.58 -4.75 80.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.985 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 67.63 58.5 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.41 0.624 . . . . 0.0 110.394 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.67 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -111.58 165.43 12.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.542 -175.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.13 140.61 5.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.04 145.83 55.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.627 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.605 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.81 126.46 30.21 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.1 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 75.1 Cg_exo -51.01 122.47 10.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.393 2.729 . . . . 0.0 113.544 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -76.01 -12.82 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.491 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -64.21 -34.52 78.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.355 -175.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.33 -38.5 20.01 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.224 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.576 HD23 HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -62.07 -15.6 46.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -28.61 48.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.82 0.343 . . . . 0.0 111.856 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.529 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.4 pt -129.26 -41.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.206 0.527 . . . . 0.0 111.19 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.529 ' N ' HG13 ' A' ' 61' ' ' ILE . 5.6 m-80 -83.23 36.62 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.722 0.809 . . . . 0.0 110.194 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.617 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 24.5 pt20 -72.46 -7.4 49.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.253 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -1.45 45.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.656 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 59.3 mt -80.23 120.26 79.01 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.349 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 23.5 Cg_exo -64.85 164.38 24.68 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 112.284 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.5 tp -62.49 -8.89 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.515 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -65.24 -7.46 13.16 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 68' ' ' ASN . 74.1 m-80 -116.4 29.91 7.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.491 0.662 . . . . 0.0 110.107 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -143.82 173.14 11.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 121.49 43.92 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.933 0.397 . . . . 0.0 111.64 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -72.25 98.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.619 0.724 . . . . 0.0 109.158 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.487 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.49 161.94 40.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.17 104.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 0.0 110.273 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.62 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -59.65 127.05 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.614 -172.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.61 152.89 43.0 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.092 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.565 ' HB2' HG12 ' A' ' 93' ' ' ILE . 19.2 t -144.58 119.04 9.65 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -113.52 164.1 14.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.695 -172.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.19 127.25 18.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 175.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -36.42 108.86 0.06 OUTLIER Glycine 0 C--N 1.34 0.781 0 O-C-N 124.081 0.863 . . . . 0.0 112.763 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.624 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -82.84 129.23 34.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.17 -0.515 . . . . 0.0 110.883 -173.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 140.93 34.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.737 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -56.2 119.98 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 123.655 0.597 . . . . 0.0 111.053 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.84 -26.75 4.22 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.464 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.37 136.3 33.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.876 0.369 . . . . 0.0 110.305 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 t -74.81 -47.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -143.87 151.58 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.882 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 44' ' ' ILE . 0.7 OUTLIER -142.25 145.66 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.475 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.7 131.53 43.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.984 0.421 . . . . 0.0 110.69 -175.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 t -109.72 145.16 37.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.873 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.61 152.29 52.51 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 31.6 Cg_endo -64.09 140.44 71.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.645 2.23 . . . . 0.0 112.748 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.62 HD11 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -95.71 -62.68 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.913 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 100.94 13.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.521 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.138 178.352 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.418 ' HB3' HD22 ' A' ' 62' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.438 . . . . 0.0 110.709 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.23 114.78 28.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.67 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -77.91 111.94 21.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.725 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.1 Cg_endo -89.2 128.68 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.524 2.816 . . . . 0.0 112.381 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.588 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . . . -143.65 68.08 16.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.77 -39.83 8.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.224 1.949 . . . . 0.0 112.116 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.01 -21.23 59.51 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.868 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 49.49 69.42 0.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.29 0.567 . . . . 0.0 111.51 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.76 -173.4 14.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.205 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.46 142.73 37.67 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.345 2.696 . . . . 0.0 112.335 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -87.6 157.28 19.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.832 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.71 -25.82 38.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.006 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.2 m -60.45 -28.84 68.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.174 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -48.12 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.9 73.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.771 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -62.86 -31.48 72.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -32.75 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 0.0 111.277 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.89 16.49 6.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.141 -177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.19 175.02 10.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.898 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.67 167.43 22.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.09 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.19 -16.11 61.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.381 0.61 . . . . 0.0 110.157 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -89.76 19.37 4.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.459 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 79' ' ' SER . 1.8 mptt -132.6 156.0 47.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.597 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -105.1 123.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.197 0.522 . . . . 0.0 110.398 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -85.85 103.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.911 178.33 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -116.5 172.69 7.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 -177.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 p -126.74 128.4 46.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.921 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 34.0 t -157.32 141.38 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.379 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -98.65 94.02 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.93 0.871 . . . . 0.0 110.455 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.552 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -116.47 146.8 42.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.049 178.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -72.17 -26.03 61.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 0.0 110.269 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.42 -44.01 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.355 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 30' ' ' SER . 4.4 mt -67.3 -44.79 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -14.03 61.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.543 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.48 14.52 19.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.256 -0.278 . . . . 0.0 110.877 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.97 41.16 30.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.753 176.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 65.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.801 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -77.11 95.17 4.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.931 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.86 -157.35 9.67 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.35 4.67 50.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.024 0.44 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.03 -7.56 59.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.685 HG12 ' HB3' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -88.52 117.63 68.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.285 0.564 . . . . 0.0 111.641 -174.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -91.21 -168.56 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.683 2.922 . . . . 0.0 111.415 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 53' ' ' ASN . 5.3 tp -155.17 1.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.329 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.44 -149.2 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.668 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.15 124.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.451 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 HD11 ' SG ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -141.11 -177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.825 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 66.37 2.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 110.672 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.4 -143.52 4.07 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.534 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.91 70.4 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 19.4 m -129.04 149.58 50.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.33 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -152.55 128.51 10.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.571 ' HB3' HG21 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -75.73 123.21 25.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.175 170.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.515 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -88.52 133.21 36.78 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.327 -175.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HB3' HD22 ' A' ' 57' ' ' ASN . 51.3 Cg_exo -53.86 127.56 26.09 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.506 2.804 . . . . 0.0 112.951 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.41 -12.53 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.921 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.609 HD22 ' HB3' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -59.24 -40.68 86.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.832 -176.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.13 -25.21 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.612 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.17 -18.91 64.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -30.48 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -133.11 -38.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -176.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.635 ' HB3' HD11 ' A' ' 65' ' ' ILE . 31.3 m-20 -83.25 28.19 0.54 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.36 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.01 -8.63 55.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.422 0.63 . . . . 0.0 109.717 175.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.406 ' HB2' HD13 ' A' ' 3' ' ' ILE . 2.8 mt -78.88 -7.52 58.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.213 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 3' ' ' ILE . 42.9 mt -75.99 126.94 86.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.247 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 14.9 Cg_exo -69.59 167.59 23.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.566 2.177 . . . . 0.0 111.93 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.598 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.25 -9.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.6 -177.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -24.92 64.86 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.409 HD22 ' HG2' ' A' ' 4' ' ' PRO . 15.3 m-80 -100.32 16.14 25.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.504 0.669 . . . . 0.0 109.766 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 98.9 m-85 -126.75 176.0 7.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.99 127.46 48.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.48 98.59 3.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.46 160.64 40.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.217 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.0 112.53 0.53 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.295 0.569 . . . . 0.0 110.441 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.861 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -61.61 130.77 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.53 -174.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 m -129.36 115.58 17.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.848 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.523 ' HB2' HD11 ' A' ' 93' ' ' ILE . 20.3 t -104.96 118.25 36.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.045 0.45 . . . . 0.0 110.096 -176.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -114.9 163.35 15.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 -175.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.51 133.75 24.65 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 174.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -43.92 109.68 0.27 Allowed Glycine 0 C--N 1.335 0.495 0 O-C-N 123.792 0.683 . . . . 0.0 112.737 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.01 29.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.587 . . . . 0.0 110.508 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.54 173.4 7.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.18 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.44 117.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 123.364 0.415 . . . . 0.0 110.693 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.37 -43.02 1.61 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 84.16 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.971 0.415 . . . . 0.0 110.153 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.486 ' H ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -71.02 -41.06 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 -178.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 131.33 55.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.9 pt -132.86 163.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -107.58 120.02 41.04 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 2.9 t -108.6 135.7 49.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.319 0.581 . . . . 0.0 111.043 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.672 HG23 ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -129.72 141.67 42.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.31 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.672 ' HD2' HG23 ' A' ' 91' ' ' THR . 22.7 Cg_exo -63.39 126.6 18.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.358 2.039 . . . . 0.0 111.63 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.861 HD12 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -82.52 -52.1 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.163 0.506 . . . . 0.0 110.151 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.84 144.71 45.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.014 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.672 178.336 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.74 146.61 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.489 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.46 114.02 54.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.972 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.84 124.96 10.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.735 2.29 . . . . 0.0 111.874 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.61 88.02 9.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.98 -45.19 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.008 2.472 . . . . 0.0 112.351 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.53 27.01 5.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.463 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 48.76 65.55 1.33 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.795 0.438 . . . . 0.0 111.554 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.47 160.98 27.14 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.161 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.54 144.86 96.7 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.092 2.528 . . . . 0.0 112.267 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 154.76 29.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 0.0 110.978 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.61 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.985 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -67.2 -26.68 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.214 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -45.1 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.002 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.87 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -59.21 -29.91 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.443 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -56.72 -30.85 63.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.124 0.488 . . . . 0.0 111.362 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.45 -4.15 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.697 ' HB2' HG21 ' A' ' 93' ' ' ILE . 18.6 t -127.84 174.74 8.89 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.93 146.65 41.85 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.739 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.77 -9.52 59.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 111.08 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.97 21.98 10.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.655 0.74 . . . . 0.0 109.85 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HE2' ' SG ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -121.02 147.19 45.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.547 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.788 HG13 ' HA2' ' A' ' 80' ' ' GLY . 6.7 m -88.83 140.6 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 0.0 110.772 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.18 121.12 43.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.2 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.653 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -135.67 159.12 42.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.8 m -101.3 121.31 41.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.47 118.39 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -106.48 95.45 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.28 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.43 151.07 20.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -64.71 -37.99 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.663 -178.485 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 2.3 pm0 -73.46 -30.26 63.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.41 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.23 -32.9 74.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.529 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.47 -23.04 66.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.153 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -115.15 10.09 16.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.728 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.25 30.05 17.78 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.78 121.59 33.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.25 -177.448 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.23 155.25 20.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.446 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.64 -105.1 2.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.703 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 -38.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.181 0.515 . . . . 0.0 110.338 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -125.0 147.1 49.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.026 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.664 HG13 ' HA ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -120.24 78.85 26.79 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.537 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.18 124.13 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.025 2.484 . . . . 0.0 112.183 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mm -86.55 121.29 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.49 174.39 8.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.464 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.63 45.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.957 0.408 . . . . 0.0 111.12 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -87.03 131.93 33.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.696 178.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 85.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.256 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.78 10.01 2.13 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.071 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -134.9 -69.12 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 109.849 -178.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.3 m -146.75 139.2 24.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.783 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 129.24 15.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 22.8 t-20 -85.03 124.16 31.4 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -95.51 130.54 31.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.302 -174.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -47.95 121.88 6.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.462 2.774 . . . . 0.0 113.291 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.703 HD12 HG12 ' A' ' 24' ' ' VAL . 7.5 tp -75.17 -11.46 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.602 -173.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.24 -40.6 86.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.256 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.55 -25.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.72 -23.8 67.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -60.29 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.596 HG13 ' N ' ' A' ' 62' ' ' ASN . 5.7 pt -81.47 -44.3 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 111.141 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.596 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -92.04 38.54 1.0 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.88 -176.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.1 -14.17 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.921 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.21 1.29 51.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.89 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.703 HG22 HD22 ' A' ' 69' ' ' ASN . 1.5 tt -66.01 135.93 95.38 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.34 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 3.0 Cg_exo -77.82 161.09 30.59 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.009 2.473 . . . . 0.0 111.742 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tp -67.11 -8.68 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.887 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.433 HD21 ' HB2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -57.9 -32.3 67.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.903 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.703 HD22 HG22 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -103.48 60.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 109.316 176.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.89 173.15 16.91 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.2 133.48 49.04 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.313 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -80.54 94.18 6.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.063 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 17.9 m-20 -155.9 160.33 40.06 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -51.33 105.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.267 0.556 . . . . 0.0 110.812 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.24 135.33 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.778 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 m -144.13 148.66 35.37 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -172.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.1 p -129.18 119.62 24.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.694 0.759 . . . . 0.0 110.906 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 21.4 m -99.54 155.22 17.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.572 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.406 ' OG ' ' HG2' ' A' ' 89' ' ' GLN . 0.3 OUTLIER -52.35 128.41 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.788 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -32.6 104.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.786 0 O-C-N 124.271 0.982 . . . . 0.0 114.19 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.51 93.1 1.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.429 0.633 . . . . 0.0 110.165 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 173.1 10.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.109 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.95 129.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.352 0.596 . . . . 0.0 110.891 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.0 -26.71 11.08 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.753 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 122.84 34.81 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.0 -52.31 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.032 0.444 . . . . 0.0 110.876 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -99.12 117.48 33.7 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.7 pt -126.83 159.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.664 ' HA ' HG13 ' A' ' 42' ' ' ILE . 3.9 pt20 -109.65 128.46 55.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 42' ' ' ILE . 94.3 m -107.93 127.3 53.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.113 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 92' ' ' PRO . 18.3 m -138.3 135.61 18.5 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.581 -174.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.405 ' HD2' HG21 ' A' ' 91' ' ' THR . 11.8 Cg_endo -54.75 141.01 77.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.131 2.554 . . . . 0.0 112.794 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.697 HG21 ' HB2' ' A' ' 19' ' ' CYS . 2.1 mt -91.71 -77.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.581 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tp -74.51 121.48 21.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.787 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.969 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.829 0.347 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.72 144.97 50.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.529 0.204 . . . . 0.0 110.607 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.482 HG21 HG12 ' A' ' 65' ' ' ILE . 26.9 mt -94.93 111.45 54.57 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.835 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.885 ' HD2' HG23 ' A' ' 65' ' ' ILE . 6.1 Cg_exo -78.74 126.02 7.09 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.007 2.471 . . . . 0.0 112.38 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.11 71.09 18.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.213 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.35 -23.83 32.22 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.743 2.295 . . . . 0.0 111.821 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.82 -21.9 4.1 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.09 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.83 51.75 15.31 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.08 0.552 . . . . 0.0 111.146 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.19 32.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.441 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.82 134.41 58.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.89 2.393 . . . . 0.0 112.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 m -89.73 155.66 19.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.536 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 67' ' ' ILE . 48.4 t -65.9 -25.2 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.223 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.92 -35.43 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.034 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpp -62.65 -42.27 99.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.369 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -66.7 -45.67 78.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -60.92 -32.75 72.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.367 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -30.3 62.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.836 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HD3' HD11 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -80.07 -3.12 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.894 -175.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 174.79 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.8 151.06 38.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.254 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.02 -9.01 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 110.998 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.58 12.04 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.406 0.622 . . . . 0.0 109.748 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -119.89 166.78 12.86 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.332 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 81' ' ' GLU . 9.9 m -106.24 160.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.216 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 70' ' ' PHE . 96.6 t -115.02 116.2 51.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.668 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -131.42 149.02 52.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.504 -178.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 107.32 17.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 3.3 m -126.14 121.45 32.87 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.862 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 11.2 t-20 -86.42 113.94 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.742 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.2 144.19 32.07 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -74.79 -42.99 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.356 0.598 . . . . 0.0 110.329 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -68.77 -27.46 65.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.541 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -32.27 72.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.145 0.498 . . . . 0.0 110.757 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -8.37 54.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.533 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.65 23.84 3.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.866 0.365 . . . . 0.0 111.412 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.7 m -81.27 78.07 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.365 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -59.86 -66.86 0.45 Allowed 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.943 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.24 -39.94 14.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.509 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.34 158.61 9.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.82 -166.91 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.27 120.84 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.467 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.787 HG21 ' HB2' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -108.32 117.86 53.68 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.554 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HB3' ' HB2' ' A' ' 48' ' ' SER . 17.1 Cg_endo -91.63 99.0 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.24 2.627 . . . . 0.0 112.696 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -101.75 36.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.558 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.97 161.5 39.21 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.88 48.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -174.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 tp -127.03 -75.17 0.58 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -73.27 90.98 1.66 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 92.56 -8.45 76.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.233 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 63.87 57.47 1.35 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.243 0.544 . . . . 0.0 111.014 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -90.95 144.64 25.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.532 178.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 130.67 47.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.6 t-20 -79.59 101.1 8.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.735 HG23 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -64.88 131.59 95.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.101 -174.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.735 ' HD2' HG23 ' A' ' 54' ' ' ILE . 6.3 Cg_endo -47.84 123.62 8.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.994 3.129 . . . . 0.0 113.73 -171.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.76 -23.56 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.992 -174.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -59.45 -43.47 93.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.366 -176.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -80.12 -17.8 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 110.721 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.401 HD21 ' O ' ' A' ' 55' ' ' PRO . 1.9 mm? -71.02 -33.44 70.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.784 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -51.4 9.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.987 0.422 . . . . 0.0 112.132 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 62' ' ' ASN . 3.2 pt -99.46 -44.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.947 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.547 ' O ' HG13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -93.63 30.7 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.883 0.373 . . . . 0.0 110.987 -174.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.18 -8.43 54.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.668 . . . . 0.0 109.564 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.18 -13.26 60.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.848 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.885 HG23 ' HD2' ' A' ' 4' ' ' PRO . 21.4 mt -66.97 129.7 93.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' HG22 ' A' ' 65' ' ' ILE . 48.7 Cg_exo -56.46 152.14 41.66 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.545 2.163 . . . . 0.0 111.567 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.528 HD13 HG23 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -59.11 -8.54 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -175.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -26.09 54.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.723 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.75 13.59 19.76 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.843 0.83 . . . . 0.0 110.264 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HE2' HG13 ' A' ' 25' ' ' VAL . 1.1 m-85 -130.6 173.4 10.92 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 123.99 48.72 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.995 -170.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 96.73 2.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 3.4 t0 -156.79 163.58 39.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.213 -173.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.23 97.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 0.0 109.845 168.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.529 ' HB ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.97 135.53 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.312 -172.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 140.63 51.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.287 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.471 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 122.25 38.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.617 0.722 . . . . 0.0 109.346 174.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 14.4 m -111.87 162.97 14.72 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.686 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.403 ' HB2' HG21 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -53.38 135.36 39.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.016 0.371 . . . . 0.0 110.087 174.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -47.18 107.22 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 123.644 0.59 . . . . 0.0 112.729 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' H ' HG12 ' A' ' 24' ' ' VAL . 1.1 tt0 -55.4 119.15 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.36 26.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.349 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.48 113.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 110.518 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.15 -17.76 5.92 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.804 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 108.54 10.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.872 0.368 . . . . 0.0 110.105 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.489 ' H ' HG21 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -98.2 -28.79 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.013 0.435 . . . . 0.0 110.778 -177.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -101.09 108.77 20.55 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.403 HG21 ' HB2' ' A' ' 79' ' ' SER . 7.4 pt -110.35 162.58 7.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.822 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 23.7 mt-30 -99.47 121.09 40.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.712 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.787 ' HB2' HG21 ' A' ' 42' ' ' ILE . 89.2 m -108.3 127.61 54.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 t -132.47 139.99 36.48 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.284 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 9.5 Cg_endo -54.44 126.6 22.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.648 2.232 . . . . 0.0 111.658 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.529 HG13 ' HB ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -69.35 -38.98 78.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.0 110.437 -178.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -128.88 117.22 20.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.857 177.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.03 50.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.95 110.83 59.08 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.032 0.444 . . . . 0.0 110.046 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 131.23 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.498 2.799 . . . . 0.0 112.003 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . . . -135.77 66.44 62.8 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.91 -70.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.205 1.937 . . . . 0.0 110.27 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 74.99 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -69.24 129.6 40.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 0.0 111.251 -175.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.42 -141.07 3.23 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.423 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 133.43 58.07 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -91.64 155.09 18.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.72 -25.29 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.003 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -65.0 -29.29 70.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.582 -175.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -36.19 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 109.982 177.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.86 -35.17 78.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.116 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -70.3 -31.28 68.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -32.74 74.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.924 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 3.92 48.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.202 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HD2' ' A' ' 23' ' ' LYS . 32.7 t -127.2 175.75 7.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.68 159.47 30.57 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.167 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.83 -35.67 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 111.098 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.19 36.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.494 0.664 . . . . 0.0 110.011 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.629 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 11.2 mttt -135.97 166.01 24.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG12 ' HA2' ' A' ' 80' ' ' GLY . 2.8 m -118.8 130.1 74.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.187 0.518 . . . . 0.0 111.398 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.44 131.59 33.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.669 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.37 164.82 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.167 0.508 . . . . 0.0 110.861 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.803 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -123.76 110.14 14.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.725 ' HA ' ' CB ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -151.89 113.21 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.315 0.384 . . . . 0.0 110.15 178.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.793 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 9.8 p30 -85.29 152.84 22.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.71 0.766 . . . . 0.0 112.521 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.546 ' HB2' HD12 ' A' ' 33' ' ' LEU . 38.1 m -157.94 147.37 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.078 169.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -68.4 -31.57 71.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.154 0.502 . . . . 0.0 110.584 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -17.38 60.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.766 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 30' ' ' SER . 0.5 OUTLIER -56.95 -29.56 63.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -174.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.12 -10.02 59.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.539 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -141.68 26.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 111.251 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 33' ' ' LEU . 69.6 m -77.74 84.85 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.32 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -86.33 -42.59 13.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.48 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.73 149.43 24.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.464 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' HA3' ' OE1' ' A' ' 89' ' ' GLN . . . -118.75 137.79 13.12 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.238 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.19 -115.91 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.08 88.89 3.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.498 HG21 ' SG ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -96.76 134.26 23.38 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.866 -177.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 37.3 Cg_exo -61.25 140.59 89.52 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.187 2.591 . . . . 0.0 112.774 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 53' ' ' ASN . 5.9 tt -142.36 -17.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.832 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -161.6 -162.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.258 -0.276 . . . . 0.0 110.605 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t 63.86 10.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.895 0.747 . . . . 0.0 111.094 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.37 42.09 32.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.415 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.72 63.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.953 0.882 . . . . 0.0 109.091 172.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.94 -94.37 0.21 Allowed Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -175.48 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.157 0.503 . . . . 0.0 109.811 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.803 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 25.7 p -167.12 171.79 10.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.357 -174.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -156.87 152.8 27.25 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.077 0.236 . . . . 0.0 110.781 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.592 ' HB2' HG12 ' A' ' 44' ' ' ILE . 64.6 t30 -91.56 133.04 35.87 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -97.25 136.77 21.28 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.489 -169.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.494 ' O ' HD12 ' A' ' 59' ' ' LEU . 31.7 Cg_exo -59.48 132.99 49.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.649 2.899 . . . . 0.0 113.454 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.488 HG12 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -77.97 -27.65 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.603 -175.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.59 -35.33 65.69 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -79.04 -39.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.084 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -55.39 -26.31 40.8 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -28.54 69.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -131.49 -37.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.041 0.448 . . . . 0.0 110.648 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.7 m-80 -80.27 24.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.986 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -69.92 -7.59 41.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.381 177.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.83 -10.8 59.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.667 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 78.7 mt -73.37 126.05 90.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 10.6 Cg_exo -71.62 164.18 36.53 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.689 2.259 . . . . 0.0 111.541 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.595 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 2.2 tp -57.88 -8.9 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -26.25 62.17 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -106.44 33.76 3.72 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.699 0.762 . . . . 0.0 109.383 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.595 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 80.1 m-85 -149.04 175.94 10.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.53 115.85 31.41 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.717 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 97.83 0.91 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.793 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 18.4 t0 -155.21 162.87 40.82 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.373 -173.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.51 99.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.98 0.8 . . . . 0.0 110.017 170.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -60.69 130.18 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.345 -169.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.3 m -124.08 153.84 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.117 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.46 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -144.29 121.9 11.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.716 0.77 . . . . 0.0 109.407 171.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 5.8 t -110.46 163.41 13.71 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.9 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.629 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -54.35 134.55 45.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 172.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.569 ' N ' ' HA ' ' A' ' 23' ' ' LYS . . . -48.09 108.24 0.33 Allowed Glycine 0 CA--C 1.507 -0.444 0 O-C-N 123.558 0.536 . . . . 0.0 112.172 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.02 130.56 44.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.323 0.582 . . . . 0.0 110.406 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.89 150.65 51.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.596 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -55.14 112.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 177.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.17 -32.06 6.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 89.26 7.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -41.35 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.704 -176.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.0 105.75 17.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.19 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 79' ' ' SER . 1.5 pt -114.42 164.49 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.665 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.403 ' OE1' ' HA3' ' A' ' 39' ' ' GLY . 4.9 mm100 -106.46 112.34 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.295 . . . . 0.0 110.274 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.5 m -107.56 133.99 51.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.427 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 149.48 64.68 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.267 -175.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.23 121.85 8.66 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.871 2.381 . . . . 0.0 112.157 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.585 HD11 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -72.87 -30.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.86 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tp -133.84 103.47 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.938 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.13 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 120.511 0.196 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.4 155.62 18.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 111.424 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.643 HD13 HD13 ' A' ' 64' ' ' LEU . 4.5 mt -103.61 112.18 65.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.222 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' HG2' HD22 ' A' ' 69' ' ' ASN . 2.9 Cg_exo -76.55 125.11 8.07 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.68 2.254 . . . . 0.0 111.996 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.18 82.96 67.19 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.43 -71.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.964 2.443 . . . . 0.0 112.005 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.12 -0.82 61.47 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.753 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 53.31 54.2 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.099 0.56 . . . . 0.0 111.375 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.57 -171.22 38.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.363 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.01 145.29 98.12 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.913 2.408 . . . . 0.0 112.435 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.75 157.09 16.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.233 -177.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.558 HG11 ' HG ' ' A' ' 59' ' ' LEU . 5.3 p -63.32 -26.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.957 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.7 p -64.04 -31.13 72.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.303 -175.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -44.71 82.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.56 74.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.614 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.45 -29.3 70.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.451 HE21 ' HB3' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -57.79 -33.92 69.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.477 ' HB3' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -92.69 13.88 18.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.732 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.58 174.86 8.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.66 20.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.165 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.34 -22.45 54.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 109.842 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.53 25.45 7.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.67 0.748 . . . . 0.0 109.29 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.513 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -128.24 171.61 11.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.148 178.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' HD12 ' A' ' 56' ' ' ILE . 11.6 p -122.75 141.48 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.994 0.426 . . . . 0.0 111.443 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 ' N ' HG21 ' A' ' 24' ' ' VAL . 94.3 t -100.41 116.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.646 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.88 155.34 43.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 3.2 p -101.35 105.41 16.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 11.2 t -134.27 108.54 8.29 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.571 -175.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.963 HD22 ' HD3' ' A' ' 34' ' ' LYS . 22.6 t-20 -115.41 92.46 3.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.477 171.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.62 153.58 18.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HZ1' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -55.13 -44.71 75.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.955 0.407 . . . . 0.0 110.658 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.23 -41.49 94.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.069 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.98 -27.85 66.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -176.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.963 ' HD3' HD22 ' A' ' 29' ' ' ASN . 11.3 ttpt -78.42 -15.13 58.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.331 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -116.03 -30.52 6.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.363 -176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 m -124.96 150.1 46.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -72.08 89.21 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.653 0.263 . . . . 0.0 111.134 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 33' ' ' LEU . 3.8 m 71.0 -74.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.385 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.91 -160.71 35.62 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.587 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.57 -12.9 14.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.9 0.381 . . . . 0.0 111.34 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -95.82 61.02 2.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.842 0.353 . . . . 0.0 110.546 -179.147 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -104.77 99.84 20.64 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 -176.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 66.8 Cg_endo -99.37 162.97 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.5 2.8 . . . . 0.0 113.154 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.27 120.37 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.96 -161.41 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.152 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . 2.6 m -124.42 25.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.814 0.34 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.3 152.37 36.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.028 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.56 147.62 23.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.087 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.72 -10.09 48.67 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -174.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 31' ' ' LYS . 2.7 tp10 -138.69 -109.19 0.17 Allowed 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 3.2 m -125.48 137.16 53.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.731 -0.606 . . . . 0.0 111.397 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 46' ' ' VAL . 5.1 tmtt? -132.87 131.7 41.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.203 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.64 111.03 21.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.947 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.654 HG22 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -87.5 150.08 47.98 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.432 ' O ' HD11 ' A' ' 59' ' ' LEU . 35.6 Cg_exo -57.25 118.71 5.62 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.261 1.974 . . . . 0.0 112.858 -173.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.534 HD13 HD23 ' A' ' 59' ' ' LEU . 4.7 tp -80.04 -26.79 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -33.8 73.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.118 -173.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB2' ' A' ' 55' ' ' PRO . 1.5 pt -80.22 -26.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.084 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.558 ' HG ' HG11 ' A' ' 12' ' ' VAL . 4.7 mp -56.2 -34.36 66.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -20.76 63.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.575 HG13 ' N ' ' A' ' 62' ' ' ASN . 4.0 pt -120.28 -32.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.298 0.57 . . . . 0.0 110.945 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.575 ' N ' HG13 ' A' ' 61' ' ' ILE . 6.8 m-20 -98.64 33.26 2.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.862 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 5.5 pt20 -68.51 -10.86 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.697 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -86.74 -5.04 59.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.46 178.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 4.5 mt -71.07 126.5 92.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 6.0 Cg_exo -80.17 167.21 19.97 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.015 2.477 . . . . 0.0 112.137 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.635 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -60.42 -12.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.961 -174.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -66.89 -18.72 65.52 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.01 -0.431 . . . . 0.0 111.169 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.468 HD22 ' HG2' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.35 7.87 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.564 0.697 . . . . 0.0 109.821 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.654 ' HD1' HG22 ' A' ' 54' ' ' ILE . 44.8 m-85 -125.41 176.34 6.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.84 -175.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 134.88 45.11 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.82 96.8 9.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.482 0.658 . . . . 0.0 110.562 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 2.3 m-20 -154.18 158.34 40.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.587 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 29.9 m -43.67 108.7 0.12 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.092 0.472 . . . . 0.0 112.19 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HB ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.82 116.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.0 m -122.92 132.15 54.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 t -107.16 118.16 35.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.405 ' O ' HG11 ' A' ' 24' ' ' VAL . 3.1 m -117.96 164.54 14.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.39 -174.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.632 ' HB2' HG23 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -53.68 134.95 41.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 176.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' N ' ' HA ' ' A' ' 23' ' ' LYS . . . -33.83 113.71 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 O-C-N 123.821 0.701 . . . . 0.0 114.345 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.71 104.28 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.24 174.95 10.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.183 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 tp -67.39 137.9 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.23 46.39 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.608 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.0 130.52 36.18 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.768 -0.254 . . . . 0.0 110.752 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.1 t -79.66 -67.07 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -136.06 159.99 40.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.678 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.632 HG23 ' HB2' ' A' ' 79' ' ' SER . 1.9 pt -134.05 177.95 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.791 0.329 . . . . 0.0 110.834 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 123.87 46.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.831 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.477 ' H ' HD11 ' A' ' 42' ' ' ILE . 9.2 m -109.54 140.55 43.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.431 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 t -150.8 135.36 9.71 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.044 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.85 129.3 33.45 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.99 2.46 . . . . 0.0 112.059 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.59 HD11 ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -74.87 -65.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.335 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.22 117.04 32.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.013 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.809 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.001 0.429 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.72 146.29 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.848 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.64 HG22 HG13 ' A' ' 65' ' ' ILE . 4.1 mt -101.57 110.86 62.91 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.13 139.56 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.432 2.755 . . . . 0.0 112.243 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.6 71.38 71.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.743 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.98 -73.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 110.567 172.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.65 77.57 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.34 110.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 111.326 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.66 -149.2 5.42 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 139.92 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.441 2.094 . . . . 0.0 112.175 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -84.55 165.42 18.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.146 -177.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.483 HG11 ' N ' ' A' ' 13' ' ' SER . 2.7 p -65.62 -26.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.429 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.8 p -64.74 -27.47 68.92 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.821 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.3 ttm -63.13 -46.26 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.493 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.98 74.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.07 -30.27 71.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.161 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -57.29 -31.28 65.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.549 . . . . 0.0 110.897 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -84.66 12.06 7.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.455 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 174.86 10.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 110.326 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.42 161.85 45.18 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 -26.65 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.921 0.391 . . . . 0.0 110.669 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.19 27.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.545 0.688 . . . . 0.0 110.23 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -125.06 160.86 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.728 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.752 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 13.4 p -114.34 134.74 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.412 0.625 . . . . 0.0 110.284 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 t -99.99 104.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.059 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -111.58 163.31 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.69 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 14.0 p -101.27 104.17 15.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 101.73 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.078 0.466 . . . . 0.0 111.003 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.477 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 10.7 t-20 -100.23 119.9 39.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.21 147.91 39.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.277 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -71.44 -29.58 65.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 109.988 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.1 pm0 -71.1 -29.97 65.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.209 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' A' ' 33' ' ' LEU . 2.3 tp -69.83 -28.02 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.364 0.602 . . . . 0.0 110.068 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -8.95 59.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -105.19 -18.09 14.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.014 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.11 109.0 11.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.952 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -41.5 95.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.064 0.459 . . . . 0.0 109.78 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.4 p -159.76 168.56 25.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.508 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.49 5.5 55.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.47 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.35 116.51 22.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.273 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -76.07 128.44 35.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.165 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.13 119.55 4.43 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.232 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.96 154.25 14.86 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.511 2.14 . . . . 0.0 112.004 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mt -73.74 103.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.557 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 32.7 t0 -85.1 167.33 15.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.143 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.67 113.17 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.235 0.541 . . . . 0.0 110.355 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' HB2' ' H ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -136.72 144.55 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.635 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.15 74.98 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.418 . . . . 0.0 110.474 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.78 49.3 1.18 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.405 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -161.15 -58.11 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.151 0.5 . . . . 0.0 110.293 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 47' ' ' LEU . 1.3 m -136.98 139.59 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.965 178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.73 141.44 7.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.066 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 53.6 t30 -96.01 109.79 22.13 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -79.72 149.32 70.87 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.704 -176.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' O ' HD23 ' A' ' 59' ' ' LEU . 37.0 Cg_endo -64.6 121.54 9.14 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.77 2.314 . . . . 0.0 112.797 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -80.08 -5.41 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -37.57 83.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.698 0.285 . . . . 0.0 111.232 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -16.78 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.889 175.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.2 -14.48 62.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.227 -170.126 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -51.16 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.988 0.423 . . . . 0.0 112.098 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.9 pt -106.89 -23.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.869 0.366 . . . . 0.0 111.805 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -105.69 21.34 17.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.278 -176.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -64.91 -14.19 59.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.355 0.598 . . . . 0.0 110.041 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -5.25 35.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.496 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.64 HG13 HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -70.35 134.1 87.05 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -74.44 159.28 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.203 . . . . 0.0 111.159 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 67' ' ' ILE . 3.2 tp -61.95 -10.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.588 HD21 ' HB2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -64.07 -22.66 67.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 175.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.444 ' HB2' HG23 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -99.53 34.07 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 109.887 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -150.65 177.01 10.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -172.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.62 116.65 32.22 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -76.99 97.29 4.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.7 0.762 . . . . 0.0 109.659 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.69 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 10.1 m-20 -153.85 159.71 41.92 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 29' ' ' ASN . 21.0 m -43.51 115.28 0.76 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.183 0.516 . . . . 0.0 111.26 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.627 ' HB ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -70.37 123.86 25.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.994 -174.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.7 p -123.83 127.24 47.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.389 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.67 118.4 36.45 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.271 0.558 . . . . 0.0 109.965 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 88' ' ' ILE . 14.5 t -118.33 165.44 13.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.543 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.56 122.42 8.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.752 ' HA2' ' HB ' ' A' ' 24' ' ' VAL . . . -54.7 104.77 0.28 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.294 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.54 119.31 6.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.569 -0.816 . . . . 0.0 112.106 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -142.82 151.85 41.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.85 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.58 112.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.497 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.49 -21.45 4.28 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.545 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.45 HD21 HG22 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -92.28 96.17 10.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 0.0 110.011 177.105 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.524 ' H ' HG21 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -69.38 -37.7 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.937 -178.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -130.12 148.37 51.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.641 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.671 ' HB ' ' SG ' ' A' ' 78' ' ' CYS . 1.5 pt -131.77 151.27 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.882 0.372 . . . . 0.0 111.275 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -106.85 109.14 20.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.513 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.6 m -112.59 136.02 52.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.2 143.61 39.85 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.357 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.57 147.82 90.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.735 2.29 . . . . 0.0 112.356 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.627 HD13 ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -115.96 -73.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 78.08 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.571 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.598 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.561 HG23 HG12 ' A' ' 65' ' ' ILE . 5.2 mt -101.75 112.37 65.16 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.52 125.01 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.417 2.078 . . . . 0.0 111.227 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.81 82.29 6.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.28 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.71 -64.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.553 2.168 . . . . 0.0 111.665 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.49 53.02 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.991 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.76 -49.14 8.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.569 0.223 . . . . 0.0 111.183 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.87 -146.23 10.39 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.752 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.1 169.47 19.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.502 2.801 . . . . 0.0 113.085 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -102.94 167.47 9.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.001 -179.293 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -25.3 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.513 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.2 m -50.18 -33.9 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.602 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -45.71 64.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.66 -50.81 32.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.706 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -59.39 -29.86 68.03 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.09 68.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.444 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 15.5 2.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.032 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -144.17 174.24 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.96 143.87 37.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.528 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 -16.24 62.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 0.0 111.369 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.09 4.09 53.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.595 0.712 . . . . 0.0 110.104 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.23 153.57 20.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.618 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG23 HD13 ' A' ' 56' ' ' ILE . 12.9 p -97.01 141.41 15.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.0 t -93.37 128.94 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 110.997 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.17 138.28 23.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.64 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -100.98 124.37 46.59 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.661 -0.649 . . . . 0.0 109.681 175.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -156.17 126.04 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.451 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.618 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . 8.9 t-20 -95.13 93.04 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.33 147.8 22.6 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -69.89 -34.12 73.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.076 0.465 . . . . 0.0 109.792 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' OE2' ' HG2' ' A' ' 31' ' ' LYS . 2.0 pm0 -70.73 -40.23 72.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.419 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.783 179.637 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.667 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 1.9 Cg_endo -82.6 123.09 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.525 HG12 ' SG ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.206 0.526 . . . . 0.0 110.697 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 5.2 m . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 141.46 18.56 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.403 0.44 . . . . 0.0 110.172 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.55 130.56 35.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -100.62 132.05 22.85 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.428 ' O ' HD12 ' A' ' 59' ' ' LEU . 75.9 Cg_exo -49.26 119.81 4.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.109 2.539 . . . . 0.0 112.881 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.541 HD12 HD13 ' A' ' 59' ' ' LEU . 4.5 tp -79.89 -11.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.27 -50.22 73.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.411 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 HG13 ' H ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -78.5 -27.72 14.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.148 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.541 HD13 HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -58.35 -27.23 63.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -55.51 6.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 111.888 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -94.96 -28.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.193 0.52 . . . . 0.0 111.398 -175.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.456 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -101.84 34.78 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -68.87 -13.06 62.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.689 . . . . 0.0 109.824 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -70.07 -11.5 60.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.181 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.561 HG12 HG23 ' A' ' 3' ' ' ILE . 26.1 mt -64.44 120.6 66.68 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.253 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 21.6 Cg_exo -66.82 164.48 29.35 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.939 2.426 . . . . 0.0 112.139 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.23 -9.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.467 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -58.77 -21.77 56.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.666 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -108.15 31.19 5.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 109.891 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -149.41 172.28 15.2 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.69 117.46 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.161 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 96.78 1.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.618 ' OD1' ' HB2' ' A' ' 29' ' ' ASN . 12.0 t0 -156.92 165.19 36.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.505 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.32 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.614 0.571 . . . . 0.0 109.482 170.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.527 ' C ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.49 137.18 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.339 -174.514 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 m -123.97 137.67 54.58 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.601 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.617 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -122.1 120.32 33.93 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.854 0.835 . . . . 0.0 109.093 175.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 88' ' ' ILE . 4.8 m -112.97 163.05 15.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.849 -172.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.27 128.87 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -41.03 107.84 0.1 OUTLIER Glycine 0 C--N 1.337 0.603 0 O-C-N 123.761 0.663 . . . . 0.0 113.27 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -77.94 91.6 4.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.323 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.409 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.6 mp0 -95.0 159.11 15.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -53.41 111.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.1 -18.29 6.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.165 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -87.26 72.76 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.086 178.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.38 31.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.906 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -141.52 126.22 17.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.213 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 78' ' ' CYS . 0.5 OUTLIER -148.61 177.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.5 139.84 37.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.137 0.494 . . . . 0.0 110.858 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' A' ' 44' ' ' ILE . 57.4 m -109.77 143.22 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.544 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 141.78 33.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.48 131.45 36.03 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.617 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.9 OUTLIER -77.31 -58.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.486 0.66 . . . . 0.0 110.093 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tp -114.9 101.63 9.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.639 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.014 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 mt -100.56 110.56 60.75 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.345 . . . . 0.0 111.019 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HG2' HD22 ' A' ' 69' ' ' ASN . 7.2 Cg_endo -89.68 126.3 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.261 2.641 . . . . 0.0 111.803 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.21 70.15 55.42 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.99 -61.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.682 2.255 . . . . 0.0 112.846 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.76 18.78 41.22 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.887 -172.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 50.39 56.8 7.39 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.679 0.392 . . . . 0.0 112.025 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 161.27 35.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.458 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.56 149.79 88.22 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.833 2.355 . . . . 0.0 111.574 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 153.3 38.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.034 0.445 . . . . 0.0 111.943 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 HD12 ' A' ' 67' ' ' ILE . 29.5 m -71.37 -25.37 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.612 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -59.7 -26.22 65.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.924 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.95 88.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.107 0.48 . . . . 0.0 109.91 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.36 71.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -61.99 -31.79 72.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.606 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -32.4 67.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.281 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -85.89 -5.91 59.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.841 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HB2' HG21 ' A' ' 93' ' ' ILE . 19.9 t -115.75 175.99 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -170.9 34.95 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.807 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.85 -39.77 16.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.34 37.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.312 0.577 . . . . 0.0 110.382 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -131.61 153.05 50.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.127 -177.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.86 144.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.201 0.524 . . . . 0.0 111.146 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.62 127.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.822 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 157.96 45.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 22.9 p -115.28 100.62 8.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.602 . . . . 0.0 109.854 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.8 m -143.07 111.36 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.911 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' HB2' ' H ' ' A' ' 74' ' ' THR . 0.8 OUTLIER -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.33 0.585 . . . . 0.0 110.225 177.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 147.59 37.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.879 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HD2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.53 -28.98 70.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.755 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG3' ' HD2' ' A' ' 31' ' ' LYS . 7.1 mp0 -68.18 -38.71 82.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.646 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.537 178.756 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.621 0.248 . . . . 0.0 111.507 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -98.78 116.21 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.579 2.852 . . . . 0.0 112.871 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mt . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.054 0.454 . . . . 0.0 110.294 176.638 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 15.7 t . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -161.2 147.21 14.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.167 0.508 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -97.57 89.95 4.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.799 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -64.13 127.07 91.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.226 -176.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.53 121.21 8.69 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.011 2.474 . . . . 0.0 112.824 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -19.23 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.831 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -61.84 -31.53 71.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.157 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pp -80.0 -37.6 17.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.577 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.455 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -60.86 -14.43 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -170.163 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -40.48 64.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.736 0.303 . . . . 0.0 111.641 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.489 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -116.86 -24.14 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.338 0.59 . . . . 0.0 111.216 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 3.2 m-20 -92.57 34.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.733 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -19.0 65.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.292 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -3.01 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.846 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -70.27 131.83 88.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.333 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 8.7 Cg_exo -73.43 154.41 50.62 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.763 2.309 . . . . 0.0 111.925 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 12' ' ' VAL . 2.1 tp -61.7 -8.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.318 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -12.53 20.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.767 0.317 . . . . 0.0 111.504 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.484 HD22 ' HG2' ' A' ' 4' ' ' PRO . 14.1 m120 -97.14 3.45 51.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.49 0.662 . . . . 0.0 109.986 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -116.33 174.21 6.18 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.07 138.89 39.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.82 97.52 5.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.493 0.664 . . . . 0.0 110.563 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.56 159.72 39.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.08 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.487 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 4.2 m -50.47 102.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 110.725 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.49 120.04 6.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.425 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -127.45 125.61 40.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.624 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.749 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -106.72 141.89 37.25 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 17.9 t -134.12 163.47 29.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.107 -167.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.6 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -57.43 133.67 55.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.31 115.86 6.74 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.982 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.77 92.88 0.91 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.986 0.422 . . . . 0.0 110.391 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -124.63 168.89 12.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.61 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.19 113.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.85 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.31 -30.79 3.58 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 102.73 13.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.807 0.337 . . . . 0.0 110.4 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -77.59 -16.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.438 -179.178 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -150.35 143.87 25.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.879 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 79' ' ' SER . 11.3 pt -130.23 153.78 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.512 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.467 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -116.0 113.37 23.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.958 0.409 . . . . 0.0 110.331 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.643 ' H ' HD13 ' A' ' 42' ' ' ILE . 1.4 m -109.02 142.4 39.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.944 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 154.86 30.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.458 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.87 129.72 31.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.535 2.157 . . . . 0.0 112.005 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.749 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -91.86 -34.17 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.754 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -105.43 131.31 53.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.25 1.113 0 O-C-N 124.378 1.049 . . . . 0.0 110.313 -177.563 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 65' ' ' ILE . 4.0 mt -91.07 114.14 60.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.657 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 3.0 Cg_exo -81.69 126.18 5.18 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.188 2.592 . . . . 0.0 111.907 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.49 78.09 38.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.739 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.94 -72.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.692 2.261 . . . . 0.0 110.904 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.92 123.05 6.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.74 68.58 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.608 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 178.71 47.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.281 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.95 147.81 91.83 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.581 2.187 . . . . 0.0 111.729 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.28 154.83 40.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.92 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -65.29 -24.67 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.341 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.619 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -60.58 -29.34 69.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.885 177.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.1 tpt -69.48 -35.76 75.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.506 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.67 -30.95 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -68.77 -30.17 68.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.901 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -58.37 -32.34 68.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.243 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 93' ' ' ILE . 21.5 mmtt -73.81 -10.83 60.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.789 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 177.56 7.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.85 0.357 . . . . 0.0 110.644 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 163.47 29.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.58 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 10.13 37.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.612 . . . . 0.0 109.607 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -118.61 170.87 8.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.353 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.22 131.23 69.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.097 0.475 . . . . 0.0 110.943 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.4 133.12 30.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.918 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.37 161.22 43.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 4.4 p -110.16 99.68 8.71 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.181 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -130.02 113.45 14.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.149 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -92.7 124.85 37.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.952 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -119.47 151.7 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -71.29 -48.42 50.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.61 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -19.09 52.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.952 ' HB2' ' HB3' ' A' ' 30' ' ' SER . 4.8 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.107 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.25 148.5 13.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.79 2.326 . . . . 0.0 111.863 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.825 HG21 ' HB2' ' A' ' 53' ' ' ASN . 3.4 mm . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.799 0.333 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 73.6 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 119.42 8.02 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.431 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.825 ' HB2' HG21 ' A' ' 44' ' ' ILE . 27.3 t30 -77.72 110.22 12.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -88.9 120.95 70.09 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.65 121.28 9.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.024 2.483 . . . . 0.0 112.561 -173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.482 ' HA ' HD13 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -74.09 -8.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.624 -175.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -59.83 -43.37 94.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.11 -17.38 13.22 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.657 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.607 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 5.6 mp -74.61 -21.08 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.718 0.294 . . . . 0.0 111.041 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 -42.81 15.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.661 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.634 HG13 ' H ' ' A' ' 62' ' ' ASN . 8.7 pt -107.57 -48.66 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.239 0.543 . . . . 0.0 111.343 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.634 ' H ' HG13 ' A' ' 61' ' ' ILE . 2.4 m120 -84.8 34.42 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.788 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 22.1 pt20 -64.52 -12.14 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.549 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 mt -80.27 -0.43 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.53 ' HA ' HG23 ' A' ' 3' ' ' ILE . 15.5 mt -75.84 127.28 85.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.991 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.88 157.03 61.23 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.622 HG13 ' HB2' ' A' ' 70' ' ' PHE . 1.7 tp -62.72 -7.85 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -27.89 16.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 175.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -86.02 8.67 19.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.208 0.528 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.622 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -111.43 172.9 6.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.93 136.9 44.75 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.28 97.71 9.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.315 0.578 . . . . 0.0 111.092 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -156.31 162.78 40.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 m -44.42 104.24 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.812 0.695 . . . . 0.0 110.837 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 75' ' ' VAL . 1.5 t -56.04 122.45 5.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.968 -173.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.58 157.46 33.63 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.656 ' HB2' HG12 ' A' ' 93' ' ' ILE . 51.2 t -139.29 130.18 26.26 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 4.1 m -117.14 163.47 16.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.905 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.458 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.87 135.75 47.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 174.042 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -42.97 106.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.389 0 O-C-N 123.884 0.74 . . . . 0.0 113.39 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 122.82 16.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.412 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.76 149.32 32.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -65.92 112.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.99 176.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.84 -18.49 8.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 119.49 25.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.77 87.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.036 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.5 t30 72.46 163.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.132 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -138.17 170.18 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.445 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -116.15 126.82 54.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 178.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 73.3 m -108.81 130.03 55.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.384 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -133.54 146.92 62.57 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.266 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.5 131.54 30.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 111.672 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.656 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -108.91 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.65 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' CG2' ' A' ' 75' ' ' VAL . 7.5 tp -81.59 74.14 8.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.451 0.643 . . . . 0.0 111.008 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.246 0.903 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.639 174.575 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 65' ' ' ILE . 2.2 mp -83.16 111.23 29.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 9.6 Cg_endo -89.42 126.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.56 2.84 . . . . 0.0 112.023 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.63 81.05 70.56 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 120.902 0.382 . . . . 0.0 111.7 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.99 -41.02 47.43 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.906 2.404 . . . . 0.0 110.756 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.64 149.08 20.82 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.983 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.06 88.14 4.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.229 0.514 . . . . 0.0 110.887 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.85 165.46 19.95 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 140.93 96.5 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.476 2.117 . . . . 0.0 111.779 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.92 154.15 28.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 0.0 111.115 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.05 -24.88 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.915 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -55.11 -32.31 61.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.801 175.439 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -48.01 79.67 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.086 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.73 73.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.82 -29.49 70.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.744 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -31.23 64.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -73.46 -16.19 61.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.932 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 175.46 6.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 111.558 -176.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.16 154.58 25.5 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.633 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -16.36 62.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.777 0.322 . . . . 0.0 111.21 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.0 22.14 9.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.359 0.6 . . . . 0.0 110.379 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.98 171.31 8.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.9 p -114.68 132.31 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -175.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.52 ' CG2' ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -92.92 136.38 25.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.602 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 m -155.27 162.17 40.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.743 0.306 . . . . 0.0 110.344 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 13.2 m -99.99 101.53 12.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.3 100.36 6.8 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.177 -175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -102.84 93.74 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.147 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.07 150.74 24.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.094 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -40.65 96.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -34.98 70.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.343 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.258 -176.177 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.27 166.76 2.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.019 2.479 . . . . 0.0 111.951 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 23.7 m . . . . . 0 C--O 1.224 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -142.47 119.06 11.01 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.69 135.82 36.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.74 139.4 22.76 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.98 122.07 11.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.808 2.338 . . . . 0.0 112.754 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.625 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.9 tp -71.24 -19.77 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.573 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.29 -39.69 76.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.759 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -80.6 -25.14 11.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.738 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.97 -15.27 55.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -35.64 21.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 0.0 111.787 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 62' ' ' ASN . 2.3 pt -109.35 -22.32 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.4 0.619 . . . . 0.0 111.61 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.669 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 3.2 m-20 -108.39 26.15 10.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.411 0.624 . . . . 0.0 109.851 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -81.86 -2.52 51.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.378 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -70.04 141.4 89.22 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.051 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 3.3 Cg_exo -76.97 150.77 30.27 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.593 2.195 . . . . 0.0 110.723 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 67' ' ' ILE . 2.0 tp -58.04 -9.54 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -19.45 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -99.67 24.33 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 109.618 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.24 173.65 11.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.8 124.87 49.71 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.344 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.0 m -76.93 94.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.851 0.834 . . . . 0.0 109.368 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.94 160.89 39.52 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -42.34 104.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.558 0.694 . . . . 0.0 111.326 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.17 124.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.687 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 47.1 m -129.36 147.05 51.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.083 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 1.4 t -120.23 119.55 33.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 3.9 m -109.53 163.45 13.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.313 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.05 128.39 30.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.45 103.71 0.16 Allowed Glycine 0 C--N 1.331 0.272 0 O-C-N 123.552 0.532 . . . . 0.0 112.919 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -72.92 135.61 45.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.047 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.8 149.25 28.81 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -45.41 111.98 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.975 0.797 . . . . 0.0 110.988 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.86 -13.8 5.79 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.941 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mt -99.21 149.71 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -49.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 149.7 50.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.502 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -149.74 178.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.723 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.1 132.89 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.443 ' H ' HD12 ' A' ' 42' ' ' ILE . 8.1 m -107.52 128.94 54.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.418 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 t -134.6 142.81 44.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.099 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 35.3 Cg_endo -65.01 137.54 53.09 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.534 2.156 . . . . 0.0 112.508 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.607 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -82.4 -25.66 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.222 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.69 115.99 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.255 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.568 0.223 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.421 HG23 HG12 ' A' ' 65' ' ' ILE . 4.0 mt -81.19 112.83 36.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.704 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.18 126.03 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.066 2.511 . . . . 0.0 111.329 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 68.88 67.12 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.78 -27.01 5.13 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 111.059 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.32 100.47 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.779 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -70.04 89.2 0.61 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.477 . . . . 0.0 111.031 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.14 -140.37 11.28 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.09 136.09 43.05 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.489 2.126 . . . . 0.0 110.991 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -102.07 164.45 11.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.555 0.217 . . . . 0.0 110.918 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 1.4 p -64.74 -25.5 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -69.55 -27.12 64.87 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.135 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 ttt -62.01 -48.78 78.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.207 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.71 -30.1 66.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -67.61 -30.53 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.021 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.4 -31.69 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.52 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -10.31 44.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.645 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -113.62 176.54 4.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.88 169.55 38.77 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.958 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.14 -7.43 59.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 111.024 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.28 13.43 33.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 0.0 109.81 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.08 146.96 43.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.85 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 123.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.634 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.65 104.33 13.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.674 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -109.91 165.39 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.063 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.1 p -107.46 99.91 9.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 42.4 t -133.62 121.04 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' H ' ' A' ' 74' ' ' THR . 1.9 t30 -121.52 100.08 6.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.944 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.8 162.17 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.838 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -71.53 -40.4 70.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.304 0.573 . . . . 0.0 110.258 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.2 pm0 -64.05 -31.81 73.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.687 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.756 HD22 ' HD3' ' A' ' 92' ' ' PRO . 3.0 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.868 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 tp . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.404 0.621 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.64 135.54 18.05 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.842 2.361 . . . . 0.0 111.619 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.518 HD11 ' CB ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.429 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 93.9 m . . . . . 0 CA--C 1.518 -0.25 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 124.62 18.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.152 0.501 . . . . 0.0 110.977 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 56.1 t30 -86.57 131.83 34.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.645 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -111.5 128.24 25.69 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.066 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 72.0 Cg_exo -49.67 123.2 10.13 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.643 2.895 . . . . 0.0 113.129 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 18.4 tt -68.85 -12.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.049 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -46.02 91.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.035 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 HD22 ' A' ' 62' ' ' ASN . 1.1 pt -77.97 -17.62 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 5.2 mp -72.74 -24.57 60.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.394 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -86.02 -56.68 3.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.562 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.8 pt -93.66 -39.43 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.562 ' N ' HG13 ' A' ' 61' ' ' ILE . 34.4 m-20 -94.02 31.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 0.0 110.061 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 pt20 -66.79 -8.1 26.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.08 -6.49 57.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.182 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 71.6 mt -71.57 123.02 88.76 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.739 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 2.7 Cg_exo -77.0 167.62 24.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.906 2.404 . . . . 0.0 112.268 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.909 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.24 -9.92 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.247 0.619 . . . . 0.0 112.179 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -13.12 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.696 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -111.59 15.48 21.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 110.51 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.909 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 58.7 m-85 -129.55 173.69 10.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.879 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.37 142.97 33.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.061 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 95.93 10.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.638 0.732 . . . . 0.0 110.533 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.68 160.83 40.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.587 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 20.6 m -42.43 120.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 111.712 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.4 124.31 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.869 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -145.35 112.05 5.88 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -171.241 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' HG12 ' A' ' 93' ' ' ILE . 31.1 p -98.7 136.27 38.99 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 15.2 t -119.5 163.49 17.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.843 -174.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.427 ' HB2' HG22 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -53.9 124.93 16.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -39.25 112.08 0.22 Allowed Glycine 0 C--N 1.336 0.552 0 O-C-N 124.206 0.941 . . . . 0.0 112.772 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.24 102.44 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.167 0.508 . . . . 0.0 110.993 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.37 146.47 48.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.185 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -65.86 126.89 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.0 -13.44 11.35 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 113.51 16.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.75 -14.59 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.245 0.545 . . . . 0.0 110.54 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.54 89.27 3.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.311 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 79' ' ' SER . 3.0 pt -104.06 145.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.1 117.12 30.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.748 0.785 . . . . 0.0 110.199 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.9 m -108.98 139.76 43.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.999 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.47 145.54 32.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.882 0.373 . . . . 0.0 111.353 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.756 ' HD3' HD22 ' A' ' 33' ' ' LEU . 39.2 Cg_endo -69.12 126.84 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.459 2.106 . . . . 0.0 111.7 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.495 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.8 -42.42 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 111.027 -177.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.51 129.66 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.347 178.237 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.56 0.219 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 65' ' ' ILE . 2.3 mp -92.33 112.21 54.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.601 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.33 125.25 3.9 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.695 2.264 . . . . 0.0 111.393 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.31 68.2 46.97 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.55 32.03 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.243 2.628 . . . . 0.0 110.829 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.69 77.85 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 96.98 6.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.936 0.398 . . . . 0.0 111.078 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.62 -143.57 15.08 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.48 130.04 33.85 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.368 2.045 . . . . 0.0 111.486 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -74.82 154.82 38.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 HD12 ' A' ' 67' ' ' ILE . 34.2 m -67.6 -26.0 34.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 0.0 111.467 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -26.32 64.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -41.35 98.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.83 70.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.342 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.04 -30.96 69.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.472 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -56.0 -31.31 62.94 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.924 0.489 . . . . 0.0 111.19 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 0.88 24.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.528 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.538 ' HB2' HG23 ' A' ' 93' ' ' ILE . 1.1 t -141.77 175.91 9.33 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.242 -0.286 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.14 133.51 48.83 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.64 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.84 -18.64 64.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.899 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 31.91 4.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 110.439 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 167.8 12.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.722 HG22 ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -86.76 126.05 40.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.941 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 m -94.7 131.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.585 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.912 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -148.89 167.76 24.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.335 -178.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.583 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -122.49 113.46 19.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.469 ' CA ' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m -130.29 123.12 29.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.211 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 1.4 p30 -88.4 97.05 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.737 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.795 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.7 m -126.81 146.93 50.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.372 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.81 -42.62 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.212 0.53 . . . . 0.0 110.659 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.3 pm0 -71.77 -27.72 63.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.795 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 1.2 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.916 0.389 . . . . 0.0 111.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 96.0 Cg_endo -94.71 170.47 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.044 2.496 . . . . 0.0 112.895 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.466 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.469 ' HB2' ' CA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 124.3 28.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.053 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.912 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 42.4 t30 -85.57 120.29 26.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.704 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -90.76 139.78 26.28 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.431 -172.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.704 ' HD2' HG22 ' A' ' 54' ' ' ILE . 9.1 Cg_endo -49.98 123.07 10.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.847 3.031 . . . . 0.0 113.27 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.834 ' HA ' HD23 ' A' ' 59' ' ' LEU . 6.1 tp -72.26 -22.85 21.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.224 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -31.18 68.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -26.74 12.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -176.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.834 HD23 ' HA ' ' A' ' 56' ' ' ILE . 1.4 mm? -60.47 -27.77 67.81 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -168.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -43.83 66.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 112.047 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.0 pt -105.64 -37.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.351 0.596 . . . . 0.0 111.45 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.44 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.35 29.92 0.93 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.397 -175.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -63.65 -20.02 65.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.501 0.667 . . . . 0.0 109.708 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.12 0.56 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.764 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.553 HG13 HG23 ' A' ' 3' ' ' ILE . 1.9 tt -81.37 130.5 61.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.328 0.585 . . . . 0.0 109.86 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -75.19 158.18 41.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.414 2.076 . . . . 0.0 111.674 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.572 HD12 HG12 ' A' ' 12' ' ' VAL . 3.1 tp -59.66 -9.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.413 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -21.01 66.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.634 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -100.18 27.73 5.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.652 0.739 . . . . 0.0 109.661 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.26 174.45 10.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.95 118.96 37.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.609 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.58 97.86 1.39 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.479 -172.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.46 100.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 109.871 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -58.69 130.44 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.224 -172.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -120.94 119.8 33.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.279 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.0 t -110.86 121.17 44.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.688 ' HB3' HG23 ' A' ' 24' ' ' VAL . 6.2 t -120.67 162.65 19.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.501 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.548 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -60.49 124.8 21.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.722 ' HA2' HG22 ' A' ' 24' ' ' VAL . . . -46.47 113.44 1.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 O-C-N 123.692 0.62 . . . . 0.0 113.013 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 90.12 1.37 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.36 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -138.31 174.59 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.561 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.1 121.87 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.016 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.37 -21.71 9.16 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.703 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 95.51 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 111.331 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -22.5 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.405 176.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.01 107.65 18.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 79' ' ' SER . 9.5 pt -121.43 159.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.394 . . . . 0.0 110.916 -172.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.85 113.32 17.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.767 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.37 134.27 50.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.767 179.096 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 157.27 77.07 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.839 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.7 Cg_exo -61.6 126.89 20.17 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.829 2.352 . . . . 0.0 112.341 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.582 HG13 ' HB ' ' A' ' 75' ' ' VAL . 1.3 mt -76.92 -36.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.031 0.443 . . . . 0.0 111.814 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.32 116.19 17.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.034 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.515 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 65' ' ' ILE . 12.9 mt -87.0 109.1 21.95 Favored Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.165 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -89.0 136.81 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.79 89.47 2.63 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.28 -53.29 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.627 2.218 . . . . 0.0 111.9 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.83 49.46 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.326 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -84.04 -47.17 11.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 10' ' ' PRO . . . 125.99 -101.01 0.6 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.021 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 9' ' ' GLY . 50.1 Cg_exo -52.93 148.08 30.78 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.322 2.681 . . . . 0.0 113.297 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.49 167.15 10.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -66.36 -27.34 40.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 110.732 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -26.61 64.89 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.979 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -48.19 80.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.164 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.22 -41.75 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.221 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' A' ' 25' ' ' VAL . 30.9 tt0 -61.4 -31.24 71.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -56.51 -31.2 63.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.06 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -80.93 -4.34 54.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.028 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -127.7 175.39 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.158 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.59 153.44 40.66 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.363 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.09 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.12 27.64 8.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 0.0 111.045 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.9 153.07 29.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.36 122.84 47.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.195 -173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.513 HG21 ' HG3' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -92.04 103.8 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.453 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.93 148.96 35.94 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.369 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.727 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 29.8 p -102.96 101.55 11.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -157.34 109.97 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.508 -176.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.72 147.97 22.77 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.44 155.06 45.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.803 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.84 -48.0 82.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.233 0.54 . . . . 0.0 110.566 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -70.37 -23.79 62.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.871 0.367 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 9.3 Cg_exo -73.25 156.29 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.986 2.457 . . . . 0.0 111.579 175.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 53' ' ' ASN . 2.7 mp . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.973 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.727 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 12.8 p . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.11 154.46 12.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.55 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' HB2' HG21 ' A' ' 44' ' ' ILE . 1.3 t30 -77.5 114.88 16.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.321 172.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.836 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -83.63 141.21 41.52 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.532 -176.107 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.14 119.95 7.3 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.768 2.312 . . . . 0.0 113.173 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -78.75 -12.55 13.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.362 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.45 -45.88 80.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.193 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -33.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.97 -23.24 31.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -54.38 15.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.77 0.319 . . . . 0.0 111.455 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -92.33 -35.94 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 0.0 110.736 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -91.12 35.99 0.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.779 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -66.88 -13.42 61.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.202 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.84 18.25 6.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.359 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 10.7 tt -91.94 135.85 26.84 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.731 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 7.3 Cg_exo -75.85 163.72 33.0 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.879 2.386 . . . . 0.0 112.309 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 4.4 tp -65.19 -8.71 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.564 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -56.88 -24.23 50.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -94.8 12.3 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.836 ' HD1' HG21 ' A' ' 54' ' ' ILE . 86.9 m-85 -127.04 174.16 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.004 -174.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.38 138.8 40.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.225 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.47 99.42 7.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.205 0.526 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 0.7 OUTLIER -153.98 158.88 41.29 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 m -50.85 113.5 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.969 0.414 . . . . 0.0 110.419 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -61.95 125.58 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.354 -176.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -127.4 112.96 15.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.577 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.573 ' HB2' HG12 ' A' ' 93' ' ' ILE . 35.9 t -98.11 119.45 36.77 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.932 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 2.4 m -115.07 163.83 15.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.321 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.33 119.16 3.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -34.1 107.05 0.03 OUTLIER Glycine 0 C--N 1.337 0.635 0 O-C-N 124.442 1.089 . . . . 0.0 113.91 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 109.02 2.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.307 0.575 . . . . 0.0 110.598 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 156.05 33.76 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.586 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 pt -58.33 112.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 123.476 0.485 . . . . 0.0 110.605 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.01 -12.43 11.52 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.034 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 103.26 15.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.069 0.462 . . . . 0.0 110.488 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.14 -50.51 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.329 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.43 129.86 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 pt -146.56 170.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.11 131.65 55.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.023 0.44 . . . . 0.0 110.648 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.408 ' SG ' HG13 ' A' ' 44' ' ' ILE . 12.0 m -110.01 127.25 54.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.05 135.21 21.0 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.623 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.96 127.78 23.4 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.899 2.399 . . . . 0.0 112.038 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.28 -61.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.893 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 100.34 13.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.052 0.453 . . . . 0.0 110.651 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.033 176.232 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mt -100.76 109.58 58.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 8.9 Cg_endo -90.42 126.09 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.861 3.041 . . . . 0.0 111.818 175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -140.34 61.64 17.39 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.453 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 17.0 Cg_exo -68.04 -53.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.428 2.085 . . . . 0.0 110.325 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.47 78.75 0.28 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.33 2.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.532 . . . . 0.0 110.9 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.04 -155.08 7.89 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.081 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.08 124.6 16.67 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.47 2.113 . . . . 0.0 111.854 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -83.35 156.11 23.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.208 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.5 p -61.31 -27.81 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.109 0.481 . . . . 0.0 110.788 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 63' ' ' GLN . 36.6 m -56.04 -38.92 71.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.9 tpp -64.45 -47.24 79.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.911 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.25 74.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.884 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -31.97 64.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.173 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -77.22 -4.8 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.492 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 175.05 8.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.03 134.94 43.3 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.38 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -23.74 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.945 0.402 . . . . 0.0 111.054 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 37.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.703 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -125.4 158.66 33.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.296 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.06 125.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 110.25 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.2 114.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.573 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 144.15 50.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.79 101.99 12.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.514 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.815 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 1.8 t -142.4 112.89 7.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.181 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.931 ' HB2' ' H ' ' A' ' 74' ' ' THR . 26.9 t30 -106.07 94.2 5.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.48 150.93 23.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.904 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -36.62 79.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.276 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.517 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -61.83 -31.45 71.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.798 178.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 42' ' ' ILE . 4.9 mp . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.552 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.53 152.76 20.3 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 123.346 2.697 . . . . 0.0 112.195 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.982 -178.781 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.815 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.38 147.18 25.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 112.155 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -83.55 110.2 18.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.625 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.734 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -87.67 143.18 33.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.279 -176.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 32.1 Cg_exo -59.19 120.75 8.79 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.86 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -23.56 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -34.95 70.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.22 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.39 -31.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.202 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -33.34 68.55 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -170.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -26.28 68.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.567 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.6 pt -121.15 -40.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.452 0.644 . . . . 0.0 110.749 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.567 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -89.48 35.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.507 -176.421 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -70.73 -8.47 52.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 179.042 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -5.05 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.144 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.507 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 5.4 mt -70.68 128.65 90.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.385 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.1 Cg_exo -81.08 164.72 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.288 2.659 . . . . 0.0 111.602 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.795 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -60.01 -13.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -13.65 59.17 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 111.4 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.56 12.64 36.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.384 0.611 . . . . 0.0 109.885 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.795 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 66.3 m-85 -130.99 177.55 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.35 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.11 145.02 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.074 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.23 96.72 7.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.0 110.125 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -156.2 159.47 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.26 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.931 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 65.2 m -51.9 107.96 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.13 0.49 . . . . 0.0 110.27 175.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.49 124.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.205 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 58.8 m -127.31 133.89 50.07 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.936 -175.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.642 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -110.2 123.3 49.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -120.45 162.05 20.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.273 -173.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.51 126.68 20.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.502 0.192 . . . . 0.0 110.56 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.79 106.04 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.508 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.59 138.46 43.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.553 -0.324 . . . . 0.0 111.096 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.62 171.5 18.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.406 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 83' ' ' ILE . 2.4 pt -62.94 123.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.72 -27.7 7.78 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.693 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.23 147.13 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.142 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -117.14 -66.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.344 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.77 127.12 56.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -113.68 152.26 15.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.74 118.72 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.03 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 9.5 t -116.43 138.64 51.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.583 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -143.1 141.23 19.04 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.312 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 25.9 Cg_exo -62.74 130.79 30.73 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.642 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -84.49 -43.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.678 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.06 120.41 37.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.726 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.858 -1.068 . . . . 0.0 109.264 176.796 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -80.8 111.22 21.56 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.742 0.306 . . . . 0.0 110.728 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 1.1 Cg_endo -87.95 128.74 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.219 2.612 . . . . 0.0 112.05 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.34 91.12 4.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.77 -53.63 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.25 47.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.311 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -83.12 -59.02 2.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.12 -89.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.242 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.92 137.1 77.9 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.23 2.62 . . . . 0.0 113.331 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.801 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -93.73 157.63 16.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.514 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.35 -27.27 23.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -37.14 85.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.021 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -42.73 86.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -49.67 38.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.21 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' A' ' 25' ' ' VAL . 3.3 tt0 -63.43 -28.83 70.25 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.745 -176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -30.25 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.942 0.401 . . . . 0.0 111.232 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -7.44 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.88 174.76 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.33 166.71 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.804 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.14 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.452 . . . . 0.0 110.967 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.92 37.46 1.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.42 0.629 . . . . 0.0 109.906 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.68 155.95 31.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.991 177.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.57 132.4 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.751 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 54' ' ' ILE . 89.1 t -86.17 137.49 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -148.32 150.76 34.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.917 0.389 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -115.53 108.86 16.99 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.9 t -151.38 103.57 3.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -85.28 93.22 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 110.025 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 147.46 25.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -70.57 -38.87 74.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.295 0.569 . . . . 0.0 109.841 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.04 -37.98 87.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' HG3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.886 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HA ' HG13 ' A' ' 88' ' ' ILE . 86.5 Cg_endo -84.82 156.72 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.059 2.506 . . . . 0.0 112.585 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mm . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.416 . . . . 0.0 110.895 -178.378 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.94 139.35 14.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.69 175.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.18 114.69 22.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.514 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.15 134.09 56.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.796 -170.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 41.8 Cg_exo -58.07 122.56 11.91 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.394 2.729 . . . . 0.0 113.587 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.426 ' HA ' HD13 ' A' ' 56' ' ' ILE . 4.7 mm -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.559 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -34.74 58.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.39 -174.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pt -79.81 -40.3 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.417 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -22.81 57.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -58.26 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.558 HG13 ' N ' ' A' ' 62' ' ' ASN . 12.7 pt -91.09 -35.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.558 ' N ' HG13 ' A' ' 61' ' ' ILE . 7.4 m-20 -92.22 37.24 0.99 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.509 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -8.12 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.488 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HB2' HG12 ' A' ' 3' ' ' ILE . 1.4 mt -79.02 -9.49 59.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.563 ' HA ' HG23 ' A' ' 3' ' ' ILE . 54.3 mt -69.49 124.96 91.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.63 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.801 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -77.91 174.77 12.05 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.25 -8.64 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.439 ' ND2' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -60.39 -21.91 62.72 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -102.12 24.54 9.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.427 0.632 . . . . 0.0 110.003 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -142.94 172.76 12.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.62 139.11 40.72 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.076 0.465 . . . . 0.0 111.368 -171.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.91 98.39 6.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.653 0.74 . . . . 0.0 109.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.19 162.16 41.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.208 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -52.72 98.86 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -54.4 129.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.54 -171.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.0 140.29 51.19 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.387 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.66 ' HB2' HG12 ' A' ' 93' ' ' ILE . 48.2 t -135.55 122.98 21.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -122.86 164.34 18.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.612 -172.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.91 128.48 18.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.389 0.431 . . . . 0.0 110.548 174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.67 118.15 1.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.827 0.705 . . . . 0.0 113.641 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 93.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.458 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.38 160.39 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.61 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.466 ' H ' HG12 ' A' ' 83' ' ' ILE . 1.9 mm -62.12 113.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.69 -37.52 2.05 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.847 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.76 98.56 10.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.886 0.374 . . . . 0.0 110.182 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.52 -38.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.227 0.536 . . . . 0.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -118.61 114.59 23.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.508 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.603 HG13 ' HA ' ' A' ' 43' ' ' PRO . 21.0 pt -107.21 150.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.175 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -99.8 118.7 36.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 t -108.0 130.74 55.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.229 0.538 . . . . 0.0 110.346 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 m -131.51 136.23 28.24 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.26 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.624 ' HG3' HD21 ' A' ' 33' ' ' LEU . 68.7 Cg_exo -53.39 127.53 25.62 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.686 2.257 . . . . 0.0 112.376 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.66 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -79.57 -23.08 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.352 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.92 139.92 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.02 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.125 0 O-C-N 123.988 0.805 . . . . 0.0 110.842 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.623 0.249 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -90.64 111.09 45.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.9 Cg_endo -89.18 128.79 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.317 2.678 . . . . 0.0 111.984 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.402 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -129.09 66.83 77.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.59 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 9.1 Cg_exo -73.27 -41.56 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.289 1.993 . . . . 0.0 110.547 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.92 110.97 2.3 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.328 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.33 113.61 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.74 0.305 . . . . 0.0 110.794 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.37 -166.35 13.78 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.29 153.05 17.95 Favored 'Trans proline' 0 N--CA 1.471 0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.236 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.66 155.67 17.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.748 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 3.6 p -62.04 -26.27 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.608 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -69.32 -26.72 64.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.962 -177.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ttt -65.32 -43.35 91.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.051 0.453 . . . . 0.0 110.123 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.73 69.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.032 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -56.36 -31.04 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.603 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.27 3.3 36.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.559 ' SG ' HG23 ' A' ' 93' ' ' ILE . 1.5 m -135.48 174.51 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.62 0.248 . . . . 0.0 110.536 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.92 151.62 33.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.284 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.62 59.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 22' ' ' GLU . 1.7 pm0 -90.5 0.83 57.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.934 174.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -105.76 160.24 15.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.639 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 p -101.73 146.69 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.745 0.307 . . . . 0.0 110.75 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.23 129.06 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.866 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -138.29 150.99 47.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.5 115.85 26.55 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 2.9 m -132.8 146.79 52.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.168 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -111.41 93.48 4.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.983 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.02 145.92 27.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.578 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.87 61.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -61.48 -20.96 63.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.738 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.563 178.152 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 90' ' ' CYS . 2.8 mp . . . . . 0 N--CA 1.458 -0.053 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.95 120.02 6.39 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.567 2.178 . . . . 0.0 112.385 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.317 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 1.9 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.07 137.46 31.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.168 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 4.8 t-20 -79.33 97.43 6.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.367 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.525 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -60.73 125.07 82.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.71 120.74 8.6 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.452 2.101 . . . . 0.0 112.047 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -76.08 -14.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 -174.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.85 -31.48 70.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.293 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -78.83 -45.5 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.224 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -68.97 -13.83 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -166.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -32.09 71.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.035 0.445 . . . . 0.0 110.929 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.3 pt -118.99 -39.03 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.959 175.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 3.6 m-20 -82.36 34.06 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.674 -177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.2 pt20 -70.34 -8.27 49.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.628 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.48 -5.94 59.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.721 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HA ' HG23 ' A' ' 3' ' ' ILE . 60.3 mt -73.4 122.7 88.26 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.2 Cg_exo -65.85 157.49 58.78 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.849 2.366 . . . . 0.0 112.193 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.771 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 3.3 tp -61.0 -9.4 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.138 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.492 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -55.84 -24.9 39.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.141 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -100.22 9.36 42.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.254 0.55 . . . . 0.0 110.674 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.771 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 64.5 m-85 -127.21 175.0 8.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.439 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 122.69 44.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 96.42 9.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.651 0.739 . . . . 0.0 109.806 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -156.11 164.17 38.74 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.11 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.181 0.925 . . . . 0.0 112.013 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -64.76 136.85 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.726 -177.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.8 m -141.12 113.17 7.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.855 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -100.83 142.98 31.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.209 0.528 . . . . 0.0 110.051 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 6.8 m -126.57 164.08 22.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.24 132.18 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -46.92 110.1 0.49 Allowed Glycine 0 C--N 1.333 0.391 0 O-C-N 123.597 0.561 . . . . 0.0 113.098 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.34 100.47 4.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -113.86 154.4 27.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.576 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -55.92 113.06 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.37 0.605 . . . . 0.0 110.742 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.91 -18.89 3.76 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.675 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -101.39 149.35 24.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.99 -42.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.2 0.524 . . . . 0.0 110.432 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -120.62 134.73 55.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.73 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.9 pt -133.49 148.99 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.42 37.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.071 0.462 . . . . 0.0 110.322 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.435 ' HB2' HG21 ' A' ' 42' ' ' ILE . 77.3 m -110.61 144.57 39.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.31 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 142.36 30.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.496 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.15 129.2 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.674 2.249 . . . . 0.0 111.546 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.559 HG23 ' SG ' ' A' ' 19' ' ' CYS . 3.0 mt -76.31 -62.0 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.837 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 tp -106.54 138.33 42.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.279 -174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.349 179.803 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.679 HG23 HG12 ' A' ' 65' ' ' ILE . 9.9 mt -88.92 111.46 44.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 1.8 Cg_endo -82.51 147.36 14.01 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.113 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.86 76.92 77.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.599 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -96.87 10.94 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 113.758 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.28 -32.51 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.623 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.5 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.186 0.993 . . . . 0.0 112.995 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.12 -141.72 4.09 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.21 160.86 28.88 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.198 1.932 . . . . 0.0 110.985 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -115.97 155.14 28.57 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -25.19 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 0.0 111.244 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.36 -28.32 69.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.797 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -67.74 -45.06 76.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.327 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.66 73.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.673 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.026 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.21 -31.64 71.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.087 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 14.73 29.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.504 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.41 174.32 7.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.82 154.0 33.5 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.79 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.55 65.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.54 36.46 2.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.472 0.654 . . . . 0.0 110.347 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 145.99 50.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.844 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.841 ' HA ' HD13 ' A' ' 56' ' ' ILE . 5.9 p -99.53 129.11 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.941 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.8 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.744 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.459 ' HA ' HG12 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -139.07 162.04 35.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.501 -178.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 110.87 15.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 2.8 m -140.18 135.19 32.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -120.59 93.09 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.862 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.39 148.71 29.73 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.521 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -65.21 -35.39 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.2 pm0 -68.81 -31.47 70.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.453 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.417 179.373 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.27 171.24 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.68 2.253 . . . . 0.0 112.138 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.711 HD11 HD11 ' A' ' 88' ' ' ILE . 1.6 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.185 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 36.1 t . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.6 0.238 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 123.99 15.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.003 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' HB2' HG21 ' A' ' 44' ' ' ILE . 6.6 t-20 -75.92 131.58 39.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 173.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.459 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -106.96 130.31 23.07 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 51.0 Cg_exo -51.33 121.7 8.85 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.357 2.705 . . . . 0.0 113.181 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 24' ' ' VAL . 3.2 tp -79.66 -12.19 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.936 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -51.55 68.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -31.28 53.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.761 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -60.79 -14.8 23.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 m -70.09 -31.98 69.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.5 pt -131.06 -32.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.201 0.524 . . . . 0.0 111.392 -178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -87.62 29.63 0.88 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.557 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -69.82 -14.74 62.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.097 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mt -78.05 -5.4 51.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.683 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.679 HG12 HG23 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -69.8 126.53 92.56 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.793 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 6.3 Cg_exo -73.6 157.91 48.06 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.822 2.348 . . . . 0.0 111.871 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.753 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 1.5 tp -62.1 -9.6 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.81 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -59.37 -23.63 62.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.803 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.87 8.72 21.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.753 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 62.4 m-85 -139.53 174.21 10.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.527 -172.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.25 121.87 44.75 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.367 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.57 98.54 0.69 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.42 0.628 . . . . 0.0 109.764 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.77 162.44 41.11 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 106.61 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 O-C-N 123.673 0.608 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.439 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.9 OUTLIER -60.35 135.95 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.038 -172.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 1.4 m -138.3 161.81 35.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' A' ' 93' ' ' ILE . 12.3 p -158.96 122.47 3.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.396 0.617 . . . . 0.0 110.124 173.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -97.95 163.5 12.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.76 -175.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.37 136.72 24.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.59 104.57 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 123.714 0.634 . . . . 0.0 113.768 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.12 105.8 2.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -105.21 170.98 7.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.178 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.55 113.13 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.564 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.99 -12.25 57.49 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.258 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.604 ' HG ' HG23 ' A' ' 88' ' ' ILE . 2.8 tp -82.04 75.56 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 109.957 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.63 -19.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.241 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.04 109.72 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.596 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.711 HD11 HD11 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -142.96 157.49 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.546 177.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -95.5 134.62 38.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.816 0.341 . . . . 0.0 110.413 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 2.9 t -108.21 128.75 54.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.302 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p -123.84 145.26 47.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.672 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.718 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 24.6 Cg_exo -63.64 151.65 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.281 1.987 . . . . 0.0 111.45 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.478 HG12 ' SG ' ' A' ' 77' ' ' CYS . 3.4 mt -83.15 -83.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.844 0.354 . . . . 0.0 110.41 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.424 ' H ' ' HB ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -96.51 105.09 17.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.404 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 65' ' ' ILE . 4.0 mt -82.86 111.19 27.82 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.4 Cg_endo -88.48 126.51 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.88 72.48 47.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.938 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.32 -56.25 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.855 2.37 . . . . 0.0 112.278 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.57 -18.28 60.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.046 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 60.97 2.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 111.175 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.27 -175.42 31.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.9 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.24 137.15 63.64 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.073 2.516 . . . . 0.0 112.668 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.872 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -86.88 166.69 14.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.143 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.89 -26.78 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.719 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -53.33 -32.85 51.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.174 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpt -65.48 -49.23 69.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 0.0 110.078 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.45 60.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.8 -29.58 70.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.895 -173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.17 -30.94 69.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 111.198 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -77.09 7.44 4.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.606 -176.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 174.65 10.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.02 168.01 36.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.329 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.17 -4.83 46.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.451 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -95.42 5.29 52.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 110.194 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 3.6 mptt -113.95 166.55 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.612 HG23 HG23 ' A' ' 56' ' ' ILE . 13.9 p -121.84 141.78 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.39 137.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.365 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.499 ' HA ' HG12 ' A' ' 54' ' ' ILE . 40.0 m -155.3 159.74 40.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.2 m -101.73 120.66 40.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.9 t -144.87 101.05 3.59 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.901 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -84.52 92.77 8.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.523 0.678 . . . . 0.0 109.52 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p -124.36 148.81 47.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.982 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -31.54 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 173.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -60.29 -47.47 85.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.648 -1.614 . . . . 0.0 111.018 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HB2' ' OG ' ' A' ' 30' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.991 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 121.053 0.454 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 3.5 Cg_endo -85.93 135.56 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.179 2.586 . . . . 0.0 112.203 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.636 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.7 m . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.366 0.603 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.7 139.69 32.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.757 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -97.68 133.91 41.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -109.52 125.01 32.27 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.493 -174.354 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.88 122.73 12.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.464 2.776 . . . . 0.0 113.702 -173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.612 HG23 HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -75.15 -16.91 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.745 -177.378 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -53.82 -43.15 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.23 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -78.32 -36.24 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.469 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 2.7 mp -54.56 -33.32 59.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.868 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -32.5 34.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.84 -20.51 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.235 0.54 . . . . 0.0 110.971 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -99.09 28.1 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.286 -177.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -68.27 -13.83 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.371 0.605 . . . . 0.0 110.67 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.96 -8.04 55.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.553 HG13 HG23 ' A' ' 3' ' ' ILE . 1.5 tt -67.99 133.58 91.92 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 110.652 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.872 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 3.7 Cg_exo -79.57 163.42 24.19 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.937 2.425 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tp -63.02 -9.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.74 -25.38 67.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.26 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -98.31 28.04 4.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.541 0.686 . . . . 0.0 109.623 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.469 ' HZ ' HD11 ' A' ' 59' ' ' LEU . 14.9 m-85 -144.3 173.01 12.14 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.01 127.85 51.58 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.576 -172.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.3 98.78 1.81 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -154.55 161.4 41.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.218 -170.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.59 103.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.15 0.5 . . . . 0.0 109.94 172.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -54.6 115.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.695 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -113.97 135.92 53.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.326 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 5.3 t -122.99 120.68 34.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 3.2 t -118.03 163.21 16.94 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.23 138.39 50.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.6 104.91 0.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.458 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.714 ' HG2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.89 134.33 54.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.367 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.16 154.58 37.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.937 -176.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.514 ' H ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.75 112.03 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 110.413 -178.129 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.86 -19.34 5.54 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.45 -37.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.797 0.332 . . . . 0.0 111.516 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 140.51 50.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.714 HD13 ' HG2' ' A' ' 81' ' ' GLU . 2.0 pt -137.99 157.29 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.79 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -98.81 121.38 40.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.676 178.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 m -114.4 132.54 56.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.318 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.99 151.05 77.26 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.584 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 Cg_exo -61.3 127.03 20.79 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.653 2.235 . . . . 0.0 111.595 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.637 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -84.22 -41.73 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.94 104.04 13.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.692 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.369 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.484 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -71.13 115.95 41.81 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.84 126.7 4.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.085 2.523 . . . . 0.0 112.037 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 73.87 23.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 37.8 Cg_endo -69.41 -25.64 30.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.164 1.91 . . . . 0.0 110.99 171.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.17 77.18 0.38 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.576 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -72.48 127.51 32.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.246 0.546 . . . . 0.0 111.83 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 10' ' ' PRO . . . -153.57 -126.78 1.14 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 9' ' ' GLY . 19.2 Cg_endo -62.44 133.84 45.05 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.662 2.241 . . . . 0.0 112.21 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -81.22 154.79 26.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.235 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.607 HG12 HD12 ' A' ' 67' ' ' ILE . 35.8 m -67.72 -24.87 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.912 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -30.27 71.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.943 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -40.3 90.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.204 0.526 . . . . 0.0 110.13 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.15 73.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.427 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -61.01 -29.24 69.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -31.68 71.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.031 0.443 . . . . 0.0 110.997 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.76 9.61 21.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.59 -176.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' HB2' HG23 ' A' ' 93' ' ' ILE . 5.4 t -133.84 174.39 10.51 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.16 156.02 39.09 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.193 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.42 87.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.54 38.65 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.393 0.616 . . . . 0.0 110.114 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 7.1 mttt -125.47 144.45 50.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.79 129.04 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.993 0.425 . . . . 0.0 110.362 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.478 HG12 ' HE2' ' A' ' 70' ' ' PHE . 16.1 t -85.57 106.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.64 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -120.21 171.49 8.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -130.78 108.85 10.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.073 0.463 . . . . 0.0 110.482 170.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 48.6 m -137.53 144.26 42.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.45 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -105.68 99.92 9.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.804 0.335 . . . . 0.0 111.527 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.79 141.62 28.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -23.28 57.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.841 0.829 . . . . 0.0 109.613 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -84.07 -18.42 37.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.027 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 179.323 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.56 0.219 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.24 -177.02 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.038 2.492 . . . . 0.0 112.606 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.356 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 42.2 t . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.597 0.237 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.74 116.12 5.78 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.64 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.9 t30 -84.6 94.37 8.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -68.11 136.29 91.67 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.267 -172.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.439 ' O ' HD12 ' A' ' 59' ' ' LEU . 28.1 Cg_exo -61.84 123.45 12.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.171 2.581 . . . . 0.0 112.744 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.488 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -72.74 -12.68 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.433 -175.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -40.12 88.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.5 -175.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.458 HG13 ' H ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -79.84 -32.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.892 0.377 . . . . 0.0 110.576 175.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -65.58 -17.94 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 -173.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -60.83 2.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.448 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.53 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -96.22 -37.19 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.044 0.449 . . . . 0.0 111.576 -177.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.53 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.97 36.03 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.436 0.636 . . . . 0.0 109.907 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.67 -8.0 53.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.977 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.7 mm? -76.47 -7.98 56.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.953 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.484 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -62.84 137.16 96.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.969 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.2 Cg_exo -79.07 159.48 26.95 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.047 2.498 . . . . 0.0 111.679 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.607 HD12 HG12 ' A' ' 12' ' ' VAL . 2.6 tp -61.2 -9.25 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.562 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -58.74 -28.99 66.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.07 27.55 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.459 0.647 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HE2' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -142.41 174.93 10.18 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -172.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.17 127.68 49.0 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.666 -173.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.93 94.68 3.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -156.44 161.69 40.06 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.7 98.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.411 0.444 . . . . 0.0 109.87 171.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.508 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -57.53 128.08 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -173.232 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.26 105.95 4.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.226 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 27.4 p -104.96 129.56 53.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.553 0.692 . . . . 0.0 110.851 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 11.8 m -105.27 164.09 12.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.076 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.53 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -54.99 139.3 41.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 173.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -50.41 114.59 2.68 Favored Glycine 0 C--N 1.331 0.252 0 O-C-N 123.309 0.381 . . . . 0.0 112.683 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 143.19 33.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.041 0.448 . . . . 0.0 110.675 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.59 174.87 14.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.33 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.68 119.28 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.799 0.333 . . . . 0.0 110.179 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.01 4.06 31.44 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.168 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 HG23 ' A' ' 88' ' ' ILE . 2.4 mt -112.0 112.83 24.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.8 -27.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.61 135.7 16.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.338 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.76 174.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.93 -177.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.91 128.05 48.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 98.6 m -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.491 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.6 t -150.07 143.57 16.75 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.339 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.0 Cg_endo -57.41 136.64 77.27 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.64 2.227 . . . . 0.0 111.677 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.51 HG22 ' HB3' ' A' ' 18' ' ' LYS . 1.2 mt -88.39 -73.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.61 72.25 1.76 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.016 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.056 178.996 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.675 HG23 HG12 ' A' ' 65' ' ' ILE . 7.2 mt -80.25 109.92 14.46 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 4.2 Cg_endo -89.82 124.93 1.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.344 2.696 . . . . 0.0 112.261 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.559 ' HB1' ' HG3' ' A' ' 8' ' ' GLU . . . -141.47 67.66 25.09 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.757 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.78 -28.72 7.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.776 1.651 . . . . 0.0 111.842 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.83 -44.21 2.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.618 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.559 ' HG3' ' HB1' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 57.38 50.53 11.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.385 177.318 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.78 -128.64 6.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.807 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.42 143.49 69.88 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -90.11 154.16 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 0.0 111.087 -178.211 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.06 -27.76 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.448 0.642 . . . . 0.0 110.028 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -67.06 -26.32 66.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.941 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 ttm -64.11 -47.27 80.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.97 -36.99 72.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 20.9 tt0 -64.0 -29.58 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.139 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -31.29 64.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 111.404 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -76.8 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 -177.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 175.03 7.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.85 -165.05 22.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.497 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.51 -7.07 48.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 0.0 110.942 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.83 9.64 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.274 0.559 . . . . 0.0 110.116 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -126.98 153.68 45.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG11 ' HG2' ' A' ' 81' ' ' GLU . 6.6 p -108.53 131.17 59.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.058 0.456 . . . . 0.0 110.586 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 t -83.89 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.615 ' HA ' HG12 ' A' ' 54' ' ' ILE . 8.0 t -154.74 170.31 21.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.691 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.502 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -122.52 99.97 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 172.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.688 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 16.1 m -131.56 109.82 10.52 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 3.0 p30 -88.68 134.58 33.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 0.0 110.957 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 38.4 m -158.52 155.43 28.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.763 176.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -70.56 -38.23 74.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 109.888 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -20.44 64.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.465 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.04 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.604 HG13 ' HD2' ' A' ' 43' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--O 1.239 0.507 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.604 ' HD2' HG13 ' A' ' 42' ' ' ILE . 92.1 Cg_endo -88.72 -175.89 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.71 2.273 . . . . 0.0 112.366 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 90' ' ' CYS . 4.3 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.688 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.13 140.61 5.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.04 145.83 55.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.627 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.81 126.46 30.21 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.1 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 75.1 Cg_exo -51.01 122.47 10.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.393 2.729 . . . . 0.0 113.544 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -76.01 -12.82 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.491 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -34.52 78.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.355 -175.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.33 -38.5 20.01 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.224 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -15.6 46.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -28.61 48.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.82 0.343 . . . . 0.0 111.856 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.53 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.4 pt -129.26 -41.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.206 0.527 . . . . 0.0 111.19 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.53 ' N ' HG13 ' A' ' 61' ' ' ILE . 5.6 m-80 -83.23 36.62 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.722 0.809 . . . . 0.0 110.194 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 24.5 pt20 -72.46 -7.4 49.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.253 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -1.45 45.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.656 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 3' ' ' ILE . 59.3 mt -80.23 120.26 79.01 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.349 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 23.5 Cg_exo -64.85 164.38 24.68 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 112.284 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.5 tp -62.49 -8.89 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.515 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -65.24 -7.46 13.16 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -116.4 29.91 7.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.491 0.662 . . . . 0.0 110.107 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -143.82 173.14 11.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 121.49 43.92 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.933 0.397 . . . . 0.0 111.64 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -72.25 98.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.619 0.724 . . . . 0.0 109.158 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.49 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.49 161.94 40.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.17 104.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 0.0 110.273 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -59.65 127.05 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.614 -172.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.61 152.89 43.0 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.092 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.581 ' HB2' HG12 ' A' ' 93' ' ' ILE . 19.2 t -144.58 119.04 9.65 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -113.52 164.1 14.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.695 -172.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.19 127.25 18.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 175.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -36.42 108.86 0.06 OUTLIER Glycine 0 C--N 1.34 0.781 0 O-C-N 124.081 0.863 . . . . 0.0 112.763 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.692 ' HG2' HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -82.84 129.23 34.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.17 -0.515 . . . . 0.0 110.883 -173.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 140.93 34.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.737 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -56.2 119.98 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 123.655 0.597 . . . . 0.0 111.053 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.84 -26.75 4.22 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.464 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.37 136.3 33.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.876 0.369 . . . . 0.0 110.305 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 t -74.81 -47.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -143.87 151.58 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.882 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -142.25 145.66 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.7 131.53 43.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.984 0.421 . . . . 0.0 110.69 -175.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 t -109.72 145.16 37.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.873 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.61 152.29 52.51 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 31.6 Cg_endo -64.09 140.44 71.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.645 2.23 . . . . 0.0 112.748 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.581 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -95.71 -62.68 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.913 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 100.94 13.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.521 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.138 178.352 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.863 HG23 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -77.91 111.94 21.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.725 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.1 Cg_endo -89.2 128.68 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.524 2.816 . . . . 0.0 112.381 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.65 68.08 16.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.77 -39.83 8.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.224 1.949 . . . . 0.0 112.116 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.01 -21.23 59.51 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.868 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 49.49 69.42 0.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.29 0.567 . . . . 0.0 111.51 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.76 -173.4 14.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.205 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.46 142.73 37.67 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.345 2.696 . . . . 0.0 112.335 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -87.6 157.28 19.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.832 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.71 -25.82 38.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.006 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 16' ' ' GLN . 40.2 m -60.45 -28.84 68.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.174 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -48.12 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.9 73.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.771 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 23.4 tt0 -62.86 -31.48 72.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.328 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -32.75 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 0.0 111.277 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -88.89 16.49 6.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.141 -177.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.19 175.02 10.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.898 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.67 167.43 22.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.09 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.19 -16.11 61.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.381 0.61 . . . . 0.0 110.157 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -89.76 19.37 4.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.459 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 79' ' ' SER . 1.8 mptt -132.6 156.0 47.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.597 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -105.1 123.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.197 0.522 . . . . 0.0 110.398 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.85 103.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.911 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -116.5 172.69 7.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 -177.244 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 p -126.74 128.4 46.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.921 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 34.0 t -157.32 141.38 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.379 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -98.65 94.02 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.93 0.871 . . . . 0.0 110.455 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.489 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -116.47 146.8 42.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.049 178.26 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -72.17 -26.03 61.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 0.0 110.269 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.42 -44.01 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.355 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.489 HD12 ' H ' ' A' ' 30' ' ' SER . 4.4 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.717 HG12 ' HB3' ' A' ' 90' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.285 0.564 . . . . 0.0 111.641 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 13.0 Cg_endo -91.21 -168.56 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.683 2.922 . . . . 0.0 111.415 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 26' ' ' SER . 5.3 tp . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.329 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 19.4 m . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -152.55 128.51 10.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -75.73 123.21 25.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.175 170.034 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.579 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -88.52 133.21 36.78 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.327 -175.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.86 127.56 26.09 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.506 2.804 . . . . 0.0 112.951 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.41 -12.53 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.921 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.24 -40.68 86.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.832 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.13 -25.21 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.612 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.17 -18.91 64.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -30.48 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.11 -38.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.25 28.19 0.54 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.36 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -8.63 55.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.422 0.63 . . . . 0.0 109.717 175.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.88 -7.52 58.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.213 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 3' ' ' ILE . 42.9 mt -75.99 126.94 86.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.247 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 14.9 Cg_exo -69.59 167.59 23.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.566 2.177 . . . . 0.0 111.93 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.626 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.25 -9.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.6 -177.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -24.92 64.86 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -100.32 16.14 25.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.504 0.669 . . . . 0.0 109.766 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.626 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 98.9 m-85 -126.75 176.0 7.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.99 127.46 48.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.48 98.59 3.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.46 160.64 40.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.217 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.0 112.53 0.53 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.295 0.569 . . . . 0.0 110.441 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.6 ' HB ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -61.61 130.77 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.53 -174.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 m -129.36 115.58 17.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.848 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 20.3 t -104.96 118.25 36.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.045 0.45 . . . . 0.0 110.096 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -114.9 163.35 15.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 -175.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.439 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.51 133.75 24.65 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 174.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -43.92 109.68 0.27 Allowed Glycine 0 C--N 1.335 0.495 0 O-C-N 123.792 0.683 . . . . 0.0 112.737 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.01 29.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.587 . . . . 0.0 110.508 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.54 173.4 7.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.18 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.44 117.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 123.364 0.415 . . . . 0.0 110.693 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.37 -43.02 1.61 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 84.16 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.971 0.415 . . . . 0.0 110.153 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -41.06 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 131.33 55.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.9 pt -132.86 163.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -107.58 120.02 41.04 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.717 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 t -108.6 135.7 49.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.319 0.581 . . . . 0.0 111.043 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -129.72 141.67 42.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.31 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 91' ' ' THR . 22.7 Cg_exo -63.39 126.6 18.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.358 2.039 . . . . 0.0 111.63 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.6 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -82.52 -52.1 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.163 0.506 . . . . 0.0 110.151 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.84 144.71 45.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.014 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.672 178.336 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.543 0.211 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.721 HG23 HG13 ' A' ' 65' ' ' ILE . 6.6 mt -85.46 114.02 54.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.972 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 7.5 Cg_exo -72.84 124.96 10.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.735 2.29 . . . . 0.0 111.874 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.61 88.02 9.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.98 -45.19 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.008 2.472 . . . . 0.0 112.351 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.53 27.01 5.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.463 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 48.76 65.55 1.33 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.795 0.438 . . . . 0.0 111.554 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.47 160.98 27.14 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.161 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.54 144.86 96.7 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.092 2.528 . . . . 0.0 112.267 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 154.76 29.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 0.0 110.978 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.61 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.985 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -67.2 -26.68 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.214 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -45.1 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.002 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.87 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -59.21 -29.91 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.443 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -56.72 -30.85 63.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.124 0.488 . . . . 0.0 111.362 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.45 -4.15 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.777 ' HB2' HG23 ' A' ' 93' ' ' ILE . 18.6 t -127.84 174.74 8.89 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.93 146.65 41.85 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.739 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.77 -9.52 59.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 111.08 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.97 21.98 10.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.655 0.74 . . . . 0.0 109.85 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HE2' ' SG ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -121.02 147.19 45.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.547 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.789 HG13 ' HA2' ' A' ' 80' ' ' GLY . 6.7 m -88.83 140.6 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 0.0 110.772 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.18 121.12 43.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.2 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.676 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -135.67 159.12 42.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.8 m -101.3 121.31 41.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.47 118.39 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -106.48 95.45 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.28 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.43 151.07 20.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -64.71 -37.99 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.663 -178.485 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.3 pm0 -73.46 -30.26 63.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.41 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.529 179.032 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.697 HG13 ' HA ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.537 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.18 124.13 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.025 2.484 . . . . 0.0 112.183 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' A' ' 44' ' ' ILE . 2.6 mm . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 129.24 15.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 22.8 t-20 -85.03 124.16 31.4 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.474 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -95.51 130.54 31.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.302 -174.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 79.4 Cg_exo -47.95 121.88 6.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.462 2.774 . . . . 0.0 113.291 -174.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.699 HD13 HG12 ' A' ' 24' ' ' VAL . 7.5 tp -75.17 -11.46 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.602 -173.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.24 -40.6 86.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.256 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.55 -25.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 56' ' ' ILE . 1.3 mm? -63.72 -23.8 67.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -60.29 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.595 HG13 ' N ' ' A' ' 62' ' ' ASN . 5.7 pt -81.47 -44.3 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 111.141 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.603 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -92.04 38.54 1.0 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.88 -176.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.1 -14.17 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.921 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.21 1.29 51.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.89 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.721 HG13 HG23 ' A' ' 3' ' ' ILE . 1.5 tt -66.01 135.93 95.38 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.34 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 3.0 Cg_exo -77.82 161.09 30.59 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.009 2.473 . . . . 0.0 111.742 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 67' ' ' ILE . 2.4 tp -67.11 -8.68 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.887 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.9 -32.3 67.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.903 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.417 HD21 HG12 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -103.48 60.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 109.316 176.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.89 173.15 16.91 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.2 133.48 49.04 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.313 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -80.54 94.18 6.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.063 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.588 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 17.9 m-20 -155.9 160.33 40.06 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -51.33 105.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.267 0.556 . . . . 0.0 110.812 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -62.24 135.33 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.778 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 m -144.13 148.66 35.37 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -172.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.1 p -129.18 119.62 24.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.694 0.759 . . . . 0.0 110.906 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 21.4 m -99.54 155.22 17.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.572 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 89' ' ' GLN . 0.3 OUTLIER -52.35 128.41 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.789 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -32.6 104.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.786 0 O-C-N 124.271 0.982 . . . . 0.0 114.19 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.51 93.1 1.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.429 0.633 . . . . 0.0 110.165 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 173.1 10.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.109 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.95 129.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.352 0.596 . . . . 0.0 110.891 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.0 -26.71 11.08 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.753 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 122.84 34.81 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.0 -52.31 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.032 0.444 . . . . 0.0 110.876 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -99.12 117.48 33.7 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 78' ' ' CYS . 17.7 pt -126.83 159.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.697 ' HA ' HG13 ' A' ' 42' ' ' ILE . 3.9 pt20 -109.65 128.46 55.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.488 ' HB2' ' CG2' ' A' ' 42' ' ' ILE . 94.3 m -107.93 127.3 53.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.113 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -138.3 135.61 18.5 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.581 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.75 141.01 77.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.131 2.554 . . . . 0.0 112.794 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 19' ' ' CYS . 2.1 mt -91.71 -77.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.581 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tp -74.51 121.48 21.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.787 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.969 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.529 0.204 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 65' ' ' ILE . 26.9 mt -94.93 111.45 54.57 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.835 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 65' ' ' ILE . 6.1 Cg_exo -78.74 126.02 7.09 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.007 2.471 . . . . 0.0 112.38 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.11 71.09 18.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.213 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.35 -23.83 32.22 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.743 2.295 . . . . 0.0 111.821 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.82 -21.9 4.1 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.09 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.83 51.75 15.31 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.08 0.552 . . . . 0.0 111.146 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.19 32.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.441 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.82 134.41 58.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.89 2.393 . . . . 0.0 112.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 m -89.73 155.66 19.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.536 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 67' ' ' ILE . 48.4 t -65.9 -25.2 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.223 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.92 -35.43 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.034 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpp -62.65 -42.27 99.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.369 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.67 78.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -60.92 -32.75 72.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.367 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -30.3 62.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.836 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.07 -3.12 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.894 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 174.79 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.8 151.06 38.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.254 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.02 -9.01 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 110.998 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.58 12.04 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.406 0.622 . . . . 0.0 109.748 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -119.89 166.78 12.86 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.332 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.858 HG13 ' HA2' ' A' ' 80' ' ' GLY . 9.9 m -106.24 160.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.216 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.02 116.2 51.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.668 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -131.42 149.02 52.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.504 -178.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 107.32 17.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 3.3 m -126.14 121.45 32.87 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.862 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 11.2 t-20 -86.42 113.94 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.742 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.2 144.19 32.07 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -74.79 -42.99 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.356 0.598 . . . . 0.0 110.329 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.3 pm0 -68.77 -27.46 65.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.541 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.145 0.498 . . . . 0.0 110.757 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.635 HG21 ' HB2' ' A' ' 90' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 17.1 Cg_endo -91.63 99.0 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.24 2.627 . . . . 0.0 112.696 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.558 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 130.67 47.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.6 t-20 -79.59 101.1 8.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.546 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -64.88 131.59 95.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.101 -174.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.562 ' O ' HG13 ' A' ' 58' ' ' ILE . 6.3 Cg_endo -47.84 123.62 8.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.994 3.129 . . . . 0.0 113.73 -171.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.76 -23.56 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.992 -174.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.559 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -59.45 -43.47 93.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.366 -176.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -80.12 -17.8 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 110.721 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 59' ' ' LEU . 1.9 mm? -71.02 -33.44 70.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.784 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -51.4 9.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.987 0.422 . . . . 0.0 112.132 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 62' ' ' ASN . 3.2 pt -99.46 -44.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.947 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' HG13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -93.63 30.7 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.883 0.373 . . . . 0.0 110.987 -174.34 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.18 -8.43 54.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.668 . . . . 0.0 109.564 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.18 -13.26 60.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.848 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 3' ' ' ILE . 21.4 mt -66.97 129.7 93.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 48.7 Cg_exo -56.46 152.14 41.66 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.545 2.163 . . . . 0.0 111.567 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.741 HD12 HG22 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -59.11 -8.54 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -175.263 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -56.58 -26.09 54.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.723 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.75 13.59 19.76 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.843 0.83 . . . . 0.0 110.264 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.465 ' CE2' HG13 ' A' ' 54' ' ' ILE . 1.1 m-85 -130.6 173.4 10.92 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 123.99 48.72 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.995 -170.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 96.73 2.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 3.4 t0 -156.79 163.58 39.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.213 -173.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.23 97.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 0.0 109.845 168.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -71.97 135.53 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.312 -172.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 140.63 51.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.287 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.483 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 122.25 38.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.617 0.722 . . . . 0.0 109.346 174.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 14.4 m -111.87 162.97 14.72 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.686 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.38 135.36 39.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.016 0.371 . . . . 0.0 110.087 174.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.858 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -47.18 107.22 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 123.644 0.59 . . . . 0.0 112.729 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -55.4 119.15 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.735 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.36 26.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.349 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.516 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.48 113.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 110.518 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.15 -17.76 5.92 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.804 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 108.54 10.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.872 0.368 . . . . 0.0 110.105 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.79 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.013 0.435 . . . . 0.0 110.778 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -101.09 108.77 20.55 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -110.35 162.58 7.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.822 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 23.7 mt-30 -99.47 121.09 40.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.712 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.635 ' HB2' HG21 ' A' ' 42' ' ' ILE . 89.2 m -108.3 127.61 54.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 t -132.47 139.99 36.48 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.284 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 9.5 Cg_endo -54.44 126.6 22.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.648 2.232 . . . . 0.0 111.658 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -69.35 -38.98 78.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.0 110.437 -178.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.88 117.22 20.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.857 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.525 HG23 HG12 ' A' ' 65' ' ' ILE . 2.8 mp -98.95 110.83 59.08 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.032 0.444 . . . . 0.0 110.046 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 131.23 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.498 2.799 . . . . 0.0 112.003 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 8' ' ' GLU . . . -135.77 66.44 62.8 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 6.5 Cg_exo -73.91 -70.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.205 1.937 . . . . 0.0 110.27 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 74.99 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.435 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -69.24 129.6 40.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 0.0 111.251 -175.484 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.42 -141.07 3.23 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.423 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 133.43 58.07 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -91.64 155.09 18.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.72 -25.29 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.003 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -65.0 -29.29 70.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.582 -175.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -36.19 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 109.982 177.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.86 -35.17 78.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.116 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -70.3 -31.28 68.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -32.74 74.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.924 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -88.54 3.92 48.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.202 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HD2' ' A' ' 23' ' ' LYS . 32.7 t -127.2 175.75 7.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.68 159.47 30.57 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.167 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.83 -35.67 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 111.098 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -89.19 36.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.494 0.664 . . . . 0.0 110.011 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 11.2 mttt -135.97 166.01 24.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.614 HG13 ' HA2' ' A' ' 80' ' ' GLY . 2.8 m -118.8 130.1 74.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.187 0.518 . . . . 0.0 111.398 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.44 131.59 33.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.669 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.37 164.82 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.167 0.508 . . . . 0.0 110.861 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.813 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -123.76 110.14 14.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.735 ' HA ' ' CB ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -151.89 113.21 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.315 0.384 . . . . 0.0 110.15 178.225 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.804 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 9.8 p30 -85.29 152.84 22.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.71 0.766 . . . . 0.0 112.521 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 m -157.94 147.37 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.078 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -68.4 -31.57 71.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.154 0.502 . . . . 0.0 110.584 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -17.38 60.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.766 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 37.3 Cg_exo -61.25 140.59 89.52 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.187 2.591 . . . . 0.0 112.774 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.603 HG12 ' HB2' ' A' ' 53' ' ' ASN . 5.9 tt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.832 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 25.7 p . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -156.87 152.8 27.25 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.077 0.236 . . . . 0.0 110.781 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.603 ' HB2' HG12 ' A' ' 44' ' ' ILE . 64.6 t30 -91.56 133.04 35.87 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.529 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -97.25 136.77 21.28 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.489 -169.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 31.7 Cg_exo -59.48 132.99 49.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.649 2.899 . . . . 0.0 113.454 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -77.97 -27.65 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.603 -175.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -55.59 -35.33 65.69 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -79.04 -39.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.084 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -55.39 -26.31 40.8 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.403 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -28.54 69.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.413 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -131.49 -37.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.041 0.448 . . . . 0.0 110.648 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.7 m-80 -80.27 24.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.986 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -69.92 -7.59 41.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.381 177.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.83 -10.8 59.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.667 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 3' ' ' ILE . 78.7 mt -73.37 126.05 90.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 10.6 Cg_exo -71.62 164.18 36.53 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.689 2.259 . . . . 0.0 111.541 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 2.2 tp -57.88 -8.9 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -26.25 62.17 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -106.44 33.76 3.72 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.699 0.762 . . . . 0.0 109.383 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.624 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 80.1 m-85 -149.04 175.94 10.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.53 115.85 31.41 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.717 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 97.83 0.91 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.804 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 18.4 t0 -155.21 162.87 40.82 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.373 -173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.51 99.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.98 0.8 . . . . 0.0 110.017 170.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -60.69 130.18 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.345 -169.24 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.3 m -124.08 153.84 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.117 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -144.29 121.9 11.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.716 0.77 . . . . 0.0 109.407 171.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 5.8 t -110.46 163.41 13.71 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.9 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.628 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -54.35 134.55 45.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 172.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -48.09 108.24 0.33 Allowed Glycine 0 CA--C 1.507 -0.444 0 O-C-N 123.558 0.536 . . . . 0.0 112.172 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.02 130.56 44.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.323 0.582 . . . . 0.0 110.406 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.89 150.65 51.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.596 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -55.14 112.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 177.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.17 -32.06 6.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 89.26 7.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -77.71 -41.35 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.704 -176.706 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.0 105.75 17.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.19 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 79' ' ' SER . 1.5 pt -114.42 164.49 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.665 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -106.46 112.34 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.295 . . . . 0.0 110.274 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.5 m -107.56 133.99 51.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.427 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 149.48 64.68 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.267 -175.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.23 121.85 8.66 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.871 2.381 . . . . 0.0 112.157 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -72.87 -30.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.86 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tp -133.84 103.47 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.938 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.13 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.967 0.413 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.562 HG23 HG12 ' A' ' 65' ' ' ILE . 4.5 mt -103.61 112.18 65.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.222 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 2.9 Cg_exo -76.55 125.11 8.07 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.68 2.254 . . . . 0.0 111.996 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.18 82.96 67.19 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.43 -71.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.964 2.443 . . . . 0.0 112.005 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.12 -0.82 61.47 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.753 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 53.31 54.2 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.099 0.56 . . . . 0.0 111.375 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.57 -171.22 38.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.363 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.01 145.29 98.12 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.913 2.408 . . . . 0.0 112.435 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.75 157.09 16.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.233 -177.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.3 p -63.32 -26.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.957 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.765 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.7 p -64.04 -31.13 72.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.303 -175.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -44.71 82.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.56 74.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.614 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.45 -29.3 70.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.79 -33.92 69.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -92.69 13.88 18.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.732 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.58 174.86 8.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.66 20.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.165 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.34 -22.45 54.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 109.842 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.53 25.45 7.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.67 0.748 . . . . 0.0 109.29 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -128.24 171.61 11.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.148 178.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 56' ' ' ILE . 11.6 p -122.75 141.48 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.994 0.426 . . . . 0.0 111.443 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.41 116.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.646 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.88 155.34 43.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 3.2 p -101.35 105.41 16.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 11.2 t -134.27 108.54 8.29 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.571 -175.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.641 ' HB2' ' H ' ' A' ' 74' ' ' THR . 22.6 t-20 -115.41 92.46 3.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.477 171.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.62 153.58 18.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -44.71 75.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.955 0.407 . . . . 0.0 110.658 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.23 -41.49 94.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.069 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.866 HD12 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -99.37 162.97 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.5 2.8 . . . . 0.0 113.154 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 3.2 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -132.87 131.7 41.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.203 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.64 111.03 21.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.947 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.426 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -87.5 150.08 47.98 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' O ' HD13 ' A' ' 59' ' ' LEU . 35.6 Cg_exo -57.25 118.71 5.62 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.261 1.974 . . . . 0.0 112.858 -173.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.613 HD12 HD22 ' A' ' 59' ' ' LEU . 4.7 tp -80.04 -26.79 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -33.8 73.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.118 -173.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 55' ' ' PRO . 1.5 pt -80.22 -26.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.084 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 56' ' ' ILE . 4.7 mp -56.2 -34.36 66.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -20.76 63.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 62' ' ' ASN . 4.0 pt -120.28 -32.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.298 0.57 . . . . 0.0 110.945 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.578 ' N ' HG13 ' A' ' 61' ' ' ILE . 6.8 m-20 -98.64 33.26 2.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.862 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.765 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 5.5 pt20 -68.51 -10.86 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.697 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.74 -5.04 59.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.46 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.562 HG12 HG23 ' A' ' 3' ' ' ILE . 4.5 mt -71.07 126.5 92.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 6.0 Cg_exo -80.17 167.21 19.97 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.015 2.477 . . . . 0.0 112.137 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.655 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -60.42 -12.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.961 -174.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -66.89 -18.72 65.52 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.01 -0.431 . . . . 0.0 111.169 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -97.35 7.87 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.564 0.697 . . . . 0.0 109.821 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.655 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 44.8 m-85 -125.41 176.34 6.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.84 -175.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 134.88 45.11 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.82 96.8 9.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.482 0.658 . . . . 0.0 110.562 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 2.3 m-20 -154.18 158.34 40.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.641 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 29.9 m -43.67 108.7 0.12 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.092 0.472 . . . . 0.0 112.19 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.82 116.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 17.0 m -122.92 132.15 54.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 -177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 t -107.16 118.16 35.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 3.1 m -117.96 164.54 14.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.39 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.68 134.95 41.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.518 ' N ' ' HA ' ' A' ' 23' ' ' LYS . . . -33.83 113.71 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 O-C-N 123.821 0.701 . . . . 0.0 114.345 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.71 104.28 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.24 174.95 10.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.183 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 tp -67.39 137.9 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.23 46.39 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.608 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.0 130.52 36.18 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.768 -0.254 . . . . 0.0 110.752 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.1 t -79.66 -67.07 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -136.06 159.99 40.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.678 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.05 177.95 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.791 0.329 . . . . 0.0 110.834 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 123.87 46.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.831 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.866 ' H ' HD12 ' A' ' 42' ' ' ILE . 9.2 m -109.54 140.55 43.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.431 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 t -150.8 135.36 9.71 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.044 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 9.4 Cg_endo -53.85 129.3 33.45 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.99 2.46 . . . . 0.0 112.059 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.517 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -74.87 -65.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.335 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD12 HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -105.22 117.04 32.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.013 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.809 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.621 0.248 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.971 HG23 HG13 ' A' ' 65' ' ' ILE . 4.1 mt -101.57 110.86 62.91 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.13 139.56 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.432 2.755 . . . . 0.0 112.243 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.6 71.38 71.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.743 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HD2' ' ND2' ' A' ' 68' ' ' ASN . 12.9 Cg_exo -71.98 -73.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 110.567 172.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.65 77.57 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.34 110.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 111.326 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.66 -149.2 5.42 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 139.92 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.441 2.094 . . . . 0.0 112.175 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -84.55 165.42 18.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.146 -177.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.62 -26.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.429 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.8 p -64.74 -27.47 68.92 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.821 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.3 ttm -63.13 -46.26 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.493 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.98 74.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.07 -30.27 71.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.161 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -57.29 -31.28 65.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.549 . . . . 0.0 110.897 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -84.66 12.06 7.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.455 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 174.86 10.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 110.326 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.42 161.85 45.18 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 -26.65 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.921 0.391 . . . . 0.0 110.669 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.19 27.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.545 0.688 . . . . 0.0 110.23 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -125.06 160.86 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.728 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.779 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 13.4 p -114.34 134.74 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.412 0.625 . . . . 0.0 110.284 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 t -99.99 104.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.059 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -111.58 163.31 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.717 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 14.0 p -101.27 104.17 15.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -131.8 101.73 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.078 0.466 . . . . 0.0 111.003 -177.419 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 10.7 t-20 -100.23 119.9 39.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.21 147.91 39.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.277 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -71.44 -29.58 65.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 109.988 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.1 pm0 -71.1 -29.97 65.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.209 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 42' ' ' ILE . 2.3 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.364 0.602 . . . . 0.0 110.068 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.96 154.25 14.86 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.511 2.14 . . . . 0.0 112.004 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.557 179.298 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.73 141.44 7.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.066 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 53.6 t30 -96.01 109.79 22.13 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.481 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -79.72 149.32 70.87 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.704 -176.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 54' ' ' ILE . 37.0 Cg_endo -64.6 121.54 9.14 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.77 2.314 . . . . 0.0 112.797 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.522 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -80.08 -5.41 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.482 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.35 -37.57 83.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.698 0.285 . . . . 0.0 111.232 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -16.78 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.889 175.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.2 -14.48 62.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.227 -170.126 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -51.16 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.988 0.423 . . . . 0.0 112.098 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.9 pt -106.89 -23.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.869 0.366 . . . . 0.0 111.805 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -105.69 21.34 17.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.278 -176.078 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -64.91 -14.19 59.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.355 0.598 . . . . 0.0 110.041 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -72.35 -5.25 35.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.496 176.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.971 HG13 HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -70.35 134.1 87.05 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -74.44 159.28 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.203 . . . . 0.0 111.159 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.502 ' HA ' HD12 ' A' ' 67' ' ' ILE . 3.2 tp -61.95 -10.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.415 ' ND2' ' HD2' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -64.07 -22.66 67.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 175.071 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.53 34.07 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -150.65 177.01 10.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -172.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.62 116.65 32.22 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -76.99 97.29 4.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.7 0.762 . . . . 0.0 109.659 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.717 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 10.1 m-20 -153.85 159.71 41.92 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 29' ' ' ASN . 21.0 m -43.51 115.28 0.76 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.183 0.516 . . . . 0.0 111.26 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.37 123.86 25.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.994 -174.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 28' ' ' CYS . 84.7 p -123.83 127.24 47.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.389 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.67 118.4 36.45 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.271 0.558 . . . . 0.0 109.965 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.686 ' SG ' ' HB ' ' A' ' 88' ' ' ILE . 14.5 t -118.33 165.44 13.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.543 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.617 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -51.56 122.42 8.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.779 ' HA2' ' HB ' ' A' ' 24' ' ' VAL . . . -54.7 104.77 0.28 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.294 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.54 119.31 6.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.569 -0.816 . . . . 0.0 112.106 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.82 151.85 41.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.85 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.58 112.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.497 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.49 -21.45 4.28 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.545 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.28 96.17 10.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 0.0 110.011 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -37.7 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.937 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.12 148.37 51.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.641 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.686 ' HB ' ' SG ' ' A' ' 78' ' ' CYS . 1.5 pt -131.77 151.27 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.882 0.372 . . . . 0.0 111.275 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -106.85 109.14 20.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.513 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.6 m -112.59 136.02 52.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -138.2 143.61 39.85 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.357 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.437 ' HD2' HG22 ' A' ' 91' ' ' THR . 32.8 Cg_endo -64.57 147.82 90.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.735 2.29 . . . . 0.0 112.356 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -115.96 -73.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 78.08 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.571 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.598 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.64 143.0 41.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 111.389 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.561 HG23 HG12 ' A' ' 65' ' ' ILE . 5.2 mt -101.75 112.37 65.16 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.52 125.01 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.417 2.078 . . . . 0.0 111.227 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.81 82.29 6.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.28 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.71 -64.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.553 2.168 . . . . 0.0 111.665 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.49 53.02 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.991 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.76 -49.14 8.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.569 0.223 . . . . 0.0 111.183 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.87 -146.23 10.39 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.752 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.1 169.47 19.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.502 2.801 . . . . 0.0 113.085 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -102.94 167.47 9.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.001 -179.293 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -25.3 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.513 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.2 m -50.18 -33.9 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.602 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -45.71 64.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.66 -50.81 32.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.706 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -59.39 -29.86 68.03 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.09 68.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.444 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 15.5 2.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.032 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -144.17 174.24 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.96 143.87 37.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.528 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 -16.24 62.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 0.0 111.369 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.09 4.09 53.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.595 0.712 . . . . 0.0 110.104 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.23 153.57 20.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.618 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG23 HD13 ' A' ' 56' ' ' ILE . 12.9 p -97.01 141.41 15.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.0 t -93.37 128.94 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 110.997 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.17 138.28 23.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.64 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -100.98 124.37 46.59 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.661 -0.649 . . . . 0.0 109.681 175.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -156.17 126.04 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.451 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.618 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . 8.9 t-20 -95.13 93.04 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.33 147.8 22.6 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -69.89 -34.12 73.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.076 0.465 . . . . 0.0 109.792 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' OE2' ' HG2' ' A' ' 31' ' ' LYS . 2.0 pm0 -70.73 -40.23 72.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.419 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.26 -39.67 71.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -23.98 66.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.368 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -107.38 10.57 29.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.32 45.96 27.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.066 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.29 41.82 3.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.047 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.96 108.49 4.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.781 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.2 -45.27 4.16 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 -12.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -82.03 50.63 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.294 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -129.14 123.94 21.99 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.847 0.356 . . . . 0.0 110.667 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HB2' HG22 ' A' ' 46' ' ' VAL . 1.9 Cg_endo -82.6 123.09 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.525 HG12 ' SG ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -68.33 -51.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.206 0.526 . . . . 0.0 110.697 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.34 115.8 31.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.1 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 43' ' ' PRO . 6.6 t -129.68 -98.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.824 0.345 . . . . 0.0 110.889 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 47' ' ' LEU . 10.9 tp -121.44 150.39 41.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.861 0.363 . . . . 0.0 111.359 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 98.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.447 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.01 -8.68 9.12 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.276 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.2 mt-10 -115.19 -61.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 5.2 m -140.95 137.77 33.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.309 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 141.46 18.56 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.403 0.44 . . . . 0.0 110.172 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.55 130.56 35.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -100.62 132.05 22.85 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' O ' HD12 ' A' ' 59' ' ' LEU . 75.9 Cg_exo -49.26 119.81 4.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.109 2.539 . . . . 0.0 112.881 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.541 HD12 HD13 ' A' ' 59' ' ' LEU . 4.5 tp -79.89 -11.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.27 -50.22 73.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.411 -177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 HG13 ' H ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -78.5 -27.72 14.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.148 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.541 HD13 HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -58.35 -27.23 63.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -55.51 6.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 111.888 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -94.96 -28.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.193 0.52 . . . . 0.0 111.398 -175.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -101.84 34.78 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -68.87 -13.06 62.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.689 . . . . 0.0 109.824 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -70.07 -11.5 60.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.181 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.561 HG12 HG23 ' A' ' 3' ' ' ILE . 26.1 mt -64.44 120.6 66.68 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.253 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 21.6 Cg_exo -66.82 164.48 29.35 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.939 2.426 . . . . 0.0 112.139 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.23 -9.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.467 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -58.77 -21.77 56.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.666 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -108.15 31.19 5.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 109.891 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -149.41 172.28 15.2 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.69 117.46 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.161 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 96.78 1.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.618 ' OD1' ' HB2' ' A' ' 29' ' ' ASN . 12.0 t0 -156.92 165.19 36.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.505 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.32 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.614 0.571 . . . . 0.0 109.482 170.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.527 ' C ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.49 137.18 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.339 -174.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 m -123.97 137.67 54.58 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.601 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.617 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -122.1 120.32 33.93 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.854 0.835 . . . . 0.0 109.093 175.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 88' ' ' ILE . 4.8 m -112.97 163.05 15.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.849 -172.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.27 128.87 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -41.03 107.84 0.1 OUTLIER Glycine 0 C--N 1.337 0.603 0 O-C-N 123.761 0.663 . . . . 0.0 113.27 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -77.94 91.6 4.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.323 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.409 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.6 mp0 -95.0 159.11 15.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -53.41 111.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.1 -18.29 6.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.165 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -87.26 72.76 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.086 178.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.38 31.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.906 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -141.52 126.22 17.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.213 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 78' ' ' CYS . 0.5 OUTLIER -148.61 177.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.5 139.84 37.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.137 0.494 . . . . 0.0 110.858 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' A' ' 44' ' ' ILE . 57.4 m -109.77 143.22 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.544 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 141.78 33.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.48 131.45 36.03 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.617 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.9 OUTLIER -77.31 -58.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.486 0.66 . . . . 0.0 110.093 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tp -114.9 101.63 9.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.639 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.014 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.417 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.859 0.361 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.6 154.15 28.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.052 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 mt -100.56 110.56 60.75 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.345 . . . . 0.0 111.019 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HG2' HD22 ' A' ' 69' ' ' ASN . 7.2 Cg_endo -89.68 126.3 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.261 2.641 . . . . 0.0 111.803 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.21 70.15 55.42 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.99 -61.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.682 2.255 . . . . 0.0 112.846 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.76 18.78 41.22 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.887 -172.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 50.39 56.8 7.39 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.679 0.392 . . . . 0.0 112.025 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 161.27 35.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.458 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.56 149.79 88.22 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.833 2.355 . . . . 0.0 111.574 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 153.3 38.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.034 0.445 . . . . 0.0 111.943 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 HD12 ' A' ' 67' ' ' ILE . 29.5 m -71.37 -25.37 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.612 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -59.7 -26.22 65.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.924 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.95 88.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.107 0.48 . . . . 0.0 109.91 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.36 71.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -61.99 -31.79 72.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.606 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -32.4 67.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.281 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -85.89 -5.91 59.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.841 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HB2' HG21 ' A' ' 93' ' ' ILE . 19.9 t -115.75 175.99 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -170.9 34.95 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.807 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.85 -39.77 16.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.34 37.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.312 0.577 . . . . 0.0 110.382 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -131.61 153.05 50.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.127 -177.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.86 144.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.201 0.524 . . . . 0.0 111.146 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.62 127.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.822 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 157.96 45.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 22.9 p -115.28 100.62 8.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.602 . . . . 0.0 109.854 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.8 m -143.07 111.36 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.911 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' HB2' ' H ' ' A' ' 74' ' ' THR . 0.8 OUTLIER -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.33 0.585 . . . . 0.0 110.225 177.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 147.59 37.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.879 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HD2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.53 -28.98 70.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.755 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG3' ' HD2' ' A' ' 31' ' ' LYS . 7.1 mp0 -68.18 -38.71 82.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.646 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.78 -31.58 69.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.537 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.5 -12.51 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.986 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -107.45 2.67 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.314 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 53.77 43.49 30.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.712 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 137.64 14.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 110.809 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.08 91.46 4.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.92 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.2 -21.03 78.67 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.721 177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.71 -171.91 2.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -81.58 158.26 24.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -100.83 101.57 16.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.621 0.248 . . . . 0.0 111.507 -174.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 58.5 Cg_endo -98.78 116.21 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.579 2.852 . . . . 0.0 112.871 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mt -77.78 103.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.054 0.454 . . . . 0.0 110.294 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -165.03 -141.44 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 t -113.03 101.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.844 0.354 . . . . 0.0 110.169 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.538 ' H ' ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -96.9 -161.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.7 m -75.2 81.79 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 111.113 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.39 -105.22 0.33 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.38 149.77 41.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 15.7 t -178.34 143.71 0.29 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -161.2 147.21 14.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.167 0.508 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -97.57 89.95 4.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.799 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -64.13 127.07 91.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.226 -176.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.53 121.21 8.69 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.011 2.474 . . . . 0.0 112.824 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -19.23 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.831 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -61.84 -31.53 71.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.157 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pp -80.0 -37.6 17.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.577 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.455 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -60.86 -14.43 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -170.163 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -40.48 64.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.736 0.303 . . . . 0.0 111.641 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.489 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -116.86 -24.14 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.338 0.59 . . . . 0.0 111.216 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.4 OUTLIER -92.57 34.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.733 -178.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -19.0 65.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.292 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -3.01 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.846 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -70.27 131.83 88.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.333 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 8.7 Cg_exo -73.43 154.41 50.62 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.763 2.309 . . . . 0.0 111.925 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 12' ' ' VAL . 2.1 tp -61.7 -8.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.318 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -12.53 20.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.767 0.317 . . . . 0.0 111.504 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.484 HD22 ' HG2' ' A' ' 4' ' ' PRO . 14.1 m120 -97.14 3.45 51.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.49 0.662 . . . . 0.0 109.986 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -116.33 174.21 6.18 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.07 138.89 39.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.82 97.52 5.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.493 0.664 . . . . 0.0 110.563 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.56 159.72 39.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.08 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.487 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 4.2 m -50.47 102.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 110.725 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.49 120.04 6.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.425 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -127.45 125.61 40.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.624 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.749 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -106.72 141.89 37.25 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 17.9 t -134.12 163.47 29.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.107 -167.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.6 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -57.43 133.67 55.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.31 115.86 6.74 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.982 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.77 92.88 0.91 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.986 0.422 . . . . 0.0 110.391 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -124.63 168.89 12.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.61 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.19 113.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.85 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.31 -30.79 3.58 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 102.73 13.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.807 0.337 . . . . 0.0 110.4 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -77.59 -16.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.438 -179.178 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -150.35 143.87 25.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.879 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 79' ' ' SER . 11.3 pt -130.23 153.78 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.512 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.467 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -116.0 113.37 23.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.958 0.409 . . . . 0.0 110.331 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.643 ' H ' HD13 ' A' ' 42' ' ' ILE . 1.4 m -109.02 142.4 39.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.944 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 154.86 30.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.458 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.87 129.72 31.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.535 2.157 . . . . 0.0 112.005 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.749 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -91.86 -34.17 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.754 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -105.43 131.31 53.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.25 1.113 0 O-C-N 124.378 1.049 . . . . 0.0 110.313 -177.563 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.04 110.63 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.993 0.425 . . . . 0.0 110.584 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 65' ' ' ILE . 4.0 mt -91.07 114.14 60.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.657 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 3.0 Cg_exo -81.69 126.18 5.18 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.188 2.592 . . . . 0.0 111.907 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.49 78.09 38.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.739 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.94 -72.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.692 2.261 . . . . 0.0 110.904 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.92 123.05 6.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.74 68.58 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.608 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 178.71 47.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.281 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.95 147.81 91.83 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.581 2.187 . . . . 0.0 111.729 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.28 154.83 40.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.92 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -65.29 -24.67 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.341 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.619 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -60.58 -29.34 69.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.885 177.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.1 tpt -69.48 -35.76 75.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.506 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.67 -30.95 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -68.77 -30.17 68.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.901 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -58.37 -32.34 68.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.243 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 93' ' ' ILE . 21.5 mmtt -73.81 -10.83 60.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.789 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 177.56 7.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.85 0.357 . . . . 0.0 110.644 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 163.47 29.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.58 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 10.13 37.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.612 . . . . 0.0 109.607 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -118.61 170.87 8.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.353 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.22 131.23 69.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.097 0.475 . . . . 0.0 110.943 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.4 133.12 30.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.918 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.37 161.22 43.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 4.4 p -110.16 99.68 8.71 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.181 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -130.02 113.45 14.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.149 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -92.7 124.85 37.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.952 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -119.47 151.7 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -71.29 -48.42 50.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.61 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -19.09 52.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.952 ' HB2' ' HB3' ' A' ' 30' ' ' SER . 4.8 tp -62.59 -28.02 69.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.107 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -81.98 -34.56 29.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.976 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -92.57 -23.32 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.001 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.64 -171.5 3.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.711 0.291 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -112.31 73.4 0.81 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.031 0.444 . . . . 0.0 110.487 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.49 ' HB2' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -100.4 -128.59 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.731 -178.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.49 ' H ' ' HB2' ' A' ' 38' ' ' SER . . . 79.17 19.95 71.0 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.048 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.48 -46.58 87.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.976 0.417 . . . . 0.0 111.277 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -137.42 114.76 10.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.812 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -155.24 124.08 3.03 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.683 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.25 148.5 13.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.79 2.326 . . . . 0.0 111.863 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.825 HG21 ' HB2' ' A' ' 53' ' ' ASN . 3.4 mm -102.73 137.2 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.799 0.333 . . . . 0.0 110.589 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.73 -170.5 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.92 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.79 108.48 25.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -152.84 118.67 5.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.562 177.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.17 91.77 1.3 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.716 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.24 6.61 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.902 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -131.56 -78.89 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 73.6 m -142.89 138.25 30.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.361 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 119.42 8.02 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.431 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.825 ' HB2' HG21 ' A' ' 44' ' ' ILE . 27.3 t30 -77.72 110.22 12.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -88.9 120.95 70.09 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.65 121.28 9.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.024 2.483 . . . . 0.0 112.561 -173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.482 ' HA ' HD13 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -74.09 -8.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.624 -175.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -59.83 -43.37 94.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.634 HG22 HD22 ' A' ' 62' ' ' ASN . 0.9 OUTLIER -79.11 -17.38 13.22 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.657 178.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.607 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 5.6 mp -74.61 -21.08 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.718 0.294 . . . . 0.0 111.041 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 -42.81 15.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.661 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.634 HG13 ' H ' ' A' ' 62' ' ' ASN . 8.7 pt -107.57 -48.66 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.239 0.543 . . . . 0.0 111.343 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.634 ' H ' HG13 ' A' ' 61' ' ' ILE . 42.4 m-20 -84.8 34.42 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.788 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 22.1 pt20 -64.52 -12.14 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.549 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 mt -80.27 -0.43 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.53 ' HA ' HG23 ' A' ' 3' ' ' ILE . 15.5 mt -75.84 127.28 85.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.991 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.88 157.03 61.23 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.622 HG13 ' HB2' ' A' ' 70' ' ' PHE . 1.7 tp -62.72 -7.85 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -27.89 16.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 175.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -86.02 8.67 19.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.208 0.528 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.622 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -111.43 172.9 6.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.93 136.9 44.75 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.28 97.71 9.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.315 0.578 . . . . 0.0 111.092 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -156.31 162.78 40.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 m -44.42 104.24 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.812 0.695 . . . . 0.0 110.837 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 75' ' ' VAL . 1.5 t -56.04 122.45 5.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.968 -173.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.58 157.46 33.63 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.656 ' HB2' HG12 ' A' ' 93' ' ' ILE . 51.2 t -139.29 130.18 26.26 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 4.1 m -117.14 163.47 16.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.905 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.458 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.87 135.75 47.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 174.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -42.97 106.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.389 0 O-C-N 123.884 0.74 . . . . 0.0 113.39 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 122.82 16.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.412 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.76 149.32 32.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -65.92 112.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.99 176.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.84 -18.49 8.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 119.49 25.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.77 87.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.036 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 72.46 163.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.132 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -138.17 170.18 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.445 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -116.15 126.82 54.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 178.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 73.3 m -108.81 130.03 55.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.384 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -133.54 146.92 62.57 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.266 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.5 131.54 30.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 111.672 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.656 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -108.91 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.65 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' CG2' ' A' ' 75' ' ' VAL . 7.5 tp -81.59 74.14 8.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.451 0.643 . . . . 0.0 111.008 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.246 0.903 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.639 174.575 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.7 139.11 32.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 65' ' ' ILE . 2.2 mp -83.16 111.23 29.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 9.6 Cg_endo -89.42 126.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.56 2.84 . . . . 0.0 112.023 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.63 81.05 70.56 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 120.902 0.382 . . . . 0.0 111.7 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.99 -41.02 47.43 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.906 2.404 . . . . 0.0 110.756 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.64 149.08 20.82 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.983 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.06 88.14 4.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.229 0.514 . . . . 0.0 110.887 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.85 165.46 19.95 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 140.93 96.5 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.476 2.117 . . . . 0.0 111.779 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.92 154.15 28.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 0.0 111.115 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.05 -24.88 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.915 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -55.11 -32.31 61.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.801 175.439 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -48.01 79.67 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.086 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.73 73.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.82 -29.49 70.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.744 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -31.23 64.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -73.46 -16.19 61.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.932 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 175.46 6.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 111.558 -176.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.16 154.58 25.5 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.633 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -16.36 62.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.777 0.322 . . . . 0.0 111.21 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.0 22.14 9.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.359 0.6 . . . . 0.0 110.379 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.98 171.31 8.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.9 p -114.68 132.31 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -175.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.52 ' CG2' ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -92.92 136.38 25.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.602 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 m -155.27 162.17 40.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.743 0.306 . . . . 0.0 110.344 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 13.2 m -99.99 101.53 12.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.3 100.36 6.8 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.177 -175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -102.84 93.74 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.147 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.07 150.74 24.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.094 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -40.65 96.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -34.98 70.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.343 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 1.7 tp -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.258 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.65 -22.0 66.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.242 0.544 . . . . 0.0 110.756 -179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -96.03 26.38 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.713 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.81 47.18 24.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.77 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -153.49 136.91 15.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.947 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.79 76.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.393 0.616 . . . . 0.0 109.983 174.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 179.0 38.41 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.079 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.76 -23.6 10.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.391 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -107.1 85.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.55 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -119.38 96.14 49.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 -178.014 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.27 166.76 2.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.019 2.479 . . . . 0.0 111.951 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -131.75 -98.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.461 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.531 ' H ' ' HB ' ' A' ' 44' ' ' ILE . 3.7 t70 55.99 -140.88 0.86 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.588 0.555 . . . . 0.0 111.314 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG13 ' HE2' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -119.43 70.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 0.0 110.556 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 51' ' ' CYS . 0.2 OUTLIER -84.52 115.88 22.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.96 91.39 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.074 0.464 . . . . 0.0 111.62 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.46 19.63 9.72 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.534 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB2' HD12 ' A' ' 47' ' ' LEU . 4.1 mt-10 -144.45 -76.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.033 0.416 . . . . 0.0 110.536 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 23.7 m -121.62 137.47 54.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.817 0.341 . . . . 0.0 110.083 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HE2' HG13 ' A' ' 46' ' ' VAL . 1.7 tmtt? -142.47 119.06 11.01 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.69 135.82 36.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.74 139.4 22.76 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.98 122.07 11.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.808 2.338 . . . . 0.0 112.754 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.625 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.9 tp -71.24 -19.77 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.573 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.29 -39.69 76.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.759 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -80.6 -25.14 11.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.738 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.97 -15.27 55.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -35.64 21.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 0.0 111.787 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 62' ' ' ASN . 2.3 pt -109.35 -22.32 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.4 0.619 . . . . 0.0 111.61 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.669 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -108.39 26.15 10.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -174.283 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.411 0.624 . . . . 0.0 109.851 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -81.86 -2.52 51.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.378 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -70.04 141.4 89.22 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.051 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 3.3 Cg_exo -76.97 150.77 30.27 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.593 2.195 . . . . 0.0 110.723 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 67' ' ' ILE . 2.0 tp -58.04 -9.54 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -19.45 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -99.67 24.33 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 109.618 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.24 173.65 11.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.8 124.87 49.71 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.344 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.0 m -76.93 94.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.851 0.834 . . . . 0.0 109.368 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.94 160.89 39.52 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -42.34 104.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.558 0.694 . . . . 0.0 111.326 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.17 124.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.687 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 47.1 m -129.36 147.05 51.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.083 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 1.4 t -120.23 119.55 33.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 3.9 m -109.53 163.45 13.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.313 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.05 128.39 30.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.45 103.71 0.16 Allowed Glycine 0 C--N 1.331 0.272 0 O-C-N 123.552 0.532 . . . . 0.0 112.919 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -72.92 135.61 45.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.047 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.8 149.25 28.81 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -45.41 111.98 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.975 0.797 . . . . 0.0 110.988 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.86 -13.8 5.79 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.941 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mt -99.21 149.71 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -49.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 149.7 50.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.502 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -149.74 178.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.723 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.1 132.89 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.443 ' H ' HD12 ' A' ' 42' ' ' ILE . 8.1 m -107.52 128.94 54.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.418 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 t -134.6 142.81 44.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.099 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 35.3 Cg_endo -65.01 137.54 53.09 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.534 2.156 . . . . 0.0 112.508 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.607 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -82.4 -25.66 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.222 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.69 115.99 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.255 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.632 0.253 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.54 163.02 17.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.67 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.421 HG23 HG12 ' A' ' 65' ' ' ILE . 4.0 mt -81.19 112.83 36.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.704 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.18 126.03 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.066 2.511 . . . . 0.0 111.329 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 68.88 67.12 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.78 -27.01 5.13 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 111.059 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.32 100.47 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.779 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -70.04 89.2 0.61 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.477 . . . . 0.0 111.031 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.14 -140.37 11.28 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.09 136.09 43.05 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.489 2.126 . . . . 0.0 110.991 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -102.07 164.45 11.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.555 0.217 . . . . 0.0 110.918 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 1.4 p -64.74 -25.5 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -69.55 -27.12 64.87 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.135 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 ttt -62.01 -48.78 78.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.207 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.71 -30.1 66.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -67.61 -30.53 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.021 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.4 -31.69 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.52 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -10.31 44.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.645 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -113.62 176.54 4.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.88 169.55 38.77 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.958 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.14 -7.43 59.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 111.024 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.28 13.43 33.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 0.0 109.81 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.08 146.96 43.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.85 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 123.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.634 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.65 104.33 13.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.674 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -109.91 165.39 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.063 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.1 p -107.46 99.91 9.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 42.4 t -133.62 121.04 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' H ' ' A' ' 74' ' ' THR . 1.9 t30 -121.52 100.08 6.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.944 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.8 162.17 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.838 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -71.53 -40.4 70.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.304 0.573 . . . . 0.0 110.258 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.2 pm0 -64.05 -31.81 73.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.687 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.756 HD22 ' HD3' ' A' ' 92' ' ' PRO . 3.0 mt -61.74 -28.19 69.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.868 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -8.41 55.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -121.51 13.87 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.005 0.431 . . . . 0.0 110.869 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 m -78.96 97.09 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.309 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -96.6 -48.38 5.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.076 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -22.56 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.383 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.34 153.85 8.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.096 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.98 177.6 9.71 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -104.35 117.9 35.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.177 0.298 . . . . 0.0 110.413 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 tp -151.59 86.61 4.62 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.404 0.621 . . . . 0.0 110.51 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.64 135.54 18.05 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.842 2.361 . . . . 0.0 111.619 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.518 HD11 ' CB ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -86.1 131.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.429 -177.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -120.82 -153.26 0.54 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.406 HG13 ' HE3' ' A' ' 52' ' ' LYS . 4.3 t -108.93 98.6 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.786 0.327 . . . . 0.0 110.353 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -132.73 100.03 4.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.998 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.65 99.18 0.43 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.952 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 5.21 10.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.216 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.597 ' HB2' HD22 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -142.65 -66.09 0.39 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.679 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 93.9 m -145.77 137.21 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.308 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HE3' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -139.62 124.62 18.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.152 0.501 . . . . 0.0 110.977 177.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 56.1 t30 -86.57 131.83 34.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.645 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -111.5 128.24 25.69 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.066 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 72.0 Cg_exo -49.67 123.2 10.13 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.643 2.895 . . . . 0.0 113.129 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 18.4 tt -68.85 -12.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.049 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -46.02 91.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.035 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 HD22 ' A' ' 62' ' ' ASN . 1.1 pt -77.97 -17.62 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 5.2 mp -72.74 -24.57 60.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.394 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -86.02 -56.68 3.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.562 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.8 pt -93.66 -39.43 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.562 ' N ' HG13 ' A' ' 61' ' ' ILE . 34.4 m-20 -94.02 31.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 0.0 110.061 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 pt20 -66.79 -8.1 26.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.08 -6.49 57.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.182 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 71.6 mt -71.57 123.02 88.76 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.739 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 2.7 Cg_exo -77.0 167.62 24.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.906 2.404 . . . . 0.0 112.268 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.909 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.24 -9.92 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.247 0.619 . . . . 0.0 112.179 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -13.12 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.696 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -111.59 15.48 21.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 110.51 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.909 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 58.7 m-85 -129.55 173.69 10.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.879 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.37 142.97 33.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.061 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 95.93 10.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.638 0.732 . . . . 0.0 110.533 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.68 160.83 40.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.587 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 20.6 m -42.43 120.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 111.712 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.4 124.31 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.869 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -145.35 112.05 5.88 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -171.241 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' HG12 ' A' ' 93' ' ' ILE . 31.1 p -98.7 136.27 38.99 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 15.2 t -119.5 163.49 17.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.843 -174.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.427 ' HB2' HG22 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -53.9 124.93 16.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -39.25 112.08 0.22 Allowed Glycine 0 C--N 1.336 0.552 0 O-C-N 124.206 0.941 . . . . 0.0 112.772 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.24 102.44 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.167 0.508 . . . . 0.0 110.993 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.37 146.47 48.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.185 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -65.86 126.89 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.0 -13.44 11.35 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 113.51 16.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.75 -14.59 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.245 0.545 . . . . 0.0 110.54 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.54 89.27 3.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.311 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 79' ' ' SER . 3.0 pt -104.06 145.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.1 117.12 30.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.748 0.785 . . . . 0.0 110.199 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.9 m -108.98 139.76 43.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.999 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.47 145.54 32.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.882 0.373 . . . . 0.0 111.353 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.756 ' HD3' HD22 ' A' ' 33' ' ' LEU . 39.2 Cg_endo -69.12 126.84 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.459 2.106 . . . . 0.0 111.7 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.495 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.8 -42.42 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 111.027 -177.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.51 129.66 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.347 178.237 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.044 0.45 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.46 163.03 13.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.554 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 65' ' ' ILE . 2.3 mp -92.33 112.21 54.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.601 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.33 125.25 3.9 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.695 2.264 . . . . 0.0 111.393 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.31 68.2 46.97 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.55 32.03 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.243 2.628 . . . . 0.0 110.829 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.69 77.85 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 96.98 6.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.936 0.398 . . . . 0.0 111.078 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.62 -143.57 15.08 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.48 130.04 33.85 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.368 2.045 . . . . 0.0 111.486 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -74.82 154.82 38.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 HD12 ' A' ' 67' ' ' ILE . 34.2 m -67.6 -26.0 34.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 0.0 111.467 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -26.32 64.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -41.35 98.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.83 70.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.342 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.04 -30.96 69.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.472 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -56.0 -31.31 62.94 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.924 0.489 . . . . 0.0 111.19 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 0.88 24.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.528 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.538 ' HB2' HG23 ' A' ' 93' ' ' ILE . 1.1 t -141.77 175.91 9.33 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.242 -0.286 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.14 133.51 48.83 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.64 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.84 -18.64 64.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.899 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 31.91 4.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 110.439 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 167.8 12.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.722 HG22 ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -86.76 126.05 40.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.941 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 m -94.7 131.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.585 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.912 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -148.89 167.76 24.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.335 -178.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.583 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -122.49 113.46 19.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' CA ' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m -130.29 123.12 29.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.211 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 1.4 p30 -88.4 97.05 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.737 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.795 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.7 m -126.81 146.93 50.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.372 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.81 -42.62 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.212 0.53 . . . . 0.0 110.659 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.3 pm0 -71.77 -27.72 63.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.795 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 1.2 tp -65.82 -36.98 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.916 0.389 . . . . 0.0 111.042 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -11.92 61.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.494 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -118.84 12.07 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.31 0.576 . . . . 0.0 110.425 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.485 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 61.3 m -81.57 74.73 8.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.213 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -4.4 37.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.492 ' HB2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -118.31 -102.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.405 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' H ' ' HB2' ' A' ' 38' ' ' SER . . . -151.44 151.03 23.04 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.698 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.68 144.38 8.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -93.58 81.54 4.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.292 0.568 . . . . 0.0 110.488 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -117.24 127.59 26.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 176.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 96.0 Cg_endo -94.71 170.47 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.044 2.496 . . . . 0.0 112.895 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -104.79 74.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.466 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 11.2 p30 -95.66 16.77 16.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.989 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 53.8 t 74.43 -52.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.631 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.12 25.24 1.0 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.931 -0.481 . . . . 0.0 111.595 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.42 58.21 1.66 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.651 0.739 . . . . 0.0 109.598 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . 97.69 -47.21 1.56 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.777 -175.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 3.1 tt0 152.67 61.43 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.503 1.121 . . . . 0.0 109.423 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.469 ' HB2' ' CA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -116.81 154.18 31.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 124.3 28.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.053 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.912 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 42.4 t30 -85.57 120.29 26.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.704 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -90.76 139.78 26.28 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.431 -172.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.704 ' HD2' HG22 ' A' ' 54' ' ' ILE . 9.1 Cg_endo -49.98 123.07 10.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.847 3.031 . . . . 0.0 113.27 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.834 ' HA ' HD23 ' A' ' 59' ' ' LEU . 6.1 tp -72.26 -22.85 21.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.224 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -31.18 68.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -26.74 12.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -176.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.834 HD23 ' HA ' ' A' ' 56' ' ' ILE . 1.4 mm? -60.47 -27.77 67.81 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -168.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -43.83 66.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 112.047 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.0 pt -105.64 -37.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.351 0.596 . . . . 0.0 111.45 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.44 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.35 29.92 0.93 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.397 -175.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -63.65 -20.02 65.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.501 0.667 . . . . 0.0 109.708 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.12 0.56 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.764 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.553 HG13 HG23 ' A' ' 3' ' ' ILE . 1.9 tt -81.37 130.5 61.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.328 0.585 . . . . 0.0 109.86 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -75.19 158.18 41.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.414 2.076 . . . . 0.0 111.674 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.572 HD12 HG12 ' A' ' 12' ' ' VAL . 3.1 tp -59.66 -9.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.413 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -21.01 66.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.634 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -100.18 27.73 5.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.652 0.739 . . . . 0.0 109.661 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.26 174.45 10.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.95 118.96 37.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.609 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.58 97.86 1.39 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.479 -172.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.46 100.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 109.871 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -58.69 130.44 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.224 -172.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -120.94 119.8 33.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.279 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.0 t -110.86 121.17 44.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.688 ' HB3' HG23 ' A' ' 24' ' ' VAL . 6.2 t -120.67 162.65 19.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.501 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.548 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -60.49 124.8 21.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.722 ' HA2' HG22 ' A' ' 24' ' ' VAL . . . -46.47 113.44 1.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 O-C-N 123.692 0.62 . . . . 0.0 113.013 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 90.12 1.37 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.36 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -138.31 174.59 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.561 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.1 121.87 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.016 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.37 -21.71 9.16 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.703 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 95.51 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 111.331 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -22.5 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.405 176.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.01 107.65 18.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 79' ' ' SER . 9.5 pt -121.43 159.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.394 . . . . 0.0 110.916 -172.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.85 113.32 17.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.767 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.37 134.27 50.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.767 179.096 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 157.27 77.07 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.839 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.7 Cg_exo -61.6 126.89 20.17 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.829 2.352 . . . . 0.0 112.341 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.582 HG13 ' HB ' ' A' ' 75' ' ' VAL . 1.3 mt -76.92 -36.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.031 0.443 . . . . 0.0 111.814 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.32 116.19 17.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.034 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.678 0.275 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.515 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -132.6 163.46 28.85 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 65' ' ' ILE . 12.9 mt -87.0 109.1 21.95 Favored Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.165 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -89.0 136.81 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.79 89.47 2.63 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.28 -53.29 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.627 2.218 . . . . 0.0 111.9 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.83 49.46 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.326 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -84.04 -47.17 11.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 10' ' ' PRO . . . 125.99 -101.01 0.6 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.021 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 9' ' ' GLY . 50.1 Cg_exo -52.93 148.08 30.78 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.322 2.681 . . . . 0.0 113.297 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.49 167.15 10.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -66.36 -27.34 40.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 110.732 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -26.61 64.89 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.979 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -48.19 80.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.164 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.22 -41.75 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.221 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' A' ' 25' ' ' VAL . 30.9 tt0 -61.4 -31.24 71.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -56.51 -31.2 63.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.06 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -80.93 -4.34 54.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.028 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -127.7 175.39 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.158 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.59 153.44 40.66 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.363 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.09 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.12 27.64 8.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 0.0 111.045 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.9 153.07 29.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.36 122.84 47.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.195 -173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.513 HG21 ' HG3' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -92.04 103.8 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.453 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.93 148.96 35.94 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.369 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.727 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 29.8 p -102.96 101.55 11.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -157.34 109.97 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.508 -176.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.72 147.97 22.77 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.44 155.06 45.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.803 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.84 -48.0 82.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.233 0.54 . . . . 0.0 110.566 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -70.37 -23.79 62.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -66.16 -32.86 74.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -70.31 -8.0 46.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.32 0.581 . . . . 0.0 110.74 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.43 12.83 9.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.571 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 33' ' ' LEU . 50.6 m -84.22 82.08 8.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.56 -14.26 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 109.624 173.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -124.19 172.69 8.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.693 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.65 107.55 3.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.949 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.15 139.7 33.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.74 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -80.38 70.8 7.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.244 0.545 . . . . 0.0 111.312 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp -106.91 110.85 63.83 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.414 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 9.3 Cg_exo -73.25 156.29 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.986 2.457 . . . . 0.0 111.579 175.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 53' ' ' ASN . 2.7 mp -72.67 110.63 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.973 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -72.25 144.42 48.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.961 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.26 81.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -174.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.507 HD12 ' HG3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER 62.11 25.52 15.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.955 172.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -80.23 56.08 2.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 109.477 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.06 -95.23 0.11 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.78 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.56 22.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.622 . . . . 0.0 109.949 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.727 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 12.8 p -139.1 169.69 17.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.511 -170.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' HG3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -165.11 154.46 12.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.55 -177.299 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' HB2' HG21 ' A' ' 44' ' ' ILE . 1.3 t30 -77.5 114.88 16.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.321 172.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.836 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -83.63 141.21 41.52 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.532 -176.107 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -62.14 119.95 7.3 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.768 2.312 . . . . 0.0 113.173 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -78.75 -12.55 13.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.362 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.45 -45.88 80.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.193 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -33.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.97 -23.24 31.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -54.38 15.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.77 0.319 . . . . 0.0 111.455 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -92.33 -35.94 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 0.0 110.736 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -91.12 35.99 0.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.779 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -66.88 -13.42 61.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.202 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.84 18.25 6.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.359 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 10.7 tt -91.94 135.85 26.84 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.731 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 7.3 Cg_exo -75.85 163.72 33.0 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.879 2.386 . . . . 0.0 112.309 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 4.4 tp -65.19 -8.71 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.564 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -56.88 -24.23 50.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -94.8 12.3 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.836 ' HD1' HG21 ' A' ' 54' ' ' ILE . 86.9 m-85 -127.04 174.16 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.004 -174.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.38 138.8 40.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.225 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.47 99.42 7.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.205 0.526 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 0.7 OUTLIER -153.98 158.88 41.29 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 m -50.85 113.5 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.969 0.414 . . . . 0.0 110.419 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -61.95 125.58 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.354 -176.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -127.4 112.96 15.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.577 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.573 ' HB2' HG12 ' A' ' 93' ' ' ILE . 35.9 t -98.11 119.45 36.77 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.932 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 2.4 m -115.07 163.83 15.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.321 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.33 119.16 3.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -34.1 107.05 0.03 OUTLIER Glycine 0 C--N 1.337 0.635 0 O-C-N 124.442 1.089 . . . . 0.0 113.91 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 109.02 2.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.307 0.575 . . . . 0.0 110.598 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 156.05 33.76 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.586 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 pt -58.33 112.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 123.476 0.485 . . . . 0.0 110.605 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.01 -12.43 11.52 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.034 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 103.26 15.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.069 0.462 . . . . 0.0 110.488 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.14 -50.51 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.329 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.43 129.86 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 pt -146.56 170.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.11 131.65 55.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.023 0.44 . . . . 0.0 110.648 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.408 ' SG ' HG13 ' A' ' 44' ' ' ILE . 12.0 m -110.01 127.25 54.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.05 135.21 21.0 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.623 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.96 127.78 23.4 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.899 2.399 . . . . 0.0 112.038 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.28 -61.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.893 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 100.34 13.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.052 0.453 . . . . 0.0 110.651 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.033 176.232 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -106.07 146.87 29.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mt -100.76 109.58 58.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 8.9 Cg_endo -90.42 126.09 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.861 3.041 . . . . 0.0 111.818 175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -140.34 61.64 17.39 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.453 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 17.0 Cg_exo -68.04 -53.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.428 2.085 . . . . 0.0 110.325 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.47 78.75 0.28 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.33 2.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.532 . . . . 0.0 110.9 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.04 -155.08 7.89 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.081 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.08 124.6 16.67 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.47 2.113 . . . . 0.0 111.854 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -83.35 156.11 23.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.208 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.5 p -61.31 -27.81 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.109 0.481 . . . . 0.0 110.788 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 63' ' ' GLN . 36.6 m -56.04 -38.92 71.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.9 tpp -64.45 -47.24 79.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.911 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.25 74.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.884 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -31.97 64.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.173 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -77.22 -4.8 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.492 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 175.05 8.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.03 134.94 43.3 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.38 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -23.74 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.945 0.402 . . . . 0.0 111.054 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 37.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.703 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -125.4 158.66 33.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.296 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.06 125.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 110.25 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.2 114.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.573 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 144.15 50.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.79 101.99 12.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.514 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.815 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 1.8 t -142.4 112.89 7.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.181 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.931 ' HB2' ' H ' ' A' ' 74' ' ' THR . 26.9 t30 -106.07 94.2 5.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.48 150.93 23.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.904 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -36.62 79.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.276 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.931 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -31.45 71.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.798 178.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 42' ' ' ILE . 4.9 mp -79.34 -42.67 25.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.552 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -88.92 -22.68 22.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.697 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.51 71.15 0.47 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.906 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 132.23 55.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.17 124.94 24.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.963 0.411 . . . . 0.0 110.26 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.91 -13.01 38.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.049 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.931 ' HB1' ' HB3' ' A' ' 32' ' ' GLU . . . -75.72 168.58 19.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.576 0.227 . . . . 0.0 110.626 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.86 135.56 33.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 111.394 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -110.77 98.22 36.85 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.451 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.526 ' HG2' HD13 ' A' ' 47' ' ' LEU . 5.1 Cg_exo -80.53 152.76 20.3 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 123.346 2.697 . . . . 0.0 112.195 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -138.64 -51.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.982 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -88.32 -13.3 41.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.099 -173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.0 147.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.486 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.526 HD13 ' HG2' ' A' ' 43' ' ' PRO . 7.7 tp -158.54 151.15 22.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.129 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -70.27 78.0 0.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.497 0.665 . . . . 0.0 110.722 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.12 -114.57 0.45 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.33 33.62 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.085 0.469 . . . . 0.0 109.856 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.815 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -90.35 140.45 29.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.629 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.38 147.18 25.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 112.155 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -83.55 110.2 18.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.625 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.734 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -87.67 143.18 33.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.279 -176.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 32.1 Cg_exo -59.19 120.75 8.79 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.86 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -23.56 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -34.95 70.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.22 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.39 -31.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.202 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -33.34 68.55 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -170.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -26.28 68.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.567 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.6 pt -121.15 -40.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.452 0.644 . . . . 0.0 110.749 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.567 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -89.48 35.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.507 -176.421 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -70.73 -8.47 52.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 179.042 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -5.05 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.144 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.507 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 5.4 mt -70.68 128.65 90.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.385 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.1 Cg_exo -81.08 164.72 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.288 2.659 . . . . 0.0 111.602 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.795 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -60.01 -13.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -13.65 59.17 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 111.4 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.56 12.64 36.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.384 0.611 . . . . 0.0 109.885 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.795 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 66.3 m-85 -130.99 177.55 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.35 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.11 145.02 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.074 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.23 96.72 7.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.0 110.125 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -156.2 159.47 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.26 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.931 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 65.2 m -51.9 107.96 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.13 0.49 . . . . 0.0 110.27 175.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.49 124.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.205 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 58.8 m -127.31 133.89 50.07 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.936 -175.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.642 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -110.2 123.3 49.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -120.45 162.05 20.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.273 -173.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.51 126.68 20.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.502 0.192 . . . . 0.0 110.56 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.79 106.04 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.508 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.59 138.46 43.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.553 -0.324 . . . . 0.0 111.096 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.62 171.5 18.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.406 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 83' ' ' ILE . 2.4 pt -62.94 123.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.72 -27.7 7.78 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.693 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.23 147.13 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.142 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -117.14 -66.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.344 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.77 127.12 56.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -113.68 152.26 15.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.74 118.72 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.03 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 9.5 t -116.43 138.64 51.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.583 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -143.1 141.23 19.04 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.312 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 25.9 Cg_exo -62.74 130.79 30.73 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.642 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -84.49 -43.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.678 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.06 120.41 37.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.726 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.858 -1.068 . . . . 0.0 109.264 176.796 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 121.042 0.449 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -97.71 164.1 12.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.948 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -80.8 111.22 21.56 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.742 0.306 . . . . 0.0 110.728 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 1.1 Cg_endo -87.95 128.74 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.219 2.612 . . . . 0.0 112.05 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.34 91.12 4.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.77 -53.63 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.25 47.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.311 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -83.12 -59.02 2.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.12 -89.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.242 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.92 137.1 77.9 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.23 2.62 . . . . 0.0 113.331 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.801 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -93.73 157.63 16.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.514 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.35 -27.27 23.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -37.14 85.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.021 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -42.73 86.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -49.67 38.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.21 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' A' ' 25' ' ' VAL . 3.3 tt0 -63.43 -28.83 70.25 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.745 -176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -30.25 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.942 0.401 . . . . 0.0 111.232 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -7.44 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.88 174.76 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.33 166.71 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.804 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.14 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.452 . . . . 0.0 110.967 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.92 37.46 1.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.42 0.629 . . . . 0.0 109.906 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.68 155.95 31.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.991 177.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.57 132.4 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.751 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 54' ' ' ILE . 89.1 t -86.17 137.49 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -148.32 150.76 34.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.917 0.389 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -115.53 108.86 16.99 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.9 t -151.38 103.57 3.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -85.28 93.22 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 110.025 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 147.46 25.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -70.57 -38.87 74.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.295 0.569 . . . . 0.0 109.841 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.04 -37.98 87.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' HG3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -69.51 -31.28 69.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.886 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -29.42 34.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -95.0 -30.28 14.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.867 0.365 . . . . 0.0 111.488 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.88 85.09 2.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 132.01 51.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.664 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m 65.33 59.03 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.599 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.22 137.84 23.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.45 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 -62.23 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' HG2' ' ND2' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -102.23 94.39 5.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.131 -174.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 102.96 8.96 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.007 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HA ' HG13 ' A' ' 88' ' ' ILE . 86.5 Cg_endo -84.82 156.72 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.059 2.506 . . . . 0.0 112.585 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.32 121.27 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.416 . . . . 0.0 110.895 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -127.21 156.21 42.21 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.72 91.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -95.28 174.72 6.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.61 -177.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.27 66.1 4.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.479 0.657 . . . . 0.0 110.343 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.63 -128.18 1.79 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.861 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 13.11 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.206 0.527 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.29 138.29 31.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.722 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.94 139.35 14.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.69 175.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.18 114.69 22.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.514 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.15 134.09 56.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.796 -170.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 41.8 Cg_exo -58.07 122.56 11.91 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.394 2.729 . . . . 0.0 113.587 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.426 ' HA ' HD13 ' A' ' 56' ' ' ILE . 4.7 mm -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.559 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -34.74 58.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.39 -174.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pt -79.81 -40.3 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.417 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -22.81 57.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -58.26 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.558 HG13 ' N ' ' A' ' 62' ' ' ASN . 12.7 pt -91.09 -35.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.558 ' N ' HG13 ' A' ' 61' ' ' ILE . 7.4 m-20 -92.22 37.24 0.99 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.509 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -8.12 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.488 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HB2' HG12 ' A' ' 3' ' ' ILE . 1.4 mt -79.02 -9.49 59.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.563 ' HA ' HG23 ' A' ' 3' ' ' ILE . 54.3 mt -69.49 124.96 91.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.63 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.801 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -77.91 174.77 12.05 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.25 -8.64 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.439 ' ND2' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -60.39 -21.91 62.72 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -102.12 24.54 9.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.427 0.632 . . . . 0.0 110.003 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -142.94 172.76 12.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.62 139.11 40.72 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.076 0.465 . . . . 0.0 111.368 -171.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.91 98.39 6.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.653 0.74 . . . . 0.0 109.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.19 162.16 41.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.208 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -52.72 98.86 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -54.4 129.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.54 -171.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.0 140.29 51.19 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.387 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.66 ' HB2' HG12 ' A' ' 93' ' ' ILE . 48.2 t -135.55 122.98 21.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -122.86 164.34 18.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.612 -172.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.91 128.48 18.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.389 0.431 . . . . 0.0 110.548 174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.67 118.15 1.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.827 0.705 . . . . 0.0 113.641 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 93.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.458 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.38 160.39 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.61 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.466 ' H ' HG12 ' A' ' 83' ' ' ILE . 1.9 mm -62.12 113.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.69 -37.52 2.05 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.847 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.76 98.56 10.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.886 0.374 . . . . 0.0 110.182 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.52 -38.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.227 0.536 . . . . 0.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.436 ' ND2' ' HG2' ' A' ' 41' ' ' GLU . 9.3 t-20 -118.61 114.59 23.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.508 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.603 HG13 ' HA ' ' A' ' 43' ' ' PRO . 21.0 pt -107.21 150.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.175 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -99.8 118.7 36.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 t -108.0 130.74 55.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.229 0.538 . . . . 0.0 110.346 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 m -131.51 136.23 28.24 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.26 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.624 ' HG3' HD21 ' A' ' 33' ' ' LEU . 68.7 Cg_exo -53.39 127.53 25.62 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.686 2.257 . . . . 0.0 112.376 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.66 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -79.57 -23.08 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.352 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.92 139.92 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.02 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.125 0 O-C-N 123.988 0.805 . . . . 0.0 110.842 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.916 0.389 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.9 132.22 36.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -90.64 111.09 45.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.9 Cg_endo -89.18 128.79 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.317 2.678 . . . . 0.0 111.984 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -129.09 66.83 77.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.59 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 9.1 Cg_exo -73.27 -41.56 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.289 1.993 . . . . 0.0 110.547 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.92 110.97 2.3 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.328 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.33 113.61 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.74 0.305 . . . . 0.0 110.794 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.37 -166.35 13.78 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.29 153.05 17.95 Favored 'Trans proline' 0 N--CA 1.471 0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.236 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.66 155.67 17.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.748 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 3.6 p -62.04 -26.27 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.608 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -69.32 -26.72 64.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.962 -177.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ttt -65.32 -43.35 91.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.051 0.453 . . . . 0.0 110.123 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.73 69.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.032 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -56.36 -31.04 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.603 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.27 3.3 36.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.559 ' SG ' HG23 ' A' ' 93' ' ' ILE . 1.5 m -135.48 174.51 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.62 0.248 . . . . 0.0 110.536 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.92 151.62 33.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.284 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.62 59.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 22' ' ' GLU . 1.7 pm0 -90.5 0.83 57.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.934 174.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -105.76 160.24 15.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.639 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 p -101.73 146.69 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.745 0.307 . . . . 0.0 110.75 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.23 129.06 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.866 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -138.29 150.99 47.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.5 115.85 26.55 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 2.9 m -132.8 146.79 52.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.168 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.477 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 15.3 t-20 -111.41 93.48 4.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.983 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.02 145.92 27.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.578 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.87 61.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -61.48 -20.96 63.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.738 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.96 -25.69 63.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.563 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 -8.76 23.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -113.04 22.74 14.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 51.62 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 111.388 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -87.46 37.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.427 . . . . 0.0 110.739 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.06 -55.76 0.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.202 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.56 46.24 3.79 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.579 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.61 -71.31 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.79 0.328 . . . . 0.0 111.206 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -137.17 135.01 36.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 90' ' ' CYS . 2.8 mp -128.61 119.88 20.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.828 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HB2' HG21 ' A' ' 46' ' ' VAL . 60.3 Cg_endo -72.95 120.02 6.39 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.567 2.178 . . . . 0.0 112.385 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.534 ' HB ' ' H ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -94.69 -100.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.317 177.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.534 ' H ' ' HB ' ' A' ' 44' ' ' ILE . 4.0 t70 -71.65 88.27 0.96 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.729 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 43' ' ' PRO . 3.7 m -139.45 173.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.44 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.5 tp -80.59 -23.45 39.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.892 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 102.61 0.57 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 84.03 -11.75 56.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.695 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 58.84 65.5 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 110.997 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 1.9 t -90.04 146.19 24.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.07 137.46 31.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.168 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 4.8 t-20 -79.33 97.43 6.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.367 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.525 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -60.73 125.07 82.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.71 120.74 8.6 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.452 2.101 . . . . 0.0 112.047 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -76.08 -14.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 -174.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.85 -31.48 70.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.293 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -78.83 -45.5 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.224 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -68.97 -13.83 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -166.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -32.09 71.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.035 0.445 . . . . 0.0 110.929 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.3 pt -118.99 -39.03 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.959 175.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -82.36 34.06 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.674 -177.543 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.2 pt20 -70.34 -8.27 49.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.628 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.48 -5.94 59.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.721 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HA ' HG23 ' A' ' 3' ' ' ILE . 60.3 mt -73.4 122.7 88.26 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.2 Cg_exo -65.85 157.49 58.78 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.849 2.366 . . . . 0.0 112.193 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.771 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 3.3 tp -61.0 -9.4 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.138 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.492 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -55.84 -24.9 39.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.141 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -100.22 9.36 42.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.254 0.55 . . . . 0.0 110.674 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.771 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 64.5 m-85 -127.21 175.0 8.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.439 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 122.69 44.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 96.42 9.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.651 0.739 . . . . 0.0 109.806 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -156.11 164.17 38.74 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.11 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.181 0.925 . . . . 0.0 112.013 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -64.76 136.85 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.726 -177.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.8 m -141.12 113.17 7.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.855 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -100.83 142.98 31.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.209 0.528 . . . . 0.0 110.051 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 6.8 m -126.57 164.08 22.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.24 132.18 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -46.92 110.1 0.49 Allowed Glycine 0 C--N 1.333 0.391 0 O-C-N 123.597 0.561 . . . . 0.0 113.098 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.34 100.47 4.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -113.86 154.4 27.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.576 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -55.92 113.06 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.37 0.605 . . . . 0.0 110.742 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.91 -18.89 3.76 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.675 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -101.39 149.35 24.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.99 -42.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.2 0.524 . . . . 0.0 110.432 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -120.62 134.73 55.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.73 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.9 pt -133.49 148.99 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.42 37.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.071 0.462 . . . . 0.0 110.322 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.435 ' HB2' HG21 ' A' ' 42' ' ' ILE . 77.3 m -110.61 144.57 39.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.31 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 142.36 30.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.496 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.15 129.2 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.674 2.249 . . . . 0.0 111.546 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.559 HG23 ' SG ' ' A' ' 19' ' ' CYS . 3.0 mt -76.31 -62.0 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.837 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 tp -106.54 138.33 42.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.279 -174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.349 179.803 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 121.013 0.435 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.81 148.18 23.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.96 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.679 HG23 HG12 ' A' ' 65' ' ' ILE . 9.9 mt -88.92 111.46 44.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 1.8 Cg_endo -82.51 147.36 14.01 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.113 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.86 76.92 77.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.599 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -96.87 10.94 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 113.758 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.28 -32.51 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.623 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.5 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.186 0.993 . . . . 0.0 112.995 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.12 -141.72 4.09 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.21 160.86 28.88 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.198 1.932 . . . . 0.0 110.985 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -115.97 155.14 28.57 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -25.19 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 0.0 111.244 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.36 -28.32 69.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.797 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -67.74 -45.06 76.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.327 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.66 73.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.673 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.026 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.21 -31.64 71.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.087 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 14.73 29.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.504 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.41 174.32 7.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.82 154.0 33.5 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.79 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.55 65.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.54 36.46 2.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.472 0.654 . . . . 0.0 110.347 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 145.99 50.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.844 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.841 ' HA ' HD13 ' A' ' 56' ' ' ILE . 5.9 p -99.53 129.11 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.941 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.8 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.744 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.459 ' HA ' HG12 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -139.07 162.04 35.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.501 -178.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 110.87 15.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 2.8 m -140.18 135.19 32.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -120.59 93.09 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.862 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.39 148.71 29.73 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.521 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 7.6 mttp -65.21 -35.39 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.2 pm0 -68.81 -31.47 70.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.453 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.53 -45.48 21.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.417 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -8.67 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.832 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 2.2 m-20 -118.23 4.23 11.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.052 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m 50.13 43.57 25.93 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.718 0.636 . . . . 0.0 111.479 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -89.73 -49.0 6.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.219 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 m -134.8 163.73 29.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.666 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.02 58.53 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.483 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.15 -77.4 0.17 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 110.721 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.73 74.81 9.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.23 0.538 . . . . 0.0 110.492 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.39 122.76 19.14 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.27 171.24 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.68 2.253 . . . . 0.0 112.138 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.711 HD11 HD11 ' A' ' 88' ' ' ILE . 1.6 mt -89.25 -55.1 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.185 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 46' ' ' VAL . 10.6 t70 61.86 -147.68 0.4 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.442 ' H ' ' CG ' ' A' ' 45' ' ' ASP . 4.8 p -152.02 -18.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.67 -32.33 1.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.481 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -68.95 86.86 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 111.153 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.9 29.4 7.29 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.942 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER 41.84 64.94 0.95 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.453 0.701 . . . . 0.0 111.672 176.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 36.1 t -131.82 139.39 48.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.516 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 123.99 15.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.003 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' HB2' HG21 ' A' ' 44' ' ' ILE . 6.6 t-20 -75.92 131.58 39.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 173.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.459 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -106.96 130.31 23.07 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 51.0 Cg_exo -51.33 121.7 8.85 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.357 2.705 . . . . 0.0 113.181 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 24' ' ' VAL . 3.2 tp -79.66 -12.19 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.936 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -51.55 68.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -31.28 53.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.761 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -60.79 -14.8 23.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 m -70.09 -31.98 69.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.5 pt -131.06 -32.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.201 0.524 . . . . 0.0 111.392 -178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -87.62 29.63 0.88 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.557 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -69.82 -14.74 62.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.097 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mt -78.05 -5.4 51.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.683 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.679 HG12 HG23 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -69.8 126.53 92.56 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 6.3 Cg_exo -73.6 157.91 48.06 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.822 2.348 . . . . 0.0 111.871 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.753 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 1.5 tp -62.1 -9.6 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.81 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -59.37 -23.63 62.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.803 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.87 8.72 21.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.753 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 62.4 m-85 -139.53 174.21 10.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.527 -172.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.25 121.87 44.75 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.367 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.57 98.54 0.69 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.42 0.628 . . . . 0.0 109.764 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.77 162.44 41.11 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 106.61 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 O-C-N 123.673 0.608 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.439 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.9 OUTLIER -60.35 135.95 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.038 -172.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 1.4 m -138.3 161.81 35.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' A' ' 93' ' ' ILE . 12.3 p -158.96 122.47 3.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.396 0.617 . . . . 0.0 110.124 173.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -97.95 163.5 12.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.76 -175.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.37 136.72 24.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.59 104.57 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 123.714 0.634 . . . . 0.0 113.768 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.12 105.8 2.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -105.21 170.98 7.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.178 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.55 113.13 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.564 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.99 -12.25 57.49 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.258 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.604 ' HG ' HG23 ' A' ' 88' ' ' ILE . 2.8 tp -82.04 75.56 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 109.957 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.63 -19.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.241 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.04 109.72 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.596 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.711 HD11 HD11 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -142.96 157.49 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.546 177.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -95.5 134.62 38.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.816 0.341 . . . . 0.0 110.413 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 2.9 t -108.21 128.75 54.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.302 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p -123.84 145.26 47.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.672 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.718 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 24.6 Cg_exo -63.64 151.65 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.281 1.987 . . . . 0.0 111.45 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.478 HG12 ' SG ' ' A' ' 77' ' ' CYS . 3.4 mt -83.15 -83.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.844 0.354 . . . . 0.0 110.41 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.424 ' H ' ' HB ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -96.51 105.09 17.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.404 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.84 32.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.581 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 65' ' ' ILE . 4.0 mt -82.86 111.19 27.82 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.4 Cg_endo -88.48 126.51 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.88 72.48 47.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.938 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.32 -56.25 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.855 2.37 . . . . 0.0 112.278 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.57 -18.28 60.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.046 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 60.97 2.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 111.175 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.27 -175.42 31.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.9 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.24 137.15 63.64 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.073 2.516 . . . . 0.0 112.668 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.872 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -86.88 166.69 14.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.143 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.89 -26.78 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.719 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -53.33 -32.85 51.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.174 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpt -65.48 -49.23 69.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 0.0 110.078 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.45 60.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.8 -29.58 70.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.895 -173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.17 -30.94 69.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 111.198 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -77.09 7.44 4.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.606 -176.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 174.65 10.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.02 168.01 36.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.329 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.17 -4.83 46.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.451 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -95.42 5.29 52.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 110.194 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 3.6 mptt -113.95 166.55 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.612 HG23 HG23 ' A' ' 56' ' ' ILE . 13.9 p -121.84 141.78 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.39 137.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.365 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.499 ' HA ' HG12 ' A' ' 54' ' ' ILE . 40.0 m -155.3 159.74 40.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.2 m -101.73 120.66 40.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.9 t -144.87 101.05 3.59 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.901 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -84.52 92.77 8.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.523 0.678 . . . . 0.0 109.52 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p -124.36 148.81 47.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.982 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 0.9 OUTLIER -61.23 -31.54 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 173.179 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -60.29 -47.47 85.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.648 -1.614 . . . . 0.0 111.018 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HB2' ' OG ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -65.01 -52.42 56.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.991 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.454 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -74.91 -8.62 57.0 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -127.52 26.12 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.929 0.395 . . . . 0.0 110.302 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -75.59 144.59 41.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.861 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -92.74 43.58 1.13 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.998 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.15 57.13 4.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.09 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.77 -128.06 2.1 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.365 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 65.69 -157.68 0.27 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 122.834 0.454 . . . . 0.0 110.867 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.21 142.74 50.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.771 0.319 . . . . 0.0 110.407 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -158.89 114.86 1.64 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.527 177.304 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 3.5 Cg_endo -85.93 135.56 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.179 2.586 . . . . 0.0 112.203 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.38 167.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.863 ' HB2' ' HB3' ' A' ' 53' ' ' ASN . 3.6 t0 62.69 14.6 7.36 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.375 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.23 9.35 9.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.338 0.59 . . . . 0.0 109.492 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 51.25 9.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.547 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.17 61.77 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.834 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.485 ' C ' ' HG2' ' A' ' 50' ' ' GLU . . . 99.8 -67.28 0.57 Allowed Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.566 -176.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HG2' ' C ' ' A' ' 49' ' ' GLY . 1.9 mm-40 -147.19 6.33 0.87 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.514 0.197 . . . . 0.0 110.923 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.7 m -88.54 137.73 32.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.366 0.603 . . . . 0.0 112.397 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -141.7 139.69 32.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.757 177.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.863 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.7 t-20 -97.68 133.91 41.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -109.52 125.01 32.27 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.493 -174.354 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.88 122.73 12.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.464 2.776 . . . . 0.0 113.702 -173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.612 HG23 HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -75.15 -16.91 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.745 -177.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -53.82 -43.15 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.23 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -78.32 -36.24 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.469 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 2.7 mp -54.56 -33.32 59.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.868 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -32.5 34.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.84 -20.51 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.235 0.54 . . . . 0.0 110.971 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -99.09 28.1 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.286 -177.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -68.27 -13.83 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.371 0.605 . . . . 0.0 110.67 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.96 -8.04 55.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.553 HG13 HG23 ' A' ' 3' ' ' ILE . 1.5 tt -67.99 133.58 91.92 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 110.652 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.872 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 3.7 Cg_exo -79.57 163.42 24.19 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.937 2.425 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tp -63.02 -9.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.74 -25.38 67.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.26 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -98.31 28.04 4.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.541 0.686 . . . . 0.0 109.623 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.469 ' HZ ' HD11 ' A' ' 59' ' ' LEU . 14.9 m-85 -144.3 173.01 12.14 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.01 127.85 51.58 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.576 -172.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.3 98.78 1.81 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -154.55 161.4 41.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.218 -170.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.59 103.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.15 0.5 . . . . 0.0 109.94 172.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -54.6 115.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.695 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -113.97 135.92 53.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.326 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 5.3 t -122.99 120.68 34.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 3.2 t -118.03 163.21 16.94 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.23 138.39 50.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.6 104.91 0.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.458 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.714 ' HG2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.89 134.33 54.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.367 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.16 154.58 37.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.937 -176.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' H ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.75 112.03 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 110.413 -178.129 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.86 -19.34 5.54 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.45 -37.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.797 0.332 . . . . 0.0 111.516 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 140.51 50.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.714 HD13 ' HG2' ' A' ' 81' ' ' GLU . 2.0 pt -137.99 157.29 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.79 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -98.81 121.38 40.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.676 178.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 m -114.4 132.54 56.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.318 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.99 151.05 77.26 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.584 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 Cg_exo -61.3 127.03 20.79 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.653 2.235 . . . . 0.0 111.595 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.637 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -84.22 -41.73 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.94 104.04 13.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.692 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.369 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.995 0.426 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.69 150.07 23.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.505 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.484 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -71.13 115.95 41.81 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.84 126.7 4.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.085 2.523 . . . . 0.0 112.037 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 73.87 23.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 37.8 Cg_endo -69.41 -25.64 30.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.164 1.91 . . . . 0.0 110.99 171.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.17 77.18 0.38 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.576 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -72.48 127.51 32.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.246 0.546 . . . . 0.0 111.83 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 10' ' ' PRO . . . -153.57 -126.78 1.14 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 9' ' ' GLY . 19.2 Cg_endo -62.44 133.84 45.05 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.662 2.241 . . . . 0.0 112.21 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -81.22 154.79 26.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.235 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.607 HG12 HD12 ' A' ' 67' ' ' ILE . 35.8 m -67.72 -24.87 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.912 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -30.27 71.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.943 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -40.3 90.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.204 0.526 . . . . 0.0 110.13 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.15 73.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.427 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -61.01 -29.24 69.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -31.68 71.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.031 0.443 . . . . 0.0 110.997 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.76 9.61 21.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.59 -176.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' HB2' HG23 ' A' ' 93' ' ' ILE . 5.4 t -133.84 174.39 10.51 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.16 156.02 39.09 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.193 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.42 87.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.54 38.65 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.393 0.616 . . . . 0.0 110.114 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 7.1 mttt -125.47 144.45 50.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.79 129.04 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.993 0.425 . . . . 0.0 110.362 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.478 HG12 ' HE2' ' A' ' 70' ' ' PHE . 16.1 t -85.57 106.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.64 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -120.21 171.49 8.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -130.78 108.85 10.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.073 0.463 . . . . 0.0 110.482 170.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 48.6 m -137.53 144.26 42.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.45 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.52 HD22 ' HB3' ' A' ' 50' ' ' GLU . 71.9 m-20 -105.68 99.92 9.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.804 0.335 . . . . 0.0 111.527 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.79 141.62 28.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -23.28 57.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.841 0.829 . . . . 0.0 109.613 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -84.07 -18.42 37.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.027 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.37 -32.23 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -32.9 72.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.996 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.83 -4.31 59.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.832 -177.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.76 33.68 20.13 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 38.41 2.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.225 0.536 . . . . 0.0 110.462 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.64 110.29 22.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.432 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.56 28.5 2.98 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.62 -102.75 0.41 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.69 132.99 43.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.37 71.97 26.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.645 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.24 -177.02 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.038 2.492 . . . . 0.0 112.606 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -142.29 169.26 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.356 -179.306 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.575 ' OD1' ' HG ' ' A' ' 47' ' ' LEU . 2.8 p30 -147.45 -172.25 3.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.492 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.45 35.84 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.727 0.299 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.575 ' HG ' ' OD1' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -95.88 179.67 5.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.091 0.472 . . . . 0.0 111.083 -177.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.56 71.39 4.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.897 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 -126.79 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.487 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HB3' HD22 ' A' ' 29' ' ' ASN . 24.2 mt-10 -113.99 44.54 1.63 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.458 0.171 . . . . 0.0 111.26 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 42.2 t -163.65 139.29 6.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.597 0.237 . . . . 0.0 110.386 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.74 116.12 5.78 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.64 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.9 t30 -84.6 94.37 8.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -68.11 136.29 91.67 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.267 -172.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.439 ' O ' HD12 ' A' ' 59' ' ' LEU . 28.1 Cg_exo -61.84 123.45 12.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.171 2.581 . . . . 0.0 112.744 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.488 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -72.74 -12.68 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.433 -175.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -40.12 88.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.5 -175.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.458 HG13 ' H ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -79.84 -32.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.892 0.377 . . . . 0.0 110.576 175.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -65.58 -17.94 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 -173.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -60.83 2.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.448 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.53 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -96.22 -37.19 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.044 0.449 . . . . 0.0 111.576 -177.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.97 36.03 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.436 0.636 . . . . 0.0 109.907 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.67 -8.0 53.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.977 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.7 mm? -76.47 -7.98 56.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.953 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.484 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -62.84 137.16 96.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.969 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.2 Cg_exo -79.07 159.48 26.95 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.047 2.498 . . . . 0.0 111.679 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.607 HD12 HG12 ' A' ' 12' ' ' VAL . 2.6 tp -61.2 -9.25 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.562 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -58.74 -28.99 66.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.07 27.55 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.459 0.647 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HE2' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -142.41 174.93 10.18 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -172.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.17 127.68 49.0 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.666 -173.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.93 94.68 3.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -156.44 161.69 40.06 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.7 98.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.411 0.444 . . . . 0.0 109.87 171.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.508 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -57.53 128.08 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -173.232 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.26 105.95 4.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.226 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 27.4 p -104.96 129.56 53.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.553 0.692 . . . . 0.0 110.851 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 11.8 m -105.27 164.09 12.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.076 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.53 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -54.99 139.3 41.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 173.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -50.41 114.59 2.68 Favored Glycine 0 C--N 1.331 0.252 0 O-C-N 123.309 0.381 . . . . 0.0 112.683 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 143.19 33.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.041 0.448 . . . . 0.0 110.675 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.59 174.87 14.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.33 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.68 119.28 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.799 0.333 . . . . 0.0 110.179 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.01 4.06 31.44 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.168 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 HG23 ' A' ' 88' ' ' ILE . 2.4 mt -112.0 112.83 24.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.8 -27.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.61 135.7 16.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.338 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.76 174.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.93 -177.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.91 128.05 48.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 98.6 m -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.491 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.6 t -150.07 143.57 16.75 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.339 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.0 Cg_endo -57.41 136.64 77.27 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.64 2.227 . . . . 0.0 111.677 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.51 HG22 ' HB3' ' A' ' 18' ' ' LYS . 1.2 mt -88.39 -73.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.61 72.25 1.76 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.016 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.056 178.996 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.53 158.15 17.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.675 HG23 HG12 ' A' ' 65' ' ' ILE . 7.2 mt -80.25 109.92 14.46 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 4.2 Cg_endo -89.82 124.93 1.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.344 2.696 . . . . 0.0 112.261 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.559 ' HB1' ' HG3' ' A' ' 8' ' ' GLU . . . -141.47 67.66 25.09 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.757 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.78 -28.72 7.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.776 1.651 . . . . 0.0 111.842 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.83 -44.21 2.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.618 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.559 ' HG3' ' HB1' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 57.38 50.53 11.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.385 177.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.78 -128.64 6.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.807 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.42 143.49 69.88 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -90.11 154.16 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 0.0 111.087 -178.211 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.06 -27.76 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.448 0.642 . . . . 0.0 110.028 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -67.06 -26.32 66.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.941 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 ttm -64.11 -47.27 80.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.97 -36.99 72.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 20.9 tt0 -64.0 -29.58 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.139 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -31.29 64.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 111.404 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -76.8 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 -177.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 175.03 7.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.85 -165.05 22.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.497 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.51 -7.07 48.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 0.0 110.942 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.83 9.64 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.274 0.559 . . . . 0.0 110.116 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -126.98 153.68 45.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG11 ' HG2' ' A' ' 81' ' ' GLU . 6.6 p -108.53 131.17 59.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.058 0.456 . . . . 0.0 110.586 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 t -83.89 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.615 ' HA ' HG12 ' A' ' 54' ' ' ILE . 8.0 t -154.74 170.31 21.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.691 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.502 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -122.52 99.97 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 172.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.688 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 16.1 m -131.56 109.82 10.52 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 3.0 p30 -88.68 134.58 33.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 0.0 110.957 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 38.4 m -158.52 155.43 28.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.763 176.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -70.56 -38.23 74.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 109.888 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -20.44 64.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.465 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -74.12 -29.77 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.04 177.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -90.56 -34.87 15.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -100.79 29.15 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.266 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.1 67.72 0.3 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -80.73 107.27 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 39.3 m 76.47 -51.72 0.59 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.136 0.897 . . . . 0.0 109.535 -168.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.52 164.86 34.62 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.277 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.81 155.89 49.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.87 110.32 7.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 0.0 111.094 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.604 HG13 ' HD2' ' A' ' 43' ' ' PRO . 0.4 OUTLIER -111.35 133.94 21.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.158 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.604 ' HD2' HG13 ' A' ' 42' ' ' ILE . 92.1 Cg_endo -88.72 -175.89 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.71 2.273 . . . . 0.0 112.366 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 90' ' ' CYS . 4.3 mp -119.97 120.88 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -164.33 157.91 18.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.085 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.474 HG12 ' HG2' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -82.6 45.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.418 0.628 . . . . 0.0 111.21 -176.176 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.23 -49.86 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.821 177.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.7 86.99 2.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.58 -4.75 80.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.985 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' HG2' HG12 ' A' ' 46' ' ' VAL . 2.9 tt0 67.63 58.5 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.41 0.624 . . . . 0.0 110.394 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.688 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -111.58 165.43 12.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.542 -175.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.13 140.61 5.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.04 145.83 55.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.627 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.81 126.46 30.21 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.1 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 75.1 Cg_exo -51.01 122.47 10.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.393 2.729 . . . . 0.0 113.544 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -76.01 -12.82 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.491 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -34.52 78.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.355 -175.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.33 -38.5 20.01 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.224 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -15.6 46.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -28.61 48.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.82 0.343 . . . . 0.0 111.856 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.53 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.4 pt -129.26 -41.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.206 0.527 . . . . 0.0 111.19 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' N ' HG13 ' A' ' 61' ' ' ILE . 5.6 m-80 -83.23 36.62 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.722 0.809 . . . . 0.0 110.194 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 24.5 pt20 -72.46 -7.4 49.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.253 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -1.45 45.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.656 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 3' ' ' ILE . 59.3 mt -80.23 120.26 79.01 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.349 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 23.5 Cg_exo -64.85 164.38 24.68 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 112.284 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.5 tp -62.49 -8.89 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.515 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -65.24 -7.46 13.16 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -116.4 29.91 7.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.491 0.662 . . . . 0.0 110.107 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -143.82 173.14 11.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 121.49 43.92 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.933 0.397 . . . . 0.0 111.64 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -72.25 98.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.619 0.724 . . . . 0.0 109.158 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.49 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.49 161.94 40.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.17 104.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 0.0 110.273 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -59.65 127.05 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.614 -172.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.61 152.89 43.0 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.092 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.581 ' HB2' HG12 ' A' ' 93' ' ' ILE . 19.2 t -144.58 119.04 9.65 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -113.52 164.1 14.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.695 -172.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.19 127.25 18.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 175.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -36.42 108.86 0.06 OUTLIER Glycine 0 C--N 1.34 0.781 0 O-C-N 124.081 0.863 . . . . 0.0 112.763 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.692 ' HG2' HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -82.84 129.23 34.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.17 -0.515 . . . . 0.0 110.883 -173.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 140.93 34.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.737 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -56.2 119.98 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 123.655 0.597 . . . . 0.0 111.053 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.84 -26.75 4.22 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.464 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.37 136.3 33.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.876 0.369 . . . . 0.0 110.305 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 t -74.81 -47.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -143.87 151.58 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.882 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -142.25 145.66 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.7 131.53 43.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.984 0.421 . . . . 0.0 110.69 -175.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 t -109.72 145.16 37.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.873 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.61 152.29 52.51 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 31.6 Cg_endo -64.09 140.44 71.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.645 2.23 . . . . 0.0 112.748 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.581 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -95.71 -62.68 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.913 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 100.94 13.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.521 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.138 178.352 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.438 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.23 114.78 28.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.67 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.863 HG23 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -77.91 111.94 21.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.725 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.1 Cg_endo -89.2 128.68 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.524 2.816 . . . . 0.0 112.381 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.65 68.08 16.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.77 -39.83 8.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.224 1.949 . . . . 0.0 112.116 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.01 -21.23 59.51 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.868 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 49.49 69.42 0.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.29 0.567 . . . . 0.0 111.51 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.76 -173.4 14.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.205 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.46 142.73 37.67 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.345 2.696 . . . . 0.0 112.335 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -87.6 157.28 19.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.832 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.71 -25.82 38.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.006 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 16' ' ' GLN . 40.2 m -60.45 -28.84 68.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.174 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -48.12 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.9 73.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.771 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 23.4 tt0 -62.86 -31.48 72.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.328 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -32.75 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 0.0 111.277 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -88.89 16.49 6.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.141 -177.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.19 175.02 10.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.898 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.67 167.43 22.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.09 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.19 -16.11 61.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.381 0.61 . . . . 0.0 110.157 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -89.76 19.37 4.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.459 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 79' ' ' SER . 1.8 mptt -132.6 156.0 47.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.597 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -105.1 123.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.197 0.522 . . . . 0.0 110.398 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.85 103.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.911 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -116.5 172.69 7.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 -177.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 p -126.74 128.4 46.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.921 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 34.0 t -157.32 141.38 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.379 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.414 HD21 ' CG ' ' A' ' 50' ' ' GLU . 4.7 p30 -98.65 94.02 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.93 0.871 . . . . 0.0 110.455 174.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.489 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -116.47 146.8 42.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.049 178.26 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -72.17 -26.03 61.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 0.0 110.269 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.42 -44.01 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.355 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.489 HD12 ' H ' ' A' ' 30' ' ' SER . 4.4 mt -67.3 -44.79 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -14.03 61.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.543 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.48 14.52 19.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.256 -0.278 . . . . 0.0 110.877 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.97 41.16 30.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.753 176.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 65.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.801 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -77.11 95.17 4.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.931 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.86 -157.35 9.67 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.35 4.67 50.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.024 0.44 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.03 -7.56 59.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.717 HG12 ' HB3' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -88.52 117.63 68.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.285 0.564 . . . . 0.0 111.641 -174.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 13.0 Cg_endo -91.21 -168.56 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.683 2.922 . . . . 0.0 111.415 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 26' ' ' SER . 5.3 tp -155.17 1.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.329 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.44 -149.2 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.668 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.15 124.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.451 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.444 HD11 ' SG ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -141.11 -177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.825 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 66.37 2.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 110.672 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.4 -143.52 4.07 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.534 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' CG ' HD21 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -137.91 70.4 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 -176.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 19.4 m -129.04 149.58 50.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.33 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -152.55 128.51 10.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -75.73 123.21 25.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.175 170.034 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.579 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -88.52 133.21 36.78 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.327 -175.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.86 127.56 26.09 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.506 2.804 . . . . 0.0 112.951 -175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.41 -12.53 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.921 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.24 -40.68 86.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.832 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.13 -25.21 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.612 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.17 -18.91 64.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -30.48 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.11 -38.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.25 28.19 0.54 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.36 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -8.63 55.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.422 0.63 . . . . 0.0 109.717 175.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.88 -7.52 58.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.213 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 3' ' ' ILE . 42.9 mt -75.99 126.94 86.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.247 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 14.9 Cg_exo -69.59 167.59 23.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.566 2.177 . . . . 0.0 111.93 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.626 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.25 -9.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.6 -177.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -24.92 64.86 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -100.32 16.14 25.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.504 0.669 . . . . 0.0 109.766 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.626 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 98.9 m-85 -126.75 176.0 7.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.99 127.46 48.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.48 98.59 3.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.46 160.64 40.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.217 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.0 112.53 0.53 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.295 0.569 . . . . 0.0 110.441 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.6 ' HB ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -61.61 130.77 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.53 -174.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 m -129.36 115.58 17.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.848 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 20.3 t -104.96 118.25 36.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.045 0.45 . . . . 0.0 110.096 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -114.9 163.35 15.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 -175.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.439 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.51 133.75 24.65 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 174.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -43.92 109.68 0.27 Allowed Glycine 0 C--N 1.335 0.495 0 O-C-N 123.792 0.683 . . . . 0.0 112.737 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.01 29.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.587 . . . . 0.0 110.508 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.54 173.4 7.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.18 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.44 117.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 123.364 0.415 . . . . 0.0 110.693 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.37 -43.02 1.61 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 84.16 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.971 0.415 . . . . 0.0 110.153 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -41.06 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 131.33 55.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.9 pt -132.86 163.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -107.58 120.02 41.04 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.717 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 t -108.6 135.7 49.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.319 0.581 . . . . 0.0 111.043 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -129.72 141.67 42.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.31 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 91' ' ' THR . 22.7 Cg_exo -63.39 126.6 18.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.358 2.039 . . . . 0.0 111.63 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.6 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -82.52 -52.1 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.163 0.506 . . . . 0.0 110.151 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.84 144.71 45.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.014 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.672 178.336 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.74 146.61 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.489 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.721 HG23 HG13 ' A' ' 65' ' ' ILE . 6.6 mt -85.46 114.02 54.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.972 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 7.5 Cg_exo -72.84 124.96 10.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.735 2.29 . . . . 0.0 111.874 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.61 88.02 9.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.98 -45.19 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.008 2.472 . . . . 0.0 112.351 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.53 27.01 5.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.463 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 48.76 65.55 1.33 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.795 0.438 . . . . 0.0 111.554 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.47 160.98 27.14 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.161 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.54 144.86 96.7 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.092 2.528 . . . . 0.0 112.267 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 154.76 29.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 0.0 110.978 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.61 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.985 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -67.2 -26.68 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.214 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -45.1 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.002 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.87 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -59.21 -29.91 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.443 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -56.72 -30.85 63.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.124 0.488 . . . . 0.0 111.362 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.45 -4.15 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.777 ' HB2' HG23 ' A' ' 93' ' ' ILE . 18.6 t -127.84 174.74 8.89 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.93 146.65 41.85 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.739 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.77 -9.52 59.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 111.08 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.97 21.98 10.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.655 0.74 . . . . 0.0 109.85 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HE2' ' SG ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -121.02 147.19 45.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.547 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.789 HG13 ' HA2' ' A' ' 80' ' ' GLY . 6.7 m -88.83 140.6 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 0.0 110.772 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.18 121.12 43.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.2 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.676 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -135.67 159.12 42.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.8 m -101.3 121.31 41.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.47 118.39 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -106.48 95.45 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.28 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.43 151.07 20.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -64.71 -37.99 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.663 -178.485 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.3 pm0 -73.46 -30.26 63.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.41 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.23 -32.9 74.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.529 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.47 -23.04 66.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.153 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -115.15 10.09 16.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.728 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.25 30.05 17.78 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.78 121.59 33.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.25 -177.448 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.23 155.25 20.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.446 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.64 -105.1 2.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.703 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 -38.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.181 0.515 . . . . 0.0 110.338 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -125.0 147.1 49.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.026 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.697 HG13 ' HA ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -120.24 78.85 26.79 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.537 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.18 124.13 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.025 2.484 . . . . 0.0 112.183 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' A' ' 44' ' ' ILE . 2.6 mm -86.55 121.29 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.49 174.39 8.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.464 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.63 45.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.957 0.408 . . . . 0.0 111.12 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -87.03 131.93 33.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.696 178.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 85.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.256 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.78 10.01 2.13 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.071 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -134.9 -69.12 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 109.849 -178.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.3 m -146.75 139.2 24.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.783 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 129.24 15.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 22.8 t-20 -85.03 124.16 31.4 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.474 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -95.51 130.54 31.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.302 -174.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 79.4 Cg_exo -47.95 121.88 6.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.462 2.774 . . . . 0.0 113.291 -174.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.699 HD13 HG12 ' A' ' 24' ' ' VAL . 7.5 tp -75.17 -11.46 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.602 -173.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.24 -40.6 86.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.256 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.55 -25.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 56' ' ' ILE . 1.3 mm? -63.72 -23.8 67.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -60.29 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.595 HG13 ' N ' ' A' ' 62' ' ' ASN . 5.7 pt -81.47 -44.3 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 111.141 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.603 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -92.04 38.54 1.0 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.88 -176.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.1 -14.17 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.921 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.21 1.29 51.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.89 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.721 HG13 HG23 ' A' ' 3' ' ' ILE . 1.5 tt -66.01 135.93 95.38 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.34 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 3.0 Cg_exo -77.82 161.09 30.59 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.009 2.473 . . . . 0.0 111.742 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 67' ' ' ILE . 2.4 tp -67.11 -8.68 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.887 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.9 -32.3 67.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.903 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.417 HD21 HG12 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -103.48 60.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 109.316 176.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.89 173.15 16.91 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.2 133.48 49.04 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.313 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -80.54 94.18 6.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.063 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.588 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 17.9 m-20 -155.9 160.33 40.06 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -51.33 105.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.267 0.556 . . . . 0.0 110.812 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -62.24 135.33 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.778 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 m -144.13 148.66 35.37 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -172.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.1 p -129.18 119.62 24.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.694 0.759 . . . . 0.0 110.906 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 21.4 m -99.54 155.22 17.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.572 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 89' ' ' GLN . 0.3 OUTLIER -52.35 128.41 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.789 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -32.6 104.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.786 0 O-C-N 124.271 0.982 . . . . 0.0 114.19 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.51 93.1 1.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.429 0.633 . . . . 0.0 110.165 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 173.1 10.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.109 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.95 129.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.352 0.596 . . . . 0.0 110.891 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.0 -26.71 11.08 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.753 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 122.84 34.81 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.0 -52.31 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.032 0.444 . . . . 0.0 110.876 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -99.12 117.48 33.7 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 78' ' ' CYS . 17.7 pt -126.83 159.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.697 ' HA ' HG13 ' A' ' 42' ' ' ILE . 3.9 pt20 -109.65 128.46 55.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.488 ' HB2' ' CG2' ' A' ' 42' ' ' ILE . 94.3 m -107.93 127.3 53.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.113 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -138.3 135.61 18.5 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.581 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.75 141.01 77.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.131 2.554 . . . . 0.0 112.794 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 19' ' ' CYS . 2.1 mt -91.71 -77.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.581 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tp -74.51 121.48 21.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.787 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.969 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.829 0.347 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.72 144.97 50.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.529 0.204 . . . . 0.0 110.607 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 65' ' ' ILE . 26.9 mt -94.93 111.45 54.57 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.835 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 65' ' ' ILE . 6.1 Cg_exo -78.74 126.02 7.09 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.007 2.471 . . . . 0.0 112.38 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.11 71.09 18.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.213 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.35 -23.83 32.22 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.743 2.295 . . . . 0.0 111.821 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.82 -21.9 4.1 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.09 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.83 51.75 15.31 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.08 0.552 . . . . 0.0 111.146 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.19 32.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.441 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.82 134.41 58.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.89 2.393 . . . . 0.0 112.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 m -89.73 155.66 19.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.536 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 67' ' ' ILE . 48.4 t -65.9 -25.2 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.223 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.92 -35.43 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.034 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpp -62.65 -42.27 99.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.369 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.67 78.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -60.92 -32.75 72.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.367 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -30.3 62.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.836 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.07 -3.12 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.894 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 174.79 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.8 151.06 38.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.254 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.02 -9.01 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 110.998 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.58 12.04 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.406 0.622 . . . . 0.0 109.748 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -119.89 166.78 12.86 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.332 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.858 HG13 ' HA2' ' A' ' 80' ' ' GLY . 9.9 m -106.24 160.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.216 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.02 116.2 51.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.668 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -131.42 149.02 52.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.504 -178.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 107.32 17.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 3.3 m -126.14 121.45 32.87 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.862 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 11.2 t-20 -86.42 113.94 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.742 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.2 144.19 32.07 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -74.79 -42.99 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.356 0.598 . . . . 0.0 110.329 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.3 pm0 -68.77 -27.46 65.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.541 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -32.27 72.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.145 0.498 . . . . 0.0 110.757 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -8.37 54.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.533 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.65 23.84 3.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.866 0.365 . . . . 0.0 111.412 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.7 m -81.27 78.07 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.365 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -59.86 -66.86 0.45 Allowed 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.943 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.24 -39.94 14.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.509 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.34 158.61 9.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.82 -166.91 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.27 120.84 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.467 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.635 HG21 ' HB2' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -108.32 117.86 53.68 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.554 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.44 ' HB3' ' HB2' ' A' ' 48' ' ' SER . 17.1 Cg_endo -91.63 99.0 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.24 2.627 . . . . 0.0 112.696 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -101.75 36.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.558 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.97 161.5 39.21 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.88 48.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -174.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 tp -127.03 -75.17 0.58 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -73.27 90.98 1.66 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 92.56 -8.45 76.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.233 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 63.87 57.47 1.35 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.243 0.544 . . . . 0.0 111.014 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -90.95 144.64 25.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.532 178.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 130.67 47.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.6 t-20 -79.59 101.1 8.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.546 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -64.88 131.59 95.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.101 -174.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.562 ' O ' HG13 ' A' ' 58' ' ' ILE . 6.3 Cg_endo -47.84 123.62 8.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.994 3.129 . . . . 0.0 113.73 -171.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.76 -23.56 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.992 -174.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.559 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -59.45 -43.47 93.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.366 -176.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -80.12 -17.8 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 110.721 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 59' ' ' LEU . 1.9 mm? -71.02 -33.44 70.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.784 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -51.4 9.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.987 0.422 . . . . 0.0 112.132 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 62' ' ' ASN . 3.2 pt -99.46 -44.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.947 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' HG13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -93.63 30.7 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.883 0.373 . . . . 0.0 110.987 -174.34 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.18 -8.43 54.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.668 . . . . 0.0 109.564 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.18 -13.26 60.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.848 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 3' ' ' ILE . 21.4 mt -66.97 129.7 93.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 48.7 Cg_exo -56.46 152.14 41.66 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.545 2.163 . . . . 0.0 111.567 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.741 HD12 HG22 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -59.11 -8.54 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -175.263 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -56.58 -26.09 54.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.723 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.75 13.59 19.76 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.843 0.83 . . . . 0.0 110.264 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.465 ' CE2' HG13 ' A' ' 54' ' ' ILE . 1.1 m-85 -130.6 173.4 10.92 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 123.99 48.72 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.995 -170.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 96.73 2.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 3.4 t0 -156.79 163.58 39.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.213 -173.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.23 97.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 0.0 109.845 168.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -71.97 135.53 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.312 -172.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 140.63 51.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.287 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.483 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 122.25 38.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.617 0.722 . . . . 0.0 109.346 174.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 14.4 m -111.87 162.97 14.72 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.686 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.38 135.36 39.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.016 0.371 . . . . 0.0 110.087 174.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.858 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -47.18 107.22 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 123.644 0.59 . . . . 0.0 112.729 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -55.4 119.15 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.735 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.36 26.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.349 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.516 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.48 113.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 110.518 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.15 -17.76 5.92 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.804 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 108.54 10.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.872 0.368 . . . . 0.0 110.105 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.79 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.013 0.435 . . . . 0.0 110.778 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -101.09 108.77 20.55 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -110.35 162.58 7.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.822 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 23.7 mt-30 -99.47 121.09 40.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.712 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.635 ' HB2' HG21 ' A' ' 42' ' ' ILE . 89.2 m -108.3 127.61 54.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 t -132.47 139.99 36.48 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.284 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 9.5 Cg_endo -54.44 126.6 22.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.648 2.232 . . . . 0.0 111.658 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -69.35 -38.98 78.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.0 110.437 -178.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.88 117.22 20.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.857 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.03 50.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.525 HG23 HG12 ' A' ' 65' ' ' ILE . 2.8 mp -98.95 110.83 59.08 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.032 0.444 . . . . 0.0 110.046 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 131.23 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.498 2.799 . . . . 0.0 112.003 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 8' ' ' GLU . . . -135.77 66.44 62.8 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 6.5 Cg_exo -73.91 -70.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.205 1.937 . . . . 0.0 110.27 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 74.99 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.435 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -69.24 129.6 40.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 0.0 111.251 -175.484 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.42 -141.07 3.23 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.423 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 133.43 58.07 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -91.64 155.09 18.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.72 -25.29 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.003 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -65.0 -29.29 70.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.582 -175.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -36.19 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 109.982 177.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.86 -35.17 78.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.116 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -70.3 -31.28 68.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -32.74 74.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.924 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -88.54 3.92 48.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.202 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HD2' ' A' ' 23' ' ' LYS . 32.7 t -127.2 175.75 7.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.68 159.47 30.57 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.167 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.83 -35.67 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 111.098 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -89.19 36.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.494 0.664 . . . . 0.0 110.011 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 11.2 mttt -135.97 166.01 24.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.614 HG13 ' HA2' ' A' ' 80' ' ' GLY . 2.8 m -118.8 130.1 74.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.187 0.518 . . . . 0.0 111.398 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.44 131.59 33.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.669 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.37 164.82 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.167 0.508 . . . . 0.0 110.861 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.813 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -123.76 110.14 14.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.735 ' HA ' ' CB ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -151.89 113.21 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.315 0.384 . . . . 0.0 110.15 178.225 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.804 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 9.8 p30 -85.29 152.84 22.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.71 0.766 . . . . 0.0 112.521 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 m -157.94 147.37 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.078 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -68.4 -31.57 71.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.154 0.502 . . . . 0.0 110.584 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -17.38 60.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.766 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -56.95 -29.56 63.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -174.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.12 -10.02 59.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.539 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -141.68 26.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 111.251 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 33' ' ' LEU . 69.6 m -77.74 84.85 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.32 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -86.33 -42.59 13.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.48 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.73 149.43 24.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.464 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' HA3' ' OE1' ' A' ' 89' ' ' GLN . . . -118.75 137.79 13.12 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.238 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.19 -115.91 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.08 88.89 3.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -96.76 134.26 23.38 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.866 -177.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 37.3 Cg_exo -61.25 140.59 89.52 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.187 2.591 . . . . 0.0 112.774 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.603 HG12 ' HB2' ' A' ' 53' ' ' ASN . 5.9 tt -142.36 -17.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.832 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -161.6 -162.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.258 -0.276 . . . . 0.0 110.605 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t 63.86 10.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.895 0.747 . . . . 0.0 111.094 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.37 42.09 32.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.415 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.72 63.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.953 0.882 . . . . 0.0 109.091 172.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.94 -94.37 0.21 Allowed Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -175.48 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.157 0.503 . . . . 0.0 109.811 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 25.7 p -167.12 171.79 10.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.357 -174.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -156.87 152.8 27.25 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.077 0.236 . . . . 0.0 110.781 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.603 ' HB2' HG12 ' A' ' 44' ' ' ILE . 64.6 t30 -91.56 133.04 35.87 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.529 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -97.25 136.77 21.28 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.489 -169.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 31.7 Cg_exo -59.48 132.99 49.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.649 2.899 . . . . 0.0 113.454 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -77.97 -27.65 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.603 -175.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -55.59 -35.33 65.69 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -79.04 -39.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.084 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -55.39 -26.31 40.8 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -28.54 69.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.413 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -131.49 -37.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.041 0.448 . . . . 0.0 110.648 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.7 m-80 -80.27 24.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.986 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -69.92 -7.59 41.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.381 177.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.83 -10.8 59.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.667 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 3' ' ' ILE . 78.7 mt -73.37 126.05 90.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 10.6 Cg_exo -71.62 164.18 36.53 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.689 2.259 . . . . 0.0 111.541 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 2.2 tp -57.88 -8.9 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -26.25 62.17 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -106.44 33.76 3.72 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.699 0.762 . . . . 0.0 109.383 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.624 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 80.1 m-85 -149.04 175.94 10.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.53 115.85 31.41 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.717 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 97.83 0.91 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.804 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 18.4 t0 -155.21 162.87 40.82 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.373 -173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.51 99.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.98 0.8 . . . . 0.0 110.017 170.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -60.69 130.18 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.345 -169.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.3 m -124.08 153.84 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.117 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -144.29 121.9 11.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.716 0.77 . . . . 0.0 109.407 171.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 5.8 t -110.46 163.41 13.71 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.9 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.628 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -54.35 134.55 45.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 172.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -48.09 108.24 0.33 Allowed Glycine 0 CA--C 1.507 -0.444 0 O-C-N 123.558 0.536 . . . . 0.0 112.172 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.02 130.56 44.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.323 0.582 . . . . 0.0 110.406 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.89 150.65 51.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.596 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -55.14 112.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 177.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.17 -32.06 6.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 89.26 7.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -77.71 -41.35 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.704 -176.706 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.0 105.75 17.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.19 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 79' ' ' SER . 1.5 pt -114.42 164.49 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.665 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.406 ' OE1' ' HA3' ' A' ' 39' ' ' GLY . 4.9 mm100 -106.46 112.34 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.295 . . . . 0.0 110.274 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.5 m -107.56 133.99 51.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.427 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 149.48 64.68 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.267 -175.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.23 121.85 8.66 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.871 2.381 . . . . 0.0 112.157 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -72.87 -30.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.86 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tp -133.84 103.47 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.938 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.13 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 120.511 0.196 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.4 155.62 18.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 111.424 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.562 HG23 HG12 ' A' ' 65' ' ' ILE . 4.5 mt -103.61 112.18 65.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.222 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 2.9 Cg_exo -76.55 125.11 8.07 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.68 2.254 . . . . 0.0 111.996 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.18 82.96 67.19 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.43 -71.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.964 2.443 . . . . 0.0 112.005 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.12 -0.82 61.47 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.753 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 53.31 54.2 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.099 0.56 . . . . 0.0 111.375 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.57 -171.22 38.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.363 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.01 145.29 98.12 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.913 2.408 . . . . 0.0 112.435 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.75 157.09 16.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.233 -177.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.3 p -63.32 -26.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.957 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.765 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.7 p -64.04 -31.13 72.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.303 -175.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -44.71 82.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.56 74.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.614 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.45 -29.3 70.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.79 -33.92 69.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -92.69 13.88 18.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.732 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.58 174.86 8.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.66 20.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.165 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.34 -22.45 54.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 109.842 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.53 25.45 7.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.67 0.748 . . . . 0.0 109.29 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -128.24 171.61 11.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.148 178.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 56' ' ' ILE . 11.6 p -122.75 141.48 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.994 0.426 . . . . 0.0 111.443 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.41 116.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.646 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.88 155.34 43.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 3.2 p -101.35 105.41 16.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 11.2 t -134.27 108.54 8.29 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.571 -175.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 1.0 HD21 ' HD3' ' A' ' 34' ' ' LYS . 22.6 t-20 -115.41 92.46 3.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.477 171.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.62 153.58 18.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -44.71 75.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.955 0.407 . . . . 0.0 110.658 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.23 -41.49 94.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.069 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.98 -27.85 66.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -176.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 1.0 ' HD3' HD21 ' A' ' 29' ' ' ASN . 11.3 ttpt -78.42 -15.13 58.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.331 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -116.03 -30.52 6.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.363 -176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 m -124.96 150.1 46.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -72.08 89.21 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.653 0.263 . . . . 0.0 111.134 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.559 ' HA ' HD12 ' A' ' 33' ' ' LEU . 3.8 m 71.0 -74.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.385 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.91 -160.71 35.62 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.587 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.57 -12.9 14.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.9 0.381 . . . . 0.0 111.34 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -95.82 61.02 2.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.842 0.353 . . . . 0.0 110.546 -179.147 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.866 HD12 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -104.77 99.84 20.64 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 -176.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 66.8 Cg_endo -99.37 162.97 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.5 2.8 . . . . 0.0 113.154 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.27 120.37 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' HB3' HD23 ' A' ' 47' ' ' LEU . 1.2 t70 -116.96 -161.41 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.152 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.4 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . 2.6 m -124.42 25.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.814 0.34 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -119.3 152.37 36.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.028 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.56 147.62 23.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.087 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.72 -10.09 48.67 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -174.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HB3' ' H ' ' A' ' 51' ' ' CYS . 2.7 tp10 -138.69 -109.19 0.17 Allowed 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 3.2 m -125.48 137.16 53.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.731 -0.606 . . . . 0.0 111.397 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 46' ' ' VAL . 5.1 tmtt? -132.87 131.7 41.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.203 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.64 111.03 21.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.947 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.426 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -87.5 150.08 47.98 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' O ' HD13 ' A' ' 59' ' ' LEU . 35.6 Cg_exo -57.25 118.71 5.62 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.261 1.974 . . . . 0.0 112.858 -173.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.613 HD12 HD22 ' A' ' 59' ' ' LEU . 4.7 tp -80.04 -26.79 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -33.8 73.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.118 -173.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 55' ' ' PRO . 1.5 pt -80.22 -26.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.084 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 56' ' ' ILE . 4.7 mp -56.2 -34.36 66.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -20.76 63.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 62' ' ' ASN . 4.0 pt -120.28 -32.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.298 0.57 . . . . 0.0 110.945 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.578 ' N ' HG13 ' A' ' 61' ' ' ILE . 6.8 m-20 -98.64 33.26 2.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.862 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.765 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 5.5 pt20 -68.51 -10.86 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.697 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.74 -5.04 59.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.46 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.562 HG12 HG23 ' A' ' 3' ' ' ILE . 4.5 mt -71.07 126.5 92.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 6.0 Cg_exo -80.17 167.21 19.97 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.015 2.477 . . . . 0.0 112.137 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.655 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -60.42 -12.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.961 -174.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -66.89 -18.72 65.52 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.01 -0.431 . . . . 0.0 111.169 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -97.35 7.87 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.564 0.697 . . . . 0.0 109.821 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.655 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 44.8 m-85 -125.41 176.34 6.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.84 -175.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 134.88 45.11 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.82 96.8 9.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.482 0.658 . . . . 0.0 110.562 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 2.3 m-20 -154.18 158.34 40.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.641 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 29.9 m -43.67 108.7 0.12 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.092 0.472 . . . . 0.0 112.19 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.82 116.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 17.0 m -122.92 132.15 54.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 -177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 t -107.16 118.16 35.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 3.1 m -117.96 164.54 14.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.39 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.68 134.95 41.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.518 ' N ' ' HA ' ' A' ' 23' ' ' LYS . . . -33.83 113.71 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 O-C-N 123.821 0.701 . . . . 0.0 114.345 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.71 104.28 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.24 174.95 10.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.183 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 tp -67.39 137.9 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.23 46.39 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.608 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.0 130.52 36.18 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.768 -0.254 . . . . 0.0 110.752 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.1 t -79.66 -67.07 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -136.06 159.99 40.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.678 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.05 177.95 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.791 0.329 . . . . 0.0 110.834 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 123.87 46.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.831 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.866 ' H ' HD12 ' A' ' 42' ' ' ILE . 9.2 m -109.54 140.55 43.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.431 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 t -150.8 135.36 9.71 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.044 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 9.4 Cg_endo -53.85 129.3 33.45 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.99 2.46 . . . . 0.0 112.059 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.517 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -74.87 -65.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.335 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD12 HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -105.22 117.04 32.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.013 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.809 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.001 0.429 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.72 146.29 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.848 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.971 HG23 HG13 ' A' ' 65' ' ' ILE . 4.1 mt -101.57 110.86 62.91 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.13 139.56 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.432 2.755 . . . . 0.0 112.243 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.6 71.38 71.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.743 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HD2' ' ND2' ' A' ' 68' ' ' ASN . 12.9 Cg_exo -71.98 -73.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 110.567 172.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.65 77.57 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.34 110.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 111.326 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.66 -149.2 5.42 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 139.92 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.441 2.094 . . . . 0.0 112.175 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -84.55 165.42 18.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.146 -177.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.62 -26.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.429 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.8 p -64.74 -27.47 68.92 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.821 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.3 ttm -63.13 -46.26 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.493 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.98 74.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.07 -30.27 71.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.161 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -57.29 -31.28 65.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.549 . . . . 0.0 110.897 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -84.66 12.06 7.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.455 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 174.86 10.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 110.326 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.42 161.85 45.18 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 -26.65 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.921 0.391 . . . . 0.0 110.669 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.19 27.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.545 0.688 . . . . 0.0 110.23 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -125.06 160.86 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.728 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.779 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 13.4 p -114.34 134.74 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.412 0.625 . . . . 0.0 110.284 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 t -99.99 104.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.059 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -111.58 163.31 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.717 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 14.0 p -101.27 104.17 15.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -131.8 101.73 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.078 0.466 . . . . 0.0 111.003 -177.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 10.7 t-20 -100.23 119.9 39.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.21 147.91 39.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.277 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -71.44 -29.58 65.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 109.988 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 2.1 pm0 -71.1 -29.97 65.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.209 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 42' ' ' ILE . 2.3 tp -69.83 -28.02 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.364 0.602 . . . . 0.0 110.068 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -8.95 59.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 177.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -105.19 -18.09 14.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.014 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.11 109.0 11.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.952 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -41.5 95.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.064 0.459 . . . . 0.0 109.78 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.4 p -159.76 168.56 25.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.508 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.49 5.5 55.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.47 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.35 116.51 22.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.273 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -76.07 128.44 35.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.165 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -148.13 119.55 4.43 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.232 -177.185 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.96 154.25 14.86 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.511 2.14 . . . . 0.0 112.004 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mt -73.74 103.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.557 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 32.7 t0 -85.1 167.33 15.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.143 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.67 113.17 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.235 0.541 . . . . 0.0 110.355 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HB2' ' H ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -136.72 144.55 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.635 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.15 74.98 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.418 . . . . 0.0 110.474 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.78 49.3 1.18 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.405 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -161.15 -58.11 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.151 0.5 . . . . 0.0 110.293 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.47 ' H ' ' HB2' ' A' ' 47' ' ' LEU . 1.3 m -136.98 139.59 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.965 178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.73 141.44 7.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.066 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 53.6 t30 -96.01 109.79 22.13 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.481 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -79.72 149.32 70.87 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.704 -176.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 54' ' ' ILE . 37.0 Cg_endo -64.6 121.54 9.14 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.77 2.314 . . . . 0.0 112.797 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.522 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -80.08 -5.41 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.482 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.35 -37.57 83.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.698 0.285 . . . . 0.0 111.232 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -16.78 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.889 175.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.2 -14.48 62.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.227 -170.126 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -51.16 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.988 0.423 . . . . 0.0 112.098 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.9 pt -106.89 -23.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.869 0.366 . . . . 0.0 111.805 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -105.69 21.34 17.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.278 -176.078 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -64.91 -14.19 59.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.355 0.598 . . . . 0.0 110.041 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -72.35 -5.25 35.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.496 176.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.971 HG13 HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -70.35 134.1 87.05 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -74.44 159.28 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.203 . . . . 0.0 111.159 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.502 ' HA ' HD12 ' A' ' 67' ' ' ILE . 3.2 tp -61.95 -10.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.415 ' ND2' ' HD2' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -64.07 -22.66 67.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 175.071 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.53 34.07 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -150.65 177.01 10.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -172.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.62 116.65 32.22 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -76.99 97.29 4.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.7 0.762 . . . . 0.0 109.659 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.717 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 10.1 m-20 -153.85 159.71 41.92 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 29' ' ' ASN . 21.0 m -43.51 115.28 0.76 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.183 0.516 . . . . 0.0 111.26 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.37 123.86 25.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.994 -174.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 28' ' ' CYS . 84.7 p -123.83 127.24 47.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.389 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.67 118.4 36.45 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.271 0.558 . . . . 0.0 109.965 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.686 ' SG ' ' HB ' ' A' ' 88' ' ' ILE . 14.5 t -118.33 165.44 13.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.543 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.617 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -51.56 122.42 8.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.779 ' HA2' ' HB ' ' A' ' 24' ' ' VAL . . . -54.7 104.77 0.28 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.294 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.54 119.31 6.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.569 -0.816 . . . . 0.0 112.106 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.82 151.85 41.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.85 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.58 112.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.497 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.49 -21.45 4.28 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.545 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.28 96.17 10.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 0.0 110.011 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -37.7 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.937 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.12 148.37 51.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.641 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.686 ' HB ' ' SG ' ' A' ' 78' ' ' CYS . 1.5 pt -131.77 151.27 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.882 0.372 . . . . 0.0 111.275 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -106.85 109.14 20.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.513 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.6 m -112.59 136.02 52.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -138.2 143.61 39.85 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.357 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.437 ' HD2' HG22 ' A' ' 91' ' ' THR . 32.8 Cg_endo -64.57 147.82 90.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.735 2.29 . . . . 0.0 112.356 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -115.96 -73.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 78.08 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.571 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.598 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.561 HG23 HG12 ' A' ' 65' ' ' ILE . 5.2 mt -101.75 112.37 65.16 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.52 125.01 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.417 2.078 . . . . 0.0 111.227 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.81 82.29 6.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.28 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.71 -64.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.553 2.168 . . . . 0.0 111.665 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.49 53.02 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.991 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.76 -49.14 8.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.569 0.223 . . . . 0.0 111.183 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.87 -146.23 10.39 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.752 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.1 169.47 19.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.502 2.801 . . . . 0.0 113.085 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -102.94 167.47 9.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.001 -179.293 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -25.3 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.513 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.2 m -50.18 -33.9 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.602 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -45.71 64.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.66 -50.81 32.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.706 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -59.39 -29.86 68.03 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.09 68.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.444 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 15.5 2.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.032 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -144.17 174.24 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.96 143.87 37.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.528 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 -16.24 62.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 0.0 111.369 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.09 4.09 53.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.595 0.712 . . . . 0.0 110.104 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.23 153.57 20.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.618 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG23 HD13 ' A' ' 56' ' ' ILE . 12.9 p -97.01 141.41 15.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.0 t -93.37 128.94 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 110.997 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.17 138.28 23.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.64 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -100.98 124.37 46.59 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.661 -0.649 . . . . 0.0 109.681 175.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -156.17 126.04 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.451 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.618 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . 8.9 t-20 -95.13 93.04 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.33 147.8 22.6 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -69.89 -34.12 73.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.076 0.465 . . . . 0.0 109.792 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' OE2' ' HG2' ' A' ' 31' ' ' LYS . 2.0 pm0 -70.73 -40.23 72.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.419 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.783 179.637 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.667 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 1.9 Cg_endo -82.6 123.09 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.525 HG12 ' SG ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.206 0.526 . . . . 0.0 110.697 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 5.2 m . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 141.46 18.56 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.403 0.44 . . . . 0.0 110.172 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.55 130.56 35.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -100.62 132.05 22.85 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.784 ' HB3' HD21 ' A' ' 57' ' ' ASN . 75.9 Cg_exo -49.26 119.81 4.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.109 2.539 . . . . 0.0 112.881 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.541 HD12 HD13 ' A' ' 59' ' ' LEU . 4.5 tp -79.89 -11.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.784 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -57.27 -50.22 73.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.411 -177.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 ' H ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -78.5 -27.72 14.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.148 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.541 HD13 HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -58.35 -27.23 63.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -55.51 6.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 111.888 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.521 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -94.96 -28.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.193 0.52 . . . . 0.0 111.398 -175.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.456 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -101.84 34.78 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -68.87 -13.06 62.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.689 . . . . 0.0 109.824 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -70.07 -11.5 60.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.181 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.561 HG12 HG23 ' A' ' 3' ' ' ILE . 26.1 mt -64.44 120.6 66.68 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.253 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 21.6 Cg_exo -66.82 164.48 29.35 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.939 2.426 . . . . 0.0 112.139 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.23 -9.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.467 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.401 HD22 ' HB2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -58.77 -21.77 56.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.666 176.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.463 HD22 HG23 ' A' ' 65' ' ' ILE . 68.1 m-80 -108.15 31.19 5.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 109.891 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -149.41 172.28 15.2 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.69 117.46 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.161 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 96.78 1.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.618 ' OD1' ' HB2' ' A' ' 29' ' ' ASN . 12.0 t0 -156.92 165.19 36.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.505 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.32 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.614 0.571 . . . . 0.0 109.482 170.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.527 ' C ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.49 137.18 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.339 -174.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 m -123.97 137.67 54.58 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.601 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.617 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -122.1 120.32 33.93 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.854 0.835 . . . . 0.0 109.093 175.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 88' ' ' ILE . 4.8 m -112.97 163.05 15.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.849 -172.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.27 128.87 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -41.03 107.84 0.1 OUTLIER Glycine 0 C--N 1.337 0.603 0 O-C-N 123.761 0.663 . . . . 0.0 113.27 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -77.94 91.6 4.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.323 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.409 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.6 mp0 -95.0 159.11 15.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -53.41 111.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.1 -18.29 6.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.165 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -87.26 72.76 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.086 178.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.38 31.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.906 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -141.52 126.22 17.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.213 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 78' ' ' CYS . 0.5 OUTLIER -148.61 177.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.5 139.84 37.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.137 0.494 . . . . 0.0 110.858 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' A' ' 44' ' ' ILE . 57.4 m -109.77 143.22 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.544 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 141.78 33.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.48 131.45 36.03 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.617 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.9 OUTLIER -77.31 -58.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.486 0.66 . . . . 0.0 110.093 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tp -114.9 101.63 9.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.639 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.014 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 mt -100.56 110.56 60.75 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.345 . . . . 0.0 111.019 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD2' HD21 ' A' ' 69' ' ' ASN . 7.2 Cg_endo -89.68 126.3 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.261 2.641 . . . . 0.0 111.803 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.21 70.15 55.42 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.99 -61.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.682 2.255 . . . . 0.0 112.846 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.76 18.78 41.22 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.887 -172.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 50.39 56.8 7.39 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.679 0.392 . . . . 0.0 112.025 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 161.27 35.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.458 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.56 149.79 88.22 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.833 2.355 . . . . 0.0 111.574 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 153.3 38.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.034 0.445 . . . . 0.0 111.943 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 HD12 ' A' ' 67' ' ' ILE . 29.5 m -71.37 -25.37 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.612 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -59.7 -26.22 65.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.924 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.95 88.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.107 0.48 . . . . 0.0 109.91 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.36 71.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -61.99 -31.79 72.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.606 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -32.4 67.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.281 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -85.89 -5.91 59.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.841 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HB2' HG21 ' A' ' 93' ' ' ILE . 19.9 t -115.75 175.99 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -170.9 34.95 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.807 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.85 -39.77 16.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.34 37.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.312 0.577 . . . . 0.0 110.382 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -131.61 153.05 50.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.127 -177.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 53' ' ' ASN . 12.2 p -100.86 144.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.201 0.524 . . . . 0.0 111.146 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.62 127.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.822 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 157.96 45.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 22.9 p -115.28 100.62 8.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.602 . . . . 0.0 109.854 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.8 m -143.07 111.36 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.911 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' HB2' ' H ' ' A' ' 74' ' ' THR . 0.8 OUTLIER -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.33 0.585 . . . . 0.0 110.225 177.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 147.59 37.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.879 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HD2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.53 -28.98 70.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.755 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG3' ' HD2' ' A' ' 31' ' ' LYS . 7.1 mp0 -68.18 -38.71 82.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.646 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.537 178.756 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.621 0.248 . . . . 0.0 111.507 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -98.78 116.21 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.579 2.852 . . . . 0.0 112.871 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 53' ' ' ASN . 20.5 mt . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.054 0.454 . . . . 0.0 110.294 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 15.7 t . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -161.2 147.21 14.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.167 0.508 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.569 HD21 HG21 ' A' ' 24' ' ' VAL . 10.1 t-20 -97.57 89.95 4.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.799 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -64.13 127.07 91.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.226 -176.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.631 ' HB3' HD21 ' A' ' 57' ' ' ASN . 50.6 Cg_exo -52.53 121.21 8.69 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.011 2.474 . . . . 0.0 112.824 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -19.23 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.831 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.631 HD21 ' HB3' ' A' ' 55' ' ' PRO . 7.0 p30 -61.84 -31.53 71.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.157 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pp -80.0 -37.6 17.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.577 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.455 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -60.86 -14.43 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -170.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -40.48 64.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.736 0.303 . . . . 0.0 111.641 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.489 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -116.86 -24.14 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.338 0.59 . . . . 0.0 111.216 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.4 OUTLIER -92.57 34.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.733 -178.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -19.0 65.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.292 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -3.01 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.846 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -70.27 131.83 88.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.333 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 8.7 Cg_exo -73.43 154.41 50.62 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.763 2.309 . . . . 0.0 111.925 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 12' ' ' VAL . 2.1 tp -61.7 -8.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.318 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -12.53 20.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.767 0.317 . . . . 0.0 111.504 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.495 HD21 ' HD2' ' A' ' 4' ' ' PRO . 48.5 m-80 -97.14 3.45 51.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.49 0.662 . . . . 0.0 109.986 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -116.33 174.21 6.18 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.07 138.89 39.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.82 97.52 5.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.493 0.664 . . . . 0.0 110.563 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.56 159.72 39.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.08 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.487 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 4.2 m -50.47 102.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 110.725 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.49 120.04 6.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.425 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -127.45 125.61 40.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.624 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.749 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -106.72 141.89 37.25 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 17.9 t -134.12 163.47 29.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.107 -167.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.6 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -57.43 133.67 55.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.31 115.86 6.74 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.982 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.77 92.88 0.91 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.986 0.422 . . . . 0.0 110.391 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -124.63 168.89 12.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.61 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.19 113.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.85 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.31 -30.79 3.58 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 102.73 13.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.807 0.337 . . . . 0.0 110.4 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -77.59 -16.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.438 -179.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -150.35 143.87 25.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.879 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 79' ' ' SER . 11.3 pt -130.23 153.78 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.512 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.467 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -116.0 113.37 23.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.958 0.409 . . . . 0.0 110.331 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.643 ' H ' HD13 ' A' ' 42' ' ' ILE . 1.4 m -109.02 142.4 39.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.944 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 154.86 30.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.458 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.87 129.72 31.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.535 2.157 . . . . 0.0 112.005 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.749 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -91.86 -34.17 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.754 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -105.43 131.31 53.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.25 1.113 0 O-C-N 124.378 1.049 . . . . 0.0 110.313 -177.563 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 65' ' ' ILE . 4.0 mt -91.07 114.14 60.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.657 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HG2' HD21 ' A' ' 69' ' ' ASN . 3.0 Cg_exo -81.69 126.18 5.18 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.188 2.592 . . . . 0.0 111.907 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.49 78.09 38.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.739 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.94 -72.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.692 2.261 . . . . 0.0 110.904 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.92 123.05 6.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.74 68.58 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.608 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 178.71 47.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.281 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.95 147.81 91.83 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.581 2.187 . . . . 0.0 111.729 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.28 154.83 40.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.92 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -65.29 -24.67 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.341 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.619 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -60.58 -29.34 69.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.885 177.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.1 tpt -69.48 -35.76 75.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.506 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.67 -30.95 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.77 -30.17 68.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.901 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -58.37 -32.34 68.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.243 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 93' ' ' ILE . 21.5 mmtt -73.81 -10.83 60.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.789 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 177.56 7.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.85 0.357 . . . . 0.0 110.644 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 163.47 29.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.58 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 10.13 37.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.612 . . . . 0.0 109.607 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -118.61 170.87 8.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.353 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.463 HG21 HD21 ' A' ' 53' ' ' ASN . 7.1 p -116.22 131.23 69.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.097 0.475 . . . . 0.0 110.943 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.4 133.12 30.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.918 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.37 161.22 43.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 4.4 p -110.16 99.68 8.71 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.181 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -130.02 113.45 14.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.149 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -92.7 124.85 37.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.952 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -119.47 151.7 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -71.29 -48.42 50.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.61 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -19.09 52.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.952 ' HB2' ' HB3' ' A' ' 30' ' ' SER . 4.8 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.107 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.25 148.5 13.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.79 2.326 . . . . 0.0 111.863 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.825 HG21 ' HB2' ' A' ' 53' ' ' ASN . 3.4 mm . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.799 0.333 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 73.6 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 119.42 8.02 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.431 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.825 ' HB2' HG21 ' A' ' 44' ' ' ILE . 19.8 t-20 -77.72 110.22 12.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -88.9 120.95 70.09 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.605 ' HB2' HD22 ' A' ' 57' ' ' ASN . 11.5 Cg_endo -54.65 121.28 9.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.024 2.483 . . . . 0.0 112.561 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.482 ' HA ' HD13 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -74.09 -8.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.624 -175.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.605 HD22 ' HB2' ' A' ' 55' ' ' PRO . 1.1 m-80 -59.83 -43.37 94.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.634 HG22 HD22 ' A' ' 62' ' ' ASN . 0.9 OUTLIER -79.11 -17.38 13.22 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.657 178.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.607 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 5.6 mp -74.61 -21.08 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.718 0.294 . . . . 0.0 111.041 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 -42.81 15.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.661 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.634 HG13 ' H ' ' A' ' 62' ' ' ASN . 8.7 pt -107.57 -48.66 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.239 0.543 . . . . 0.0 111.343 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.634 HD22 HG22 ' A' ' 58' ' ' ILE . 42.4 m-20 -84.8 34.42 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.788 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 22.1 pt20 -64.52 -12.14 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.549 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 mt -80.27 -0.43 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.53 ' HA ' HG23 ' A' ' 3' ' ' ILE . 15.5 mt -75.84 127.28 85.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.991 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.88 157.03 61.23 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.622 HG13 ' HB2' ' A' ' 70' ' ' PHE . 1.7 tp -62.72 -7.85 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -27.89 16.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 175.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.481 HD21 ' HG2' ' A' ' 4' ' ' PRO . 22.3 m-20 -86.02 8.67 19.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.208 0.528 . . . . 0.0 111.086 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.622 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -111.43 172.9 6.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.93 136.9 44.75 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.28 97.71 9.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.315 0.578 . . . . 0.0 111.092 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -156.31 162.78 40.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 m -44.42 104.24 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.812 0.695 . . . . 0.0 110.837 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 75' ' ' VAL . 1.5 t -56.04 122.45 5.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.968 -173.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.58 157.46 33.63 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.656 ' HB2' HG12 ' A' ' 93' ' ' ILE . 51.2 t -139.29 130.18 26.26 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 4.1 m -117.14 163.47 16.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.905 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.458 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.87 135.75 47.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 174.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -42.97 106.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.389 0 O-C-N 123.884 0.74 . . . . 0.0 113.39 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 122.82 16.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.412 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.76 149.32 32.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -65.92 112.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.99 176.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.84 -18.49 8.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 119.49 25.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.77 87.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.036 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.5 t30 72.46 163.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.132 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -138.17 170.18 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.445 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -116.15 126.82 54.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 178.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 73.3 m -108.81 130.03 55.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.384 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -133.54 146.92 62.57 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.266 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.5 131.54 30.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 111.672 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.656 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -108.91 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.65 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' CG2' ' A' ' 75' ' ' VAL . 7.5 tp -81.59 74.14 8.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.451 0.643 . . . . 0.0 111.008 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.246 0.903 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.639 174.575 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 65' ' ' ILE . 2.2 mp -83.16 111.23 29.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 9.6 Cg_endo -89.42 126.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.56 2.84 . . . . 0.0 112.023 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.63 81.05 70.56 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 120.902 0.382 . . . . 0.0 111.7 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.99 -41.02 47.43 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.906 2.404 . . . . 0.0 110.756 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.64 149.08 20.82 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.983 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.06 88.14 4.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.229 0.514 . . . . 0.0 110.887 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.85 165.46 19.95 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 140.93 96.5 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.476 2.117 . . . . 0.0 111.779 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.92 154.15 28.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 0.0 111.115 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.05 -24.88 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.915 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -55.11 -32.31 61.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.801 175.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -48.01 79.67 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.086 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.73 73.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.82 -29.49 70.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.744 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -31.23 64.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -73.46 -16.19 61.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.932 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 175.46 6.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 111.558 -176.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.16 154.58 25.5 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.633 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -16.36 62.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.777 0.322 . . . . 0.0 111.21 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.0 22.14 9.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.359 0.6 . . . . 0.0 110.379 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.98 171.31 8.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.9 p -114.68 132.31 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -175.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.52 ' CG2' ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -92.92 136.38 25.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.602 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 m -155.27 162.17 40.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.743 0.306 . . . . 0.0 110.344 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 13.2 m -99.99 101.53 12.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.3 100.36 6.8 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.177 -175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -102.84 93.74 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.147 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.07 150.74 24.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.094 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -40.65 96.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -34.98 70.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.343 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.258 -176.177 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.27 166.76 2.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.019 2.479 . . . . 0.0 111.951 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 23.7 m . . . . . 0 C--O 1.224 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -142.47 119.06 11.01 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.69 135.82 36.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.74 139.4 22.76 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.98 122.07 11.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.808 2.338 . . . . 0.0 112.754 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.625 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.9 tp -71.24 -19.77 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.573 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -39.69 76.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.759 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -80.6 -25.14 11.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.738 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.97 -15.27 55.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -35.64 21.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 0.0 111.787 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 62' ' ' ASN . 2.3 pt -109.35 -22.32 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.4 0.619 . . . . 0.0 111.61 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.669 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -108.39 26.15 10.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -174.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.411 0.624 . . . . 0.0 109.851 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -81.86 -2.52 51.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.378 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -70.04 141.4 89.22 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.051 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HB2' HD22 ' A' ' 68' ' ' ASN . 3.3 Cg_exo -76.97 150.77 30.27 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.593 2.195 . . . . 0.0 110.723 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 67' ' ' ILE . 2.0 tp -58.04 -9.54 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.543 HD22 ' HB2' ' A' ' 66' ' ' PRO . 0.4 OUTLIER -63.96 -19.45 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 176.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.67 24.33 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 109.618 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.24 173.65 11.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.8 124.87 49.71 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.344 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.0 m -76.93 94.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.851 0.834 . . . . 0.0 109.368 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.94 160.89 39.52 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -42.34 104.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.558 0.694 . . . . 0.0 111.326 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.17 124.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.687 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 47.1 m -129.36 147.05 51.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.083 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 1.4 t -120.23 119.55 33.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 3.9 m -109.53 163.45 13.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.313 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.05 128.39 30.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.45 103.71 0.16 Allowed Glycine 0 C--N 1.331 0.272 0 O-C-N 123.552 0.532 . . . . 0.0 112.919 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -72.92 135.61 45.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.047 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.8 149.25 28.81 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -45.41 111.98 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.975 0.797 . . . . 0.0 110.988 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.86 -13.8 5.79 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.941 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mt -99.21 149.71 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -49.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 149.7 50.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.502 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -149.74 178.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.723 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.1 132.89 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.443 ' H ' HD12 ' A' ' 42' ' ' ILE . 8.1 m -107.52 128.94 54.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.418 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 t -134.6 142.81 44.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.099 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 35.3 Cg_endo -65.01 137.54 53.09 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.534 2.156 . . . . 0.0 112.508 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.607 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -82.4 -25.66 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.222 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.69 115.99 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.255 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.568 0.223 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.421 HG23 HG12 ' A' ' 65' ' ' ILE . 4.0 mt -81.19 112.83 36.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.704 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HG2' HD21 ' A' ' 69' ' ' ASN . 1.3 Cg_endo -85.18 126.03 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.066 2.511 . . . . 0.0 111.329 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 68.88 67.12 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.78 -27.01 5.13 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 111.059 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.32 100.47 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.779 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -70.04 89.2 0.61 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.477 . . . . 0.0 111.031 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.14 -140.37 11.28 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.09 136.09 43.05 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.489 2.126 . . . . 0.0 110.991 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -102.07 164.45 11.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.555 0.217 . . . . 0.0 110.918 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 1.4 p -64.74 -25.5 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -69.55 -27.12 64.87 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 ttt -62.01 -48.78 78.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.207 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.71 -30.1 66.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -67.61 -30.53 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.021 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.4 -31.69 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.52 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -10.31 44.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.645 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -113.62 176.54 4.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.88 169.55 38.77 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.958 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.14 -7.43 59.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 111.024 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.28 13.43 33.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 0.0 109.81 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.08 146.96 43.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.85 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 123.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.634 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.65 104.33 13.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.674 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -109.91 165.39 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.063 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.1 p -107.46 99.91 9.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 42.4 t -133.62 121.04 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' H ' ' A' ' 74' ' ' THR . 1.9 t30 -121.52 100.08 6.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.944 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.8 162.17 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.838 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -71.53 -40.4 70.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.304 0.573 . . . . 0.0 110.258 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.2 pm0 -64.05 -31.81 73.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.687 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.756 HD22 ' HD3' ' A' ' 92' ' ' PRO . 3.0 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.868 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 tp . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.404 0.621 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.64 135.54 18.05 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.842 2.361 . . . . 0.0 111.619 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.518 HD11 ' CB ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.429 -177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 93.9 m . . . . . 0 CA--C 1.518 -0.25 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 124.62 18.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.152 0.501 . . . . 0.0 110.977 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 56.1 t30 -86.57 131.83 34.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.645 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -111.5 128.24 25.69 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.066 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 72.0 Cg_exo -49.67 123.2 10.13 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.643 2.895 . . . . 0.0 113.129 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 18.4 tt -68.85 -12.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.049 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.4 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -61.96 -46.02 91.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.035 -178.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 HD22 ' A' ' 62' ' ' ASN . 1.1 pt -77.97 -17.62 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 5.2 mp -72.74 -24.57 60.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.394 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -86.02 -56.68 3.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.562 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.8 pt -93.66 -39.43 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.562 ' N ' HG13 ' A' ' 61' ' ' ILE . 34.4 m-20 -94.02 31.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 0.0 110.061 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 pt20 -66.79 -8.1 26.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.08 -6.49 57.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.182 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 71.6 mt -71.57 123.02 88.76 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.739 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 2.7 Cg_exo -77.0 167.62 24.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.906 2.404 . . . . 0.0 112.268 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.909 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.24 -9.92 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.247 0.619 . . . . 0.0 112.179 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.12 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.696 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.438 HD21 ' HG2' ' A' ' 4' ' ' PRO . 1.7 m-80 -111.59 15.48 21.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 110.51 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.909 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 58.7 m-85 -129.55 173.69 10.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.879 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.37 142.97 33.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.061 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 95.93 10.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.638 0.732 . . . . 0.0 110.533 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.68 160.83 40.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.587 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 20.6 m -42.43 120.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 111.712 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.4 124.31 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.869 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -145.35 112.05 5.88 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -171.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' HG12 ' A' ' 93' ' ' ILE . 31.1 p -98.7 136.27 38.99 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 15.2 t -119.5 163.49 17.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.843 -174.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.427 ' HB2' HG22 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -53.9 124.93 16.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -39.25 112.08 0.22 Allowed Glycine 0 C--N 1.336 0.552 0 O-C-N 124.206 0.941 . . . . 0.0 112.772 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.24 102.44 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.167 0.508 . . . . 0.0 110.993 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.37 146.47 48.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.185 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -65.86 126.89 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.0 -13.44 11.35 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 113.51 16.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.75 -14.59 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.245 0.545 . . . . 0.0 110.54 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.54 89.27 3.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.311 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 79' ' ' SER . 3.0 pt -104.06 145.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.1 117.12 30.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.748 0.785 . . . . 0.0 110.199 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.9 m -108.98 139.76 43.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.999 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.47 145.54 32.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.882 0.373 . . . . 0.0 111.353 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.756 ' HD3' HD22 ' A' ' 33' ' ' LEU . 39.2 Cg_endo -69.12 126.84 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.459 2.106 . . . . 0.0 111.7 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.495 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.8 -42.42 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 111.027 -177.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.51 129.66 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.347 178.237 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.56 0.219 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 65' ' ' ILE . 2.3 mp -92.33 112.21 54.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.601 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.33 125.25 3.9 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.695 2.264 . . . . 0.0 111.393 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.31 68.2 46.97 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.55 32.03 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.243 2.628 . . . . 0.0 110.829 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.69 77.85 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 96.98 6.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.936 0.398 . . . . 0.0 111.078 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.62 -143.57 15.08 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.48 130.04 33.85 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.368 2.045 . . . . 0.0 111.486 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -74.82 154.82 38.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 HD12 ' A' ' 67' ' ' ILE . 34.2 m -67.6 -26.0 34.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 0.0 111.467 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -26.32 64.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -41.35 98.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.83 70.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.342 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.04 -30.96 69.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.472 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -56.0 -31.31 62.94 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.924 0.489 . . . . 0.0 111.19 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 0.88 24.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.528 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.538 ' HB2' HG23 ' A' ' 93' ' ' ILE . 1.1 t -141.77 175.91 9.33 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.242 -0.286 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.14 133.51 48.83 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.64 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.84 -18.64 64.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.899 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 31.91 4.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 110.439 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 167.8 12.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.722 HG22 ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -86.76 126.05 40.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.941 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 m -94.7 131.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.585 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.912 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -148.89 167.76 24.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.335 -178.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.583 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -122.49 113.46 19.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.469 ' CA ' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m -130.29 123.12 29.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.211 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 1.4 p30 -88.4 97.05 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.737 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.795 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.7 m -126.81 146.93 50.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.372 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.81 -42.62 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.212 0.53 . . . . 0.0 110.659 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -71.77 -27.72 63.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.795 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 1.2 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.916 0.389 . . . . 0.0 111.042 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 96.0 Cg_endo -94.71 170.47 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.044 2.496 . . . . 0.0 112.895 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.466 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.469 ' HB2' ' CA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 124.3 28.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.053 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.912 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 17.9 t-20 -85.57 120.29 26.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.704 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -90.76 139.78 26.28 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.431 -172.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.704 ' HD2' HG22 ' A' ' 54' ' ' ILE . 9.1 Cg_endo -49.98 123.07 10.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.847 3.031 . . . . 0.0 113.27 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.834 ' HA ' HD23 ' A' ' 59' ' ' LEU . 6.1 tp -72.26 -22.85 21.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.224 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.458 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -58.78 -31.18 68.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -26.74 12.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -176.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.834 HD23 ' HA ' ' A' ' 56' ' ' ILE . 1.4 mm? -60.47 -27.77 67.81 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -168.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -43.83 66.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 112.047 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.0 pt -105.64 -37.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.351 0.596 . . . . 0.0 111.45 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.44 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.35 29.92 0.93 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.397 -175.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -63.65 -20.02 65.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.501 0.667 . . . . 0.0 109.708 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.12 0.56 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.764 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.553 HG13 HG23 ' A' ' 3' ' ' ILE . 1.9 tt -81.37 130.5 61.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.328 0.585 . . . . 0.0 109.86 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -75.19 158.18 41.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.414 2.076 . . . . 0.0 111.674 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.572 HD12 HG12 ' A' ' 12' ' ' VAL . 3.1 tp -59.66 -9.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.413 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -21.01 66.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.634 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.47 HD22 HG12 ' A' ' 65' ' ' ILE . 50.7 m-80 -100.18 27.73 5.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.652 0.739 . . . . 0.0 109.661 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.26 174.45 10.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.95 118.96 37.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.609 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.58 97.86 1.39 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.479 -172.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.46 100.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 109.871 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -58.69 130.44 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.224 -172.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -120.94 119.8 33.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.279 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.0 t -110.86 121.17 44.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.688 ' HB3' HG23 ' A' ' 24' ' ' VAL . 6.2 t -120.67 162.65 19.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.501 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.548 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -60.49 124.8 21.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.722 ' HA2' HG22 ' A' ' 24' ' ' VAL . . . -46.47 113.44 1.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 O-C-N 123.692 0.62 . . . . 0.0 113.013 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 90.12 1.37 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.36 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -138.31 174.59 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.561 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.1 121.87 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.016 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.37 -21.71 9.16 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.703 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 95.51 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 111.331 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -22.5 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.405 176.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.01 107.65 18.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 79' ' ' SER . 9.5 pt -121.43 159.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.394 . . . . 0.0 110.916 -172.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.85 113.32 17.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.767 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.37 134.27 50.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.767 179.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 157.27 77.07 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.839 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.7 Cg_exo -61.6 126.89 20.17 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.829 2.352 . . . . 0.0 112.341 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.582 HG13 ' HB ' ' A' ' 75' ' ' VAL . 1.3 mt -76.92 -36.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.031 0.443 . . . . 0.0 111.814 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.32 116.19 17.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.034 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.515 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 65' ' ' ILE . 12.9 mt -87.0 109.1 21.95 Favored Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.165 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -89.0 136.81 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.79 89.47 2.63 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.28 -53.29 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.627 2.218 . . . . 0.0 111.9 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.83 49.46 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.326 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -84.04 -47.17 11.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 10' ' ' PRO . . . 125.99 -101.01 0.6 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.021 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 9' ' ' GLY . 50.1 Cg_exo -52.93 148.08 30.78 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.322 2.681 . . . . 0.0 113.297 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.49 167.15 10.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -66.36 -27.34 40.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 110.732 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -26.61 64.89 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.979 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -48.19 80.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.164 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.22 -41.75 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.221 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' A' ' 25' ' ' VAL . 30.9 tt0 -61.4 -31.24 71.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -56.51 -31.2 63.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.06 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -80.93 -4.34 54.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.028 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -127.7 175.39 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.158 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.59 153.44 40.66 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.363 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.09 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.12 27.64 8.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 0.0 111.045 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.9 153.07 29.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.774 HG21 HD21 ' A' ' 53' ' ' ASN . 7.6 p -95.36 122.84 47.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.195 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.513 HG21 ' HG3' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -92.04 103.8 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.453 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.93 148.96 35.94 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.369 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.727 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 29.8 p -102.96 101.55 11.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -157.34 109.97 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.508 -176.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.72 147.97 22.77 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.44 155.06 45.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.803 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.84 -48.0 82.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.233 0.54 . . . . 0.0 110.566 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -70.37 -23.79 62.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.871 0.367 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 9.3 Cg_exo -73.25 156.29 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.986 2.457 . . . . 0.0 111.579 175.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.619 HD13 HD22 ' A' ' 53' ' ' ASN . 2.7 mp . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.973 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.727 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 12.8 p . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.11 154.46 12.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.55 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.774 HD21 HG21 ' A' ' 24' ' ' VAL . 17.0 t-20 -77.5 114.88 16.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.321 172.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.836 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -83.63 141.21 41.52 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.532 -176.107 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HB2' HD22 ' A' ' 57' ' ' ASN . 23.4 Cg_endo -62.14 119.95 7.3 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.768 2.312 . . . . 0.0 113.173 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -78.75 -12.55 13.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.362 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.497 HD22 ' HB2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -56.45 -45.88 80.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.193 -178.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -33.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.97 -23.24 31.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -54.38 15.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.77 0.319 . . . . 0.0 111.455 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -92.33 -35.94 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 0.0 110.736 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -91.12 35.99 0.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.779 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -66.88 -13.42 61.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.202 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.84 18.25 6.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.359 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 10.7 tt -91.94 135.85 26.84 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.731 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 7.3 Cg_exo -75.85 163.72 33.0 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.879 2.386 . . . . 0.0 112.309 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 4.4 tp -65.19 -8.71 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.564 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -56.88 -24.23 50.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.489 HD21 ' HG2' ' A' ' 4' ' ' PRO . 2.6 m-80 -94.8 12.3 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.836 ' HD1' HG21 ' A' ' 54' ' ' ILE . 86.9 m-85 -127.04 174.16 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.004 -174.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.38 138.8 40.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.225 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.47 99.42 7.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.205 0.526 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 0.7 OUTLIER -153.98 158.88 41.29 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 m -50.85 113.5 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.969 0.414 . . . . 0.0 110.419 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -61.95 125.58 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.354 -176.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -127.4 112.96 15.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.577 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.573 ' HB2' HG12 ' A' ' 93' ' ' ILE . 35.9 t -98.11 119.45 36.77 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.932 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 2.4 m -115.07 163.83 15.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.321 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.33 119.16 3.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -34.1 107.05 0.03 OUTLIER Glycine 0 C--N 1.337 0.635 0 O-C-N 124.442 1.089 . . . . 0.0 113.91 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 109.02 2.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.307 0.575 . . . . 0.0 110.598 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 156.05 33.76 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.586 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 pt -58.33 112.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 123.476 0.485 . . . . 0.0 110.605 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.01 -12.43 11.52 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.034 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 103.26 15.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.069 0.462 . . . . 0.0 110.488 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.14 -50.51 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.329 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.43 129.86 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 pt -146.56 170.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.11 131.65 55.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.023 0.44 . . . . 0.0 110.648 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.408 ' SG ' HG13 ' A' ' 44' ' ' ILE . 12.0 m -110.01 127.25 54.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.05 135.21 21.0 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.623 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.96 127.78 23.4 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.899 2.399 . . . . 0.0 112.038 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.28 -61.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.893 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 100.34 13.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.052 0.453 . . . . 0.0 110.651 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.033 176.232 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mt -100.76 109.58 58.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 8.9 Cg_endo -90.42 126.09 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.861 3.041 . . . . 0.0 111.818 175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -140.34 61.64 17.39 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.453 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 17.0 Cg_exo -68.04 -53.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.428 2.085 . . . . 0.0 110.325 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.47 78.75 0.28 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.33 2.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.532 . . . . 0.0 110.9 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.04 -155.08 7.89 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.081 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.08 124.6 16.67 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.47 2.113 . . . . 0.0 111.854 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -83.35 156.11 23.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.208 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.5 p -61.31 -27.81 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.109 0.481 . . . . 0.0 110.788 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 63' ' ' GLN . 36.6 m -56.04 -38.92 71.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.9 tpp -64.45 -47.24 79.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.911 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.25 74.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.884 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -31.97 64.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.173 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -77.22 -4.8 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.492 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 175.05 8.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.03 134.94 43.3 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.38 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -23.74 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.945 0.402 . . . . 0.0 111.054 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 37.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.703 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -125.4 158.66 33.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.296 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.06 125.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 110.25 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.2 114.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.573 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 144.15 50.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.79 101.99 12.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.514 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.815 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 1.8 t -142.4 112.89 7.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.181 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.931 ' HB2' ' H ' ' A' ' 74' ' ' THR . 26.9 t30 -106.07 94.2 5.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.48 150.93 23.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.904 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -36.62 79.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.276 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.517 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -61.83 -31.45 71.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.798 178.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 42' ' ' ILE . 4.9 mp . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.552 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.53 152.76 20.3 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 123.346 2.697 . . . . 0.0 112.195 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.982 -178.781 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.815 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.38 147.18 25.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 112.155 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -83.55 110.2 18.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.625 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.734 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -87.67 143.18 33.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.279 -176.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 32.1 Cg_exo -59.19 120.75 8.79 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.86 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -23.56 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -34.95 70.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.22 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.39 -31.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.202 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -33.34 68.55 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -170.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -26.28 68.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.567 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.6 pt -121.15 -40.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.452 0.644 . . . . 0.0 110.749 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.567 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -89.48 35.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.507 -176.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -70.73 -8.47 52.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 179.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -5.05 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.144 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.507 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 5.4 mt -70.68 128.65 90.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.385 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.1 Cg_exo -81.08 164.72 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.288 2.659 . . . . 0.0 111.602 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.795 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -60.01 -13.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -13.65 59.17 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 111.4 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.56 12.64 36.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.384 0.611 . . . . 0.0 109.885 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.795 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 66.3 m-85 -130.99 177.55 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.35 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.11 145.02 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.074 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.23 96.72 7.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.0 110.125 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -156.2 159.47 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.26 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.931 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 65.2 m -51.9 107.96 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.13 0.49 . . . . 0.0 110.27 175.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.49 124.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.205 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 58.8 m -127.31 133.89 50.07 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.936 -175.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.642 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -110.2 123.3 49.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -120.45 162.05 20.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.273 -173.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.51 126.68 20.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.502 0.192 . . . . 0.0 110.56 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.79 106.04 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.508 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.59 138.46 43.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.553 -0.324 . . . . 0.0 111.096 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.62 171.5 18.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.406 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 83' ' ' ILE . 2.4 pt -62.94 123.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.72 -27.7 7.78 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.693 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.23 147.13 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.142 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -117.14 -66.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.344 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.77 127.12 56.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -113.68 152.26 15.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.74 118.72 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.03 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 9.5 t -116.43 138.64 51.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.583 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -143.1 141.23 19.04 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.312 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 25.9 Cg_exo -62.74 130.79 30.73 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.642 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -84.49 -43.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.678 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.06 120.41 37.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.726 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.858 -1.068 . . . . 0.0 109.264 176.796 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -80.8 111.22 21.56 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.742 0.306 . . . . 0.0 110.728 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.731 ' HG2' HD21 ' A' ' 69' ' ' ASN . 1.1 Cg_endo -87.95 128.74 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.219 2.612 . . . . 0.0 112.05 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.34 91.12 4.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.77 -53.63 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.25 47.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.311 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -83.12 -59.02 2.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.12 -89.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.242 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.92 137.1 77.9 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.23 2.62 . . . . 0.0 113.331 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.801 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -93.73 157.63 16.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.514 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.35 -27.27 23.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -37.14 85.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.021 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -42.73 86.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -49.67 38.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.21 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' A' ' 25' ' ' VAL . 3.3 tt0 -63.43 -28.83 70.25 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.745 -176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -30.25 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.942 0.401 . . . . 0.0 111.232 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -7.44 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.88 174.76 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.33 166.71 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.804 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.14 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.452 . . . . 0.0 110.967 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.92 37.46 1.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.42 0.629 . . . . 0.0 109.906 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.68 155.95 31.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.991 177.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.57 132.4 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.751 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 54' ' ' ILE . 89.1 t -86.17 137.49 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -148.32 150.76 34.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.917 0.389 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -115.53 108.86 16.99 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.9 t -151.38 103.57 3.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -85.28 93.22 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 110.025 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 147.46 25.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -70.57 -38.87 74.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.295 0.569 . . . . 0.0 109.841 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.04 -37.98 87.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' HG3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.886 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HA ' HG13 ' A' ' 88' ' ' ILE . 86.5 Cg_endo -84.82 156.72 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.059 2.506 . . . . 0.0 112.585 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mm . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.416 . . . . 0.0 110.895 -178.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.94 139.35 14.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.69 175.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.18 114.69 22.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.514 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.15 134.09 56.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.796 -170.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.534 ' HB3' HD21 ' A' ' 57' ' ' ASN . 41.8 Cg_exo -58.07 122.56 11.91 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.394 2.729 . . . . 0.0 113.587 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 56' ' ' ILE . 4.7 mm -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.559 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.534 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -53.35 -34.74 58.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.39 -174.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pt -79.81 -40.3 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.417 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -22.81 57.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -58.26 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.558 HG13 ' N ' ' A' ' 62' ' ' ASN . 12.7 pt -91.09 -35.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.558 ' N ' HG13 ' A' ' 61' ' ' ILE . 7.4 m-20 -92.22 37.24 0.99 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.509 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -8.12 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.488 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HB2' HG12 ' A' ' 3' ' ' ILE . 1.4 mt -79.02 -9.49 59.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.563 ' HA ' HG23 ' A' ' 3' ' ' ILE . 54.3 mt -69.49 124.96 91.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.63 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.801 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -77.91 174.77 12.05 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.25 -8.64 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.439 ' ND2' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -60.39 -21.91 62.72 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.731 HD21 ' HG2' ' A' ' 4' ' ' PRO . 5.9 m-80 -102.12 24.54 9.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.427 0.632 . . . . 0.0 110.003 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -142.94 172.76 12.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.62 139.11 40.72 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.076 0.465 . . . . 0.0 111.368 -171.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.91 98.39 6.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.653 0.74 . . . . 0.0 109.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.19 162.16 41.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.208 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -52.72 98.86 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -54.4 129.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.54 -171.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.0 140.29 51.19 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.387 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.66 ' HB2' HG12 ' A' ' 93' ' ' ILE . 48.2 t -135.55 122.98 21.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -122.86 164.34 18.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.612 -172.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.91 128.48 18.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.389 0.431 . . . . 0.0 110.548 174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.67 118.15 1.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.827 0.705 . . . . 0.0 113.641 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 93.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.458 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.38 160.39 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.61 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.466 ' H ' HG12 ' A' ' 83' ' ' ILE . 1.9 mm -62.12 113.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.69 -37.52 2.05 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.847 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.76 98.56 10.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.886 0.374 . . . . 0.0 110.182 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.52 -38.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.227 0.536 . . . . 0.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -118.61 114.59 23.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.508 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.603 HG13 ' HA ' ' A' ' 43' ' ' PRO . 21.0 pt -107.21 150.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.175 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -99.8 118.7 36.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 t -108.0 130.74 55.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.229 0.538 . . . . 0.0 110.346 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 m -131.51 136.23 28.24 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.26 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.624 ' HG3' HD21 ' A' ' 33' ' ' LEU . 68.7 Cg_exo -53.39 127.53 25.62 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.686 2.257 . . . . 0.0 112.376 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.66 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -79.57 -23.08 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.352 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.92 139.92 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.02 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.125 0 O-C-N 123.988 0.805 . . . . 0.0 110.842 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.623 0.249 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -90.64 111.09 45.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.9 Cg_endo -89.18 128.79 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.317 2.678 . . . . 0.0 111.984 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.402 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -129.09 66.83 77.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.59 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 9.1 Cg_exo -73.27 -41.56 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.289 1.993 . . . . 0.0 110.547 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.92 110.97 2.3 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.328 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.33 113.61 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.74 0.305 . . . . 0.0 110.794 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.37 -166.35 13.78 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.29 153.05 17.95 Favored 'Trans proline' 0 N--CA 1.471 0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.236 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.66 155.67 17.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.748 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 3.6 p -62.04 -26.27 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.608 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -69.32 -26.72 64.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.962 -177.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ttt -65.32 -43.35 91.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.051 0.453 . . . . 0.0 110.123 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.73 69.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.032 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -56.36 -31.04 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.603 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.27 3.3 36.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.559 ' SG ' HG23 ' A' ' 93' ' ' ILE . 1.5 m -135.48 174.51 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.62 0.248 . . . . 0.0 110.536 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.92 151.62 33.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.284 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.62 59.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 22' ' ' GLU . 1.7 pm0 -90.5 0.83 57.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.934 174.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -105.76 160.24 15.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.639 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 p -101.73 146.69 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.745 0.307 . . . . 0.0 110.75 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.23 129.06 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.866 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -138.29 150.99 47.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.5 115.85 26.55 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 2.9 m -132.8 146.79 52.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.168 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -111.41 93.48 4.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.983 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.02 145.92 27.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.578 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.87 61.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -61.48 -20.96 63.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.738 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.563 178.152 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 90' ' ' CYS . 2.8 mp . . . . . 0 N--CA 1.458 -0.053 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.95 120.02 6.39 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.567 2.178 . . . . 0.0 112.385 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.317 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 1.9 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.07 137.46 31.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.168 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 4.8 t-20 -79.33 97.43 6.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.367 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.525 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -60.73 125.07 82.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HB3' HD21 ' A' ' 57' ' ' ASN . 51.9 Cg_exo -54.71 120.74 8.6 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.452 2.101 . . . . 0.0 112.047 -176.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -76.08 -14.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 -174.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.487 HD21 ' HB3' ' A' ' 55' ' ' PRO . 1.1 p30 -68.85 -31.48 70.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.293 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -78.83 -45.5 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.224 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -68.97 -13.83 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -166.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -32.09 71.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.035 0.445 . . . . 0.0 110.929 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.3 pt -118.99 -39.03 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.959 175.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -82.36 34.06 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.674 -177.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.2 pt20 -70.34 -8.27 49.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.628 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.48 -5.94 59.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.721 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HA ' HG23 ' A' ' 3' ' ' ILE . 60.3 mt -73.4 122.7 88.26 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.2 Cg_exo -65.85 157.49 58.78 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.849 2.366 . . . . 0.0 112.193 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.771 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 3.3 tp -61.0 -9.4 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.138 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.492 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -55.84 -24.9 39.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.141 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.416 HD21 ' HG2' ' A' ' 4' ' ' PRO . 37.2 m-20 -100.22 9.36 42.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.254 0.55 . . . . 0.0 110.674 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.771 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 64.5 m-85 -127.21 175.0 8.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.439 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 122.69 44.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 96.42 9.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.651 0.739 . . . . 0.0 109.806 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -156.11 164.17 38.74 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.11 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.181 0.925 . . . . 0.0 112.013 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -64.76 136.85 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.726 -177.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.8 m -141.12 113.17 7.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.855 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -100.83 142.98 31.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.209 0.528 . . . . 0.0 110.051 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 6.8 m -126.57 164.08 22.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.24 132.18 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -46.92 110.1 0.49 Allowed Glycine 0 C--N 1.333 0.391 0 O-C-N 123.597 0.561 . . . . 0.0 113.098 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.34 100.47 4.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -113.86 154.4 27.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.576 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -55.92 113.06 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.37 0.605 . . . . 0.0 110.742 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.91 -18.89 3.76 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.675 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -101.39 149.35 24.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.99 -42.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.2 0.524 . . . . 0.0 110.432 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -120.62 134.73 55.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.73 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.9 pt -133.49 148.99 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.42 37.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.071 0.462 . . . . 0.0 110.322 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.435 ' HB2' HG21 ' A' ' 42' ' ' ILE . 77.3 m -110.61 144.57 39.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.31 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 142.36 30.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.496 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.15 129.2 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.674 2.249 . . . . 0.0 111.546 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.559 HG23 ' SG ' ' A' ' 19' ' ' CYS . 3.0 mt -76.31 -62.0 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.837 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 tp -106.54 138.33 42.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.279 -174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.349 179.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.679 HG23 HG12 ' A' ' 65' ' ' ILE . 9.9 mt -88.92 111.46 44.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 1.8 Cg_endo -82.51 147.36 14.01 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.113 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.86 76.92 77.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.599 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -96.87 10.94 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 113.758 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.28 -32.51 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.623 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.5 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.186 0.993 . . . . 0.0 112.995 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.12 -141.72 4.09 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.21 160.86 28.88 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.198 1.932 . . . . 0.0 110.985 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -115.97 155.14 28.57 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -25.19 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 0.0 111.244 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.36 -28.32 69.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.797 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -67.74 -45.06 76.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.327 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.66 73.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.673 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.026 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.21 -31.64 71.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.087 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 14.73 29.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.504 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.41 174.32 7.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.82 154.0 33.5 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.79 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.55 65.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.54 36.46 2.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.472 0.654 . . . . 0.0 110.347 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 145.99 50.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.844 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.841 ' HA ' HD13 ' A' ' 56' ' ' ILE . 5.9 p -99.53 129.11 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.941 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.8 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.744 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.459 ' HA ' HG12 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -139.07 162.04 35.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.501 -178.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 110.87 15.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 2.8 m -140.18 135.19 32.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -120.59 93.09 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.862 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.39 148.71 29.73 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.521 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -65.21 -35.39 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.2 pm0 -68.81 -31.47 70.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.453 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.417 179.373 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.27 171.24 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.68 2.253 . . . . 0.0 112.138 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.711 HD11 HD11 ' A' ' 88' ' ' ILE . 1.6 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.185 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 36.1 t . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.6 0.238 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 123.99 15.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.003 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' HB2' HG21 ' A' ' 44' ' ' ILE . 6.6 t-20 -75.92 131.58 39.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 173.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.96 130.31 23.07 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HB3' HD21 ' A' ' 57' ' ' ASN . 51.0 Cg_exo -51.33 121.7 8.85 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.357 2.705 . . . . 0.0 113.181 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 24' ' ' VAL . 3.2 tp -79.66 -12.19 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.936 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.476 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -60.57 -51.55 68.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -31.28 53.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.761 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -60.79 -14.8 23.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 m -70.09 -31.98 69.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.5 pt -131.06 -32.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.201 0.524 . . . . 0.0 111.392 -178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -87.62 29.63 0.88 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.557 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -69.82 -14.74 62.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.097 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mt -78.05 -5.4 51.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.683 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.679 HG12 HG23 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -69.8 126.53 92.56 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.68 ' HB2' HD22 ' A' ' 68' ' ' ASN . 6.3 Cg_exo -73.6 157.91 48.06 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.822 2.348 . . . . 0.0 111.871 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.753 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 1.5 tp -62.1 -9.6 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.81 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.68 HD22 ' HB2' ' A' ' 66' ' ' PRO . 2.8 p30 -59.37 -23.63 62.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.803 175.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.87 8.72 21.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.753 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 62.4 m-85 -139.53 174.21 10.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.527 -172.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.25 121.87 44.75 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.367 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.57 98.54 0.69 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.42 0.628 . . . . 0.0 109.764 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.77 162.44 41.11 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 106.61 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 O-C-N 123.673 0.608 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.439 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.9 OUTLIER -60.35 135.95 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.038 -172.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 1.4 m -138.3 161.81 35.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' A' ' 93' ' ' ILE . 12.3 p -158.96 122.47 3.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.396 0.617 . . . . 0.0 110.124 173.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -97.95 163.5 12.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.76 -175.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.37 136.72 24.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.59 104.57 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 123.714 0.634 . . . . 0.0 113.768 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.12 105.8 2.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -105.21 170.98 7.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.178 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.55 113.13 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.564 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.99 -12.25 57.49 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.258 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.604 ' HG ' HG23 ' A' ' 88' ' ' ILE . 2.8 tp -82.04 75.56 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 109.957 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.63 -19.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.241 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.04 109.72 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.596 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.711 HD11 HD11 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -142.96 157.49 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.546 177.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -95.5 134.62 38.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.816 0.341 . . . . 0.0 110.413 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 2.9 t -108.21 128.75 54.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.302 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p -123.84 145.26 47.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.672 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.718 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 24.6 Cg_exo -63.64 151.65 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.281 1.987 . . . . 0.0 111.45 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.478 HG12 ' SG ' ' A' ' 77' ' ' CYS . 3.4 mt -83.15 -83.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.844 0.354 . . . . 0.0 110.41 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.424 ' H ' ' HB ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -96.51 105.09 17.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.404 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 65' ' ' ILE . 4.0 mt -82.86 111.19 27.82 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HG2' HD21 ' A' ' 69' ' ' ASN . 5.4 Cg_endo -88.48 126.51 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.88 72.48 47.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.938 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.32 -56.25 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.855 2.37 . . . . 0.0 112.278 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.57 -18.28 60.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.046 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 60.97 2.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 111.175 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.27 -175.42 31.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.9 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.24 137.15 63.64 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.073 2.516 . . . . 0.0 112.668 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.872 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -86.88 166.69 14.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.143 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.89 -26.78 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.719 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -53.33 -32.85 51.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.174 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpt -65.48 -49.23 69.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 0.0 110.078 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.45 60.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.8 -29.58 70.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.895 -173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.17 -30.94 69.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 111.198 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -77.09 7.44 4.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.606 -176.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 174.65 10.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.02 168.01 36.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.329 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.17 -4.83 46.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.451 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -95.42 5.29 52.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 110.194 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 3.6 mptt -113.95 166.55 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.612 HG23 HG23 ' A' ' 56' ' ' ILE . 13.9 p -121.84 141.78 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.39 137.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.365 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.499 ' HA ' HG12 ' A' ' 54' ' ' ILE . 40.0 m -155.3 159.74 40.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.2 m -101.73 120.66 40.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.9 t -144.87 101.05 3.59 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.901 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -84.52 92.77 8.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.523 0.678 . . . . 0.0 109.52 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p -124.36 148.81 47.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.982 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -31.54 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 173.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -60.29 -47.47 85.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.648 -1.614 . . . . 0.0 111.018 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HB2' ' OG ' ' A' ' 30' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.991 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 121.053 0.454 . . . . 0.0 110.527 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 3.5 Cg_endo -85.93 135.56 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.179 2.586 . . . . 0.0 112.203 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.636 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.7 m . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.366 0.603 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.7 139.69 32.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.757 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -97.68 133.91 41.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -109.52 125.01 32.27 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.493 -174.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HB3' ' ND2' ' A' ' 57' ' ' ASN . 52.4 Cg_exo -56.88 122.73 12.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.464 2.776 . . . . 0.0 113.702 -173.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.612 HG23 HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -75.15 -16.91 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.745 -177.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -53.82 -43.15 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.23 -173.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -78.32 -36.24 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.469 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 2.7 mp -54.56 -33.32 59.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.868 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -32.5 34.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.84 -20.51 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.235 0.54 . . . . 0.0 110.971 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -99.09 28.1 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.286 -177.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -68.27 -13.83 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.371 0.605 . . . . 0.0 110.67 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.96 -8.04 55.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.553 HG13 HG23 ' A' ' 3' ' ' ILE . 1.5 tt -67.99 133.58 91.92 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 110.652 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.872 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 3.7 Cg_exo -79.57 163.42 24.19 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.937 2.425 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tp -63.02 -9.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -25.38 67.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.26 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.443 HD21 ' HG2' ' A' ' 4' ' ' PRO . 1.5 m-80 -98.31 28.04 4.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.541 0.686 . . . . 0.0 109.623 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.469 ' HZ ' HD11 ' A' ' 59' ' ' LEU . 14.9 m-85 -144.3 173.01 12.14 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.01 127.85 51.58 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.576 -172.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.3 98.78 1.81 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -154.55 161.4 41.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.218 -170.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.59 103.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.15 0.5 . . . . 0.0 109.94 172.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -54.6 115.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.695 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -113.97 135.92 53.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.326 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 5.3 t -122.99 120.68 34.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 3.2 t -118.03 163.21 16.94 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.23 138.39 50.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.6 104.91 0.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.458 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.714 ' HG2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.89 134.33 54.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.367 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.16 154.58 37.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.937 -176.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.514 ' H ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.75 112.03 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 110.413 -178.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.86 -19.34 5.54 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.45 -37.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.797 0.332 . . . . 0.0 111.516 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 140.51 50.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.714 HD13 ' HG2' ' A' ' 81' ' ' GLU . 2.0 pt -137.99 157.29 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.79 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -98.81 121.38 40.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.676 178.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 m -114.4 132.54 56.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.318 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.99 151.05 77.26 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.584 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 Cg_exo -61.3 127.03 20.79 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.653 2.235 . . . . 0.0 111.595 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.637 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -84.22 -41.73 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.94 104.04 13.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.692 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.369 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.794 0.33 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.484 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -71.13 115.95 41.81 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.84 126.7 4.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.085 2.523 . . . . 0.0 112.037 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 73.87 23.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 37.8 Cg_endo -69.41 -25.64 30.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.164 1.91 . . . . 0.0 110.99 171.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.17 77.18 0.38 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.576 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -72.48 127.51 32.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.246 0.546 . . . . 0.0 111.83 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 10' ' ' PRO . . . -153.57 -126.78 1.14 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 9' ' ' GLY . 19.2 Cg_endo -62.44 133.84 45.05 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.662 2.241 . . . . 0.0 112.21 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -81.22 154.79 26.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.235 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.607 HG12 HD12 ' A' ' 67' ' ' ILE . 35.8 m -67.72 -24.87 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.912 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -30.27 71.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.943 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -40.3 90.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.204 0.526 . . . . 0.0 110.13 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.15 73.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.427 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -61.01 -29.24 69.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -31.68 71.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.031 0.443 . . . . 0.0 110.997 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.76 9.61 21.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.59 -176.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' HB2' HG23 ' A' ' 93' ' ' ILE . 5.4 t -133.84 174.39 10.51 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.16 156.02 39.09 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.193 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.42 87.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.54 38.65 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.393 0.616 . . . . 0.0 110.114 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 7.1 mttt -125.47 144.45 50.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.79 129.04 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.993 0.425 . . . . 0.0 110.362 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.478 HG12 ' HE2' ' A' ' 70' ' ' PHE . 16.1 t -85.57 106.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.64 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -120.21 171.49 8.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -130.78 108.85 10.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.073 0.463 . . . . 0.0 110.482 170.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 48.6 m -137.53 144.26 42.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.45 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -105.68 99.92 9.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.804 0.335 . . . . 0.0 111.527 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.79 141.62 28.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -23.28 57.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.841 0.829 . . . . 0.0 109.613 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -84.07 -18.42 37.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.027 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 179.323 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.56 0.219 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.24 -177.02 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.038 2.492 . . . . 0.0 112.606 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.356 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 42.2 t . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 120.597 0.237 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.74 116.12 5.78 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.64 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.9 t30 -84.6 94.37 8.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -68.11 136.29 91.67 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.267 -172.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.439 ' O ' HD12 ' A' ' 59' ' ' LEU . 28.1 Cg_exo -61.84 123.45 12.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.171 2.581 . . . . 0.0 112.744 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.488 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -72.74 -12.68 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.433 -175.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -40.12 88.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.5 -175.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.458 ' H ' HG13 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -79.84 -32.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.892 0.377 . . . . 0.0 110.576 175.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -65.58 -17.94 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 -173.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -60.83 2.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.448 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.53 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -96.22 -37.19 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.044 0.449 . . . . 0.0 111.576 -177.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.53 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.97 36.03 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.436 0.636 . . . . 0.0 109.907 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.67 -8.0 53.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.977 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 64' ' ' LEU . 3.7 mm? -76.47 -7.98 56.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.953 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.484 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -62.84 137.16 96.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.969 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.2 Cg_exo -79.07 159.48 26.95 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.047 2.498 . . . . 0.0 111.679 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.607 HD12 HG12 ' A' ' 12' ' ' VAL . 2.6 tp -61.2 -9.25 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.562 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -58.74 -28.99 66.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.07 27.55 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.459 0.647 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HE2' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -142.41 174.93 10.18 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -172.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.17 127.68 49.0 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.666 -173.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.93 94.68 3.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -156.44 161.69 40.06 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.7 98.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.411 0.444 . . . . 0.0 109.87 171.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.508 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -57.53 128.08 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -173.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.26 105.95 4.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.226 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 27.4 p -104.96 129.56 53.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.553 0.692 . . . . 0.0 110.851 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 11.8 m -105.27 164.09 12.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.076 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.53 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -54.99 139.3 41.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 173.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -50.41 114.59 2.68 Favored Glycine 0 C--N 1.331 0.252 0 O-C-N 123.309 0.381 . . . . 0.0 112.683 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 143.19 33.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.041 0.448 . . . . 0.0 110.675 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.59 174.87 14.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.33 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.68 119.28 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.799 0.333 . . . . 0.0 110.179 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.01 4.06 31.44 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.168 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 HG23 ' A' ' 88' ' ' ILE . 2.4 mt -112.0 112.83 24.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.8 -27.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.61 135.7 16.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.338 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.76 174.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.93 -177.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.91 128.05 48.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 98.6 m -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.491 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.6 t -150.07 143.57 16.75 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.339 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.0 Cg_endo -57.41 136.64 77.27 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.64 2.227 . . . . 0.0 111.677 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.51 HG22 ' HB3' ' A' ' 18' ' ' LYS . 1.2 mt -88.39 -73.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.61 72.25 1.76 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.016 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.056 178.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.675 HG23 HG12 ' A' ' 65' ' ' ILE . 7.2 mt -80.25 109.92 14.46 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 4.2 Cg_endo -89.82 124.93 1.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.344 2.696 . . . . 0.0 112.261 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.559 ' HB1' ' HG3' ' A' ' 8' ' ' GLU . . . -141.47 67.66 25.09 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.757 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.78 -28.72 7.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.776 1.651 . . . . 0.0 111.842 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.83 -44.21 2.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.618 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.559 ' HG3' ' HB1' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 57.38 50.53 11.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.385 177.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.78 -128.64 6.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.807 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.42 143.49 69.88 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -90.11 154.16 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 0.0 111.087 -178.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.06 -27.76 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.448 0.642 . . . . 0.0 110.028 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -67.06 -26.32 66.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.941 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 ttm -64.11 -47.27 80.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.97 -36.99 72.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 20.9 tt0 -64.0 -29.58 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.139 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -31.29 64.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 111.404 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -76.8 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 -177.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 175.03 7.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.85 -165.05 22.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.497 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.51 -7.07 48.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 0.0 110.942 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.83 9.64 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.274 0.559 . . . . 0.0 110.116 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -126.98 153.68 45.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.692 HG11 ' HG2' ' A' ' 81' ' ' GLU . 6.6 p -108.53 131.17 59.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.058 0.456 . . . . 0.0 110.586 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 t -83.89 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.615 ' HA ' HG12 ' A' ' 54' ' ' ILE . 8.0 t -154.74 170.31 21.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.691 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.502 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -122.52 99.97 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 172.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.688 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 16.1 m -131.56 109.82 10.52 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 3.0 p30 -88.68 134.58 33.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 0.0 110.957 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 38.4 m -158.52 155.43 28.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.763 176.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -70.56 -38.23 74.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 109.888 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -20.44 64.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.465 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.04 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.604 HG13 ' HD2' ' A' ' 43' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--O 1.239 0.507 0 CA-C-O 120.817 0.341 . . . . 0.0 110.158 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.604 ' HD2' HG13 ' A' ' 42' ' ' ILE . 92.1 Cg_endo -88.72 -175.89 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.71 2.273 . . . . 0.0 112.366 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 90' ' ' CYS . 4.3 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.688 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.13 140.61 5.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.04 145.83 55.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.627 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.81 126.46 30.21 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.1 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 75.1 Cg_exo -51.01 122.47 10.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.393 2.729 . . . . 0.0 113.544 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -76.01 -12.82 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.491 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.541 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -64.21 -34.52 78.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.355 -175.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.33 -38.5 20.01 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.224 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -15.6 46.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -28.61 48.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.82 0.343 . . . . 0.0 111.856 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.53 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.4 pt -129.26 -41.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.206 0.527 . . . . 0.0 111.19 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.53 ' N ' HG13 ' A' ' 61' ' ' ILE . 5.6 m-80 -83.23 36.62 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.722 0.809 . . . . 0.0 110.194 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 24.5 pt20 -72.46 -7.4 49.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.253 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -1.45 45.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.656 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 3' ' ' ILE . 59.3 mt -80.23 120.26 79.01 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.349 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 23.5 Cg_exo -64.85 164.38 24.68 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 112.284 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.5 tp -62.49 -8.89 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.515 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -65.24 -7.46 13.16 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.462 ' N ' HD22 ' A' ' 68' ' ' ASN . 74.1 m-80 -116.4 29.91 7.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.491 0.662 . . . . 0.0 110.107 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -143.82 173.14 11.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 121.49 43.92 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.933 0.397 . . . . 0.0 111.64 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -72.25 98.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.619 0.724 . . . . 0.0 109.158 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.49 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.49 161.94 40.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.17 104.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 0.0 110.273 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -59.65 127.05 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.614 -172.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.61 152.89 43.0 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.092 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.581 ' HB2' HG12 ' A' ' 93' ' ' ILE . 19.2 t -144.58 119.04 9.65 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -113.52 164.1 14.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.695 -172.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.19 127.25 18.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 175.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -36.42 108.86 0.06 OUTLIER Glycine 0 C--N 1.34 0.781 0 O-C-N 124.081 0.863 . . . . 0.0 112.763 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.692 ' HG2' HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -82.84 129.23 34.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.17 -0.515 . . . . 0.0 110.883 -173.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 140.93 34.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.737 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -56.2 119.98 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 123.655 0.597 . . . . 0.0 111.053 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.84 -26.75 4.22 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.464 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.37 136.3 33.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.876 0.369 . . . . 0.0 110.305 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 t -74.81 -47.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -143.87 151.58 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.882 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -142.25 145.66 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.7 131.53 43.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.984 0.421 . . . . 0.0 110.69 -175.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 t -109.72 145.16 37.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.873 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.61 152.29 52.51 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 31.6 Cg_endo -64.09 140.44 71.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.645 2.23 . . . . 0.0 112.748 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.581 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -95.71 -62.68 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.913 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 100.94 13.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.521 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.138 178.352 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.863 HG23 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -77.91 111.94 21.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.725 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.1 Cg_endo -89.2 128.68 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.524 2.816 . . . . 0.0 112.381 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.65 68.08 16.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.77 -39.83 8.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.224 1.949 . . . . 0.0 112.116 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.01 -21.23 59.51 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.868 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 49.49 69.42 0.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.29 0.567 . . . . 0.0 111.51 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.76 -173.4 14.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.205 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.46 142.73 37.67 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.345 2.696 . . . . 0.0 112.335 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -87.6 157.28 19.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.832 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.71 -25.82 38.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.006 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 16' ' ' GLN . 40.2 m -60.45 -28.84 68.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.174 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -48.12 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.9 73.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.771 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 23.4 tt0 -62.86 -31.48 72.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.328 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -32.75 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 0.0 111.277 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -88.89 16.49 6.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.141 -177.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.19 175.02 10.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.898 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.67 167.43 22.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.09 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.19 -16.11 61.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.381 0.61 . . . . 0.0 110.157 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -89.76 19.37 4.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.459 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 79' ' ' SER . 1.8 mptt -132.6 156.0 47.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.597 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -105.1 123.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.197 0.522 . . . . 0.0 110.398 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.85 103.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.911 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -116.5 172.69 7.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 -177.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 p -126.74 128.4 46.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.921 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 34.0 t -157.32 141.38 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.379 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -98.65 94.02 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.93 0.871 . . . . 0.0 110.455 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.489 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -116.47 146.8 42.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.049 178.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -72.17 -26.03 61.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 0.0 110.269 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.42 -44.01 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.355 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.489 HD12 ' H ' ' A' ' 30' ' ' SER . 4.4 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.717 HG12 ' HB3' ' A' ' 90' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.285 0.564 . . . . 0.0 111.641 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 13.0 Cg_endo -91.21 -168.56 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.683 2.922 . . . . 0.0 111.415 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 26' ' ' SER . 5.3 tp . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.329 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 19.4 m . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -152.55 128.51 10.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -75.73 123.21 25.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.175 170.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.579 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -88.52 133.21 36.78 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.327 -175.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.662 ' HB3' HD21 ' A' ' 57' ' ' ASN . 51.3 Cg_exo -53.86 127.56 26.09 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.506 2.804 . . . . 0.0 112.951 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.41 -12.53 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.921 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.662 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -59.24 -40.68 86.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.832 -176.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.13 -25.21 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.612 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.17 -18.91 64.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -30.48 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.11 -38.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -83.25 28.19 0.54 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.36 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -8.63 55.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.422 0.63 . . . . 0.0 109.717 175.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.88 -7.52 58.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.213 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 3' ' ' ILE . 42.9 mt -75.99 126.94 86.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.247 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 14.9 Cg_exo -69.59 167.59 23.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.566 2.177 . . . . 0.0 111.93 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.626 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.25 -9.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.6 -177.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -24.92 64.86 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.412 HD21 ' HG2' ' A' ' 4' ' ' PRO . 15.3 m-80 -100.32 16.14 25.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.504 0.669 . . . . 0.0 109.766 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.626 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 98.9 m-85 -126.75 176.0 7.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.99 127.46 48.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.48 98.59 3.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.46 160.64 40.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.217 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.0 112.53 0.53 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.295 0.569 . . . . 0.0 110.441 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.6 ' HB ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -61.61 130.77 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.53 -174.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 m -129.36 115.58 17.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.848 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 20.3 t -104.96 118.25 36.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.045 0.45 . . . . 0.0 110.096 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -114.9 163.35 15.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 -175.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.439 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.51 133.75 24.65 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 174.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -43.92 109.68 0.27 Allowed Glycine 0 C--N 1.335 0.495 0 O-C-N 123.792 0.683 . . . . 0.0 112.737 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.01 29.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.587 . . . . 0.0 110.508 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.54 173.4 7.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.18 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.44 117.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 123.364 0.415 . . . . 0.0 110.693 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.37 -43.02 1.61 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 84.16 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.971 0.415 . . . . 0.0 110.153 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -41.06 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 131.33 55.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.9 pt -132.86 163.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -107.58 120.02 41.04 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.717 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 t -108.6 135.7 49.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.319 0.581 . . . . 0.0 111.043 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -129.72 141.67 42.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.31 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 91' ' ' THR . 22.7 Cg_exo -63.39 126.6 18.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.358 2.039 . . . . 0.0 111.63 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.6 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -82.52 -52.1 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.163 0.506 . . . . 0.0 110.151 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.84 144.71 45.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.014 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.672 178.336 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.543 0.211 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.721 HG23 HG13 ' A' ' 65' ' ' ILE . 6.6 mt -85.46 114.02 54.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.972 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 7.5 Cg_exo -72.84 124.96 10.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.735 2.29 . . . . 0.0 111.874 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.61 88.02 9.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.98 -45.19 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.008 2.472 . . . . 0.0 112.351 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.53 27.01 5.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.463 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 48.76 65.55 1.33 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.795 0.438 . . . . 0.0 111.554 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.47 160.98 27.14 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.161 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.54 144.86 96.7 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.092 2.528 . . . . 0.0 112.267 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 154.76 29.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 0.0 110.978 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.61 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.985 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -67.2 -26.68 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.214 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -45.1 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.002 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.87 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -59.21 -29.91 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.443 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -56.72 -30.85 63.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.124 0.488 . . . . 0.0 111.362 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.45 -4.15 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.777 ' HB2' HG23 ' A' ' 93' ' ' ILE . 18.6 t -127.84 174.74 8.89 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.93 146.65 41.85 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.739 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.77 -9.52 59.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 111.08 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.97 21.98 10.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.655 0.74 . . . . 0.0 109.85 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HE2' ' SG ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -121.02 147.19 45.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.547 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.789 HG13 ' HA2' ' A' ' 80' ' ' GLY . 6.7 m -88.83 140.6 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 0.0 110.772 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.18 121.12 43.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.2 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.676 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -135.67 159.12 42.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.8 m -101.3 121.31 41.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.47 118.39 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -106.48 95.45 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.28 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.43 151.07 20.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -64.71 -37.99 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.663 -178.485 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -73.46 -30.26 63.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.41 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.529 179.032 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.697 HG13 ' HA ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.537 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.18 124.13 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.025 2.484 . . . . 0.0 112.183 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 44' ' ' ILE . 2.6 mm . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 129.24 15.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 22.8 t-20 -85.03 124.16 31.4 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.474 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -95.51 130.54 31.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.302 -174.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 79.4 Cg_exo -47.95 121.88 6.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.462 2.774 . . . . 0.0 113.291 -174.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.699 HD13 HG12 ' A' ' 24' ' ' VAL . 7.5 tp -75.17 -11.46 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.602 -173.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.24 -40.6 86.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.256 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.55 -25.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 56' ' ' ILE . 1.3 mm? -63.72 -23.8 67.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -60.29 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.595 HG13 ' N ' ' A' ' 62' ' ' ASN . 5.7 pt -81.47 -44.3 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 111.141 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.603 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -92.04 38.54 1.0 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.88 -176.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.1 -14.17 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.921 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.21 1.29 51.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.89 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.721 HG13 HG23 ' A' ' 3' ' ' ILE . 1.5 tt -66.01 135.93 95.38 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.34 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 3.0 Cg_exo -77.82 161.09 30.59 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.009 2.473 . . . . 0.0 111.742 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 67' ' ' ILE . 2.4 tp -67.11 -8.68 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.887 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.464 HD22 ' HB2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -57.9 -32.3 67.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.903 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.417 HD21 HG12 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -103.48 60.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 109.316 176.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.89 173.15 16.91 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.2 133.48 49.04 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.313 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -80.54 94.18 6.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.063 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.588 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 17.9 m-20 -155.9 160.33 40.06 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -51.33 105.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.267 0.556 . . . . 0.0 110.812 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -62.24 135.33 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.778 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 m -144.13 148.66 35.37 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -172.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.1 p -129.18 119.62 24.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.694 0.759 . . . . 0.0 110.906 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 21.4 m -99.54 155.22 17.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.572 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 89' ' ' GLN . 0.3 OUTLIER -52.35 128.41 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.789 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -32.6 104.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.786 0 O-C-N 124.271 0.982 . . . . 0.0 114.19 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.51 93.1 1.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.429 0.633 . . . . 0.0 110.165 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 173.1 10.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.109 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.95 129.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.352 0.596 . . . . 0.0 110.891 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.0 -26.71 11.08 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.753 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 122.84 34.81 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.0 -52.31 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.032 0.444 . . . . 0.0 110.876 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -99.12 117.48 33.7 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 78' ' ' CYS . 17.7 pt -126.83 159.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.697 ' HA ' HG13 ' A' ' 42' ' ' ILE . 3.9 pt20 -109.65 128.46 55.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.488 ' HB2' ' CG2' ' A' ' 42' ' ' ILE . 94.3 m -107.93 127.3 53.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.113 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -138.3 135.61 18.5 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.581 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.75 141.01 77.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.131 2.554 . . . . 0.0 112.794 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 19' ' ' CYS . 2.1 mt -91.71 -77.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.581 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tp -74.51 121.48 21.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.787 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.969 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.529 0.204 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 65' ' ' ILE . 26.9 mt -94.93 111.45 54.57 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.835 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 65' ' ' ILE . 6.1 Cg_exo -78.74 126.02 7.09 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.007 2.471 . . . . 0.0 112.38 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.11 71.09 18.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.213 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.35 -23.83 32.22 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.743 2.295 . . . . 0.0 111.821 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.82 -21.9 4.1 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.09 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.83 51.75 15.31 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.08 0.552 . . . . 0.0 111.146 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.19 32.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.441 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.82 134.41 58.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.89 2.393 . . . . 0.0 112.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 m -89.73 155.66 19.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.536 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 67' ' ' ILE . 48.4 t -65.9 -25.2 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.223 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.92 -35.43 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.034 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpp -62.65 -42.27 99.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.369 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.67 78.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -60.92 -32.75 72.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.367 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -30.3 62.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.836 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.07 -3.12 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.894 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 174.79 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.8 151.06 38.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.254 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.02 -9.01 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 110.998 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.58 12.04 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.406 0.622 . . . . 0.0 109.748 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -119.89 166.78 12.86 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.332 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.858 HG13 ' HA2' ' A' ' 80' ' ' GLY . 9.9 m -106.24 160.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.216 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.02 116.2 51.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.668 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -131.42 149.02 52.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.504 -178.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 107.32 17.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 3.3 m -126.14 121.45 32.87 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.862 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 11.2 t-20 -86.42 113.94 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.742 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.2 144.19 32.07 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -74.79 -42.99 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.356 0.598 . . . . 0.0 110.329 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -68.77 -27.46 65.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.541 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.145 0.498 . . . . 0.0 110.757 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.635 HG21 ' HB2' ' A' ' 90' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 17.1 Cg_endo -91.63 99.0 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.24 2.627 . . . . 0.0 112.696 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.558 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 130.67 47.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.6 t-20 -79.59 101.1 8.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.546 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -64.88 131.59 95.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.101 -174.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.562 ' O ' HG13 ' A' ' 58' ' ' ILE . 6.3 Cg_endo -47.84 123.62 8.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.994 3.129 . . . . 0.0 113.73 -171.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.76 -23.56 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.992 -174.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.559 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -59.45 -43.47 93.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.366 -176.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -80.12 -17.8 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 110.721 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 59' ' ' LEU . 1.9 mm? -71.02 -33.44 70.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.784 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -51.4 9.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.987 0.422 . . . . 0.0 112.132 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 62' ' ' ASN . 3.2 pt -99.46 -44.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.947 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' HG13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -93.63 30.7 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.883 0.373 . . . . 0.0 110.987 -174.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.18 -8.43 54.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.668 . . . . 0.0 109.564 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.18 -13.26 60.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.848 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 3' ' ' ILE . 21.4 mt -66.97 129.7 93.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 48.7 Cg_exo -56.46 152.14 41.66 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.545 2.163 . . . . 0.0 111.567 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.741 HD12 HG22 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -59.11 -8.54 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -175.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -26.09 54.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.723 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.75 13.59 19.76 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.843 0.83 . . . . 0.0 110.264 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.465 ' CE2' HG13 ' A' ' 54' ' ' ILE . 1.1 m-85 -130.6 173.4 10.92 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 123.99 48.72 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.995 -170.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 96.73 2.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 3.4 t0 -156.79 163.58 39.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.213 -173.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.23 97.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 0.0 109.845 168.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -71.97 135.53 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.312 -172.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 140.63 51.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.287 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.483 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 122.25 38.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.617 0.722 . . . . 0.0 109.346 174.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 14.4 m -111.87 162.97 14.72 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.686 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.38 135.36 39.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.016 0.371 . . . . 0.0 110.087 174.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.858 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -47.18 107.22 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 123.644 0.59 . . . . 0.0 112.729 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -55.4 119.15 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.735 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.36 26.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.349 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.516 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.48 113.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 110.518 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.15 -17.76 5.92 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.804 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 108.54 10.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.872 0.368 . . . . 0.0 110.105 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.79 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.013 0.435 . . . . 0.0 110.778 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -101.09 108.77 20.55 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -110.35 162.58 7.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.822 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 23.7 mt-30 -99.47 121.09 40.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.712 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.635 ' HB2' HG21 ' A' ' 42' ' ' ILE . 89.2 m -108.3 127.61 54.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 t -132.47 139.99 36.48 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.284 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 9.5 Cg_endo -54.44 126.6 22.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.648 2.232 . . . . 0.0 111.658 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -69.35 -38.98 78.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.0 110.437 -178.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.88 117.22 20.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.857 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.525 HG23 HG12 ' A' ' 65' ' ' ILE . 2.8 mp -98.95 110.83 59.08 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.032 0.444 . . . . 0.0 110.046 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 131.23 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.498 2.799 . . . . 0.0 112.003 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 8' ' ' GLU . . . -135.77 66.44 62.8 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 6.5 Cg_exo -73.91 -70.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.205 1.937 . . . . 0.0 110.27 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 74.99 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.435 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -69.24 129.6 40.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 0.0 111.251 -175.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.42 -141.07 3.23 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.423 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 133.43 58.07 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -91.64 155.09 18.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.72 -25.29 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.003 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -65.0 -29.29 70.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.582 -175.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -36.19 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 109.982 177.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.86 -35.17 78.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.116 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -70.3 -31.28 68.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -32.74 74.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.924 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -88.54 3.92 48.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.202 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HD2' ' A' ' 23' ' ' LYS . 32.7 t -127.2 175.75 7.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.68 159.47 30.57 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.167 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.83 -35.67 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 111.098 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -89.19 36.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.494 0.664 . . . . 0.0 110.011 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 11.2 mttt -135.97 166.01 24.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.614 HG13 ' HA2' ' A' ' 80' ' ' GLY . 2.8 m -118.8 130.1 74.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.187 0.518 . . . . 0.0 111.398 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.44 131.59 33.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.669 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.37 164.82 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.167 0.508 . . . . 0.0 110.861 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.813 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -123.76 110.14 14.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.735 ' HA ' ' CB ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -151.89 113.21 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.315 0.384 . . . . 0.0 110.15 178.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.804 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 9.8 p30 -85.29 152.84 22.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.71 0.766 . . . . 0.0 112.521 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 m -157.94 147.37 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.078 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -68.4 -31.57 71.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.154 0.502 . . . . 0.0 110.584 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -17.38 60.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.766 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 37.3 Cg_exo -61.25 140.59 89.52 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.187 2.591 . . . . 0.0 112.774 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.603 HG12 ' HB2' ' A' ' 53' ' ' ASN . 5.9 tt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.832 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 25.7 p . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -156.87 152.8 27.25 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.077 0.236 . . . . 0.0 110.781 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.603 ' HB2' HG12 ' A' ' 44' ' ' ILE . 64.6 t30 -91.56 133.04 35.87 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.529 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -97.25 136.77 21.28 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.489 -169.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 31.7 Cg_exo -59.48 132.99 49.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.649 2.899 . . . . 0.0 113.454 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -77.97 -27.65 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.603 -175.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.59 -35.33 65.69 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -79.04 -39.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.084 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -55.39 -26.31 40.8 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -28.54 69.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.413 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -131.49 -37.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.041 0.448 . . . . 0.0 110.648 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.7 m-80 -80.27 24.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.986 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -69.92 -7.59 41.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.381 177.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.83 -10.8 59.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.667 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 3' ' ' ILE . 78.7 mt -73.37 126.05 90.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 10.6 Cg_exo -71.62 164.18 36.53 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.689 2.259 . . . . 0.0 111.541 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 2.2 tp -57.88 -8.9 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -26.25 62.17 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -106.44 33.76 3.72 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.699 0.762 . . . . 0.0 109.383 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.624 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 80.1 m-85 -149.04 175.94 10.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.53 115.85 31.41 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.717 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 97.83 0.91 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.804 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 18.4 t0 -155.21 162.87 40.82 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.373 -173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.51 99.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.98 0.8 . . . . 0.0 110.017 170.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -60.69 130.18 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.345 -169.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.3 m -124.08 153.84 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.117 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -144.29 121.9 11.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.716 0.77 . . . . 0.0 109.407 171.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 5.8 t -110.46 163.41 13.71 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.9 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.628 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -54.35 134.55 45.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 172.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -48.09 108.24 0.33 Allowed Glycine 0 CA--C 1.507 -0.444 0 O-C-N 123.558 0.536 . . . . 0.0 112.172 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.02 130.56 44.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.323 0.582 . . . . 0.0 110.406 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.89 150.65 51.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.596 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -55.14 112.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 177.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.17 -32.06 6.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 89.26 7.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -77.71 -41.35 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.704 -176.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.0 105.75 17.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.19 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 79' ' ' SER . 1.5 pt -114.42 164.49 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.665 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -106.46 112.34 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.295 . . . . 0.0 110.274 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.5 m -107.56 133.99 51.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.427 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 149.48 64.68 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.267 -175.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.23 121.85 8.66 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.871 2.381 . . . . 0.0 112.157 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -72.87 -30.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.86 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tp -133.84 103.47 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.938 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.13 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.967 0.413 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.562 HG23 HG12 ' A' ' 65' ' ' ILE . 4.5 mt -103.61 112.18 65.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.222 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HG2' HD21 ' A' ' 69' ' ' ASN . 2.9 Cg_exo -76.55 125.11 8.07 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.68 2.254 . . . . 0.0 111.996 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.18 82.96 67.19 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.43 -71.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.964 2.443 . . . . 0.0 112.005 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.12 -0.82 61.47 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.753 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 53.31 54.2 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.099 0.56 . . . . 0.0 111.375 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.57 -171.22 38.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.363 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.01 145.29 98.12 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.913 2.408 . . . . 0.0 112.435 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.75 157.09 16.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.233 -177.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.3 p -63.32 -26.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.957 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.765 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.7 p -64.04 -31.13 72.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.303 -175.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -44.71 82.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.56 74.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.614 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.45 -29.3 70.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.487 HE21 ' HB3' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -57.79 -33.92 69.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -92.69 13.88 18.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.732 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.58 174.86 8.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.66 20.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.165 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.34 -22.45 54.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 109.842 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.53 25.45 7.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.67 0.748 . . . . 0.0 109.29 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -128.24 171.61 11.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.148 178.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 56' ' ' ILE . 11.6 p -122.75 141.48 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.994 0.426 . . . . 0.0 111.443 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.41 116.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.646 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.88 155.34 43.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 3.2 p -101.35 105.41 16.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 11.2 t -134.27 108.54 8.29 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.571 -175.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.641 ' HB2' ' H ' ' A' ' 74' ' ' THR . 22.6 t-20 -115.41 92.46 3.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.477 171.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.62 153.58 18.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -44.71 75.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.955 0.407 . . . . 0.0 110.658 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.23 -41.49 94.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.069 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.866 HD12 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -99.37 162.97 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.5 2.8 . . . . 0.0 113.154 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 3.2 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -132.87 131.7 41.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.203 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.64 111.03 21.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.947 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -87.5 150.08 47.98 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' O ' HD13 ' A' ' 59' ' ' LEU . 35.6 Cg_exo -57.25 118.71 5.62 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.261 1.974 . . . . 0.0 112.858 -173.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.613 HD12 HD22 ' A' ' 59' ' ' LEU . 4.7 tp -80.04 -26.79 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.466 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -61.02 -33.8 73.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.118 -173.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 55' ' ' PRO . 1.5 pt -80.22 -26.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.084 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 56' ' ' ILE . 4.7 mp -56.2 -34.36 66.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -20.76 63.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 62' ' ' ASN . 4.0 pt -120.28 -32.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.298 0.57 . . . . 0.0 110.945 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.578 ' N ' HG13 ' A' ' 61' ' ' ILE . 6.8 m-20 -98.64 33.26 2.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.862 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.765 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 5.5 pt20 -68.51 -10.86 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.697 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.74 -5.04 59.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.46 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.562 HG12 HG23 ' A' ' 3' ' ' ILE . 4.5 mt -71.07 126.5 92.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 6.0 Cg_exo -80.17 167.21 19.97 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.015 2.477 . . . . 0.0 112.137 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.655 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -60.42 -12.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.961 -174.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.425 HD22 ' HB2' ' A' ' 66' ' ' PRO . 10.7 p30 -66.89 -18.72 65.52 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.01 -0.431 . . . . 0.0 111.169 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.459 HD21 ' HG2' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.35 7.87 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.564 0.697 . . . . 0.0 109.821 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.655 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 44.8 m-85 -125.41 176.34 6.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.84 -175.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 134.88 45.11 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.82 96.8 9.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.482 0.658 . . . . 0.0 110.562 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 2.3 m-20 -154.18 158.34 40.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.641 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 29.9 m -43.67 108.7 0.12 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.092 0.472 . . . . 0.0 112.19 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.82 116.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 17.0 m -122.92 132.15 54.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 -177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 t -107.16 118.16 35.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 3.1 m -117.96 164.54 14.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.39 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.68 134.95 41.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.518 ' N ' ' HA ' ' A' ' 23' ' ' LYS . . . -33.83 113.71 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 O-C-N 123.821 0.701 . . . . 0.0 114.345 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.71 104.28 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.24 174.95 10.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.183 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 tp -67.39 137.9 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.23 46.39 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.608 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.0 130.52 36.18 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.768 -0.254 . . . . 0.0 110.752 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.1 t -79.66 -67.07 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -136.06 159.99 40.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.678 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.05 177.95 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.791 0.329 . . . . 0.0 110.834 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 123.87 46.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.831 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.866 ' H ' HD12 ' A' ' 42' ' ' ILE . 9.2 m -109.54 140.55 43.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.431 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 t -150.8 135.36 9.71 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.044 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 9.4 Cg_endo -53.85 129.3 33.45 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.99 2.46 . . . . 0.0 112.059 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.517 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -74.87 -65.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.335 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD12 HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -105.22 117.04 32.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.013 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.809 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.621 0.248 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.971 HG23 HG13 ' A' ' 65' ' ' ILE . 4.1 mt -101.57 110.86 62.91 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.13 139.56 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.432 2.755 . . . . 0.0 112.243 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.6 71.38 71.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.743 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.98 -73.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 110.567 172.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.65 77.57 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.34 110.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 111.326 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.66 -149.2 5.42 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 139.92 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.441 2.094 . . . . 0.0 112.175 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -84.55 165.42 18.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.146 -177.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.62 -26.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.429 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.8 p -64.74 -27.47 68.92 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.821 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.3 ttm -63.13 -46.26 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.493 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.98 74.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.07 -30.27 71.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.161 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -57.29 -31.28 65.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.549 . . . . 0.0 110.897 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -84.66 12.06 7.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.455 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 174.86 10.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 110.326 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.42 161.85 45.18 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 -26.65 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.921 0.391 . . . . 0.0 110.669 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.19 27.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.545 0.688 . . . . 0.0 110.23 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -125.06 160.86 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.728 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.779 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 13.4 p -114.34 134.74 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.412 0.625 . . . . 0.0 110.284 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 t -99.99 104.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.059 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -111.58 163.31 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.717 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 14.0 p -101.27 104.17 15.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -131.8 101.73 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.078 0.466 . . . . 0.0 111.003 -177.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 10.7 t-20 -100.23 119.9 39.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.21 147.91 39.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.277 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -71.44 -29.58 65.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 109.988 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.1 pm0 -71.1 -29.97 65.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.209 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 42' ' ' ILE . 2.3 tp . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.364 0.602 . . . . 0.0 110.068 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.96 154.25 14.86 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.511 2.14 . . . . 0.0 112.004 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.557 179.298 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.73 141.44 7.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.066 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 53.6 t30 -96.01 109.79 22.13 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.481 HG12 ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -79.72 149.32 70.87 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.704 -176.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 54' ' ' ILE . 37.0 Cg_endo -64.6 121.54 9.14 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.77 2.314 . . . . 0.0 112.797 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.522 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -80.08 -5.41 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -67.35 -37.57 83.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.698 0.285 . . . . 0.0 111.232 -175.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -16.78 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.889 175.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.2 -14.48 62.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.227 -170.126 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -51.16 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.988 0.423 . . . . 0.0 112.098 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.9 pt -106.89 -23.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.869 0.366 . . . . 0.0 111.805 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -105.69 21.34 17.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.278 -176.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -64.91 -14.19 59.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.355 0.598 . . . . 0.0 110.041 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -72.35 -5.25 35.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.496 176.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.971 HG13 HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -70.35 134.1 87.05 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -74.44 159.28 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.203 . . . . 0.0 111.159 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.502 ' HA ' HD12 ' A' ' 67' ' ' ILE . 3.2 tp -61.95 -10.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.62 HD22 ' HB2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -64.07 -22.66 67.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 175.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.53 34.07 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -150.65 177.01 10.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -172.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.62 116.65 32.22 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -76.99 97.29 4.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.7 0.762 . . . . 0.0 109.659 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.717 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 10.1 m-20 -153.85 159.71 41.92 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 29' ' ' ASN . 21.0 m -43.51 115.28 0.76 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.183 0.516 . . . . 0.0 111.26 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.37 123.86 25.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.994 -174.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 28' ' ' CYS . 84.7 p -123.83 127.24 47.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.389 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.67 118.4 36.45 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.271 0.558 . . . . 0.0 109.965 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.686 ' SG ' ' HB ' ' A' ' 88' ' ' ILE . 14.5 t -118.33 165.44 13.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.543 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.617 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -51.56 122.42 8.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.779 ' HA2' ' HB ' ' A' ' 24' ' ' VAL . . . -54.7 104.77 0.28 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.294 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.54 119.31 6.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.569 -0.816 . . . . 0.0 112.106 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.507 HE21 ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -142.82 151.85 41.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.85 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.58 112.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.497 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.49 -21.45 4.28 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.545 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.28 96.17 10.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 0.0 110.011 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -37.7 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.937 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.524 HD22 ' HA ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -130.12 148.37 51.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.641 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.686 ' HB ' ' SG ' ' A' ' 78' ' ' CYS . 1.5 pt -131.77 151.27 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.882 0.372 . . . . 0.0 111.275 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -106.85 109.14 20.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.513 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.6 m -112.59 136.02 52.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -138.2 143.61 39.85 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.357 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.437 ' HD2' HG22 ' A' ' 91' ' ' THR . 32.8 Cg_endo -64.57 147.82 90.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.735 2.29 . . . . 0.0 112.356 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -115.96 -73.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 78.08 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.571 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.598 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.64 143.0 41.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.911 0.386 . . . . 0.0 111.389 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.561 HG23 HG12 ' A' ' 65' ' ' ILE . 5.2 mt -101.75 112.37 65.16 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.52 125.01 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.417 2.078 . . . . 0.0 111.227 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.81 82.29 6.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.28 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.71 -64.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.553 2.168 . . . . 0.0 111.665 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.49 53.02 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.991 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.76 -49.14 8.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.569 0.223 . . . . 0.0 111.183 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.87 -146.23 10.39 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.752 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.1 169.47 19.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.502 2.801 . . . . 0.0 113.085 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -102.94 167.47 9.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.001 -179.293 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -25.3 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.513 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.2 m -50.18 -33.9 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.602 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -45.71 64.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.66 -50.81 32.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.706 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -59.39 -29.86 68.03 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.9 -31.09 68.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.444 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 15.5 2.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.032 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -144.17 174.24 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.96 143.87 37.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.528 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 -16.24 62.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.959 0.409 . . . . 0.0 111.369 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.09 4.09 53.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.595 0.712 . . . . 0.0 110.104 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.23 153.57 20.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.618 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG23 HD13 ' A' ' 56' ' ' ILE . 12.9 p -97.01 141.41 15.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.0 t -93.37 128.94 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.893 0.378 . . . . 0.0 110.997 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.17 138.28 23.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.64 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -100.98 124.37 46.59 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.661 -0.649 . . . . 0.0 109.681 175.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -156.17 126.04 6.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.451 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.618 ' HB2' ' OD1' ' A' ' 73' ' ' ASP . 8.9 t-20 -95.13 93.04 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.33 147.8 22.6 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.203 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -69.89 -34.12 73.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.076 0.465 . . . . 0.0 109.792 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' OE2' ' HG2' ' A' ' 31' ' ' LYS . 2.0 pm0 -70.73 -40.23 72.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.419 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tp -71.26 -39.67 71.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -23.98 66.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.368 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -107.38 10.57 29.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.32 45.96 27.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.066 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.29 41.82 3.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.047 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.96 108.49 4.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.781 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.2 -45.27 4.16 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 -12.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -82.03 50.63 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.294 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -129.14 123.94 21.99 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.847 0.356 . . . . 0.0 110.667 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HB2' HG22 ' A' ' 46' ' ' VAL . 1.9 Cg_endo -82.6 123.09 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.525 HG12 ' SG ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -68.33 -51.2 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.206 0.526 . . . . 0.0 110.697 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.34 115.8 31.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.1 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 43' ' ' PRO . 6.6 t -129.68 -98.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.824 0.345 . . . . 0.0 110.889 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 47' ' ' LEU . 10.9 tp -121.44 150.39 41.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.861 0.363 . . . . 0.0 111.359 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 98.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.447 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.01 -8.68 9.12 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.276 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.2 mt-10 -115.19 -61.91 1.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 5.2 m -140.95 137.77 33.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.309 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 141.46 18.56 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.403 0.44 . . . . 0.0 110.172 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -82.55 130.56 35.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -100.62 132.05 22.85 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.784 ' HB3' HD21 ' A' ' 57' ' ' ASN . 75.9 Cg_exo -49.26 119.81 4.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.109 2.539 . . . . 0.0 112.881 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.541 HD12 HD13 ' A' ' 59' ' ' LEU . 4.5 tp -79.89 -11.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.784 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -57.27 -50.22 73.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.411 -177.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' H ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -78.5 -27.72 14.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.148 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.541 HD13 HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -58.35 -27.23 63.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -55.51 6.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 111.888 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.521 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -94.96 -28.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.193 0.52 . . . . 0.0 111.398 -175.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -101.84 34.78 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -68.87 -13.06 62.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.546 0.689 . . . . 0.0 109.824 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -70.07 -11.5 60.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.181 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.561 HG12 HG23 ' A' ' 3' ' ' ILE . 26.1 mt -64.44 120.6 66.68 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.253 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 21.6 Cg_exo -66.82 164.48 29.35 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.939 2.426 . . . . 0.0 112.139 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.23 -9.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.467 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.401 HD22 ' HB2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -58.77 -21.77 56.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.666 176.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.463 HD22 HG23 ' A' ' 65' ' ' ILE . 68.1 m-80 -108.15 31.19 5.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 109.891 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -149.41 172.28 15.2 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.69 117.46 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.161 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 96.78 1.66 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.618 ' OD1' ' HB2' ' A' ' 29' ' ' ASN . 12.0 t0 -156.92 165.19 36.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.505 -174.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.32 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.614 0.571 . . . . 0.0 109.482 170.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.527 ' C ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.49 137.18 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.339 -174.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 m -123.97 137.67 54.58 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.601 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.617 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -122.1 120.32 33.93 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 121.854 0.835 . . . . 0.0 109.093 175.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 88' ' ' ILE . 4.8 m -112.97 163.05 15.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.849 -172.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.27 128.87 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -41.03 107.84 0.1 OUTLIER Glycine 0 C--N 1.337 0.603 0 O-C-N 123.761 0.663 . . . . 0.0 113.27 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -77.94 91.6 4.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.323 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.409 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.6 mp0 -95.0 159.11 15.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mp -53.41 111.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 110.493 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.1 -18.29 6.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.165 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -87.26 72.76 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.086 178.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.38 31.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.906 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -141.52 126.22 17.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.213 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 78' ' ' CYS . 0.5 OUTLIER -148.61 177.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.5 139.84 37.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.137 0.494 . . . . 0.0 110.858 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' A' ' 44' ' ' ILE . 57.4 m -109.77 143.22 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.544 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.06 141.78 33.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.48 131.45 36.03 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.617 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.9 OUTLIER -77.31 -58.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.486 0.66 . . . . 0.0 110.093 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tp -114.9 101.63 9.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.639 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.014 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.417 ' HB2' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.859 0.361 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.6 154.15 28.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.052 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 mt -100.56 110.56 60.75 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.345 . . . . 0.0 111.019 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD2' HD21 ' A' ' 69' ' ' ASN . 7.2 Cg_endo -89.68 126.3 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.261 2.641 . . . . 0.0 111.803 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.21 70.15 55.42 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.99 -61.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.682 2.255 . . . . 0.0 112.846 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.76 18.78 41.22 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.887 -172.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 50.39 56.8 7.39 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.679 0.392 . . . . 0.0 112.025 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 161.27 35.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.458 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.56 149.79 88.22 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.833 2.355 . . . . 0.0 111.574 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 153.3 38.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.034 0.445 . . . . 0.0 111.943 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 HD12 ' A' ' 67' ' ' ILE . 29.5 m -71.37 -25.37 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.612 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -59.7 -26.22 65.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.924 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.95 88.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.107 0.48 . . . . 0.0 109.91 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.36 71.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -61.99 -31.79 72.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.606 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -32.4 67.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.281 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -85.89 -5.91 59.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.841 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HB2' HG21 ' A' ' 93' ' ' ILE . 19.9 t -115.75 175.99 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -170.9 34.95 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.807 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.85 -39.77 16.69 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.34 37.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.312 0.577 . . . . 0.0 110.382 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HG3' ' HA ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -131.61 153.05 50.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.127 -177.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 53' ' ' ASN . 12.2 p -100.86 144.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.201 0.524 . . . . 0.0 111.146 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.62 127.04 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.822 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 157.96 45.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 22.9 p -115.28 100.62 8.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.602 . . . . 0.0 109.854 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.8 m -143.07 111.36 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.911 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' HB2' ' H ' ' A' ' 74' ' ' THR . 0.8 OUTLIER -93.58 111.67 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.33 0.585 . . . . 0.0 110.225 177.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 147.59 37.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.879 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HD2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -62.53 -28.98 70.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.755 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG3' ' HD2' ' A' ' 31' ' ' LYS . 7.1 mp0 -68.18 -38.71 82.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.646 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.78 -31.58 69.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.537 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.5 -12.51 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.986 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.45 2.67 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.314 -177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 53.77 43.49 30.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.712 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 137.64 14.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.039 0.447 . . . . 0.0 110.809 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.08 91.46 4.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.92 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.2 -21.03 78.67 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.721 177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.71 -171.91 2.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -81.58 158.26 24.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -100.83 101.57 16.25 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.621 0.248 . . . . 0.0 111.507 -174.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 58.5 Cg_endo -98.78 116.21 0.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.579 2.852 . . . . 0.0 112.871 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 53' ' ' ASN . 20.5 mt -77.78 103.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.054 0.454 . . . . 0.0 110.294 176.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -165.03 -141.44 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 t -113.03 101.07 11.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.844 0.354 . . . . 0.0 110.169 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.538 ' H ' ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -96.9 -161.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.7 m -75.2 81.79 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 111.113 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.39 -105.22 0.33 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.38 149.77 41.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 15.7 t -178.34 143.71 0.29 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -161.2 147.21 14.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.167 0.508 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.569 HD21 HG21 ' A' ' 24' ' ' VAL . 10.1 t-20 -97.57 89.95 4.85 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.799 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.423 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -64.13 127.07 91.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.226 -176.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.631 ' HB3' HD21 ' A' ' 57' ' ' ASN . 50.6 Cg_exo -52.53 121.21 8.69 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.011 2.474 . . . . 0.0 112.824 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -19.23 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.831 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.631 HD21 ' HB3' ' A' ' 55' ' ' PRO . 7.0 p30 -61.84 -31.53 71.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.157 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pp -80.0 -37.6 17.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.577 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.455 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -60.86 -14.43 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -170.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -40.48 64.76 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.736 0.303 . . . . 0.0 111.641 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.489 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -116.86 -24.14 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.338 0.59 . . . . 0.0 111.216 -178.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.4 OUTLIER -92.57 34.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.733 -178.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -19.0 65.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.292 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.68 -3.01 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.846 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -70.27 131.83 88.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.333 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 8.7 Cg_exo -73.43 154.41 50.62 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.763 2.309 . . . . 0.0 111.925 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 12' ' ' VAL . 2.1 tp -61.7 -8.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.318 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -12.53 20.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.767 0.317 . . . . 0.0 111.504 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.495 HD21 ' HD2' ' A' ' 4' ' ' PRO . 48.5 m-80 -97.14 3.45 51.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.49 0.662 . . . . 0.0 109.986 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -116.33 174.21 6.18 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.07 138.89 39.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.82 97.52 5.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.493 0.664 . . . . 0.0 110.563 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.56 159.72 39.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.08 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.487 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 4.2 m -50.47 102.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 110.725 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.49 120.04 6.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.425 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.7 m -127.45 125.61 40.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.624 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.749 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -106.72 141.89 37.25 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 17.9 t -134.12 163.47 29.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.107 -167.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.6 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -57.43 133.67 55.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.31 115.86 6.74 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.249 -0.5 . . . . 0.0 111.982 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.77 92.88 0.91 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.986 0.422 . . . . 0.0 110.391 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -124.63 168.89 12.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.61 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.19 113.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.85 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.31 -30.79 3.58 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.36 102.73 13.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.807 0.337 . . . . 0.0 110.4 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -77.59 -16.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.438 -179.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -150.35 143.87 25.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.879 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.6 HG22 ' HB2' ' A' ' 79' ' ' SER . 11.3 pt -130.23 153.78 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.512 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.467 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -116.0 113.37 23.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.958 0.409 . . . . 0.0 110.331 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.643 ' H ' HD13 ' A' ' 42' ' ' ILE . 1.4 m -109.02 142.4 39.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.944 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 154.86 30.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.458 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.87 129.72 31.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.535 2.157 . . . . 0.0 112.005 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.749 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -91.86 -34.17 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.754 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -105.43 131.31 53.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.25 1.113 0 O-C-N 124.378 1.049 . . . . 0.0 110.313 -177.563 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.04 110.63 5.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.993 0.425 . . . . 0.0 110.584 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 65' ' ' ILE . 4.0 mt -91.07 114.14 60.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.657 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HG2' HD21 ' A' ' 69' ' ' ASN . 3.0 Cg_exo -81.69 126.18 5.18 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.188 2.592 . . . . 0.0 111.907 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.49 78.09 38.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.739 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.94 -72.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.692 2.261 . . . . 0.0 110.904 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.92 123.05 6.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.74 68.58 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.608 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 178.71 47.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.281 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.95 147.81 91.83 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.581 2.187 . . . . 0.0 111.729 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.28 154.83 40.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.92 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -65.29 -24.67 35.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.341 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.619 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -60.58 -29.34 69.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.885 177.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.1 tpt -69.48 -35.76 75.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.506 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.67 -30.95 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.77 -30.17 68.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.901 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -58.37 -32.34 68.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.243 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 93' ' ' ILE . 21.5 mmtt -73.81 -10.83 60.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.789 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -133.65 177.56 7.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.85 0.357 . . . . 0.0 110.644 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.51 163.47 29.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.58 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.746 0.308 . . . . 0.0 111.425 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 10.13 37.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.612 . . . . 0.0 109.607 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -118.61 170.87 8.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.353 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.463 HG21 HD21 ' A' ' 53' ' ' ASN . 7.1 p -116.22 131.23 69.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.097 0.475 . . . . 0.0 110.943 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.4 133.12 30.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.918 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.6 m -151.37 161.22 43.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 4.4 p -110.16 99.68 8.71 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.181 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -130.02 113.45 14.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.149 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -92.7 124.85 37.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.952 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -119.47 151.7 38.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -71.29 -48.42 50.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.61 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -19.09 52.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.952 ' HB2' ' HB3' ' A' ' 30' ' ' SER . 4.8 tp -62.59 -28.02 69.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.107 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -81.98 -34.56 29.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.976 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -92.57 -23.32 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.001 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.64 -171.5 3.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.711 0.291 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -112.31 73.4 0.81 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.031 0.444 . . . . 0.0 110.487 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.49 ' HB2' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -100.4 -128.59 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.731 -178.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.49 ' H ' ' HB2' ' A' ' 38' ' ' SER . . . 79.17 19.95 71.0 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.048 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.48 -46.58 87.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.976 0.417 . . . . 0.0 111.277 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HG2' HD22 ' A' ' 87' ' ' ASN . 2.9 tt0 -137.42 114.76 10.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.812 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -155.24 124.08 3.03 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.683 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.25 148.5 13.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.79 2.326 . . . . 0.0 111.863 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.825 HG21 ' HB2' ' A' ' 53' ' ' ASN . 3.4 mm -102.73 137.2 31.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.799 0.333 . . . . 0.0 110.589 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.73 -170.5 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.92 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.79 108.48 25.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -152.84 118.67 5.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.562 177.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.17 91.77 1.3 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.926 0.393 . . . . 0.0 110.716 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.24 6.61 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.902 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -131.56 -78.89 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 73.6 m -142.89 138.25 30.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.361 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 119.42 8.02 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.431 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.825 ' HB2' HG21 ' A' ' 44' ' ' ILE . 19.8 t-20 -77.72 110.22 12.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -88.9 120.95 70.09 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.605 ' HB2' HD22 ' A' ' 57' ' ' ASN . 11.5 Cg_endo -54.65 121.28 9.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.024 2.483 . . . . 0.0 112.561 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.482 ' HA ' HD13 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -74.09 -8.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.624 -175.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.605 HD22 ' HB2' ' A' ' 55' ' ' PRO . 1.1 m-80 -59.83 -43.37 94.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.634 HG22 HD22 ' A' ' 62' ' ' ASN . 0.9 OUTLIER -79.11 -17.38 13.22 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.657 178.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.607 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 5.6 mp -74.61 -21.08 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.718 0.294 . . . . 0.0 111.041 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 -42.81 15.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.0 111.661 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.634 HG13 ' H ' ' A' ' 62' ' ' ASN . 8.7 pt -107.57 -48.66 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.239 0.543 . . . . 0.0 111.343 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.634 HD22 HG22 ' A' ' 58' ' ' ILE . 42.4 m-20 -84.8 34.42 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.788 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 22.1 pt20 -64.52 -12.14 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.549 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 mt -80.27 -0.43 36.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.354 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.53 ' HA ' HG23 ' A' ' 3' ' ' ILE . 15.5 mt -75.84 127.28 85.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.991 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.88 157.03 61.23 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.622 HG13 ' HB2' ' A' ' 70' ' ' PHE . 1.7 tp -62.72 -7.85 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -27.89 16.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 175.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.481 HD21 ' HG2' ' A' ' 4' ' ' PRO . 22.3 m-20 -86.02 8.67 19.68 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.208 0.528 . . . . 0.0 111.086 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.622 ' HB2' HG13 ' A' ' 67' ' ' ILE . 3.1 m-85 -111.43 172.9 6.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.93 136.9 44.75 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.28 97.71 9.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.315 0.578 . . . . 0.0 111.092 -174.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -156.31 162.78 40.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 m -44.42 104.24 0.04 OUTLIER 'General case' 0 C--O 1.234 0.253 0 O-C-N 123.812 0.695 . . . . 0.0 110.837 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 75' ' ' VAL . 1.5 t -56.04 122.45 5.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.968 -173.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.58 157.46 33.63 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.722 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.656 ' HB2' HG12 ' A' ' 93' ' ' ILE . 51.2 t -139.29 130.18 26.26 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 4.1 m -117.14 163.47 16.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.905 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.458 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.87 135.75 47.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 174.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -42.97 106.09 0.08 OUTLIER Glycine 0 C--N 1.333 0.389 0 O-C-N 123.884 0.74 . . . . 0.0 113.39 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.91 122.82 16.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.412 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.76 149.32 32.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.432 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -65.92 112.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.99 176.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.84 -18.49 8.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 119.49 25.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.77 87.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.036 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.53 HD22 ' HG2' ' A' ' 41' ' ' GLU . 11.5 t30 72.46 163.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.132 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 pt -138.17 170.18 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.445 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -116.15 126.82 54.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 178.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 73.3 m -108.81 130.03 55.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.384 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -133.54 146.92 62.57 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.266 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.5 131.54 30.16 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 111.672 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.656 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -108.91 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.65 -176.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' CG2' ' A' ' 75' ' ' VAL . 7.5 tp -81.59 74.14 8.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.451 0.643 . . . . 0.0 111.008 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.246 0.903 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.639 174.575 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.7 139.11 32.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 65' ' ' ILE . 2.2 mp -83.16 111.23 29.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.751 0.31 . . . . 0.0 110.285 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 9.6 Cg_endo -89.42 126.48 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.56 2.84 . . . . 0.0 112.023 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.63 81.05 70.56 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 120.902 0.382 . . . . 0.0 111.7 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.99 -41.02 47.43 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.906 2.404 . . . . 0.0 110.756 172.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.64 149.08 20.82 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.983 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.06 88.14 4.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.229 0.514 . . . . 0.0 110.887 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.85 165.46 19.95 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 140.93 96.5 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.476 2.117 . . . . 0.0 111.779 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.92 154.15 28.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.161 0.505 . . . . 0.0 111.115 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.05 -24.88 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.915 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -55.11 -32.31 61.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.801 175.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -48.01 79.67 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.086 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.73 73.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.82 -29.49 70.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.744 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -31.23 64.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.172 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -73.46 -16.19 61.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.932 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.94 175.46 6.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 111.558 -176.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.16 154.58 25.5 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.633 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.52 -16.36 62.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.777 0.322 . . . . 0.0 111.21 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.0 22.14 9.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.359 0.6 . . . . 0.0 110.379 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.98 171.31 8.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.9 p -114.68 132.31 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -175.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.52 ' CG2' ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -92.92 136.38 25.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.602 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 m -155.27 162.17 40.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.743 0.306 . . . . 0.0 110.344 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' CYS . 13.2 m -99.99 101.53 12.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.3 100.36 6.8 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.177 -175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -102.84 93.74 5.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.147 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.07 150.74 24.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.094 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -40.65 96.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -34.98 70.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.343 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 1.7 tp -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.258 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.65 -22.0 66.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.242 0.544 . . . . 0.0 110.756 -179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -96.03 26.38 4.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.713 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.81 47.18 24.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.77 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -153.49 136.91 15.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.947 -179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.79 76.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.393 0.616 . . . . 0.0 109.983 174.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.34 179.0 38.41 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.079 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.76 -23.6 10.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.391 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -107.1 85.03 2.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.55 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -119.38 96.14 49.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 -178.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.27 166.76 2.96 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.019 2.479 . . . . 0.0 111.951 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -131.75 -98.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.531 ' H ' ' HB ' ' A' ' 44' ' ' ILE . 3.7 t70 55.99 -140.88 0.86 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.588 0.555 . . . . 0.0 111.314 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG13 ' HE2' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -119.43 70.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 0.0 110.556 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 51' ' ' CYS . 0.2 OUTLIER -84.52 115.88 22.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.96 91.39 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.074 0.464 . . . . 0.0 111.62 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.46 19.63 9.72 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.534 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB2' HD12 ' A' ' 47' ' ' LEU . 4.1 mt-10 -144.45 -76.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.033 0.416 . . . . 0.0 110.536 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 23.7 m -121.62 137.47 54.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.817 0.341 . . . . 0.0 110.083 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HE2' HG13 ' A' ' 46' ' ' VAL . 1.7 tmtt? -142.47 119.06 11.01 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.69 135.82 36.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.74 139.4 22.76 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.98 122.07 11.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.808 2.338 . . . . 0.0 112.754 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.625 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.9 tp -71.24 -19.77 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.573 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -39.69 76.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.759 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -80.6 -25.14 11.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.738 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -62.97 -15.27 55.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -170.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -35.64 21.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 0.0 111.787 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 62' ' ' ASN . 2.3 pt -109.35 -22.32 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.4 0.619 . . . . 0.0 111.61 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.669 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -108.39 26.15 10.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -174.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.411 0.624 . . . . 0.0 109.851 177.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -81.86 -2.52 51.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.378 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -70.04 141.4 89.22 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.051 178.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HB2' HD22 ' A' ' 68' ' ' ASN . 3.3 Cg_exo -76.97 150.77 30.27 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.593 2.195 . . . . 0.0 110.723 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 67' ' ' ILE . 2.0 tp -58.04 -9.54 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.543 HD22 ' HB2' ' A' ' 66' ' ' PRO . 0.4 OUTLIER -63.96 -19.45 65.15 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 176.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.67 24.33 8.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.667 0.746 . . . . 0.0 109.618 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.24 173.65 11.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.8 124.87 49.71 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.344 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.0 m -76.93 94.0 3.87 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.851 0.834 . . . . 0.0 109.368 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.94 160.89 39.52 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -42.34 104.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.558 0.694 . . . . 0.0 111.326 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.17 124.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.687 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 47.1 m -129.36 147.05 51.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.083 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 1.4 t -120.23 119.55 33.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 3.9 m -109.53 163.45 13.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.313 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.05 128.39 30.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.45 103.71 0.16 Allowed Glycine 0 C--N 1.331 0.272 0 O-C-N 123.552 0.532 . . . . 0.0 112.919 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -72.92 135.61 45.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.047 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.8 149.25 28.81 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -45.41 111.98 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 123.975 0.797 . . . . 0.0 110.988 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.86 -13.8 5.79 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.941 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 mt -99.21 149.71 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -49.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.151 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 149.7 50.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.502 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -149.74 178.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.723 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.1 132.89 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.443 ' H ' HD12 ' A' ' 42' ' ' ILE . 8.1 m -107.52 128.94 54.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.418 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 t -134.6 142.81 44.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.099 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 35.3 Cg_endo -65.01 137.54 53.09 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.534 2.156 . . . . 0.0 112.508 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.607 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -82.4 -25.66 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.209 0.528 . . . . 0.0 110.222 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.69 115.99 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.255 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.632 0.253 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.54 163.02 17.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.67 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.421 HG23 HG12 ' A' ' 65' ' ' ILE . 4.0 mt -81.19 112.83 36.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.704 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HG2' HD21 ' A' ' 69' ' ' ASN . 1.3 Cg_endo -85.18 126.03 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.066 2.511 . . . . 0.0 111.329 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 68.88 67.12 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.576 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.78 -27.01 5.13 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 111.059 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.32 100.47 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.779 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -70.04 89.2 0.61 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.477 . . . . 0.0 111.031 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.14 -140.37 11.28 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.09 136.09 43.05 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.489 2.126 . . . . 0.0 110.991 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -102.07 164.45 11.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.555 0.217 . . . . 0.0 110.918 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 1.4 p -64.74 -25.5 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -69.55 -27.12 64.87 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.636 -178.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 ttt -62.01 -48.78 78.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.207 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.71 -30.1 66.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.709 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -67.61 -30.53 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.021 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -58.4 -31.69 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.52 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -10.31 44.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.645 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -113.62 176.54 4.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.88 169.55 38.77 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.958 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.14 -7.43 59.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 111.024 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.28 13.43 33.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.518 0.675 . . . . 0.0 109.81 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.08 146.96 43.72 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.85 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.43 123.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.634 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -85.65 104.33 13.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.674 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -109.91 165.39 11.75 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.063 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.1 p -107.46 99.91 9.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 42.4 t -133.62 121.04 21.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB2' ' H ' ' A' ' 74' ' ' THR . 1.9 t30 -121.52 100.08 6.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.944 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.8 162.17 20.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.838 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -71.53 -40.4 70.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.304 0.573 . . . . 0.0 110.258 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.2 pm0 -64.05 -31.81 73.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.687 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.756 HD22 ' HD3' ' A' ' 92' ' ' PRO . 3.0 mt -61.74 -28.19 69.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.868 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -8.41 55.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -121.51 13.87 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.005 0.431 . . . . 0.0 110.869 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.1 m -78.96 97.09 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.309 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -96.6 -48.38 5.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.076 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -22.56 17.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.383 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.34 153.85 8.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.096 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.98 177.6 9.71 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -104.35 117.9 35.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.177 0.298 . . . . 0.0 110.413 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 tp -151.59 86.61 4.62 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.404 0.621 . . . . 0.0 110.51 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.64 135.54 18.05 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.842 2.361 . . . . 0.0 111.619 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.518 HD11 ' CB ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -86.1 131.63 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.429 -177.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -120.82 -153.26 0.54 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.406 HG13 ' HE3' ' A' ' 52' ' ' LYS . 4.3 t -108.93 98.6 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.786 0.327 . . . . 0.0 110.353 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -132.73 100.03 4.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.998 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.65 99.18 0.43 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.952 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.61 5.21 10.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.216 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.597 ' HB2' HD22 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -142.65 -66.09 0.39 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.081 0.467 . . . . 0.0 110.679 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 93.9 m -145.77 137.21 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.308 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HE3' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -139.62 124.62 18.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.152 0.501 . . . . 0.0 110.977 177.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 56.1 t30 -86.57 131.83 34.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.645 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -111.5 128.24 25.69 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.066 -177.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 72.0 Cg_exo -49.67 123.2 10.13 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.643 2.895 . . . . 0.0 113.129 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 18.4 tt -68.85 -12.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.049 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.4 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -61.96 -46.02 91.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.035 -178.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 HD22 ' A' ' 62' ' ' ASN . 1.1 pt -77.97 -17.62 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 5.2 mp -72.74 -24.57 60.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.394 -177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -86.02 -56.68 3.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.562 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.8 pt -93.66 -39.43 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.759 0.314 . . . . 0.0 111.351 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.562 ' N ' HG13 ' A' ' 61' ' ' ILE . 34.4 m-20 -94.02 31.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.5 0.667 . . . . 0.0 110.061 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 2.4 pt20 -66.79 -8.1 26.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.893 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -80.08 -6.49 57.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.182 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.458 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 71.6 mt -71.57 123.02 88.76 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.739 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 2.7 Cg_exo -77.0 167.62 24.8 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.906 2.404 . . . . 0.0 112.268 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.909 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.24 -9.92 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.247 0.619 . . . . 0.0 112.179 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.12 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.696 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.438 HD21 ' HG2' ' A' ' 4' ' ' PRO . 1.7 m-80 -111.59 15.48 21.09 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 110.51 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.909 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 58.7 m-85 -129.55 173.69 10.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.879 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.37 142.97 33.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.061 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 95.93 10.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.638 0.732 . . . . 0.0 110.533 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.68 160.83 40.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.587 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 20.6 m -42.43 120.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 111.712 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.4 124.31 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.869 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -145.35 112.05 5.88 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -171.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' HG12 ' A' ' 93' ' ' ILE . 31.1 p -98.7 136.27 38.99 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 15.2 t -119.5 163.49 17.2 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.843 -174.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.427 ' HB2' HG22 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -53.9 124.93 16.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -39.25 112.08 0.22 Allowed Glycine 0 C--N 1.336 0.552 0 O-C-N 124.206 0.941 . . . . 0.0 112.772 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.24 102.44 0.3 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.167 0.508 . . . . 0.0 110.993 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.37 146.47 48.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.185 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -65.86 126.89 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.979 0.419 . . . . 0.0 110.487 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.0 -13.44 11.35 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 113.51 16.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.75 -14.59 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.245 0.545 . . . . 0.0 110.54 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.54 89.27 3.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.311 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 79' ' ' SER . 3.0 pt -104.06 145.74 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.1 117.12 30.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.748 0.785 . . . . 0.0 110.199 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.9 m -108.98 139.76 43.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.999 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.47 145.54 32.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.882 0.373 . . . . 0.0 111.353 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.756 ' HD3' HD22 ' A' ' 33' ' ' LEU . 39.2 Cg_endo -69.12 126.84 14.24 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.459 2.106 . . . . 0.0 111.7 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.495 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.8 -42.42 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 111.027 -177.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.51 129.66 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.347 178.237 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.044 0.45 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.46 163.03 13.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.554 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 65' ' ' ILE . 2.3 mp -92.33 112.21 54.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.601 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.33 125.25 3.9 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.695 2.264 . . . . 0.0 111.393 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.31 68.2 46.97 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.55 32.03 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.243 2.628 . . . . 0.0 110.829 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.69 77.85 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 96.98 6.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.936 0.398 . . . . 0.0 111.078 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.62 -143.57 15.08 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.48 130.04 33.85 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.368 2.045 . . . . 0.0 111.486 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -74.82 154.82 38.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 HD12 ' A' ' 67' ' ' ILE . 34.2 m -67.6 -26.0 34.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.793 0.33 . . . . 0.0 111.467 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -26.32 64.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -41.35 98.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.83 70.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.342 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.04 -30.96 69.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.472 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -56.0 -31.31 62.94 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.924 0.489 . . . . 0.0 111.19 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 0.88 24.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.528 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.538 ' HB2' HG23 ' A' ' 93' ' ' ILE . 1.1 t -141.77 175.91 9.33 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.242 -0.286 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.14 133.51 48.83 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.64 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.84 -18.64 64.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.833 0.349 . . . . 0.0 111.899 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 31.91 4.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 0.0 110.439 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 167.8 12.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.109 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.722 HG22 ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -86.76 126.05 40.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.941 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 m -94.7 131.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.585 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.912 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -148.89 167.76 24.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.335 -178.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.583 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -122.49 113.46 19.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' CA ' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m -130.29 123.12 29.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.211 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 1.4 p30 -88.4 97.05 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 110.737 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.795 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 3.7 m -126.81 146.93 50.07 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.372 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.81 -42.62 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.212 0.53 . . . . 0.0 110.659 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -71.77 -27.72 63.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.795 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 1.2 tp -65.82 -36.98 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.916 0.389 . . . . 0.0 111.042 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -11.92 61.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.494 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -118.84 12.07 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.31 0.576 . . . . 0.0 110.425 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.485 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 61.3 m -81.57 74.73 8.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.213 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -4.4 37.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.492 ' HB2' ' H ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -118.31 -102.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.405 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' H ' ' HB2' ' A' ' 38' ' ' SER . . . -151.44 151.03 23.04 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.698 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.68 144.38 8.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -93.58 81.54 4.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.292 0.568 . . . . 0.0 110.488 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -117.24 127.59 26.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 176.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 96.0 Cg_endo -94.71 170.47 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.044 2.496 . . . . 0.0 112.895 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -104.79 74.03 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.466 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 11.2 p30 -95.66 16.77 16.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.989 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 53.8 t 74.43 -52.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.631 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.12 25.24 1.0 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.931 -0.481 . . . . 0.0 111.595 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.42 58.21 1.66 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.651 0.739 . . . . 0.0 109.598 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 50' ' ' GLU . . . 97.69 -47.21 1.56 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.777 -175.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 3.1 tt0 152.67 61.43 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.503 1.121 . . . . 0.0 109.423 -174.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.469 ' HB2' ' CA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -116.81 154.18 31.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 124.3 28.57 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.053 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.912 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 17.9 t-20 -85.57 120.29 26.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.704 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -90.76 139.78 26.28 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.431 -172.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.704 ' HD2' HG22 ' A' ' 54' ' ' ILE . 9.1 Cg_endo -49.98 123.07 10.17 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.847 3.031 . . . . 0.0 113.27 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.834 ' HA ' HD23 ' A' ' 59' ' ' LEU . 6.1 tp -72.26 -22.85 21.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.224 -175.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.458 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -58.78 -31.18 68.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -173.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -26.74 12.98 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -176.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.834 HD23 ' HA ' ' A' ' 56' ' ' ILE . 1.4 mm? -60.47 -27.77 67.81 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -168.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -43.83 66.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 112.047 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.0 pt -105.64 -37.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.351 0.596 . . . . 0.0 111.45 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.44 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.35 29.92 0.93 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.397 -175.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -63.65 -20.02 65.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.501 0.667 . . . . 0.0 109.708 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.12 0.56 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.764 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.553 HG13 HG23 ' A' ' 3' ' ' ILE . 1.9 tt -81.37 130.5 61.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.328 0.585 . . . . 0.0 109.86 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -75.19 158.18 41.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.414 2.076 . . . . 0.0 111.674 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.572 HD12 HG12 ' A' ' 12' ' ' VAL . 3.1 tp -59.66 -9.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.413 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -21.01 66.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.634 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.47 HD22 HG12 ' A' ' 65' ' ' ILE . 50.7 m-80 -100.18 27.73 5.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.652 0.739 . . . . 0.0 109.661 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.26 174.45 10.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.95 118.96 37.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.609 -174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.58 97.86 1.39 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.5 OUTLIER -155.35 163.1 40.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.479 -172.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.46 100.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 109.871 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -58.69 130.44 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.224 -172.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -120.94 119.8 33.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.279 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.0 t -110.86 121.17 44.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.688 ' HB3' HG23 ' A' ' 24' ' ' VAL . 6.2 t -120.67 162.65 19.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.501 -174.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.548 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -60.49 124.8 21.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 169.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.722 ' HA2' HG22 ' A' ' 24' ' ' VAL . . . -46.47 113.44 1.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 O-C-N 123.692 0.62 . . . . 0.0 113.013 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.69 90.12 1.37 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.36 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -138.31 174.59 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.561 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.1 121.87 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.016 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.37 -21.71 9.16 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.703 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 95.51 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 111.331 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -22.5 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.405 176.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.01 107.65 18.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 79' ' ' SER . 9.5 pt -121.43 159.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.394 . . . . 0.0 110.916 -172.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.85 113.32 17.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.767 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.37 134.27 50.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.767 179.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 157.27 77.07 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.839 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.7 Cg_exo -61.6 126.89 20.17 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.829 2.352 . . . . 0.0 112.341 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.582 HG13 ' HB ' ' A' ' 75' ' ' VAL . 1.3 mt -76.92 -36.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.031 0.443 . . . . 0.0 111.814 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.32 116.19 17.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.575 -0.726 . . . . 0.0 110.034 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.678 0.275 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.515 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -132.6 163.46 28.85 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 65' ' ' ILE . 12.9 mt -87.0 109.1 21.95 Favored Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.165 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -89.0 136.81 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.79 89.47 2.63 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.28 -53.29 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.627 2.218 . . . . 0.0 111.9 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.83 49.46 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.326 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -84.04 -47.17 11.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 10' ' ' PRO . . . 125.99 -101.01 0.6 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.021 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 9' ' ' GLY . 50.1 Cg_exo -52.93 148.08 30.78 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.322 2.681 . . . . 0.0 113.297 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -113.49 167.15 10.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -66.36 -27.34 40.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 110.732 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -26.61 64.89 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.979 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -48.19 80.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.164 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.22 -41.75 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.221 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' A' ' 25' ' ' VAL . 30.9 tt0 -61.4 -31.24 71.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -56.51 -31.2 63.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.06 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -80.93 -4.34 54.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.028 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -127.7 175.39 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.158 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.59 153.44 40.66 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.363 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.09 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 0.0 111.742 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.12 27.64 8.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 0.0 111.045 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.9 153.07 29.86 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.774 HG21 HD21 ' A' ' 53' ' ' ASN . 7.6 p -95.36 122.84 47.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.195 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.513 HG21 ' HG3' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -92.04 103.8 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.453 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.93 148.96 35.94 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.369 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.727 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 29.8 p -102.96 101.55 11.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -157.34 109.97 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.508 -176.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.72 147.97 22.77 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.44 155.06 45.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.803 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -61.84 -48.0 82.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.233 0.54 . . . . 0.0 110.566 179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -70.37 -23.79 62.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -66.16 -32.86 74.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -70.31 -8.0 46.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.32 0.581 . . . . 0.0 110.74 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.43 12.83 9.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.571 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 33' ' ' LEU . 50.6 m -84.22 82.08 8.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.56 -14.26 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 109.624 173.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -124.19 172.69 8.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.693 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.65 107.55 3.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.949 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.15 139.7 33.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.694 0.283 . . . . 0.0 110.74 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -80.38 70.8 7.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.244 0.545 . . . . 0.0 111.312 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp -106.91 110.85 63.83 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.414 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 9.3 Cg_exo -73.25 156.29 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.986 2.457 . . . . 0.0 111.579 175.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.619 HD13 HD22 ' A' ' 53' ' ' ASN . 2.7 mp -72.67 110.63 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.973 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -72.25 144.42 48.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.961 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.26 81.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -174.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.507 HD12 ' HG3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER 62.11 25.52 15.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.955 172.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -80.23 56.08 2.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 109.477 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.06 -95.23 0.11 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.78 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.56 22.44 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.622 . . . . 0.0 109.949 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.727 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 12.8 p -139.1 169.69 17.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.511 -170.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' HG3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -165.11 154.46 12.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.28 0.562 . . . . 0.0 111.55 -177.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.774 HD21 HG21 ' A' ' 24' ' ' VAL . 17.0 t-20 -77.5 114.88 16.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.321 172.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.836 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -83.63 141.21 41.52 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.532 -176.107 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HB2' HD22 ' A' ' 57' ' ' ASN . 23.4 Cg_endo -62.14 119.95 7.3 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.768 2.312 . . . . 0.0 113.173 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -78.75 -12.55 13.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.362 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.497 HD22 ' HB2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -56.45 -45.88 80.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.193 -178.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -33.7 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.97 -23.24 31.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -173.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -54.38 15.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.77 0.319 . . . . 0.0 111.455 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -92.33 -35.94 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.196 0.522 . . . . 0.0 110.736 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -91.12 35.99 0.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.779 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -66.88 -13.42 61.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.202 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.84 18.25 6.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.359 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 10.7 tt -91.94 135.85 26.84 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.663 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.731 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 7.3 Cg_exo -75.85 163.72 33.0 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.879 2.386 . . . . 0.0 112.309 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 4.4 tp -65.19 -8.71 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.564 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -56.88 -24.23 50.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.489 HD21 ' HG2' ' A' ' 4' ' ' PRO . 2.6 m-80 -94.8 12.3 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.836 ' HD1' HG21 ' A' ' 54' ' ' ILE . 86.9 m-85 -127.04 174.16 9.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.004 -174.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.38 138.8 40.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.225 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.47 99.42 7.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.205 0.526 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 51' ' ' CYS . 0.7 OUTLIER -153.98 158.88 41.29 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 m -50.85 113.5 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.969 0.414 . . . . 0.0 110.419 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -61.95 125.58 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.354 -176.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -127.4 112.96 15.6 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.577 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.573 ' HB2' HG12 ' A' ' 93' ' ' ILE . 35.9 t -98.11 119.45 36.77 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.932 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 2.4 m -115.07 163.83 15.05 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.321 -172.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.33 119.16 3.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -34.1 107.05 0.03 OUTLIER Glycine 0 C--N 1.337 0.635 0 O-C-N 124.442 1.089 . . . . 0.0 113.91 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.09 109.02 2.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.307 0.575 . . . . 0.0 110.598 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.6 156.05 33.76 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.586 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 pt -58.33 112.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 123.476 0.485 . . . . 0.0 110.605 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.01 -12.43 11.52 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.034 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 mt -90.72 103.26 15.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.069 0.462 . . . . 0.0 110.488 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.14 -50.51 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.329 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -107.43 129.86 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 pt -146.56 170.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.11 131.65 55.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.023 0.44 . . . . 0.0 110.648 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.408 ' SG ' HG13 ' A' ' 44' ' ' ILE . 12.0 m -110.01 127.25 54.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.05 135.21 21.0 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.623 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 20.5 Cg_endo -60.96 127.78 23.4 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.899 2.399 . . . . 0.0 112.038 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.28 -61.69 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.893 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 100.34 13.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.052 0.453 . . . . 0.0 110.651 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.033 176.232 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -106.07 146.87 29.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.87 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 mt -100.76 109.58 58.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 8.9 Cg_endo -90.42 126.09 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.861 3.041 . . . . 0.0 111.818 175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -140.34 61.64 17.39 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.453 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 17.0 Cg_exo -68.04 -53.03 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.428 2.085 . . . . 0.0 110.325 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.47 78.75 0.28 Allowed Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.33 2.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.532 . . . . 0.0 110.9 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.04 -155.08 7.89 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.081 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.08 124.6 16.67 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.47 2.113 . . . . 0.0 111.854 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -83.35 156.11 23.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.208 178.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.5 p -61.31 -27.81 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.109 0.481 . . . . 0.0 110.788 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 63' ' ' GLN . 36.6 m -56.04 -38.92 71.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.143 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.9 tpp -64.45 -47.24 79.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.911 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.25 74.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.884 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.59 -31.97 64.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.173 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -77.22 -4.8 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.492 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.05 175.05 8.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.03 134.94 43.3 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.38 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.17 -23.74 64.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.945 0.402 . . . . 0.0 111.054 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.89 37.78 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.703 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -125.4 158.66 33.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.296 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.06 125.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 110.25 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.2 114.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.573 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 144.15 50.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.79 101.99 12.55 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.514 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.815 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 1.8 t -142.4 112.89 7.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.181 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.931 ' HB2' ' H ' ' A' ' 74' ' ' THR . 26.9 t30 -106.07 94.2 5.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.48 150.93 23.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.904 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -36.62 79.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.276 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.931 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -61.83 -31.45 71.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.798 178.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 42' ' ' ILE . 4.9 mp -79.34 -42.67 25.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.552 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.946 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.92 -22.68 22.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.697 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.51 71.15 0.47 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.906 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.27 132.23 55.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.268 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.17 124.94 24.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.963 0.411 . . . . 0.0 110.26 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.91 -13.01 38.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.049 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.931 ' HB1' ' HB3' ' A' ' 32' ' ' GLU . . . -75.72 168.58 19.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.576 0.227 . . . . 0.0 110.626 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.86 135.56 33.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 111.394 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -110.77 98.22 36.85 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.451 178.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.526 ' HG2' HD13 ' A' ' 47' ' ' LEU . 5.1 Cg_exo -80.53 152.76 20.3 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 123.346 2.697 . . . . 0.0 112.195 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mp -138.64 -51.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.982 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -88.32 -13.3 41.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.099 -173.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 p -169.0 147.41 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 111.486 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.526 HD13 ' HG2' ' A' ' 43' ' ' PRO . 7.7 tp -158.54 151.15 22.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.129 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -70.27 78.0 0.53 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.497 0.665 . . . . 0.0 110.722 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.12 -114.57 0.45 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.33 33.62 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.085 0.469 . . . . 0.0 109.856 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.815 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -90.35 140.45 29.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.629 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.38 147.18 25.99 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 112.155 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -83.55 110.2 18.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.625 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.734 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -87.67 143.18 33.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.279 -176.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 32.1 Cg_exo -59.19 120.75 8.79 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.86 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -23.56 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.92 -34.95 70.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.22 -175.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.39 -31.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.202 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -33.34 68.55 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -170.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -26.28 68.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.567 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.6 pt -121.15 -40.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.452 0.644 . . . . 0.0 110.749 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.567 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -89.48 35.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.507 -176.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -70.73 -8.47 52.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.59 179.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.99 -5.05 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.144 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.507 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 5.4 mt -70.68 128.65 90.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.385 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.1 Cg_exo -81.08 164.72 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.288 2.659 . . . . 0.0 111.602 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.795 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -60.01 -13.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -13.65 59.17 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.934 0.397 . . . . 0.0 111.4 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.56 12.64 36.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.384 0.611 . . . . 0.0 109.885 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.795 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 66.3 m-85 -130.99 177.55 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.35 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.11 145.02 29.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.074 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.23 96.72 7.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.0 110.125 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -156.2 159.47 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.26 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.931 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 65.2 m -51.9 107.96 0.24 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.13 0.49 . . . . 0.0 110.27 175.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.49 124.02 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.205 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 58.8 m -127.31 133.89 50.07 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.936 -175.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.642 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -110.2 123.3 49.51 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -120.45 162.05 20.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.273 -173.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.51 126.68 20.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.502 0.192 . . . . 0.0 110.56 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.79 106.04 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.508 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.59 138.46 43.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.553 -0.324 . . . . 0.0 111.096 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.62 171.5 18.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.406 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 83' ' ' ILE . 2.4 pt -62.94 123.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.72 -27.7 7.78 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.693 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.23 147.13 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.142 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -117.14 -66.4 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.344 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.77 127.12 56.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.642 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -113.68 152.26 15.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.816 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.74 118.72 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.03 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 9.5 t -116.43 138.64 51.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.583 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -143.1 141.23 19.04 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.312 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 25.9 Cg_exo -62.74 130.79 30.73 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.642 HG12 ' HB3' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -84.49 -43.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.678 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.06 120.41 37.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.726 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.858 -1.068 . . . . 0.0 109.264 176.796 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 121.042 0.449 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -97.71 164.1 12.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.948 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -80.8 111.22 21.56 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.742 0.306 . . . . 0.0 110.728 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.731 ' HG2' HD21 ' A' ' 69' ' ' ASN . 1.1 Cg_endo -87.95 128.74 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.219 2.612 . . . . 0.0 112.05 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.34 91.12 4.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.77 -53.63 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.647 2.231 . . . . 0.0 111.982 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.25 47.25 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.311 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -83.12 -59.02 2.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.12 -89.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.302 -0.952 . . . . 0.0 113.242 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.92 137.1 77.9 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.23 2.62 . . . . 0.0 113.331 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.801 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -93.73 157.63 16.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.514 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.35 -27.27 23.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.944 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -37.14 85.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.021 -175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -42.73 86.77 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -49.67 38.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.21 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG3' ' CG2' ' A' ' 25' ' ' VAL . 3.3 tt0 -63.43 -28.83 70.25 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.745 -176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -30.25 60.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.942 0.401 . . . . 0.0 111.232 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -7.44 55.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.88 174.76 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.33 166.71 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.804 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.14 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.452 . . . . 0.0 110.967 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.92 37.46 1.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.42 0.629 . . . . 0.0 109.906 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -119.68 155.95 31.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.481 -0.781 . . . . 0.0 108.991 177.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.57 132.4 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.751 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 54' ' ' ILE . 89.1 t -86.17 137.49 20.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -148.32 150.76 34.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.917 0.389 . . . . 0.0 110.082 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -115.53 108.86 16.99 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 169.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.9 t -151.38 103.57 3.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -85.28 93.22 8.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 110.025 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 147.46 25.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -70.57 -38.87 74.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.295 0.569 . . . . 0.0 109.841 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.04 -37.98 87.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.624 HD21 ' HG3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -69.51 -31.28 69.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.886 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -29.42 34.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -95.0 -30.28 14.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.867 0.365 . . . . 0.0 111.488 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.88 85.09 2.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 132.01 51.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.664 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m 65.33 59.03 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.599 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.22 137.84 23.49 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.45 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 -62.23 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' HG2' ' ND2' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -102.23 94.39 5.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.131 -174.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 102.96 8.96 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.007 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HA ' HG13 ' A' ' 88' ' ' ILE . 86.5 Cg_endo -84.82 156.72 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.059 2.506 . . . . 0.0 112.585 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.32 121.27 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.416 . . . . 0.0 110.895 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -127.21 156.21 42.21 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.72 91.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -95.28 174.72 6.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.61 -177.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.27 66.1 4.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.479 0.657 . . . . 0.0 110.343 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.63 -128.18 1.79 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.861 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.99 13.11 6.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.206 0.527 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.7 m -90.29 138.29 31.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.722 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.94 139.35 14.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.69 175.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -85.18 114.69 22.48 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.514 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -80.15 134.09 56.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.796 -170.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.534 ' HB3' HD21 ' A' ' 57' ' ' ASN . 41.8 Cg_exo -58.07 122.56 11.91 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.394 2.729 . . . . 0.0 113.587 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 56' ' ' ILE . 4.7 mm -74.75 -25.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.559 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.534 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -53.35 -34.74 58.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.39 -174.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 1.1 pt -79.81 -40.3 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.417 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.66 -22.81 57.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -170.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -58.26 7.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 0.0 111.376 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.558 HG13 ' N ' ' A' ' 62' ' ' ASN . 12.7 pt -91.09 -35.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 0.0 110.641 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.558 ' N ' HG13 ' A' ' 61' ' ' ILE . 7.4 m-20 -92.22 37.24 0.99 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.509 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -8.12 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.488 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HB2' HG12 ' A' ' 3' ' ' ILE . 1.4 mt -79.02 -9.49 59.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.766 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.563 ' HA ' HG23 ' A' ' 3' ' ' ILE . 54.3 mt -69.49 124.96 91.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.63 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.801 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 2.9 Cg_exo -77.91 174.77 12.05 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.038 2.492 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.25 -8.64 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.439 ' ND2' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -60.39 -21.91 62.72 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.731 HD21 ' HG2' ' A' ' 4' ' ' PRO . 5.9 m-80 -102.12 24.54 9.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.427 0.632 . . . . 0.0 110.003 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -142.94 172.76 12.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.62 139.11 40.72 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.076 0.465 . . . . 0.0 111.368 -171.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.91 98.39 6.37 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.653 0.74 . . . . 0.0 109.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.19 162.16 41.62 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.208 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.5 m -52.72 98.86 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -54.4 129.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.54 -171.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.0 140.29 51.19 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.387 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.66 ' HB2' HG12 ' A' ' 93' ' ' ILE . 48.2 t -135.55 122.98 21.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -122.86 164.34 18.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.612 -172.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.91 128.48 18.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.389 0.431 . . . . 0.0 110.548 174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.67 118.15 1.12 Allowed Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.827 0.705 . . . . 0.0 113.641 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 93.21 0.13 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.458 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.38 160.39 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.61 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.466 ' H ' HG12 ' A' ' 83' ' ' ILE . 1.9 mm -62.12 113.6 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.69 -37.52 2.05 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.847 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.76 98.56 10.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.886 0.374 . . . . 0.0 110.182 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -80.52 -38.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.227 0.536 . . . . 0.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.436 ' ND2' ' HG2' ' A' ' 41' ' ' GLU . 9.3 t-20 -118.61 114.59 23.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.508 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.603 HG13 ' HA ' ' A' ' 43' ' ' PRO . 21.0 pt -107.21 150.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.175 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -99.8 118.7 36.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 t -108.0 130.74 55.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.229 0.538 . . . . 0.0 110.346 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 m -131.51 136.23 28.24 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.26 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.624 ' HG3' HD21 ' A' ' 33' ' ' LEU . 68.7 Cg_exo -53.39 127.53 25.62 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.686 2.257 . . . . 0.0 112.376 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.66 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -79.57 -23.08 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.352 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.92 139.92 45.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.02 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.125 0 O-C-N 123.988 0.805 . . . . 0.0 110.842 -178.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.916 0.389 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.9 132.22 36.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -90.64 111.09 45.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.9 Cg_endo -89.18 128.79 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.317 2.678 . . . . 0.0 111.984 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -129.09 66.83 77.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.59 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 9.1 Cg_exo -73.27 -41.56 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.289 1.993 . . . . 0.0 110.547 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.92 110.97 2.3 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.328 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.33 113.61 10.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.74 0.305 . . . . 0.0 110.794 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.37 -166.35 13.78 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.29 153.05 17.95 Favored 'Trans proline' 0 N--CA 1.471 0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.236 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.66 155.67 17.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.748 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 3.6 p -62.04 -26.27 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.608 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -69.32 -26.72 64.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.962 -177.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ttt -65.32 -43.35 91.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.051 0.453 . . . . 0.0 110.123 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.73 69.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.032 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -56.36 -31.04 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.603 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.27 3.3 36.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.559 ' SG ' HG23 ' A' ' 93' ' ' ILE . 1.5 m -135.48 174.51 10.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.62 0.248 . . . . 0.0 110.536 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.92 151.62 33.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.284 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.61 -13.62 59.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 22' ' ' GLU . 1.7 pm0 -90.5 0.83 57.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.934 174.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -105.76 160.24 15.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.639 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 p -101.73 146.69 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.745 0.307 . . . . 0.0 110.75 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.23 129.06 52.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.866 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -138.29 150.99 47.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.6 p -116.5 115.85 26.55 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 2.9 m -132.8 146.79 52.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.168 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.477 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 15.3 t-20 -111.41 93.48 4.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.983 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.02 145.92 27.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.578 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -28.87 61.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.947 0.403 . . . . 0.0 110.996 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -61.48 -20.96 63.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.738 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.96 -25.69 63.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.563 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 -8.76 23.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -113.04 22.74 14.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 51.62 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 111.388 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -87.46 37.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.427 . . . . 0.0 110.739 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.06 -55.76 0.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.202 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.56 46.24 3.79 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.579 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.61 -71.31 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.79 0.328 . . . . 0.0 111.206 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -137.17 135.01 36.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.757 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 90' ' ' CYS . 2.8 mp -128.61 119.88 20.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.828 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HB2' HG21 ' A' ' 46' ' ' VAL . 60.3 Cg_endo -72.95 120.02 6.39 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.567 2.178 . . . . 0.0 112.385 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.534 ' HB ' ' H ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -94.69 -100.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.317 177.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.534 ' H ' ' HB ' ' A' ' 44' ' ' ILE . 4.0 t70 -71.65 88.27 0.96 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.729 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 43' ' ' PRO . 3.7 m -139.45 173.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.44 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.5 tp -80.59 -23.45 39.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.892 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 102.61 0.57 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.448 177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 84.03 -11.75 56.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.695 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 58.84 65.5 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 110.997 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 1.9 t -90.04 146.19 24.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.07 137.46 31.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.168 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 4.8 t-20 -79.33 97.43 6.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.367 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.525 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -60.73 125.07 82.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HB3' HD21 ' A' ' 57' ' ' ASN . 51.9 Cg_exo -54.71 120.74 8.6 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.452 2.101 . . . . 0.0 112.047 -176.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -76.08 -14.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 -174.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.487 HD21 ' HB3' ' A' ' 55' ' ' PRO . 1.1 p30 -68.85 -31.48 70.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.293 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -78.83 -45.5 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.224 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -68.97 -13.83 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -166.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -32.09 71.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.035 0.445 . . . . 0.0 110.929 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.507 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.3 pt -118.99 -39.03 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.959 175.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -82.36 34.06 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.674 -177.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.2 pt20 -70.34 -8.27 49.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.628 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.48 -5.94 59.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.721 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HA ' HG23 ' A' ' 3' ' ' ILE . 60.3 mt -73.4 122.7 88.26 Favored Pre-proline 0 C--O 1.235 0.317 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.2 Cg_exo -65.85 157.49 58.78 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.849 2.366 . . . . 0.0 112.193 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.771 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 3.3 tp -61.0 -9.4 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.138 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.492 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -55.84 -24.9 39.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.141 177.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.416 HD21 ' HG2' ' A' ' 4' ' ' PRO . 37.2 m-20 -100.22 9.36 42.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.254 0.55 . . . . 0.0 110.674 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.771 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 64.5 m-85 -127.21 175.0 8.48 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.439 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.36 122.69 44.76 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.152 0.501 . . . . 0.0 109.695 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 96.42 9.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.651 0.739 . . . . 0.0 109.806 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -156.11 164.17 38.74 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.591 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.11 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.181 0.925 . . . . 0.0 112.013 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -64.76 136.85 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.726 -177.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.8 m -141.12 113.17 7.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.855 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -100.83 142.98 31.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.209 0.528 . . . . 0.0 110.051 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 6.8 m -126.57 164.08 22.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.846 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.24 132.18 38.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -46.92 110.1 0.49 Allowed Glycine 0 C--N 1.333 0.391 0 O-C-N 123.597 0.561 . . . . 0.0 113.098 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -75.34 100.47 4.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -113.86 154.4 27.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.576 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -55.92 113.06 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.37 0.605 . . . . 0.0 110.742 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.91 -18.89 3.76 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.675 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -101.39 149.35 24.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.99 -42.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.2 0.524 . . . . 0.0 110.432 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -120.62 134.73 55.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.73 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.9 pt -133.49 148.99 30.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.42 37.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.071 0.462 . . . . 0.0 110.322 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.435 ' HB2' HG21 ' A' ' 42' ' ' ILE . 77.3 m -110.61 144.57 39.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.31 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -139.79 142.36 30.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.496 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.15 129.2 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.674 2.249 . . . . 0.0 111.546 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.559 HG23 ' SG ' ' A' ' 19' ' ' CYS . 3.0 mt -76.31 -62.0 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.837 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 tp -106.54 138.33 42.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.279 -174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.349 179.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 121.013 0.435 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.81 148.18 23.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.96 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.679 HG23 HG12 ' A' ' 65' ' ' ILE . 9.9 mt -88.92 111.46 44.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 1.8 Cg_endo -82.51 147.36 14.01 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.556 2.837 . . . . 0.0 113.113 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.86 76.92 77.03 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.599 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -96.87 10.94 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 113.758 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.28 -32.51 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.623 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 72.5 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.186 0.993 . . . . 0.0 112.995 173.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.12 -141.72 4.09 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 172.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.21 160.86 28.88 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.198 1.932 . . . . 0.0 110.985 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -115.97 155.14 28.57 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -25.19 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 0.0 111.244 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.36 -28.32 69.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.797 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -67.74 -45.06 76.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.327 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.9 -42.66 73.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.673 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -62.1 -29.84 70.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.026 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.21 -31.64 71.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.087 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.18 14.73 29.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.504 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.41 174.32 7.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.82 154.0 33.5 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.79 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.55 65.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.54 36.46 2.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.472 0.654 . . . . 0.0 110.347 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 145.99 50.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.844 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.841 ' HA ' HD13 ' A' ' 56' ' ' ILE . 5.9 p -99.53 129.11 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.941 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -72.8 134.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.744 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.459 ' HA ' HG12 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -139.07 162.04 35.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.501 -178.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 110.87 15.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 2.8 m -140.18 135.19 32.18 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -120.59 93.09 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.862 174.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.39 148.71 29.73 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.521 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 7.6 mttp -65.21 -35.39 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.2 pm0 -68.81 -31.47 70.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.453 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.53 -45.48 21.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.417 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -8.67 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.832 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -118.23 4.23 11.94 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.052 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m 50.13 43.57 25.93 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.718 0.636 . . . . 0.0 111.479 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -89.73 -49.0 6.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.219 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 m -134.8 163.73 29.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.666 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.02 58.53 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.483 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.15 -77.4 0.17 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 110.721 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.73 74.81 9.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.23 0.538 . . . . 0.0 110.492 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.39 122.76 19.14 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.27 171.24 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.68 2.253 . . . . 0.0 112.138 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.711 HD11 HD11 ' A' ' 88' ' ' ILE . 1.6 mt -89.25 -55.1 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.185 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 46' ' ' VAL . 10.6 t70 61.86 -147.68 0.4 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.442 ' H ' ' CG ' ' A' ' 45' ' ' ASP . 4.8 p -152.02 -18.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.67 -32.33 1.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.481 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -68.95 86.86 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.343 0.592 . . . . 0.0 111.153 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.9 29.4 7.29 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.942 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER 41.84 64.94 0.95 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.453 0.701 . . . . 0.0 111.672 176.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 36.1 t -131.82 139.39 48.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.516 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 123.99 15.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.003 175.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' HB2' HG21 ' A' ' 44' ' ' ILE . 6.6 t-20 -75.92 131.58 39.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 173.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.96 130.31 23.07 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HB3' HD21 ' A' ' 57' ' ' ASN . 51.0 Cg_exo -51.33 121.7 8.85 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.357 2.705 . . . . 0.0 113.181 -172.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 24' ' ' VAL . 3.2 tp -79.66 -12.19 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.936 -175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.476 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -60.57 -51.55 68.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -31.28 53.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.761 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -60.79 -14.8 23.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.2 m -70.09 -31.98 69.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 62' ' ' ASN . 6.5 pt -131.06 -32.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.201 0.524 . . . . 0.0 111.392 -178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -87.62 29.63 0.88 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.557 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -69.82 -14.74 62.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.097 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mt -78.05 -5.4 51.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.683 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.679 HG12 HG23 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -69.8 126.53 92.56 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.68 ' HB2' HD22 ' A' ' 68' ' ' ASN . 6.3 Cg_exo -73.6 157.91 48.06 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.822 2.348 . . . . 0.0 111.871 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.753 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 1.5 tp -62.1 -9.6 3.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.81 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.68 HD22 ' HB2' ' A' ' 66' ' ' PRO . 2.8 p30 -59.37 -23.63 62.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.803 175.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.87 8.72 21.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.243 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.753 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 62.4 m-85 -139.53 174.21 10.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.527 -172.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -105.25 121.87 44.75 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.367 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.57 98.54 0.69 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.42 0.628 . . . . 0.0 109.764 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.77 162.44 41.11 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 106.61 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 O-C-N 123.673 0.608 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.439 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.9 OUTLIER -60.35 135.95 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.038 -172.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 1.4 m -138.3 161.81 35.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' A' ' 93' ' ' ILE . 12.3 p -158.96 122.47 3.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.396 0.617 . . . . 0.0 110.124 173.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -97.95 163.5 12.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.76 -175.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.37 136.72 24.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.59 104.57 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 123.714 0.634 . . . . 0.0 113.768 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -68.12 105.8 2.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.872 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -105.21 170.98 7.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.178 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.55 113.13 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.564 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.99 -12.25 57.49 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.258 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.604 ' HG ' HG23 ' A' ' 88' ' ' ILE . 2.8 tp -82.04 75.56 8.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 109.957 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.63 -19.13 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.241 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.04 109.72 13.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.596 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.711 HD11 HD11 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -142.96 157.49 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.546 177.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -95.5 134.62 38.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.816 0.341 . . . . 0.0 110.413 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 2.9 t -108.21 128.75 54.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.302 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 1.8 p -123.84 145.26 47.13 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.672 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.718 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 24.6 Cg_exo -63.64 151.65 84.05 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.281 1.987 . . . . 0.0 111.45 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.478 HG12 ' SG ' ' A' ' 77' ' ' CYS . 3.4 mt -83.15 -83.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.844 0.354 . . . . 0.0 110.41 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.424 ' H ' ' HB ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -96.51 105.09 17.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.404 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.925 0.393 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.83 153.84 32.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.581 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 65' ' ' ILE . 4.0 mt -82.86 111.19 27.82 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HG2' HD21 ' A' ' 69' ' ' ASN . 5.4 Cg_endo -88.48 126.51 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.88 72.48 47.97 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.938 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.32 -56.25 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.855 2.37 . . . . 0.0 112.278 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.57 -18.28 60.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.046 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 60.97 2.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 111.175 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.27 -175.42 31.54 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.9 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.24 137.15 63.64 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.073 2.516 . . . . 0.0 112.668 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.872 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -86.88 166.69 14.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.143 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.89 -26.78 40.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.719 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -53.33 -32.85 51.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.174 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpt -65.48 -49.23 69.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 0.0 110.078 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.45 60.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.8 -29.58 70.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.895 -173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.17 -30.94 69.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 111.198 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.637 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -77.09 7.44 4.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.606 -176.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.34 174.65 10.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.02 168.01 36.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.329 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.17 -4.83 46.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.807 0.337 . . . . 0.0 111.451 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -95.42 5.29 52.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 110.194 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 3.6 mptt -113.95 166.55 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.965 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.612 HG23 HG23 ' A' ' 56' ' ' ILE . 13.9 p -121.84 141.78 40.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.39 137.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.365 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.499 ' HA ' HG12 ' A' ' 54' ' ' ILE . 40.0 m -155.3 159.74 40.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.2 m -101.73 120.66 40.7 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.9 t -144.87 101.05 3.59 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.901 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -84.52 92.77 8.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.523 0.678 . . . . 0.0 109.52 170.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p -124.36 148.81 47.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.982 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 35' ' ' ASN . 0.9 OUTLIER -61.23 -31.54 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 173.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -60.29 -47.47 85.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.648 -1.614 . . . . 0.0 111.018 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HB2' ' OG ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -65.01 -52.42 56.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.991 -176.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.454 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -74.91 -8.62 57.0 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -127.52 26.12 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.929 0.395 . . . . 0.0 110.302 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -75.59 144.59 41.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.861 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -92.74 43.58 1.13 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.998 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.15 57.13 4.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.09 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.77 -128.06 2.1 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.365 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 65.69 -157.68 0.27 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 122.834 0.454 . . . . 0.0 110.867 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.21 142.74 50.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.771 0.319 . . . . 0.0 110.407 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -158.89 114.86 1.64 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.527 177.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 3.5 Cg_endo -85.93 135.56 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.179 2.586 . . . . 0.0 112.203 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.38 167.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.863 ' HB2' ' HB3' ' A' ' 53' ' ' ASN . 3.6 t0 62.69 14.6 7.36 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.375 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.23 9.35 9.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.338 0.59 . . . . 0.0 109.492 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.85 51.25 9.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.547 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.17 61.77 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.834 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.485 ' C ' ' HG2' ' A' ' 50' ' ' GLU . . . 99.8 -67.28 0.57 Allowed Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.566 -176.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' HG2' ' C ' ' A' ' 49' ' ' GLY . 1.9 mm-40 -147.19 6.33 0.87 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.514 0.197 . . . . 0.0 110.923 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.7 m -88.54 137.73 32.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.366 0.603 . . . . 0.0 112.397 -168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -141.7 139.69 32.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.757 177.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.863 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.7 t-20 -97.68 133.91 41.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -109.52 125.01 32.27 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.493 -174.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HB3' ' ND2' ' A' ' 57' ' ' ASN . 52.4 Cg_exo -56.88 122.73 12.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.464 2.776 . . . . 0.0 113.702 -173.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.612 HG23 HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -75.15 -16.91 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.745 -177.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -53.82 -43.15 69.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.23 -173.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -78.32 -36.24 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.469 HD11 ' HZ ' ' A' ' 70' ' ' PHE . 2.7 mp -54.56 -33.32 59.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.868 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -32.5 34.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.84 -20.51 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.235 0.54 . . . . 0.0 110.971 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -99.09 28.1 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.286 -177.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -68.27 -13.83 62.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.371 0.605 . . . . 0.0 110.67 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.96 -8.04 55.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.553 HG13 HG23 ' A' ' 3' ' ' ILE . 1.5 tt -67.99 133.58 91.92 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 110.652 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.872 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 3.7 Cg_exo -79.57 163.42 24.19 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.937 2.425 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 tp -63.02 -9.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -25.38 67.41 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.26 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.443 HD21 ' HG2' ' A' ' 4' ' ' PRO . 1.5 m-80 -98.31 28.04 4.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.541 0.686 . . . . 0.0 109.623 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.469 ' HZ ' HD11 ' A' ' 59' ' ' LEU . 14.9 m-85 -144.3 173.01 12.14 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.01 127.85 51.58 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.576 -172.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.3 98.78 1.81 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -154.55 161.4 41.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.218 -170.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.59 103.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.15 0.5 . . . . 0.0 109.94 172.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.1 OUTLIER -54.6 115.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.695 -173.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -113.97 135.92 53.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.326 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 23' ' ' LYS . 5.3 t -122.99 120.68 34.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 3.2 t -118.03 163.21 16.94 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.996 -174.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.23 138.39 50.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.6 104.91 0.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.458 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.714 ' HG2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -63.89 134.33 54.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.367 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.16 154.58 37.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.937 -176.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' H ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -62.75 112.03 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.127 0.489 . . . . 0.0 110.413 -178.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.86 -19.34 5.54 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.45 -37.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.797 0.332 . . . . 0.0 111.516 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 140.51 50.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.714 HD13 ' HG2' ' A' ' 81' ' ' GLU . 2.0 pt -137.99 157.29 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.79 -174.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -98.81 121.38 40.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.676 178.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 m -114.4 132.54 56.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.318 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.99 151.05 77.26 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.584 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 Cg_exo -61.3 127.03 20.79 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.653 2.235 . . . . 0.0 111.595 174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.637 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -84.22 -41.73 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.204 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.94 104.04 13.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.692 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.369 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.995 0.426 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.69 150.07 23.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.505 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.484 HG23 ' HA ' ' A' ' 65' ' ' ILE . 3.1 mp -71.13 115.95 41.81 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.84 126.7 4.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.085 2.523 . . . . 0.0 112.037 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 73.87 23.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD2' ' OD1' ' A' ' 68' ' ' ASN . 37.8 Cg_endo -69.41 -25.64 30.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.164 1.91 . . . . 0.0 110.99 171.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.17 77.18 0.38 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.576 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -72.48 127.51 32.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.246 0.546 . . . . 0.0 111.83 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 10' ' ' PRO . . . -153.57 -126.78 1.14 Allowed Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 9' ' ' GLY . 19.2 Cg_endo -62.44 133.84 45.05 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.662 2.241 . . . . 0.0 112.21 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -81.22 154.79 26.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.235 178.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.607 HG12 HD12 ' A' ' 67' ' ' ILE . 35.8 m -67.72 -24.87 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.912 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -30.27 71.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.943 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -40.3 90.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.204 0.526 . . . . 0.0 110.13 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.15 73.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.427 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -61.01 -29.24 69.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.23 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -31.68 71.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.031 0.443 . . . . 0.0 110.997 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.76 9.61 21.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.59 -176.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' HB2' HG23 ' A' ' 93' ' ' ILE . 5.4 t -133.84 174.39 10.51 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.16 156.02 39.09 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.193 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.42 87.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.54 38.65 1.2 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.393 0.616 . . . . 0.0 110.114 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 7.1 mttt -125.47 144.45 50.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.537 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.79 129.04 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.993 0.425 . . . . 0.0 110.362 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.478 HG12 ' HE2' ' A' ' 70' ' ' PHE . 16.1 t -85.57 106.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.64 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -120.21 171.49 8.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -130.78 108.85 10.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.073 0.463 . . . . 0.0 110.482 170.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 48.6 m -137.53 144.26 42.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.45 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.52 HD22 ' HB3' ' A' ' 50' ' ' GLU . 71.9 m-20 -105.68 99.92 9.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.804 0.335 . . . . 0.0 111.527 -176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.79 141.62 28.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -23.28 57.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.841 0.829 . . . . 0.0 109.613 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -84.07 -18.42 37.01 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.027 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.37 -32.23 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.222 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -32.9 72.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.996 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.83 -4.31 59.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.832 -177.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.76 33.68 20.13 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 38.41 2.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.225 0.536 . . . . 0.0 110.462 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.64 110.29 22.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.432 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.56 28.5 2.98 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.62 -102.75 0.41 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.69 132.99 43.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.37 71.97 26.4 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.645 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.24 -177.02 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.038 2.492 . . . . 0.0 112.606 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -142.29 169.26 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.356 -179.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.575 ' OD1' ' HG ' ' A' ' 47' ' ' LEU . 2.8 p30 -147.45 -172.25 3.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.492 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.45 35.84 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.727 0.299 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.575 ' HG ' ' OD1' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -95.88 179.67 5.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.091 0.472 . . . . 0.0 111.083 -177.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.56 71.39 4.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.897 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 -126.79 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.487 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HB3' HD22 ' A' ' 29' ' ' ASN . 24.2 mt-10 -113.99 44.54 1.63 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.458 0.171 . . . . 0.0 111.26 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 42.2 t -163.65 139.29 6.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.597 0.237 . . . . 0.0 110.386 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.74 116.12 5.78 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.64 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.9 t30 -84.6 94.37 8.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -68.11 136.29 91.67 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.267 -172.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.439 ' O ' HD12 ' A' ' 59' ' ' LEU . 28.1 Cg_exo -61.84 123.45 12.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.171 2.581 . . . . 0.0 112.744 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.488 ' H ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -72.74 -12.68 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.433 -175.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -40.12 88.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.5 -175.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.458 ' H ' HG13 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -79.84 -32.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.892 0.377 . . . . 0.0 110.576 175.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -65.58 -17.94 64.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 -173.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -60.83 2.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.448 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.53 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -96.22 -37.19 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.044 0.449 . . . . 0.0 111.576 -177.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' N ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -88.97 36.03 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.436 0.636 . . . . 0.0 109.907 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -72.67 -8.0 53.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.977 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 64' ' ' LEU . 3.7 mm? -76.47 -7.98 56.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.953 176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.484 ' HA ' HG23 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -62.84 137.16 96.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.969 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.2 Cg_exo -79.07 159.48 26.95 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.047 2.498 . . . . 0.0 111.679 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.607 HD12 HG12 ' A' ' 12' ' ' VAL . 2.6 tp -61.2 -9.25 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.562 ' OD1' ' HD2' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -58.74 -28.99 66.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.791 0.329 . . . . 0.0 111.171 173.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.07 27.55 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.459 0.647 . . . . 0.0 109.997 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' HE2' HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -142.41 174.93 10.18 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -172.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.17 127.68 49.0 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.666 -173.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.93 94.68 3.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -156.44 161.69 40.06 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.7 98.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.411 0.444 . . . . 0.0 109.87 171.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.508 ' HB ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -57.53 128.08 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -173.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.26 105.95 4.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.226 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 27.4 p -104.96 129.56 53.36 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.553 0.692 . . . . 0.0 110.851 -177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 11.8 m -105.27 164.09 12.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.076 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.53 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -54.99 139.3 41.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 173.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -50.41 114.59 2.68 Favored Glycine 0 C--N 1.331 0.252 0 O-C-N 123.309 0.381 . . . . 0.0 112.683 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 143.19 33.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.041 0.448 . . . . 0.0 110.675 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.59 174.87 14.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.33 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.68 119.28 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.799 0.333 . . . . 0.0 110.179 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.01 4.06 31.44 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.168 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.402 HD22 HG23 ' A' ' 88' ' ' ILE . 2.4 mt -112.0 112.83 24.74 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.8 -27.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.61 135.7 16.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.338 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.76 174.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.93 -177.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.91 128.05 48.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 98.6 m -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.491 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.6 t -150.07 143.57 16.75 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.339 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.0 Cg_endo -57.41 136.64 77.27 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.64 2.227 . . . . 0.0 111.677 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.51 HG22 ' HB3' ' A' ' 18' ' ' LYS . 1.2 mt -88.39 -73.03 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.61 72.25 1.76 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.016 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.056 178.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.883 0.373 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.53 158.15 17.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.675 HG23 HG12 ' A' ' 65' ' ' ILE . 7.2 mt -80.25 109.92 14.46 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 4.2 Cg_endo -89.82 124.93 1.29 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.344 2.696 . . . . 0.0 112.261 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.559 ' HB1' ' HG3' ' A' ' 8' ' ' GLU . . . -141.47 67.66 25.09 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.757 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.78 -28.72 7.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.776 1.651 . . . . 0.0 111.842 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.83 -44.21 2.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.618 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.559 ' HG3' ' HB1' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 57.38 50.53 11.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.033 0.444 . . . . 0.0 111.385 177.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.78 -128.64 6.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.807 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.42 143.49 69.88 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -90.11 154.16 19.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 0.0 111.087 -178.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.06 -27.76 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.448 0.642 . . . . 0.0 110.028 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -67.06 -26.32 66.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.941 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 ttm -64.11 -47.27 80.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.97 -36.99 72.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 20.9 tt0 -64.0 -29.58 70.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.139 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -31.29 64.67 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 111.404 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -76.8 -10.06 59.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 -177.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 175.03 7.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.85 -165.05 22.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.497 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.51 -7.07 48.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.904 0.383 . . . . 0.0 110.942 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.83 9.64 42.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.274 0.559 . . . . 0.0 110.116 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -126.98 153.68 45.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.369 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.692 HG11 ' HG2' ' A' ' 81' ' ' GLU . 6.6 p -108.53 131.17 59.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.058 0.456 . . . . 0.0 110.586 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 t -83.89 144.5 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.615 ' HA ' HG12 ' A' ' 54' ' ' ILE . 8.0 t -154.74 170.31 21.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.691 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.502 ' SG ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -122.52 99.97 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 172.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.688 ' HA ' ' HB2' ' A' ' 51' ' ' CYS . 16.1 m -131.56 109.82 10.52 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.089 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 3.0 p30 -88.68 134.58 33.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.191 0.519 . . . . 0.0 110.957 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 38.4 m -158.52 155.43 28.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.763 176.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -70.56 -38.23 74.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.205 0.526 . . . . 0.0 109.888 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -20.44 64.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.465 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -74.12 -29.77 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.04 177.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -90.56 -34.87 15.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -100.79 29.15 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.266 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.1 67.72 0.3 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -80.73 107.27 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 39.3 m 76.47 -51.72 0.59 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.136 0.897 . . . . 0.0 109.535 -168.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.52 164.86 34.62 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.277 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.81 155.89 49.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.87 110.32 7.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 0.0 111.094 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.604 HG13 ' HD2' ' A' ' 43' ' ' PRO . 0.4 OUTLIER -111.35 133.94 21.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.158 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.604 ' HD2' HG13 ' A' ' 42' ' ' ILE . 92.1 Cg_endo -88.72 -175.89 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.71 2.273 . . . . 0.0 112.366 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 90' ' ' CYS . 4.3 mp -119.97 120.88 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -164.33 157.91 18.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.085 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.474 HG12 ' HG2' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -82.6 45.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.418 0.628 . . . . 0.0 111.21 -176.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.23 -49.86 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.821 177.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.7 86.99 2.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.58 -4.75 80.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.985 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' HG2' HG12 ' A' ' 46' ' ' VAL . 2.9 tt0 67.63 58.5 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.41 0.624 . . . . 0.0 110.394 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.688 ' HB2' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -111.58 165.43 12.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.542 -175.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.13 140.61 5.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.04 145.83 55.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.627 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -106.81 126.46 30.21 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.1 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 75.1 Cg_exo -51.01 122.47 10.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.393 2.729 . . . . 0.0 113.544 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -76.01 -12.82 14.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.491 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.541 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -64.21 -34.52 78.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.355 -175.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.33 -38.5 20.01 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.224 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -15.6 46.09 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -28.61 48.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.82 0.343 . . . . 0.0 111.856 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.53 HG13 ' N ' ' A' ' 62' ' ' ASN . 8.4 pt -129.26 -41.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.206 0.527 . . . . 0.0 111.19 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' N ' HG13 ' A' ' 61' ' ' ILE . 5.6 m-80 -83.23 36.62 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.722 0.809 . . . . 0.0 110.194 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 24.5 pt20 -72.46 -7.4 49.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.253 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -1.45 45.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.656 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 3' ' ' ILE . 59.3 mt -80.23 120.26 79.01 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.349 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 23.5 Cg_exo -64.85 164.38 24.68 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 112.284 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.5 tp -62.49 -8.89 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.515 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -65.24 -7.46 13.16 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.462 ' N ' HD22 ' A' ' 68' ' ' ASN . 74.1 m-80 -116.4 29.91 7.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.491 0.662 . . . . 0.0 110.107 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -143.82 173.14 11.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 121.49 43.92 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.933 0.397 . . . . 0.0 111.64 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -72.25 98.14 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.619 0.724 . . . . 0.0 109.158 172.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.49 ' CG ' ' HB3' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -155.49 161.94 40.82 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.17 104.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 0.0 110.273 174.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -59.65 127.05 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.614 -172.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.61 152.89 43.0 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.092 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.581 ' HB2' HG12 ' A' ' 93' ' ' ILE . 19.2 t -144.58 119.04 9.65 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -113.52 164.1 14.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.695 -172.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.19 127.25 18.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 175.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -36.42 108.86 0.06 OUTLIER Glycine 0 C--N 1.34 0.781 0 O-C-N 124.081 0.863 . . . . 0.0 112.763 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.692 ' HG2' HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -82.84 129.23 34.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.17 -0.515 . . . . 0.0 110.883 -173.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 140.93 34.47 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.737 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 mt -56.2 119.98 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 123.655 0.597 . . . . 0.0 111.053 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.84 -26.75 4.22 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.464 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.37 136.3 33.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.876 0.369 . . . . 0.0 110.305 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 t -74.81 -47.89 35.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -143.87 151.58 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.882 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -142.25 145.66 23.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -96.7 131.53 43.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.984 0.421 . . . . 0.0 110.69 -175.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.8 t -109.72 145.16 37.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.873 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.61 152.29 52.51 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 31.6 Cg_endo -64.09 140.44 71.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.645 2.23 . . . . 0.0 112.748 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.581 HG12 ' HB2' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -95.71 -62.68 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.913 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 100.94 13.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.12 0.486 . . . . 0.0 110.521 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.138 178.352 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.451 ' HB3' HD21 ' A' ' 62' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.438 . . . . 0.0 110.709 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.23 114.78 28.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.67 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.863 HG23 HG12 ' A' ' 65' ' ' ILE . 8.0 mt -77.91 111.94 21.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.725 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 5.1 Cg_endo -89.2 128.68 1.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.524 2.816 . . . . 0.0 112.381 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.65 68.08 16.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.77 -39.83 8.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.224 1.949 . . . . 0.0 112.116 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.01 -21.23 59.51 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.868 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 49.49 69.42 0.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.29 0.567 . . . . 0.0 111.51 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.76 -173.4 14.82 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.205 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.46 142.73 37.67 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.345 2.696 . . . . 0.0 112.335 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -87.6 157.28 19.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.832 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.71 -25.82 38.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.006 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 16' ' ' GLN . 40.2 m -60.45 -28.84 68.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.174 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -48.12 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.63 -37.9 73.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.771 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 13' ' ' SER . 23.4 tt0 -62.86 -31.48 72.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.328 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -32.75 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.82 0.343 . . . . 0.0 111.277 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -88.89 16.49 6.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.141 -177.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.19 175.02 10.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.898 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.67 167.43 22.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.09 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.19 -16.11 61.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.381 0.61 . . . . 0.0 110.157 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -89.76 19.37 4.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.459 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 79' ' ' SER . 1.8 mptt -132.6 156.0 47.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.597 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -105.1 123.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.197 0.522 . . . . 0.0 110.398 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.85 103.63 12.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.911 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -116.5 172.69 7.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.439 -177.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 p -126.74 128.4 46.6 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.921 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . 34.0 t -157.32 141.38 16.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.379 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.414 HD21 ' CG ' ' A' ' 50' ' ' GLU . 4.7 p30 -98.65 94.02 6.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.93 0.871 . . . . 0.0 110.455 174.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.489 ' H ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -116.47 146.8 42.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.049 178.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -72.17 -26.03 61.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 0.0 110.269 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.42 -44.01 92.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.355 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.489 HD12 ' H ' ' A' ' 30' ' ' SER . 4.4 mt -67.3 -44.79 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -14.03 61.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.543 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.48 14.52 19.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.256 -0.278 . . . . 0.0 110.877 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.97 41.16 30.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.753 176.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 65.39 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.801 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -77.11 95.17 4.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.931 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.86 -157.35 9.67 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.35 4.67 50.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.024 0.44 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.03 -7.56 59.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.717 HG12 ' HB3' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -88.52 117.63 68.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.285 0.564 . . . . 0.0 111.641 -174.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 13.0 Cg_endo -91.21 -168.56 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.683 2.922 . . . . 0.0 111.415 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 26' ' ' SER . 5.3 tp -155.17 1.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.329 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.44 -149.2 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.668 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.15 124.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.973 0.416 . . . . 0.0 111.451 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.444 HD11 ' SG ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -141.11 -177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.825 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 66.37 2.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.096 0.474 . . . . 0.0 110.672 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.4 -143.52 4.07 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.534 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' CG ' HD21 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -137.91 70.4 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 -176.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 28' ' ' CYS . 19.4 m -129.04 149.58 50.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.33 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -152.55 128.51 10.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -75.73 123.21 25.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.175 170.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.579 HG21 ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -88.52 133.21 36.78 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.327 -175.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.662 ' HB3' HD21 ' A' ' 57' ' ' ASN . 51.3 Cg_exo -53.86 127.56 26.09 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.506 2.804 . . . . 0.0 112.951 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.41 -12.53 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.921 -174.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.662 HD21 ' HB3' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -59.24 -40.68 86.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.832 -176.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.13 -25.21 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.612 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.17 -18.91 64.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -170.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -30.48 56.89 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.11 -38.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.127 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 HD21 ' HB3' ' A' ' 1' ' ' SER . 31.3 m-20 -83.25 28.19 0.54 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.36 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -8.63 55.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.422 0.63 . . . . 0.0 109.717 175.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.88 -7.52 58.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.213 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 3' ' ' ILE . 42.9 mt -75.99 126.94 86.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.247 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.727 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 14.9 Cg_exo -69.59 167.59 23.78 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.566 2.177 . . . . 0.0 111.93 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.626 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -58.25 -9.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.6 -177.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -24.92 64.86 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.412 HD21 ' HG2' ' A' ' 4' ' ' PRO . 15.3 m-80 -100.32 16.14 25.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.504 0.669 . . . . 0.0 109.766 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.626 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 98.9 m-85 -126.75 176.0 7.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.99 127.46 48.84 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -177.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.48 98.59 3.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.46 160.64 40.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.217 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.0 112.53 0.53 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.295 0.569 . . . . 0.0 110.441 173.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.6 ' HB ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -61.61 130.77 26.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.53 -174.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 m -129.36 115.58 17.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.848 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 20.3 t -104.96 118.25 36.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.045 0.45 . . . . 0.0 110.096 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -114.9 163.35 15.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 -175.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.439 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.51 133.75 24.65 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 174.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -43.92 109.68 0.27 Allowed Glycine 0 C--N 1.335 0.495 0 O-C-N 123.792 0.683 . . . . 0.0 112.737 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.01 29.18 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.332 0.587 . . . . 0.0 110.508 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.54 173.4 7.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.18 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.44 117.05 2.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 123.364 0.415 . . . . 0.0 110.693 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.37 -43.02 1.61 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 84.16 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.971 0.415 . . . . 0.0 110.153 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -41.06 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 131.33 55.25 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.9 pt -132.86 163.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.429 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -107.58 120.02 41.04 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.717 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 t -108.6 135.7 49.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.319 0.581 . . . . 0.0 111.043 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -129.72 141.67 42.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.31 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 91' ' ' THR . 22.7 Cg_exo -63.39 126.6 18.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.358 2.039 . . . . 0.0 111.63 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.6 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -82.52 -52.1 13.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.163 0.506 . . . . 0.0 110.151 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.84 144.71 45.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.014 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.672 178.336 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.74 146.61 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.489 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.721 HG23 HG13 ' A' ' 65' ' ' ILE . 6.6 mt -85.46 114.02 54.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.972 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 7.5 Cg_exo -72.84 124.96 10.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.735 2.29 . . . . 0.0 111.874 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.61 88.02 9.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.98 -45.19 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.008 2.472 . . . . 0.0 112.351 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.53 27.01 5.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.463 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 48.76 65.55 1.33 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.795 0.438 . . . . 0.0 111.554 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.47 160.98 27.14 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.161 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.54 144.86 96.7 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.092 2.528 . . . . 0.0 112.267 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 154.76 29.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.982 0.42 . . . . 0.0 110.978 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.61 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.985 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 p -67.2 -26.68 66.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.214 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -45.1 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.0 110.002 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.64 -39.87 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -59.21 -29.91 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.443 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -56.72 -30.85 63.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.124 0.488 . . . . 0.0 111.362 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.45 -4.15 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.777 ' HB2' HG23 ' A' ' 93' ' ' ILE . 18.6 t -127.84 174.74 8.89 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.93 146.65 41.85 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.739 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.77 -9.52 59.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 111.08 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.97 21.98 10.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.655 0.74 . . . . 0.0 109.85 176.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HE2' ' SG ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -121.02 147.19 45.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.547 179.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.789 HG13 ' HA2' ' A' ' 80' ' ' GLY . 6.7 m -88.83 140.6 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 0.0 110.772 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.18 121.12 43.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.2 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.676 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -135.67 159.12 42.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.967 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.8 m -101.3 121.31 41.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.47 118.39 5.84 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -106.48 95.45 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.28 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.43 151.07 20.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -64.71 -37.99 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.663 -178.485 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -73.46 -30.26 63.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.41 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.23 -32.9 74.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.529 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -62.47 -23.04 66.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.153 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -115.15 10.09 16.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.728 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.25 30.05 17.78 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.78 121.59 33.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.25 -177.448 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.23 155.25 20.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.446 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.64 -105.1 2.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.703 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.37 -38.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.181 0.515 . . . . 0.0 110.338 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -125.0 147.1 49.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.026 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.697 HG13 ' HA ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -120.24 78.85 26.79 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.537 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.18 124.13 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.025 2.484 . . . . 0.0 112.183 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 44' ' ' ILE . 2.6 mm -86.55 121.29 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.94 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.49 174.39 8.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.464 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.63 45.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.957 0.408 . . . . 0.0 111.12 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -87.03 131.93 33.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.696 178.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.27 85.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.256 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.78 10.01 2.13 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.071 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -134.9 -69.12 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 109.849 -178.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.3 m -146.75 139.2 24.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.783 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.41 129.24 15.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 22.8 t-20 -85.03 124.16 31.4 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.474 ' H ' HG12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -95.51 130.54 31.73 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.302 -174.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 79.4 Cg_exo -47.95 121.88 6.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.462 2.774 . . . . 0.0 113.291 -174.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.699 HD13 HG12 ' A' ' 24' ' ' VAL . 7.5 tp -75.17 -11.46 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.602 -173.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.24 -40.6 86.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.256 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.55 -25.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.702 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 56' ' ' ILE . 1.3 mm? -63.72 -23.8 67.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -60.29 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.595 HG13 ' N ' ' A' ' 62' ' ' ASN . 5.7 pt -81.47 -44.3 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 111.141 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.603 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -92.04 38.54 1.0 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.88 -176.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.1 -14.17 62.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.921 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.21 1.29 51.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.89 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.721 HG13 HG23 ' A' ' 3' ' ' ILE . 1.5 tt -66.01 135.93 95.38 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.34 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 3.0 Cg_exo -77.82 161.09 30.59 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.009 2.473 . . . . 0.0 111.742 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 67' ' ' ILE . 2.4 tp -67.11 -8.68 8.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.887 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.464 HD22 ' HB2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -57.9 -32.3 67.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.903 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.417 HD21 HG12 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -103.48 60.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 109.316 176.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.89 173.15 16.91 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.2 133.48 49.04 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.313 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 m -80.54 94.18 6.21 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.063 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.588 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 17.9 m-20 -155.9 160.33 40.06 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -51.33 105.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.267 0.556 . . . . 0.0 110.812 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -62.24 135.33 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.778 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 m -144.13 148.66 35.37 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -172.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 20.1 p -129.18 119.62 24.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.694 0.759 . . . . 0.0 110.906 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 21.4 m -99.54 155.22 17.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.572 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 89' ' ' GLN . 0.3 OUTLIER -52.35 128.41 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.789 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -32.6 104.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.786 0 O-C-N 124.271 0.982 . . . . 0.0 114.19 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.51 93.1 1.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.429 0.633 . . . . 0.0 110.165 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.69 173.1 10.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.109 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.95 129.56 29.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.352 0.596 . . . . 0.0 110.891 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.0 -26.71 11.08 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.753 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 122.84 34.81 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.0 -52.31 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.032 0.444 . . . . 0.0 110.876 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -99.12 117.48 33.7 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 78' ' ' CYS . 17.7 pt -126.83 159.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.697 ' HA ' HG13 ' A' ' 42' ' ' ILE . 3.9 pt20 -109.65 128.46 55.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.488 ' HB2' ' CG2' ' A' ' 42' ' ' ILE . 94.3 m -107.93 127.3 53.63 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.113 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -138.3 135.61 18.5 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.581 -174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.75 141.01 77.22 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.131 2.554 . . . . 0.0 112.794 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 19' ' ' CYS . 2.1 mt -91.71 -77.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.581 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tp -74.51 121.48 21.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.787 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.969 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.829 0.347 . . . . 0.0 111.496 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.72 144.97 50.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.529 0.204 . . . . 0.0 110.607 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 65' ' ' ILE . 26.9 mt -94.93 111.45 54.57 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.835 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 65' ' ' ILE . 6.1 Cg_exo -78.74 126.02 7.09 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.007 2.471 . . . . 0.0 112.38 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.11 71.09 18.42 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.213 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.35 -23.83 32.22 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.743 2.295 . . . . 0.0 111.821 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.82 -21.9 4.1 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.09 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.83 51.75 15.31 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.08 0.552 . . . . 0.0 111.146 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.96 -156.19 32.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.441 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.82 134.41 58.88 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.89 2.393 . . . . 0.0 112.11 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 m -89.73 155.66 19.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.227 0.536 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 67' ' ' ILE . 48.4 t -65.9 -25.2 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.223 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.92 -35.43 66.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.034 177.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.4 tpp -62.65 -42.27 99.52 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.369 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.67 78.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -60.92 -32.75 72.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.367 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -30.3 62.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.836 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.07 -3.12 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.894 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 174.79 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.8 151.06 38.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.254 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.02 -9.01 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 110.998 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.58 12.04 24.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.406 0.622 . . . . 0.0 109.748 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -119.89 166.78 12.86 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.332 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.858 HG13 ' HA2' ' A' ' 80' ' ' GLY . 9.9 m -106.24 160.61 5.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.216 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.02 116.2 51.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.668 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -131.42 149.02 52.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.504 -178.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 107.32 17.89 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 51' ' ' CYS . 3.3 m -126.14 121.45 32.87 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.862 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 11.2 t-20 -86.42 113.94 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.742 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.2 144.19 32.07 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -74.79 -42.99 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.356 0.598 . . . . 0.0 110.329 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.3 pm0 -68.77 -27.46 65.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.541 -175.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -32.27 72.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.145 0.498 . . . . 0.0 110.757 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -8.37 54.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.533 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.65 23.84 3.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.866 0.365 . . . . 0.0 111.412 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.7 m -81.27 78.07 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.365 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -59.86 -66.86 0.45 Allowed 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.943 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.24 -39.94 14.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.509 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.34 158.61 9.34 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.82 -166.91 1.98 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.27 120.84 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.467 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.635 HG21 ' HB2' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -108.32 117.86 53.68 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.554 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.44 ' HB3' ' HB2' ' A' ' 48' ' ' SER . 17.1 Cg_endo -91.63 99.0 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.24 2.627 . . . . 0.0 112.696 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -101.75 36.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.558 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.97 161.5 39.21 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.88 48.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.591 -174.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 tp -127.03 -75.17 0.58 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -73.27 90.98 1.66 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.751 179.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 92.56 -8.45 76.95 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.233 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 63.87 57.47 1.35 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.243 0.544 . . . . 0.0 111.014 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -90.95 144.64 25.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.532 178.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 130.67 47.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 37.6 t-20 -79.59 101.1 8.11 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.546 HG22 ' HD2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -64.88 131.59 95.23 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.101 -174.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.562 ' O ' HG13 ' A' ' 58' ' ' ILE . 6.3 Cg_endo -47.84 123.62 8.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.994 3.129 . . . . 0.0 113.73 -171.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.76 -23.56 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.992 -174.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.559 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -59.45 -43.47 93.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.366 -176.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -80.12 -17.8 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.918 0.389 . . . . 0.0 110.721 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 59' ' ' LEU . 1.9 mm? -71.02 -33.44 70.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.784 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -51.4 9.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.987 0.422 . . . . 0.0 112.132 -176.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 62' ' ' ASN . 3.2 pt -99.46 -44.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.947 -174.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' O ' HG13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -93.63 30.7 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.883 0.373 . . . . 0.0 110.987 -174.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.18 -8.43 54.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.504 0.668 . . . . 0.0 109.564 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mt -75.18 -13.26 60.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.848 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 3' ' ' ILE . 21.4 mt -66.97 129.7 93.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 48.7 Cg_exo -56.46 152.14 41.66 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.545 2.163 . . . . 0.0 111.567 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.741 HD12 HG22 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -59.11 -8.54 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -175.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -26.09 54.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.723 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.75 13.59 19.76 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.843 0.83 . . . . 0.0 110.264 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.465 ' CE2' HG13 ' A' ' 54' ' ' ILE . 1.1 m-85 -130.6 173.4 10.92 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 123.99 48.72 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.995 -170.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 96.73 2.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 3.4 t0 -156.79 163.58 39.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.213 -173.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.23 97.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 0.0 109.845 168.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -71.97 135.53 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.312 -172.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 140.63 51.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.287 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.483 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 122.25 38.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.617 0.722 . . . . 0.0 109.346 174.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 89' ' ' GLN . 14.4 m -111.87 162.97 14.72 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.686 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.38 135.36 39.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.016 0.371 . . . . 0.0 110.087 174.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.858 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -47.18 107.22 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 123.644 0.59 . . . . 0.0 112.729 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -55.4 119.15 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.735 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.36 26.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.349 -177.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.516 HG13 ' H ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.48 113.13 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.912 0.387 . . . . 0.0 110.518 -178.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.15 -17.76 5.92 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.804 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 108.54 10.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.872 0.368 . . . . 0.0 110.105 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.79 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.013 0.435 . . . . 0.0 110.778 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -101.09 108.77 20.55 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -110.35 162.58 7.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.822 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 23.7 mt-30 -99.47 121.09 40.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.712 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.635 ' HB2' HG21 ' A' ' 42' ' ' ILE . 89.2 m -108.3 127.61 54.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.137 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 t -132.47 139.99 36.48 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.284 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 9.5 Cg_endo -54.44 126.6 22.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.648 2.232 . . . . 0.0 111.658 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -69.35 -38.98 78.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.158 0.504 . . . . 0.0 110.437 -178.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.88 117.22 20.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.857 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.48 143.03 50.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.525 HG23 HG12 ' A' ' 65' ' ' ILE . 2.8 mp -98.95 110.83 59.08 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.032 0.444 . . . . 0.0 110.046 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 131.23 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.498 2.799 . . . . 0.0 112.003 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 8' ' ' GLU . . . -135.77 66.44 62.8 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 6.5 Cg_exo -73.91 -70.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.205 1.937 . . . . 0.0 110.27 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.33 74.99 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.435 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -69.24 129.6 40.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 0.0 111.251 -175.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.42 -141.07 3.23 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.423 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 133.43 58.07 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -91.64 155.09 18.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.72 -25.29 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.003 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -65.0 -29.29 70.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.582 -175.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -36.19 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 109.982 177.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.86 -35.17 78.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.116 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -70.3 -31.28 68.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -32.74 74.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.924 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -88.54 3.92 48.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.202 -179.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.488 ' SG ' ' HD2' ' A' ' 23' ' ' LYS . 32.7 t -127.2 175.75 7.91 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.68 159.47 30.57 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.167 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.83 -35.67 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 111.098 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -89.19 36.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.494 0.664 . . . . 0.0 110.011 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 79' ' ' SER . 11.2 mttt -135.97 166.01 24.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.614 HG13 ' HA2' ' A' ' 80' ' ' GLY . 2.8 m -118.8 130.1 74.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.187 0.518 . . . . 0.0 111.398 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -81.44 131.59 33.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.669 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.37 164.82 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.167 0.508 . . . . 0.0 110.861 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.813 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -123.76 110.14 14.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.735 ' HA ' ' CB ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -151.89 113.21 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.315 0.384 . . . . 0.0 110.15 178.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.804 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . 9.8 p30 -85.29 152.84 22.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.71 0.766 . . . . 0.0 112.521 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 m -157.94 147.37 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.078 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -68.4 -31.57 71.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.154 0.502 . . . . 0.0 110.584 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -17.38 60.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.766 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -56.95 -29.56 63.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -174.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -71.12 -10.02 59.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.539 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -141.68 26.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 111.251 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 33' ' ' LEU . 69.6 m -77.74 84.85 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 0.0 111.32 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -86.33 -42.59 13.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.48 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.73 149.43 24.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.464 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' HA3' ' OE1' ' A' ' 89' ' ' GLN . . . -118.75 137.79 13.12 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.238 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.19 -115.91 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -101.08 88.89 3.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -96.76 134.26 23.38 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.866 -177.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 42' ' ' ILE . 37.3 Cg_exo -61.25 140.59 89.52 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.187 2.591 . . . . 0.0 112.774 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.603 HG12 ' HB2' ' A' ' 53' ' ' ASN . 5.9 tt -142.36 -17.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.832 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -161.6 -162.34 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.258 -0.276 . . . . 0.0 110.605 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t 63.86 10.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.895 0.747 . . . . 0.0 111.094 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 53.37 42.09 32.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.415 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.72 63.88 1.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.953 0.882 . . . . 0.0 109.091 172.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.94 -94.37 0.21 Allowed Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -172.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -175.48 70.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.157 0.503 . . . . 0.0 109.811 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 25.7 p -167.12 171.79 10.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.357 -174.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -156.87 152.8 27.25 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.077 0.236 . . . . 0.0 110.781 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.603 ' HB2' HG12 ' A' ' 44' ' ' ILE . 64.6 t30 -91.56 133.04 35.87 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.529 HD11 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -97.25 136.77 21.28 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.489 -169.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 31.7 Cg_exo -59.48 132.99 49.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.649 2.899 . . . . 0.0 113.454 -177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -77.97 -27.65 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.603 -175.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -55.59 -35.33 65.69 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -79.04 -39.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.084 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -55.39 -26.31 40.8 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -28.54 69.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.413 HG12 ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -131.49 -37.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.041 0.448 . . . . 0.0 110.648 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 9.7 m-80 -80.27 24.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.986 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -69.92 -7.59 41.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.381 177.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.83 -10.8 59.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.667 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 3' ' ' ILE . 78.7 mt -73.37 126.05 90.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.409 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 10.6 Cg_exo -71.62 164.18 36.53 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.689 2.259 . . . . 0.0 111.541 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.624 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 2.2 tp -57.88 -8.9 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -26.25 62.17 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -106.44 33.76 3.72 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.699 0.762 . . . . 0.0 109.383 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.624 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 80.1 m-85 -149.04 175.94 10.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.53 115.85 31.41 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.717 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 97.83 0.91 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.804 ' OD1' ' HB3' ' A' ' 29' ' ' ASN . 18.4 t0 -155.21 162.87 40.82 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.373 -173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.51 99.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.98 0.8 . . . . 0.0 110.017 170.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -60.69 130.18 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.345 -169.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.3 m -124.08 153.84 40.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.117 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -144.29 121.9 11.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.716 0.77 . . . . 0.0 109.407 171.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 90' ' ' CYS . 5.8 t -110.46 163.41 13.71 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.9 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.628 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -54.35 134.55 45.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 172.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 24' ' ' VAL . . . -48.09 108.24 0.33 Allowed Glycine 0 CA--C 1.507 -0.444 0 O-C-N 123.558 0.536 . . . . 0.0 112.172 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.02 130.56 44.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.323 0.582 . . . . 0.0 110.406 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.89 150.65 51.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.596 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -55.14 112.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 177.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.17 -32.06 6.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 89.26 7.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -77.71 -41.35 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.704 -176.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.0 105.75 17.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.924 0.393 . . . . 0.0 111.19 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 79' ' ' SER . 1.5 pt -114.42 164.49 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.665 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.406 ' OE1' ' HA3' ' A' ' 39' ' ' GLY . 4.9 mm100 -106.46 112.34 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.295 . . . . 0.0 110.274 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 3.5 m -107.56 133.99 51.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.427 -177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 149.48 64.68 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.267 -175.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.23 121.85 8.66 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.871 2.381 . . . . 0.0 112.157 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -72.87 -30.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.86 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tp -133.84 103.47 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.938 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.13 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 120.511 0.196 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.4 155.62 18.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.967 0.413 . . . . 0.0 111.424 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.562 HG23 HG12 ' A' ' 65' ' ' ILE . 4.5 mt -103.61 112.18 65.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.222 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HG2' HD21 ' A' ' 69' ' ' ASN . 2.9 Cg_exo -76.55 125.11 8.07 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.68 2.254 . . . . 0.0 111.996 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.18 82.96 67.19 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.133 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.43 -71.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.964 2.443 . . . . 0.0 112.005 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.12 -0.82 61.47 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.753 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 53.31 54.2 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.099 0.56 . . . . 0.0 111.375 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.57 -171.22 38.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.363 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.01 145.29 98.12 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.913 2.408 . . . . 0.0 112.435 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -95.75 157.09 16.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.233 -177.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 70' ' ' PHE . 5.3 p -63.32 -26.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.957 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.765 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.7 p -64.04 -31.13 72.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.303 -175.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -44.71 82.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.56 74.43 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.614 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.45 -29.3 70.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.405 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.487 HE21 ' HB3' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -57.79 -33.92 69.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HB3' HG22 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -92.69 13.88 18.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.732 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.58 174.86 8.36 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.66 20.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.165 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.34 -22.45 54.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 109.842 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.53 25.45 7.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.67 0.748 . . . . 0.0 109.29 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -128.24 171.61 11.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.148 178.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 56' ' ' ILE . 11.6 p -122.75 141.48 42.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.994 0.426 . . . . 0.0 111.443 -174.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.41 116.37 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.646 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.88 155.34 43.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 3.2 p -101.35 105.41 16.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 11.2 t -134.27 108.54 8.29 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.571 -175.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 1.0 HD21 ' HD3' ' A' ' 34' ' ' LYS . 22.6 t-20 -115.41 92.46 3.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.477 171.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.62 153.58 18.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -44.71 75.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.955 0.407 . . . . 0.0 110.658 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.23 -41.49 94.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.069 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.98 -27.85 66.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.291 -176.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 1.0 ' HD3' HD21 ' A' ' 29' ' ' ASN . 11.3 ttpt -78.42 -15.13 58.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.331 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -116.03 -30.52 6.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.363 -176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 m -124.96 150.1 46.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -72.08 89.21 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.653 0.263 . . . . 0.0 111.134 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.559 ' HA ' HD12 ' A' ' 33' ' ' LEU . 3.8 m 71.0 -74.29 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.385 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.91 -160.71 35.62 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.587 -175.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.57 -12.9 14.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.9 0.381 . . . . 0.0 111.34 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -95.82 61.02 2.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.842 0.353 . . . . 0.0 110.546 -179.147 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.866 HD12 ' H ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -104.77 99.84 20.64 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 -176.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 66.8 Cg_endo -99.37 162.97 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.5 2.8 . . . . 0.0 113.154 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.27 120.37 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' HB3' HD23 ' A' ' 47' ' ' LEU . 1.2 t70 -116.96 -161.41 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.152 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.4 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . 2.6 m -124.42 25.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.814 0.34 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -119.3 152.37 36.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.028 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.56 147.62 23.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.087 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.72 -10.09 48.67 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -174.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HB3' ' H ' ' A' ' 51' ' ' CYS . 2.7 tp10 -138.69 -109.19 0.17 Allowed 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 3.2 m -125.48 137.16 53.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.731 -0.606 . . . . 0.0 111.397 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 46' ' ' VAL . 5.1 tmtt? -132.87 131.7 41.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.203 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.64 111.03 21.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.947 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -87.5 150.08 47.98 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' O ' HD13 ' A' ' 59' ' ' LEU . 35.6 Cg_exo -57.25 118.71 5.62 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.261 1.974 . . . . 0.0 112.858 -173.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.613 HD12 HD22 ' A' ' 59' ' ' LEU . 4.7 tp -80.04 -26.79 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.466 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -61.02 -33.8 73.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.118 -173.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 55' ' ' PRO . 1.5 pt -80.22 -26.3 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.084 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 56' ' ' ILE . 4.7 mp -56.2 -34.36 66.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -20.76 63.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 62' ' ' ASN . 4.0 pt -120.28 -32.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.298 0.57 . . . . 0.0 110.945 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.578 ' N ' HG13 ' A' ' 61' ' ' ILE . 6.8 m-20 -98.64 33.26 2.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.862 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.765 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 5.5 pt20 -68.51 -10.86 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.697 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.74 -5.04 59.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.46 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.562 HG12 HG23 ' A' ' 3' ' ' ILE . 4.5 mt -71.07 126.5 92.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 6.0 Cg_exo -80.17 167.21 19.97 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.015 2.477 . . . . 0.0 112.137 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.655 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -60.42 -12.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.961 -174.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.425 HD22 ' HB2' ' A' ' 66' ' ' PRO . 10.7 p30 -66.89 -18.72 65.52 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.01 -0.431 . . . . 0.0 111.169 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.459 HD21 ' HG2' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.35 7.87 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.564 0.697 . . . . 0.0 109.821 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.655 ' HD2' ' HA ' ' A' ' 67' ' ' ILE . 44.8 m-85 -125.41 176.34 6.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.84 -175.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 134.88 45.11 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.82 96.8 9.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.482 0.658 . . . . 0.0 110.562 -177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 2.3 m-20 -154.18 158.34 40.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.641 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 29.9 m -43.67 108.7 0.12 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.092 0.472 . . . . 0.0 112.19 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -58.82 116.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 92' ' ' PRO . 17.0 m -122.92 132.15 54.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.268 -177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 t -107.16 118.16 35.96 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 3.1 m -117.96 164.54 14.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.39 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.68 134.95 41.67 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.518 ' N ' ' HA ' ' A' ' 23' ' ' LYS . . . -33.83 113.71 0.1 Allowed Glycine 0 C--N 1.336 0.568 0 O-C-N 123.821 0.701 . . . . 0.0 114.345 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.71 104.28 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.24 174.95 10.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.183 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 tp -67.39 137.9 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.888 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.29 -19.23 46.39 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.608 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.0 130.52 36.18 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.768 -0.254 . . . . 0.0 110.752 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.1 t -79.66 -67.07 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.328 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -136.06 159.99 40.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.678 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.05 177.95 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.791 0.329 . . . . 0.0 110.834 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 123.87 46.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.831 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.866 ' H ' HD12 ' A' ' 42' ' ' ILE . 9.2 m -109.54 140.55 43.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.431 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 t -150.8 135.36 9.71 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.044 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 9.4 Cg_endo -53.85 129.3 33.45 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.99 2.46 . . . . 0.0 112.059 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.517 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -74.87 -65.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.335 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD12 HG21 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -105.22 117.04 32.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.013 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.809 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 121.001 0.429 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.72 146.29 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.848 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.971 HG23 HG13 ' A' ' 65' ' ' ILE . 4.1 mt -101.57 110.86 62.91 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.466 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.13 139.56 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.432 2.755 . . . . 0.0 112.243 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.6 71.38 71.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.743 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.98 -73.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 110.567 172.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.65 77.57 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.34 110.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 111.326 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.66 -149.2 5.42 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 139.92 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.441 2.094 . . . . 0.0 112.175 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -84.55 165.42 18.04 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.146 -177.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.62 -26.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.429 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 1.8 p -64.74 -27.47 68.92 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.821 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.3 ttm -63.13 -46.26 88.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.493 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.98 74.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.07 -30.27 71.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.161 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -57.29 -31.28 65.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.549 . . . . 0.0 110.897 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -84.66 12.06 7.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.455 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.95 174.86 10.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 110.326 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.42 161.85 45.18 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.417 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 -26.65 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.921 0.391 . . . . 0.0 110.669 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.19 27.45 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.545 0.688 . . . . 0.0 110.23 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -125.06 160.86 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.728 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.779 ' HB ' ' HA2' ' A' ' 80' ' ' GLY . 13.4 p -114.34 134.74 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.412 0.625 . . . . 0.0 110.284 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 t -99.99 104.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.059 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -111.58 163.31 14.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.717 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 14.0 p -101.27 104.17 15.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -131.8 101.73 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.078 0.466 . . . . 0.0 111.003 -177.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 10.7 t-20 -100.23 119.9 39.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.234 0.54 . . . . 0.0 111.093 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.21 147.91 39.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.277 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HG2' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -71.44 -29.58 65.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 109.988 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 2.1 pm0 -71.1 -29.97 65.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.209 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.539 HD11 HG21 ' A' ' 42' ' ' ILE . 2.3 tp -69.83 -28.02 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.364 0.602 . . . . 0.0 110.068 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -8.95 59.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 177.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -105.19 -18.09 14.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.014 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.11 109.0 11.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.952 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -41.5 95.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.064 0.459 . . . . 0.0 109.78 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.4 p -159.76 168.56 25.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.508 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.49 5.5 55.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.47 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.35 116.51 22.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.717 0.294 . . . . 0.0 110.273 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -76.07 128.44 35.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.165 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -148.13 119.55 4.43 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.232 -177.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.96 154.25 14.86 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.511 2.14 . . . . 0.0 112.004 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mt -73.74 103.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.557 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' CYS . 32.7 t0 -85.1 167.33 15.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.143 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.67 113.17 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.235 0.541 . . . . 0.0 110.355 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HB2' ' H ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -136.72 144.55 43.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.635 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.15 74.98 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.977 0.418 . . . . 0.0 110.474 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.78 49.3 1.18 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.405 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -161.15 -58.11 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.151 0.5 . . . . 0.0 110.293 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.47 ' H ' ' HB2' ' A' ' 47' ' ' LEU . 1.3 m -136.98 139.59 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.965 178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.73 141.44 7.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.066 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 53.6 t30 -96.01 109.79 22.13 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.481 HG12 ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -79.72 149.32 70.87 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.704 -176.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 54' ' ' ILE . 37.0 Cg_endo -64.6 121.54 9.14 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.77 2.314 . . . . 0.0 112.797 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.522 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -80.08 -5.41 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -176.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -67.35 -37.57 83.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.698 0.285 . . . . 0.0 111.232 -175.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -16.78 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.889 175.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -67.2 -14.48 62.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.227 -170.126 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -51.16 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.988 0.423 . . . . 0.0 112.098 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.9 pt -106.89 -23.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.869 0.366 . . . . 0.0 111.805 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -105.69 21.34 17.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.278 -176.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -64.91 -14.19 59.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.355 0.598 . . . . 0.0 110.041 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.486 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -72.35 -5.25 35.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.496 176.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.971 HG13 HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -70.35 134.1 87.05 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 5.7 Cg_exo -74.44 159.28 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.604 2.203 . . . . 0.0 111.159 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.502 ' HA ' HD12 ' A' ' 67' ' ' ILE . 3.2 tp -61.95 -10.51 4.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.62 HD22 ' HB2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -64.07 -22.66 67.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 175.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.53 34.07 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 109.887 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -150.65 177.01 10.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -172.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.62 116.65 32.22 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -76.99 97.29 4.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.7 0.762 . . . . 0.0 109.659 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.717 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 10.1 m-20 -153.85 159.71 41.92 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 29' ' ' ASN . 21.0 m -43.51 115.28 0.76 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.183 0.516 . . . . 0.0 111.26 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.37 123.86 25.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.994 -174.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 28' ' ' CYS . 84.7 p -123.83 127.24 47.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.389 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.67 118.4 36.45 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.271 0.558 . . . . 0.0 109.965 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.686 ' SG ' ' HB ' ' A' ' 88' ' ' ILE . 14.5 t -118.33 165.44 13.85 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.543 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.617 ' HB2' HG22 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -51.56 122.42 8.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.779 ' HA2' ' HB ' ' A' ' 24' ' ' VAL . . . -54.7 104.77 0.28 Allowed Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.294 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.54 119.31 6.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.569 -0.816 . . . . 0.0 112.106 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.507 HE21 ' HB2' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -142.82 151.85 41.58 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.85 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.58 112.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.954 0.407 . . . . 0.0 110.497 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.49 -21.45 4.28 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.545 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.28 96.17 10.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 0.0 110.011 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -37.7 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.937 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.524 HD22 ' HA ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -130.12 148.37 51.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.641 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.686 ' HB ' ' SG ' ' A' ' 78' ' ' CYS . 1.5 pt -131.77 151.27 35.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.882 0.372 . . . . 0.0 111.275 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -106.85 109.14 20.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.513 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 78' ' ' CYS . 1.6 m -112.59 136.02 52.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -138.2 143.61 39.85 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.357 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.437 ' HD2' HG22 ' A' ' 91' ' ' THR . 32.8 Cg_endo -64.57 147.82 90.32 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.735 2.29 . . . . 0.0 112.356 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -115.96 -73.75 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 78.08 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.571 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.598 -176.9 . . . . . . . . 1 1 . 1 stop_ save_